OXOPYRROLIDINE FPR2 AGONISTS

Abstract
The disclosure relates to compounds of Formula (I), which are formyl peptide 2 (FPR2) receptor agonists and/or formyl peptide 1 (FPR1) receptor agonists. The disclosure also provides compositions and methods of using the compounds, for example, for the treatment of atherosclerosis, heart failure, chronic obstructive pulmonary disease (COPD), and related diseases.
Description
BACKGROUND OF THE INVENTION

The present invention relates to novel oxopyrrolidine compounds, which are formyl peptide 2 (FPR2) receptor agonists and/or formyl peptide 1 (FPR1) receptor agonists, compositions containing them, and methods of using them, for example, for the treatment of atherosclerosis, heart failure, chronic obstructive pulmonary disease (COPD), and related diseases.


Formyl peptide receptor 2 (FPR2) belongs to a small group of seven-transmembrane domain, G protein-coupled receptors that are expressed in multiple human tissues including immune cells and are known to be important in host defense and inflammation. FPR2 shares significant sequence homology with FPR1 and FPR3 (Journal of Autoimmunity 85, 2017, 64-77). Collectively, these receptors bind a number of structurally diverse agonists, including N-formyl and nonformyl peptides which act as chemo attractants and activate phagocytes. The endogenous peptide Annexin A1 and its N-terminal fragments are examples of ligands that bind human FPR1 and FPR2. Fatty acids such as eicosanoid, lipoxin A4, which belongs to a class of small pro-resolution mediators (SPMs), has also been identified as an agonist for FPR2 (Ye RD., et al., Pharmacol. Rev., 2009, 61, 119-61).


Endogenous FPR2 pro-resolution ligands, such as lipoxin A4 and Annexin A1, have been reported to trigger a wide array of cytoplasmatic cascades such as Gi coupling, Ca2+ mobilization and β-arrestin recruitment. (Int J Mol Sci. 2013 April; 14(4): 7193-7230). FPR2 regulates both innate and adaptive immune systems including neutrophils, macrophages, T-, and B-cells. In neutrophils, FPR2 ligands modulate movement, cytotoxicity and life span. In macrophages, agonism of FPR2 prevents apoptosis and enhances efferocytosis. (Chandrasekharan JA, Sharma-Walia N,. J. Inflamm. Res., 2015, 8, 181-92). The initiation of resolution of inflammation by FPR2 agonism is responsible for enhancing anti-fibrotic wound healing and returning of the injured tissue to homeostasis (Romano M., et al., Eur. J. Pharmacol., 2015, 5, 49-63).


Chronic inflammation is part of the pathway of pathogenesis of many human diseases and stimulation of resolution pathways with FPR2 agonists may have both protective and reparative effects. Ischaemia-reperfusion (I/R) injury is a common feature of several diseases associated with high morbidity and mortality, such as myocardial infarction and stroke. Non-productive wound healing associated with cardiomyocyte death and pathological remodeling resulting from ischemia-reperfusion injury leads to scar formation, fibrosis, and progressive loss of heart function. FPR2 modulation is proposed to enhance myocardial wound healing post injury and diminish adverse myocardial remodeling (Kain V., et al., J. Mol. Cell. Cardiol., 2015, 84, 24-35). In addition, FPR2 pro-resolution agonists, in the central nervous system, may be useful therapeutics for the treatment of a variety of clinical I/R conditions, including stroke in brain (Gavins FN., Trends Pharmacol. Sci., 2010, 31, 266-76) and I/R induced spinal cord injury (Liu ZQ., et al., Int. J. Clin. Exp. Med., 2015, 8, 12826-33).


In addition to beneficial effects of targeting the FPR2 receptor with novel pro-resolution agonists for treatment of I/R induced injury therapeutic, utility of these ligands can also be applied to other diseases. In the cardiovascular system both the FPR2 receptor and its pro-resolution agonists were found to be responsible for atherogenic-plaque stabilization and healing (Petri MH., et al., Cardiovasc. Res., 2015, 105, 65-74; and Fredman G., et al., Sci. Trans. Med., 2015, 7(275);275ra20). FPR2 agonists also have been shown to be beneficial in preclinical models of chronic inflammatory human diseases, including: infectious diseases, psoriasis, dermatitis, inflammatory bowel syndrome, Crohn’s disease, occular inflammation, sepsis, pain, metabolic/diabetes diseases, cancer, COPD, asthma and allergic diseases, cystic fibrosis, acute lung injury and fibrosis, rheumatoid arthritis and other joint diseases, Alzheimer’s disease, kidney fibrosis, and organ transplantation (Romano M., et al., Eur. J. Pharmacol., 2015, 5, 49-63, Perrett, M., et al., Trends in Pharm. Sci., 2015, 36, 737-755).


SUMMARY OF THE INVENTION

The present invention provides novel oxopyrrolidines, and their analogues thereof, which are useful as FPR2 agonists, including stereoisomers, tautomers, pharmaceutically acceptable salts, or solvates thereof.


The present invention also provides processes and intermediates for making the compounds of the present invention or stereoisomers, tautomers, pharmaceutically acceptable salts, or solvates thereof.


The present invention also provides pharmaceutical compositions comprising a pharmaceutically acceptable carrier and at least one of the compounds of the present invention or stereoisomers, tautomers, pharmaceutically acceptable salts, or solvates thereof.


The compounds of the invention may be used in therapy.


The compounds of the invention may be used in the treatment and/or prophylaxis of multiple diseases or disorders associated with FPR2, such as inflammatory diseases, heart diseases, chronic airway diseases, cancers, septicemia, allergic symptoms, HIV retrovirus infection, circulatory disorders, neuroinflammation, nervous disorders, pains, prion diseases, amyloidosis, and immune disorders. The heart diseases are selected from the group consisting of angina pectoris, unstable angina, myocardial infarction, acute coronary disease, cardiac iatrogenic damage, and heart failure including, but not limited to, acute heart failure, chronic heart failure of ischemic and non-ischemic origin, systolic heart failure, diastolic heart failure, heart failure with reduced ejection fraction (HFREF), and heart failure with preserved ejection fraction (HFPEF).


The compounds of the invention can be used alone, in combination with other compounds of the present invention, or in combination with one or more other agent(s).


Other features and advantages of the invention will be apparent from the following detailed description and claims.







DESCRIPTION OF THE INVENTION

The invention encompasses compounds of Formulae (I)-(VII), which are formyl peptide 2 (FPR2) receptor agonists and/or formyl peptide 1 (FPR1) receptor agonists, compositions containing them, and methods of using them, for example, in the treatment of atherosclerosis, heart failure, chronic obstructive pulmonary disease (COPD), and related diseases.


One aspect of the invention is a compound of Formula (I):




embedded image - (I)


or a pharmaceutically acceptable salt thereof, wherein:

  • * is an asymmetric carbon atom;
  • Ar1 is aryl or pyridyl, each substituted with 1-3 R1;
  • Ar2 is C3-6 cycloalkyl, aryl, or 5- to 12-membered heterocyclyl comprising 1-4 heteroatoms selected from O, S(O)p, N, and NR2a, and each substituted with 0-3 R2;
  • Ar3 is phenyl or pyridyl, each substituted with 1 R5a, 1 R5b, and 1 R5c;
  • R1 is halo, C1-4 haloalkyl, C1-4 alkoxy, or C1-4 haloalkoxy;
  • R2 is oxo, cyano, halo, C1-6 alkyl substituted with 0-5 Re, —ORb, —NR3R4, —NR4C(O)Rb, —NR4(CRdRd)0-1C(O)NR3R4, (C1-4 alkyl)2(O)P-, C3-6 cycloalkyl, aryl, 5 to 6-membered heterocyclyl comprising 1-4 heteroatoms selected from O, S(O)p, N, and NRa;
  • R2a is hydrogen, C1-4 alkyl substituted with 0-5 Re, —(CRdRd)1-4—NR3R4, —(CRdRd)1-4—ORb, —(CRdRd)1-4—C(O)NR3R4, —(CRdRd)r—C3-6 cycloalkyl substituted with 0-5 Re, —(CRdRd)r-aryl substituted with 0-5 Re, or —(CRdRd)r-heterocyclyl comprising 1-4 heteroatoms selected from O, S(O)p, N, and NRa and substituted with 0-5 Re;
  • R3 is hydrogen, C1-4 alkyl substituted with 0-5 Re, C3-6 cycloalkyl substituted with 0-5 Re, or heterocyclyl comprising 1-4 heteroatoms selected from O, S(O)p, N, and NR8 and substituted with 0-5 Re;
  • R4 is hydrogen or C1-4 alkyl;
  • alternatively, R3 and R4 together with the nitrogen to which they are both attached form a 4- to 9-membered heterocyclyl comprising 1-4 heteroatoms selected from O, S(O)p, N, and NR8 and substituted with 1-3 R6;
  • R5a is hydrogen or halo;
  • R5b is hydrogen or halo;
  • R5c is halo, C1-4 alkyl, C1-4 haloalkyl, C1-4 alkoxy, or deuteroalkoxy;
  • R6 is hydrogen, halo, oxo, hydroxy, or C1-4 alkyl substituted with 0-5 Re;
  • R7 is hydrogen or C1-4 alkyl;
  • R8 is hydrogen, C1-4 alkyl, or -S(O)pRc;
  • Rais hydrogen or C1-6 alkyl substituted with 0-5 Re, C3-6 cycloalkyl substituted with 0-5 Re, aryl substituted with 0-5 Re, or heterocyclyl comprising 1-4 heteroatoms selected from O, S(O)p, NRd and substituted with 0-5 Re;
  • Rb is hydrogen, C1-6 alkyl substituted with 0-5 Re, C3-6 cycloalkyl substituted with 0-5 Re, aryl substituted with 0-5 Re, or heterocyclyl comprising 1-4 heteroatoms selected from O, S(O)p, NRd and substituted with 0-5 Re;
  • Rc is C1-4 alkyl substituted with 0-5 Re;
  • Rd is hydrogen or C1-4 alkyl substituted with 0-5 Re;
  • Re is halo, cyano, oxo, —ORg, —NRgRg, —C(O)NRgRg, —S(O)pC1-4 alkyl, C1-6 alkyl substituted with 0-5 Rf, —(CH2)r—C36 cycloalkyl substituted with 0-5 Rf, —(CH2)r-aryl substituted with 0-5 Rf, or —(CH2)r-heterocyclyl comprising 1-4 heteroatoms selected from O, S(O)p, N, and NRg and substituted with 0-5 Rf;
  • Rfis halo, cyano, hydroxy, oxo, C1-5 alkyl, C3-6 cycloalkyl, or phenyl;
  • Rgis hydrogen, C1-5 alkyl, C3-6 cycloalkyl, aryl, or heterocyclyl; or Rg and Rg together with the nitrogen atom to which they are both attached form a heterocyclyl;
  • n is zero or 1;
  • p is zero, 1, or 2; and
  • r is zero, 1, 2, 3, or 4.


Another aspect of the invention is a compound of Formula (II):




embedded image - (II)


or a pharmaceutically acceptable salt thereof, wherein:

  • Ar2 is C3-6 cycloalkyl, phenyl, 5- to 6-membered heterocyclyl comprising 1-2 N or NR2a, each substituted with 0-2 R2;
  • Ar3 is phenyl substituted with 1 R5a, 1 R5b, and 1 R5c;
  • R1 is halo, C1-4 haloalkyl, or C1-4 haloalkoxy;
  • R2 is oxo, cyano, halo, C1-5 alkyl substituted with 0-5 Re, —ORb, —NR3R4, —NR4C(O)Rb, (C1-3 alkyl)2(O)P-, C3-6 cycloalkyl, aryl, 5- to 6-membered heterocyclyl comprising 1-4 heteroatoms selected from O, S, N, and NRa;
  • R2a is hydrogen, C1-4 alkyl substituted with 0-4 Re, —(CHRd)1-3—C(O)NR3R4, —(CHRd)r—C3-6 cycloalkyl substituted with 0-4 Re, —(CHRd)r-aryl substituted with 0-4 Re, or —(CHRd)r-heterocyclyl comprising 1-4 heteroatoms selected from O, S, N, and NRa and substituted with 0-4 Re;
  • R3 is hydrogen, C1-4 alkyl substituted with 0-4 Re, C3-6 cycloalkyl, or heterocyclyl comprising 1-4 heteroatoms selected from O, S, N, and NR8 and substituted with 0-4 Re;
  • R4 is hydrogen or C1-3 alkyl;
  • alternatively, R3 and R4 together with the nitrogen to which they are both attached form a 4- to 8-membered heterocyclyl comprising 1-4 heteroatoms selected from O, S, N, and NR8 and substituted with 1-3 R6;
  • R5a is hydrogen or halo;
  • R5b is hydrogen or halo;
  • R5c is halo, C1-4 alkyl, C1-4 haloalkyl, or C1-4 alkoxy;
  • R6 is hydrogen, halo, oxo, hydroxy, or C1-4 alkyl substituted with 0-4 Re;
  • R7 is hydrogen or C1-3 alkyl;
  • R8 is hydrogen, C1-3 alkyl, or -S(O)pRc;
  • Rais hydrogen or C1-6 alkyl substituted with 0-5 Re;
  • Rb is hydrogen, C1-6 alkyl substituted with 0-5 Re, or heterocyclyl comprising 1-4 heteroatoms selected from O, S, N, NRd and substituted with 0-5 Re;
  • Rc is C1-3 alkyl substituted with 0-5 Re;
  • Rd is hydrogen or C1-4 alkyl substituted with 0-1 -OC1-4 alkyl;
  • Re is halo, cyano, oxo, -ORg, -NRgRg, -C(O)NRgRg, —S(O)pC1-4 alkyl, C1-4 alkyl substituted with 0-5 Rf, -(CH2)r-C3-6 cycloalkyl substituted with 0-5 Rf, -(CH2)r-aryl substituted with 0-5 Rf, or -(CH2)r-heterocyclyl comprising 1-4 heteroatoms selected from O, S, N, and NRg and substituted with 0-5 Rf;
  • Rf is halo, cyano, hydroxy, C1-5 alkyl, or C3-6 cycloalkyl;
  • Rg is hydrogen, C1-5 alkyl, or heterocyclyl;
  • n is zero; and
  • r is zero, 1, 2, or 3.


Another aspect of the invention is a compound of Formula (III):




embedded image - (III)


or a pharmaceutically acceptable salt thereof, wherein:

  • Ar2 is
  • embedded image
  • embedded image
  • embedded image
  • embedded image
  • embedded image
  • embedded image
  • embedded image
  • embedded image
  • R1 is halo, C1-3 haloalkyl, or C1-3 haloalkoxy;
  • R2 is cyano, halo, C1-4 alkyl substituted with 0-5 Re, -ORb, -NR3R4, -NR4C(O)Rb, (C1-4 alkyl)2(O)P-, C3-6 cycloalkyl, aryl, or 5- to 6-membered heterocyclyl comprising 1-4 heteroatoms selected from O, S, N, and NRa;
  • R2a is hydrogen, C1-4 alkyl substituted with 0-3 Re, —(CHRd)1-2—C(O)NR3R4, —(CH2)r—C3-6 cycloalkyl substituted with 0-3 Re, —(CH2)r-aryl substituted with 0-3 Re, or —(CH2)r-heterocyclyl comprising 1-4 heteroatoms selected from O, S, N, and NRa and substituted with 0-3 Re;
  • R3 is hydrogen, C1-4 alkyl substituted with 0-3 Re, C3-6 cycloalkyl, or heterocyclyl comprising 1-4 heteroatoms selected from O, S, N, and NR8 and substituted with 0-3 Re;
  • R4 is hydrogen or C1-2 alkyl;
  • alternatively, R3 and R4 together with the nitrogen to which they are both attached form a 4- to 8-membered heterocyclyl comprising 1-3 heteroatoms selected from O, S, N, and NR8 and substituted with 1-3 R6;
  • R5a is hydrogen or halo;
  • R5b is hydrogen or halo;
  • R5c is halo or C1-2 alkoxy;
  • R6 is hydrogen, halo, oxo, hydroxy, or C1-4 alkyl substituted with 0-3 Re;
  • R7 is hydrogen or CH3;
  • R8 is hydrogen, C1-2 alkyl, or S(O)2C1-4 alkyl;
  • Rais hydrogen or C1-5 alkyl substituted with 0-4 Re;
  • Rb is hydrogen, C1-5 alkyl substituted with 0-4 Re, heterocyclyl comprising 1-4 heteroatoms selected from O, S, N, NRd and substituted with 0-4 Re;
  • Rd is hydrogen or C1-2 alkyl substituted with 0-1 —OC1-4 alkyl;
  • Re is halo, cyano, oxo, —ORg, —NRgRg, C(O)NRgRg, —S(O)pC1-4 alkyl, C1-4 alkyl substituted with 0-4 Rf, —(CH2)r—C36 cycloalkyl substituted with 0-4 Rf, —(CH2)r-aryl substituted with 0-4 Rf, or —(CH2)r-heterocyclyl comprising 1-4 heteroatoms selected from O, S, N, and NRg and substituted with 0-4 Rf;
  • Rf is halo, cyano, hydroxy, or C1-5 alkyl;
  • Rg is hydrogen or C1-4 alkyl;
  • n is zero; and
  • r is zero, 1, or 2.


Another aspect of the invention is a compound of Formula (IVa):




embedded image - (IVa)


or a pharmaceutically acceptable salt thereof, wherein:

  • Ar2 is
  • embedded image
  • embedded image
  • embedded image
  • embedded image
  • R1 is Cl, —CF3, —OCHF2, or —OCF3;
  • R2 is cyano, halo, C1-4 alkyl substituted with 0-4 Re, —ORb, —NR3R4, —NR4C(O)Rb, (C1-2 alkyl)2(O)P, -C3-6 cycloalkyl, or heterocyclyl comprising 1-4 heteroatoms selected from O, S, N, and NRa;
  • R2a is hydrogen, C1-4 alkyl substituted with 0-4 Re, —(CHRd)1-2—C(O)NR3R4, —(CH2)r—C3-6 cycloalkyl substituted with 0-2 Re, —CH2)r-aryl substituted with 0-2 Re, or —(CH2)r-heterocyclyl comprising 1-4 heteroatoms selected from O, S, N, and NRa and substituted with 0-2 Re;
  • R3 is hydrogen, C1-4 alkyl substituted with 0-3 Re, or heterocyclyl comprising 1-4 heteroatoms selected from O, S, N, and NR8 and substituted with 0-3 Re;
  • R4 is hydrogen or C1-2 alkyl;
  • alternatively, R3 and R4 together with the nitrogen to which they are both attached form a 4- to 8-membered heterocyclyl comprising 1-3 heteroatoms selected from O, S, N, and NR8 and substituted with 1-3 R6;
  • R5a is hydrogen, F, or Cl;
  • R5b is hydrogen, F, or Cl;
  • R5c is Cl or —OCH3;
  • R6 is hydrogen, halo, oxo, hydroxy, or C1-3 alkyl substituted with 0-3 Re;
  • R7 is hydrogen or C1-2 alkyl;
  • R8 is hydrogen, C1-2 alkyl, or S(O)2C1-3 alkyl;
  • Rais hydrogen, C1-4 alkyl substituted with 0-3 Re;
  • Rb is hydrogen, C1-4 alkyl substituted with 0-3 Re, heterocyclyl comprising 1-4 heteroatoms selected from O, S, N, and NRd and substituted with 0-3 Re;
  • Rd is hydrogen or C1-2 alkyl substituted with 0-1 —OC1-4 alkyl;
  • Re is halo, cyano, oxo, —ORg, —NRgRg, —C(O)NRgRg, —S(O)2C1-4 alkyl, C1-6 alkyl substituted with 0-3 Rf, —(CH2)r—C36 cycloalkyl substituted with 0-3 Rf, or —(CH2)r-heterocyclyl comprising 1-4 heteroatoms selected from O, S, N, and NRg and substituted with 0-3 Rf;
  • Rf is halo, cyano, hydroxy, or C1-4 alkyl;
  • Rg is hydrogen or C1-3 alkyl; and
  • r is zero or 1.


Another aspect of the invention is a compound of Formula (IVa), or a pharmaceutically acceptable salt thereof, wherein:

  • Ar2 is
  • embedded image
  • embedded image
  • R2 is F, Cl, —CH2OH, —CH3, —CF3, or —CHF2; and
  • R2a is —CH3, —CH2CH3, —CH2CHF2, —CH2CF3, —CH2CH2OCH3, —CH2CH(OH)CF3, —CH2CH(OH)CH3, —CH2CH2OH, —CH2CH(CH3)OH, —CH2CH(CF3)OH, —CH2CH2CF3, —CH(CH2OH)CH2OCH3, —CH(CH2NH2)OCH3, —CH2CH(CH3)OCH3, or —CH2CH(CF3)OCH3;
  • other variables are as defined in Formula (IVa).


Another aspect of the invention is a compound of Formula (IVb):




embedded image - (IVb)


or a pharmaceutically acceptable salt thereof, wherein:

  • R1 is Cl, —CF3, —OCHF2, or —OCF3;
  • R2 is cyano, F, Cl, CH3, CF3, CHF2, or —NHC(O)CH3;
  • R2a is —CH3, —CH2CH3, —CH2CN, —CH2CHF2, —CH2CH2OCH3, —CH2CH(OH)CF3, —CH2CH(OH)CH3, —CH2CH2OH, —CF2CH2OH, —CH2CH(CH3)OH, —CH2CH2CF3, —CH(CH2OH)CH2OCH3, —CH(CH2NH2)OCH3, —CH2CH(CH3)OCH3, —CH2CH(CF3)OCH3, —CH(CH2NH2)CH2OCH3, —CH(C(O)N(CH3)2)CH2OCH3, —CH2C(CH3)(CH2OH)2, —CH2CH2N(CH3)2, —CH2CH2S(O)2C1-4 alkyl, —CHRdC(O)NR3R4, —(CH2)0-1-C3-6 cycloalkyl, —(CH2)0-3-heterocyclyl selected from
  • embedded image
  • embedded image
  • embedded image
  • R3 and R4 together with the nitrogen to which they are both attached form a heterocyclyl selected from
  • embedded image
  • embedded image
  • R5a is hydrogen or F;
  • R5b is hydrogen or F;
  • R5c is Cl or —OCH3;
  • R6 is hydrogen, oxo, halo, or —CH3, —CHF3, —CF3, or —CH2OH;
  • R7 is hydrogen or C1-2 alkyl;
  • R8 is hydrogen, C1-2 alkyl, or —S(O)2C13 alkyl; and
  • Rd is —CH2OCH3.


Another aspect of the invention is a compound of Formula (IVc):




embedded image - (IVc)


or a pharmaceutically acceptable salt thereof, wherein:

  • R1 is Cl, —CF3, —OCHF2, or —OCF3;
  • R2 is cyano, F, Cl, CH2OH, CH3, CHF2, CF3, —OCH3, —OCH(CH3)2, —NR3R4, (CH3)2(O)P—, C3-6 cycloalkyl
  • embedded image
  • embedded image
  • embedded image
  • R3 is hydrogen or C1-4 alkyl substituted with 0-2 Re,
  • embedded image
  • embedded image
  • R4 is hydrogen;
  • alternatively, R3 and R4 together with the nitrogen to which they are both attached form a heterocyclyl selected from
  • embedded image
  • embedded image
  • embedded image
  • embedded image
  • embedded image
  • embedded image
  • embedded image
  • embedded image
  • embedded image
  • embedded image
  • R5a is hydrogen or F;
  • R5b is hydrogen or F;
  • R5c is Cl or OCH3
  • R6 is hydrogen, halo, oxo, CH3, —CH2CH3, or —CH2OH;
  • R7 is hydrogen or C1-4 alkyl; and
  • R8 is hydrogen, C1-4 alkyl, or —S(O)2C13 alkyl.


Another aspect of the invention is a compound of Formula (IVd):




embedded image - (IVd)


or a pharmaceutically acceptable salt thereof, wherein:

  • R1 is Cl, —CF3, —OCHF2, or —OCF3;
  • R2 is —ORb or (C1-2alkyl)2(O)P-;
  • R5a is hydrogen or F;
  • R5b is hydrogen or F;
  • R5c is Cl or —OCH3;
  • R7 is hydrogen or —CH3;
  • Rb is hydrogen, C1-4 alkyl substituted with 0-3 Re, or
  • embedded image
  • Re is F, Cl, or —ORg; and
  • Rg is hydrogen or C1-3 alkyl.


Another aspect of the invention is a compound of Formula (IVe):




embedded image - (IVe)


or a pharmaceutically acceptable salt thereof, wherein:

  • R1 is Cl, —CF3, —OCHF2, or —OCF3;
  • R2 is cyano, F, Cl, —CH2OH, —CH3, —CHF2, —CF3, —OCH3, —OCH(CH3)2, or —NR3R4;
  • R3 is hydrogen or C1-4 alkyl;
  • R4 is hydrogen or C1-2 alkyl;
  • alternatively, R3 and R4 together with the nitrogen to which they are both attached form a heterocyclyl selected from
  • embedded image
  • embedded image
  • embedded image
  • embedded image
  • embedded image
  • embedded image
  • embedded image
  • embedded image
  • embedded image
  • embedded image
  • R5a is hydrogen or F;
  • R5b is hydrogen or F;
  • R5c is Cl or —OCH3;
  • R6 is hydrogen, halo, oxo, CH3, —CH2CH3, or —CH2OH;
  • R7 is hydrogen or C1-4 alkyl; and
  • R8 is hydrogen or C1-2 alkyl.


Another aspect of the invention is a compound of Formula (IVf):




embedded image - (IVf)


or a pharmaceutically acceptable salt thereof, wherein:

  • R1 is Cl, —CF3, —OCH3, —OCHF2, or —OCF3;
  • R2 is cyano, F, Cl, —CH2OH, —CH3, —CHF2, or —CF3;
  • R2a is —CH3, —CH2CH3, —CH2CHF2, —CH2CH2OCH3, —CH2CH(OH)CF3, —CH2CH(OH)CH3, —CH2CH2OH, —CH2CH(CH3)OH, or —CH2CH2CF3;
  • R5a is hydrogen, F, or Cl;
  • R5b is hydrogen, F, or Cl;
  • R5c is Cl or —OCH3; and
  • R7 is hydrogen or —CH3.


Another aspect of the invention is a compound of Formula (V):




embedded image - (V)


or a pharmaceutically acceptable salt thereof, wherein:

  • Ar2 is C3-5 cycloalkyl;
  • R1 is Cl, —CF3, —OCHF2, or —OCF3;
  • R5a is F or Cl;
  • R5b is F or Cl; and
  • R5c is —OCH3.


Another aspect of the invention is a compound of Formula (Va):




embedded image - (Va)


or a pharmaceutically acceptable salt thereof, wherein:

  • R1 is CF3, OCHF2, or OCF3;
  • R5a is F or Cl;
  • R5b is F or Cl; and
  • R5c is OCH3.


Another aspect of the invention is a compound of Formula (VI):




embedded image - (VI)


or a pharmaceutically acceptable salt thereof, wherein:

  • R1 is —CF3, —OCHF2, or —OCF3; R2 is F, Cl, —CH2OH, —CF3, —CHF2, —OCH3, —OCH(CH3)2, or (CH3)2(O)P—;
  • R5a is F or Cl;
  • R5b is F or Cl; and
  • R5c is —OCH3.


Another aspect of the invention is a compound of Formula (VII):




embedded image - (VII)


or a pharmaceutically acceptable salt thereof, wherein:

  • R1 is —CF3, —OCHF2, or —OCF3;
  • R2 is F, Cl, or (CH3)2(O)P—;
  • R5a is F;
  • R5b is F; and
  • R5c is —OCH3.


For a compound of Formula (I), (II), (III), (IVa), (IVb), (IVc), (IVd), (IVe), (IVf), (V), (Va), (VI), or (VII), i.e., Formulae (I-VII), the scope of any instance of a variable substituent, including Ar1, Ar2, Ar3, R1, R2, R2a, R3, R4, R5a, R5b, R5c, R6, R7, R8, Ra, Rb, Rc, Rd, Re, Rf, and Rg can be used independently with the scope of any other instance of a variable substituent. As such, the invention includes combinations of the different aspects.


In one non-limiting embodiment, for a compound of Formula (I), (II), or (III), Ar1 is phenyl substituted with 1 R1; R1 is CF3, OCHF2, or OCF3; n is zero or 1; Ar2 is phenyl, pyridinyl, or C3-6 cycloalkyl, each substituted with 0-2 R2; R2 is F, Cl, CH2OH, CF3, OCH3, OCH(CH3)2, CHF2, CF3, or (CH3)2(O)P; Ar3 is phenyl substituted with R5a, R5b, and R5c; R5a, R5b, and R5c are halo and alkoxy, respectively.


In one non-limiting embodiment, for a compound of Formula (I), (II), or (III), Ar1 is phenyl substituted with 1 R1; R1 is CF3; n is zero; Ar2 is phenyl, pyridinyl, or C3-6 cycloalkyl, each substituted with 0-2 R2; R2 is F, Cl, CH2OH, CF3, OCH3, OCH(CH3)2, CHF2, CF3, or (CH3)2(O)P; Ar3 is phenyl substituted with R5a, R5b, and R5c; R5a, R5b, and R5c are halo and alkoxy, respectively.


In one non-limiting embodiment, for a compound of Formula (I), (II), or (III), Ar1 is phenyl substituted with 1 R1; R1 is OCHF2; n is zero; Ar2 is phenyl, pyridinyl, or C3-6 cycloalkyl, each substituted with 0-2 R2; R2 is F, Cl, CH2OH, CF3, OCH3, OCH(CH3)2, CHF2, CF3, or (CH3)2(O)P; Ar3 is phenyl substituted with R5a, R5b, and R5c; R5a, R5b, and R5c are halo and alkoxy, respectively.


In one non-limiting embodiment, for a compound of Formula (I), (II), or (III), Ar1 is phenyl substituted with 1 R1; R1 is OCF3; n is zero; Ar2 is phenyl, pyridinyl, or C3-6 cycloalkyl, each substituted with 0-2 R2; R2 is F, Cl, CH2OH, CF3, OCH3, OCH(CH3)2, CHF2, CF3, or (CH3)2(O)P; Ar3 is phenyl substituted with R5a, R5b, and R5c; R5a, R5b, and R5c are halo and alkoxy, respectively.


In one non-limiting embodiment, for a compound of Formula (I), (II), or (III), Ar1 is phenyl substituted with 1 R1; R1 is CF3, OCHF2, or OCF3; n is 1; Ar2 is phenyl substituted with 0-2 R2; R2 is halo or alkoxy; Ar3 is phenyl substituted with R5a, R5b, and R5c; R5a, R5b, and R5c are halo and alkoxy, respectively.


In one non-limiting embodiment, for a compound of Formula (I), (II), or (III), Ar1 is phenyl substituted with 1 R1; R1 is CF3, OCHF2, or OCF3; n is 1; Ar2 is cyclopropyl; Ar3 is phenyl substituted with R5a, R5b, and R5c; R5a, R5b, and R5c are halo and alkoxy, respectively.


In one non-limiting embodiment, for a compound of Formula (I), (II), (III), or (IVa), Ar1 is phenyl substituted with 1 R1; R1 is Cl, CF3, OCHF2, or OCF3; n is zero; Ar2 is




embedded image


R2a is —CH3, —CH2CH3, —CH2CHF2, —CH2CF3, —CH2CH2OCH3, —CH2CH(OH)CF3, —CH2CH(OH)CH3, —CH2CH2OH, —CH2CH(CF3)OH, or —CH2CH2CF3; Ar3 is phenyl substituted with R5a, R5b, and R5c; R5a, R5b, and R5c are halo and alkoxy, respectively.


In one non-limiting embodiment, for a compound of Formula (I), (II), (III), or (IVa), Ar1 is phenyl substituted with 1 R1 ; R1 is Cl, CF3, OCHF2, or OCF3; n is zero; Ar2 is




embedded image


R2a is —CH3, —CH2CH3, —CH2CHF2, —CH2CF3, —CH2CH2OCH3, —CH2CH(OH)CF3, —CH2CH(OH)CH3, —CH2CH2OH, —CH2CH(CH3)OH, —CH2CH(CF3)OH, —CH2CH2CF3, —CH(CH2OH)CH2OCH3, —CH(CH2NH2)OCH3, —CH2CH(CH3)OCH3, or —CH2CH(CF3)OCH3; Ar3 is phenyl substituted with R5a, R5b, and R5c; R5a, R5b, and R5c are halo and alkoxy, respectively.


In one non-limiting embodiment, for a compound of Formula (I), (II), (III), or (IVa), Ar1 is phenyl substituted with 1 R1 ; R1 is Cl, CF3, OCHF2, or OCF3; n is zero; Ar2 is




embedded image


R2 is cyano, F, Cl, CH3 or —NHC(O) CH3; R2a is —CH3, —CH2CH3, —CH2CN, —CH2CHF2, —CH2CH2OCH3, —CH2CH(OH)CF3, —CH2CH(OH)CH3, —CH2CH2OH, —CF2CH2OH, —CH2CH(CH3)OH, —CH2CH2CF3, —CH(CH2OH)CH2OCH3, —CH(CH2NH2)OCH3, —CH2CH(CH3)OCH3, —CH2CH(CF3)OCH3, —CH(CH2NH2)CH2OCH3, —CH(C(O)N(CH3)2)CH2OCH3, —CH2C(CH3)(CH2OH)2, —CH2CH2N(CH3)2, —CH2CH2S(O)2C1-4 alkyl, —(CH2)0-1—C3-6 cycloalkyl, —(CH2)0-3-heterocyclyl selected from




embedded image




embedded image




embedded image


Ar3 is phenyl substituted with R5a, R5b, and R5c; R5a, R5b, and R5c are halo and alkoxy, respectively.


In one non-limiting embodiment, for a compound of Formula (I), (II), (III), or (IVa), Ar1 is phenyl substituted with 1 R1 ; R1 is Cl, CF3, OCHF2, or OCF3; n is zero; Ar2 is




embedded image


R2 is cyano, F, Cl, CH3 or —NHC(O)CH3; R2a is —CH3, —CH2CH3, —CH2CN, —CH2CHF2, —CH2CH2OCH3, —CH2CH(OH)CF3, —CH2CH(OH)CH3, —CH2CH2OH, —CF2CH2OH, —CH2CH(CH3)OH, —CH2CH2CF3, —CH(CH2OH)CH2OCH3, —CH(CH2NH2)OCH3, —CH2CH(CH3)OCH3, —CH2CH(CF3)OCH3, —CH(CH2NH2)CH2OCH3, —CH(C(O)N(CH3)2)CH2OCH3, —CH2C(CH3)(CH2OH)2, —CH2CH2N(CH3)2, —CH2CH2S(O)2C1-4 alkyl, —(CH2)0-1—C3-6 cycloalkyl, —(CH2)0-3—heterocyclyl selected from




embedded image




embedded image




embedded image


Ar3 is phenyl substituted with R5a, R5b, and R5c; R5a, R5b, and R5c are halo and alkoxy, respectively.


In one non-limiting embodiment, for a compound of Formula (I), (II), (III), or (IVa), Ar1 is phenyl substituted with 1 R1 ; R1 is Cl, CF3, OCHF2, or OCF3; n is zero; Ar2 is




embedded image


R2 is cyano, F, Cl, CH2OH, CH3, CF3, CHF2, CF3, —OCH3, —OCH(CH3)2, -NR3R4, (CH3)2(O)P-, C3-6 cycloalkyl,




embedded image




embedded image




embedded image




embedded image


is —CH3, —CH2CH3, —CH2CN, —CH2CHF2, —CH2CH2OCH3, —CH2CH(OH)CF3, —CH2CH(OH)CH3, or —CH2CH2OH; R3 is hydrogen or C1-4 alkyl substituted with 0-2 Re,




embedded image




embedded image


R4 is hydrogen or C1-2 alkyl; alternatively, R3 and R4 together with the nitrogen to which they are both attached form a heterocyclyl selected from




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image


Ar3 is phenyl substituted with R5a, R5b, and R5c; R5a, R5b, and R5c are halo and alkoxy, respectively.


In one non-limiting embodiment, for a compound of Formula (I), Ar1 is phenyl substituted with 1 R1; R1 is Cl, CF3, OCHF2, or OCF3; n is zero; Ar2 is




embedded image




embedded image


R2 is alkyl, haloalkyl, hydroxyalkyl, or cycloalkyl; Ar3 is phenyl substituted with R5a, R5b, and R5c; R5a, R5b, and R5c are halo and alkoxy, respectively.


In one non-limiting embodiment, for a compound of Formula (I), (II), (III), or (IVa), Ar1 is phenyl substituted with 1 R1; R1 is Cl, CF3, OCHF2, or OCF3; n is zero; Ar2 is




embedded image


R2 is cyano, F, Cl, CH2OH, CF3, CHF2, CF3, —OCH3, —OCH(CH3)2, -NR3R4, (CH3)2(O)P—, C3-6 cycloalkyl,




embedded image




embedded image




embedded image




embedded image




embedded image


R3 is hydrogen or C1-4 alkyl substituted with 0-2 Re,




embedded image




embedded image


R4 is hydrogen or C1-2 alkyl; alternatively, R3 and R4 together with the nitrogen to which they are both attached form a heterocyclyl selected from




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image




embedded image


Ar3 is phenyl substituted with R5a, R5b, and R5c; R5a, R5b, and R5c are halo and alkoxy, respectively.


In one non-limiting embodiment, for a compound of Formula (I), (II), (III), or (IVa), Ar1 is phenyl substituted with 1 R1 ; R1 is Cl, CF3, OCHF2, or OCF3; n is zero; Ar2 is




embedded image




embedded image




embedded image




embedded image


R2 is alkoxy; R2a is alkyl or haloalkyl; Ar3 is phenyl substituted with R5a, R5b, and R5c; R5a, R5b, and R5c are halo and alkoxy, respectively.


In one non-limiting embodiment, for a compound of Formula (I), Ar1 is phenyl substituted with 1 R1; R1 is Cl, CF3, OCHF2, or OCF3; n is zero; Ar2 is




embedded image


R2 is cyano, F, Cl, CH3 or —NHC(O) CH3; R2a is —CH3, —CH2CH3, —CH2CN, —CH2CHF2, —CH2CH2OCH3, —CH2CH(OH)CF3, —CH2CH(OH)CH3, —CH2CH2OH, —CF2CH2OH, —CH2CH(CH3)OH, —CH2CH2CF3, —CH(CH2OH)CH2OCH3, —CH(CH2NH2)OCH3, —CH2CH(CH3)OCH3, —CH2CH(CF3)OCH3, —CH(CH2NH2)CH2OCH3, —CH(C(O)N(CH3)2)CH2OCH3, —CH2C(CH3)(CH2OH)2, —CH2CH2N(CH3)2, —CH2CH2S(O)2C1-4 alkyl, —(CH2)0-1—C3-6 cycloalkyl, —(CH2)0-3—heterocyclyl selected from




embedded image




embedded image




embedded image


Ar3 is phenyl substituted with R5a, R5b, and R5c; R5a, R5b, and R5c are halo and alkoxy, respectively.


In another embodiment, the compounds of the present invention have FPR2 EC50 values ≤ 1 µM.


In another embodiment, the compounds of the present invention have FPR2 EC50 values ≤ 0.5 µM.


In another embodiment, the compounds of the present invention have FPR2 EC50 values ≤ 0.1 µM.


In another embodiment, the compounds of the present invention have FPR2 EC50 values ≤ 0.05 µM.


In another embodiment, the compounds of the present invention have FPR2 EC50 values ≤ 0.01 µM.


In another embodiment, the compounds of the present invention have FPR2 EC50 values ≤ 0.001 µM.


Unless specified otherwise, these terms have the following meanings.


A dash “-” that is not between two letters or symbols is used to indicate a point of attachment for a substituent. For example, —CONH2 is attached through the carbon atom.


A bond pointing to a wave line, such as




embedded image


as used in structural formulas herein, depicts the bond that is the point of attachment of the moiety or substituent to the core or backbone structure.


“Cyano” means —CN.


“Hydroxy” means —OH.


“Alkyl” means a straight or branched hydrocarbon group composed of 1 to 6 carbons. “Alkenyl” means a straight or branched alkyl group composed of 2 to 6 carbons with at least one double bond. “Alkynyl” means a straight or branched alkyl group composed of 2 to 6 carbons with at least one triple bond. Terms with a hydrocarbon moiety (e.g. alkoxy) include straight and branched isomers for the hydrocarbon portion.


“Halo” includes fluoro, chloro, bromo, and iodo. “Haloalkyl” and “haloalkoxy” include all halogenated isomers from monohalo to perhalo.


“Haloalkoxy” and derivatives such as “C1-6 haloalkoxy” are used interchangeably and mean halo substituted alkyl groups linked through the oxygen atom. Haloalkoxy include mono-substituted as well as multiple halo substituted alkoxy groups, up to perhalo substituted alkoxy. For example trifluoromethoxy and difluoromethoxy are included.


“Alkoxy” means an alkyl group attached via an oxygen linkage to the rest of the molecule. Representative examples of such groups are —OCH3 and —OC2H5. Unless set forth or recited to the contrary, all alkoxy groups described or claimed herein may be straight chain or branched.


“Alkoxyalkyl” means an alkoxy group as defined above directly bonded to an alkyl group as defined above, e.g., —CH2—O—CH3, —CH2CH2—O—CH3 and the like.


“Cycloalkyl” means a non-aromatic mono or multicyclic ring system having 3 to 12 carbon atoms, such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl and the like.


“Aryl” means a monocyclic or bicyclic aromatic hydrocarbon groups having 6 to 12 carbon atoms, or a bicyclic fused ring system wherein one or both of the rings is aromatic. Bicyclic fused ring systems consist of a phenyl group fused to a four- to seven-membered aromatic or non-aromatic carbocyclic ring. Representative examples of aryl groups include but are not limited to phenyl, indanyl, indenyl, naphthyl, and tetrahydronaphthyl.


“Heterocycle,” “heterocyclyl,” or “heterocyclic ring” means a stable 3-, 4-, 5-, 6-, or 7-membered monocyclic or bicyclic or 7-, 8-, 9-, 10-, 11-, 12-, 13-, or 14-membered polycyclic heterocyclic ring that is saturated, partially unsaturated, or fully unsaturated, and that contains carbon atoms and 1, 2, 3 or 4 heteroatoms independently selected from the group consisting of N, O and S; and including any polycyclic group in which any of the above-defined heterocyclic rings is fused to a benzene ring. The nitrogen and sulfur heteroatoms may optionally be oxidized (i.e., N→O and S(O)p, wherein p is 0, 1 or 2). The nitrogen atom may be substituted or unsubstituted (i.e., N or NR wherein R is H or another substituent, if defined). The heterocyclic ring may be attached to its pendant group at any heteroatom or carbon atom that results in a stable structure. The heterocyclic rings described herein may be substituted on carbon or on a nitrogen atom if the resulting compound is stable. A nitrogen in the heterocyclyl may optionally be quaternized. It is preferred that when the total number of S and O atoms in the heterocyclyl exceeds 1, then these heteroatoms are not adjacent to one another. It is preferred that the total number of S and O atoms in the heterocyclyl is not more than 1. When the term “heterocyclyl” is used, it is intended to include heteroaryl.


Bridged rings are also included in the definition of heterocyclyl. A bridged ring occurs when one or more atoms (i.e., C, O, N, or S) link two non-adjacent carbon or nitrogen atoms. Examples of bridged rings include, but are not limited to, one carbon atom, two carbon atoms, one nitrogen atom, two nitrogen atoms, and a carbon-nitrogen group. It is noted that a bridge always converts a monocyclic ring into a tricyclic ring. When a ring is bridged, the substituents recited for the ring may also be present on the bridge.


“Heteroaryl” means a 5 to 7 membered monocyclic or 8 to 11 membered bicyclic aromatic ring system with 1-5 heteroatoms independently selected from nitrogen, oxygen, and sulfur.


Where a bonding attachment location is not specified, the bonding may be attached at any appropriate location as understood by practitioners in the art. Combinations of substituents and bonding patterns are only those that result in stable compounds as understood by practitioners in the art. Parenthetic and multiparenthetic terms are intended to clarify bonding relationships to those skilled in the art. For example, a term such as ((R)alkyl) means an alkyl substituent further substituted with the substituent R.


The invention includes all pharmaceutically acceptable salt forms of the compounds. Pharmaceutically acceptable salts are those in which the counter ions do not contribute significantly to the physiological activity or toxicity of the compounds and as such function as pharmacological equivalents. These salts can be made according to common organic techniques employing commercially available reagents. Some anionic salt forms include acetate, acistrate, besylate, bromide, chloride, citrate, fumarate, glucouronate, hydrobromide, hydrochloride, hydroiodide, iodide, lactate, maleate, mesylate, nitrate, pamoate, phosphate, succinate, sulfate, tartrate, tosylate, and xinofoate. Some cationic salt forms include ammonium, aluminum, benzathine, bismuth, calcium, choline, diethylamine, diethanolamine, lithium, magnesium, meglumine, 4-phenylcyclohexylamine, piperazine, potassium, sodium, tromethamine, and zinc.


Some of the compounds of the invention exist in stereoisomeric forms including the structure below with the indicated carbon. The invention includes all stereoisomeric forms of the compounds including enantiomers and diastereomers. Methods of making and separating stereoisomers are known in the art. The invention includes all tautomeric forms of the compounds. The invention includes atropisomers and rotational isomers.


The invention is intended to include all isotopes of atoms occurring in the compounds. Isotopes include those atoms having the same atomic number but different mass numbers. By way of general example and without limitation, isotopes of hydrogen include deuterium and tritium. Isotopes of carbon include 13C and 14C. Isotopically-labeled compounds of the invention can generally be prepared by conventional techniques known to those skilled in the art or by processes analogous to those described herein, using an appropriate isotopically-labeled reagent in place of the non-labeled reagent otherwise employed. Such compounds may have a variety of potential uses, for example as standards and reagents in determining biological activity. In the case of stable isotopes, such compounds may have the potential to favorably modify biological, pharmacological, or pharmacokinetic properties.


BIOLOGICAL METHODS

N-formyl peptide receptors (FPRs) are a family of chemo attractant receptors that facilitate leukocyte response during inflammation. FPRs belong to the seven-transmembrane G protein-coupled receptor superfamily and are linked to inhibitory G-proteins (Gi). Three family members (FPR1, FPR2 and FPR3) have been identified in humans and are predominantly found in myeloid cells with varied distribution and have also been reported in multiple organs and tissues. After agonist binding, the FPRs activate a multitude of physiological pathways, such as intra cellular signaling transduction, Ca2+ mobilization and transcription. The family interacts with a diverse set of ligands that includes proteins, polypeptides and fatty acid metabolites which activate both pro-inflammatory and pro-resolution downstream responses. FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays were used to measure the activity of the compounds in this patent.


FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 µM final for FPR2 or 10 µM final for FPR1) and IBMX (200 µM final) were added to 384-well Proxiplates (Perkin-Elmer) pre-dotted with test compounds in DMSO (1% final) at final concentrations in the range of 0.020 nM to 100 µM. Chinese Hamster Ovary cells (CHO) overexpressing human FPR1 or human FPR2 receptors were cultured in F-12 (Ham’s) medium supplemented with 10% qualified FBS, 250 µg/ml zeocin and 300 µg/ml hygromycin (Life Technologies). Reactions were initiated by adding 2,000 human FPR2 cells per well or 4,000 human FPR1 cells per well in Dulbecco’s PBS (with calcium and magnesium) (Life Technologies) supplemented with 0.1% BSA (Perkin-Elmer). The reaction mixtures were incubated for 30 min at room temperature. The level of intracellular cAMP was determined using the HTRF HiRange cAMP assay reagent kit (Cisbio) according to manufacturer’s instruction. Solutions of cryptate conjugated anti-cAMP and d2 flurorophore-labelled cAMP were made in a supplied lysis buffer separately. Upon completion of the reaction, the cells were lysed with equal volume of the d2-cAMP solution and anti-cAMP solution. After a 1-h room temperature incubation, time-resolved fluorescence intensity was measured using the Envision (Perkin-Elmer) at 400 nm excitation and dual emission at 590 nm and 665 nm. A calibration curve was constructed with an external cAMP standard at concentrations ranging from 1 µM to 0.1 pM by plotting the fluorescent intensity ratio from 665 nm emission to the intensity from the 590 nm emission against cAMP concentrations. The potency and activity of a compound to inhibit cAMP production was then determined by fitting to a 4-parametric logistic equation from a plot of cAMP level versus compound concentrations.


The examples disclosed below were tested in the FPR2 and FPR1 cAMP assay described above and found having FPR2 and/or FPR1 agonist activity. Table 1 below lists EC50 values in the FPR2 and FPR1 cAMP assays measured for the following examples.





TABLE 1






Example
hFPR2 cAMP2 EC50 (µM)
hFPR1 cAMP EC50 (µM)




1
0.028
4.2


2
0.022
0.086


3
0.029
1.7


4
0.0017
0.29


5
0.0029
0.014


6
0.0051
0.65


7
0.010
1.3


8
0.015
0.28


9
0.0067
4.4


10
0.050
0.29


11
0.031
0.086


12
0.091
>10


13
0.045
0.085


14
0.037
0.043


15
0.022
1.1


16
0.180
0.48


17
0.036
0.069


18
0.037
0.20


19
0.024
0.54


20
0.032
0.56


21
0.035
2.3


22
0.013
3.2


23
0.028
1.5


24
0.045
0.30


25
0.035
>10


26
0.035
0.027


27
0.027
0.57


28
0.007
1.1


29
0.051
0.11


30
0.010
0.75


31
0.010
0.15


32
0.018
0.96


33
0.005
1.61


34
0.0038
0.30


35
0.0031
>10


36
0.0055
0.030


37
0.0089
0.016


38
0.0051
0.018


39
0.0005
0.072


40
0.0006
2.6


41
0.0006
0.11


42
0.0007
0.73


43
0.0008
>5


44
0.001
0.010


45
0.001
0.0043


46
0.001
0.002


47
0.0011
0.15


48
0.0011
0.94


49
0.0011
2.0


50
0.0012
1.7


51
0.0012
5.5


52
0.0013
0.027


53
0.0014
0.0023


54
0.0014
0.82


55
0.0014
0.0086


56
0.0014
0.004


57
0.0014
0.000066


58
0.0015
0.0035


59
0.0015
0.0066


60
0.0016
0.0026


61
0.0016
0.034


62
0.0016
0.11


63
0.0017
0.016


64
0.0017
0.0072


65
0.0017
0.18


66
0.0018
0.049


67
0.0018
0.0044


68
0.0018
0.50


69
0.0019
0.0042


70
0.0019
>10


71
0.0019
0.29


72
0.0019
0.0057


73
0.0019
0.0032


74
0.0019
0.094


75
0.002
0.0028


76
0.002
0.28


77
0.002
0.17


78
0.002
0.0052


79
0.002
0.012


80
0.0021
0.13


81
0.0022
0.0027


82
0.0022
0.0053


83
0.0022
0.0076


84
0.0023
0.12


85
0.0023
0.16


86
0.0023
0.0041


87
0.0023
0.75


88
0.0024
0.0079


89
0.0024
0.045


90
0.0025
0.0035


91
0.0026
0.016


92
0.0026
0.0036


93
0.0026
0.068


94
0.0027
0.095


95
0.0027
0.16


96
0.0027
0.046


97
0.0027
0.35


98
0.0027
0.043


99
0.0027
0.33


100
0.0027
0.022


101
0.0028
0.15


102
0.0028
0.0047


103
0.0028
0.0019


104
0.0029
0.12


105
0.0029
0.065


106
0.0029
0.87


107
0.0029
0.0057


108
0.0029
0.0004


109
0.0029
0.50


110
0.0029
0.020


111
0.003
1.1


112
0.003
0.0028


113
0.003
0.016


114
0.003
0.0059


115
0.0031
0.0024


116
0.0031
0.034


117
0.0031
0.21


118
0.0031
0.0041


119
0.0031
0.067


120
0.0031
0.013


121
0.0031
0.0014


122
0.0032
1.08


123
0.0032
0.041


124
0.0033
0.047


125
0.0033
1.1


126
0.0033
2.3


127
0.0033
0.39


128
0.0033
0.0063


129
0.0033
0.38


130
0.0034
0.34


131
0.0034
0.0008


132
0.0034
0.0008


133
0.0034
0.012


134
0.0035
0.0016


135
0.0035
0.058


136
0.0035
0.0022


137
0.0035
0.19


138
0.0035
0.0017


139
0.0035
0.57


140
0.0035
0.61


141
0.0036
0.029


142
0.0036
0.087


143
0.0036
0.053


144
0.0036
0.0231


145
0.0037
0.0082


146
0.0038
0.15


147
0.0038
0.0022


148
0.0038
0.019


149
0.0038
0.0001


150
0.0039
0.007


151
0.0039
0.0005


152
0.0039
0.46


153
0.004
0.0042


154
0.004
0.0033


155
0.004
0.0093


156
0.004
0.0013


157
0.004
0.10


158
0.0041
0.19


159
0.0041
0.074


160
0.0041
1.1


161
0.0041
0.0034


162
0.0041
0.0094


163
0.0042
1.2


164
0.0042
0.29


165
0.0042
0.0017


166
0.0043
2.3


167
0.0043
>10


168
0.0043
1.6


169
0.0043
0.021


170
0.0044
0.0009


171
0.0044
2.4


172
0.0045
0.039


173
0.0045
0.012


174
0.0045
0.067


175
0.0046
0.0093


176
0.0046
0.0065


177
0.0046
0.015


178
0.0047
0.0001


179
0.0047
0.092


180
0.0047
>10


181
0.0048
0.99


182
0.0048
0.0018


183
0.0048
0.0006


184
0.0048
0.0098


185
0.0048
0.0007


186
0.0049
0.003


187
0.0049
0.038


188
0.0049
0.038


189
0.005
3.4


190
0.005
0.13


191
0.005
0.090


192
0.0051
0.0008


193
0.0051
0.57


194
0.0051
0.15


195
0.0052
0.0013


196
0.0052
0.16


197
0.0052
0.0017


198
0.0052
0.013


199
0.0052
0.13


200
0.0052
0.29


201
0.0053
0.018


202
0.0053
0.062


203
0.0053
0.77


204
0.0053
0.52


205
0.0054
0.22


206
0.0054
0.024


207
0.0054
>5


208
0.0054
0.0014


209
0.0055
0.13


210
0.0055
0.19


211
0.0055
0.025


212
0.0056
0.10


213
0.0056
1.8


214
0.0056
2.4


215
0.0056
0.041


216
0.0057
0.27


217
0.0057
0.042


218
0.0057
0.14


219
0.0058
0.14


220
0.0058
0.99


221
0.006
0.050


222
0.006
1.4


223
0.0061
0.1


224
0.0061
1.9


225
0.0062
0.63


226
0.0062
0.023


227
0.0062
0.24


228
0.0062
0.0012


229
0.0062
0.013


230
0.0062
0.088


231
0.0063
0.46


232
0.0063
0.0032


233
0.0063
>5


234
0.0063
1.1


235
0.0065
0.084


236
0.0065
0.030


237
0.0065
0.44


238
0.0066
1.5


239
0.0066
0.65


240
0.0066
0.13


241
0.0066
0.038


242
0.0067
0.11


243
0.0067
0.17


244
0.0068
0.95


245
0.0068
0.0011


246
0.0069
0.28


247
0.0069
0.25


248
0.0069
0.0007


249
0.0069
0.013


250
0.0069
4.8


251
0.007
>5


252
0.007
0.044


253
0.007
0.011


254
0.007
0.052


255
0.007
0.052


256
0.0072
0.53


257
0.0073
0.0016


258
0.0074
0.083


259
0.0074
0.58


260
0.0075
0.0012


261
0.0075
0.94


262
0.0075
0.018


263
0.0075
1.3


264
0.0075
0.37


265
0.0076
0.0015


266
0.0076
0.41


267
0.0077
1.6


268
0.0077
0.14


269
0.0077
0.027


270
0.0078
0.18


271
0.0078
1.4


272
0.0078
0.014


273
0.0078
1.4


274
0.008
0.019


275
0.008
6.1


276
0.008
0.013


277
0.008
0.21


278
0.0081
0.34


279
0.0081
5.8


280
0.0082
0.026


281
0.0082
0.56


282
0.0083
0.70


283
0.0084
0.019


284
0.0084
0.58


285
0.0029
0.22


286
0.0085
0.13


287
0.0086
4.6


288
0.0086
0.0008


289
0.0086
0.062


290
0.0086
1.8


291
0.0087
0.0066


292
0.0087
0.95


293
0.0087
0.044


294
0.0088
0.0091


295
0.0089
0.0006


296
0.009
0.44


297
0.009
0.0001


298
0.009
0.0085


299
0.0092
1.9


300
0.0093
0.36


301
0.0093
0.15


302
0.010
0.022


303
0.0096
0.39


304
0.0096
0.090


305
0.0096
1.3


306
0.0098
0.25


307
0.0099
0.0018


308
0.0099
0.18


309
0.01
0.41


310
0.01
0.067


311
0.010
1.9


312
0.010
0.0005


313
0.010
5.4


314
0.010
0.0004


315
0.010
0.0096


316
0.010
0.095


317
0.010
0.0026


318
0.010
>10


319
0.010
0.20


320
0.010
0.044


321
0.010
0.57


322
0.01
0.097


323
0.011
0.75


324
0.011
0.13


325
0.011
0.0016


326
0.011
0.035


327
0.012
1.7


328
0.012
0.61


329
0.012
2.5


330
0.013
3.7


331
0.013
5.6


332
0.013
5.8


333
0.014
5.7


334
0.014
0.48


335
0.015
0.45


336
0.017
0.06


337
0.017
4.3


338
0.018
1.8


339
0.023
0.0006


340
0.023
0.0011


341
0.023
4.1


342
0.032
0.83


343
0.033
0.12


344
0.046
2.0


345
0.089
0.0031


346
0.097
1.9


347
0.11
0.84


348
0.1107
1.4


349
0.57
5.5


350
0.0009
0.0006


351
0.008
0.005


352
0.0048
0.003


353
0.0042
0.017


354
0.0032
0.007


355
0.0045
0.004


356
0.0035
0.031


357
0.0031
0.012


358
0.0020
0.014


359
0.0045
0.006


360
0.0032
0.018


361
0.0017
0.003


362
0.0001
0.012


363
0.0008
0.003


364
0.0023
0.001


365
0.0026
0.001


366
0.0030
0.003


367
0.0012
0.003


368
0.0017
0.086


369
0.0037
1.1


370
0.0037
1.4


371
0.0019
0.008


372
0.0028
0.017


373
0.0125
0.233


374
0.0041
0.014


375
0.0016
0.003


376
0.0004
0.004


377
0.0016
0.005


378
0.0046
3.8


379
0.0026
0.32


380
0.0018
0.003


381
0.0040
0.010


382
0.0052
0.002


383
0.0055
0.002


384
0.0019
0.001


385
0.0071
0.001


386
0.0024
0.001


387
0.0022
0.001


388
0.0046
0.002


389
<0.005
<0.005


390
0.0048
0.076


391
0.0055
0.036


392
0.0149
0.005


393
0.0024
0.002


394
0.0019
0.011


395
0.0024
0.001


396
0.0095
0.039


397
0.0027
0.015


398
0.0072
0.011


399
0.0027
0.013


400
0.0029
0.000


401
0.0037
0.007


402
0.0028
0.003


403
0.0040
0.002


404
0.0059
0.003


405
0.0047
0.002


406
0.0029
0.009


407
0.0078
0.64


408
0.0035
0.009


409
0.0063
0.036


410
0.0117
3.3


411
0.0026
0.12


412
0.0076
0.093


413
0.0006
0.12


414
0.0047
0.019


415
0.0068
0.003


416
0.0017
0.001


417
0.0029
0.017


418
0.0027
0.004


419
0.0048
0.11


420
0.0073
0.051


421
0.0033
0.015


422
0.0011
0.003


423
0.0047
1.1


424
0.0022
0.011


425
0.0079
0.001


426
0.0023
0.004


427
0.0044
0.002


428
0.0090
0.008


429
0.0015
0.000


430
0.0033
0.005


431
0.0034
0.008


432
0.0091
3.8


433
0.0018
0.001


434
0.0044
0.010


435
0.0028
0.004


436
<0.005
0.009


437
0.0010
0.001


438
0.0039
0.007


439
0.0055
0.007


440
0.0013
0.011


441
0.0052
0.003


442
0.0096
0.001


443
0.0051
0.002


444
0.0018
0.001


445
0.0042
0.62


446
<0.005
0.003


447
0.0047
2.8


448
0.0080
0.009


449
0.0035
0.0002


450
0.0030
0.003


451
0.002
1.9


452
0.0096
0.004


453
0.0095
2.9


454
0.0044
0.017


455
0.0029
0.010


456
0.0028
0.001


457
0.0032
0.002


458
0.0012
0.0008


459
0.0009
0.0002


460
0.0014
0.001


461
0.0037
0.003


462
0.0006
1.4


463
0.0039
0.006


464
0.0016
0.004


465
0.0029
0.013


466
0.0030
0.004


467
0.0018
1.5


468
0.0021
0.018


469
0.0014
0.002


470
0.0019
0.008


471
0.0011
0.002


472
0.0012
0.0017


473
0.0018
0.002


474
0.0021
0.004


475
0.0020
0.020


476
0.0017
0.014


477
0.0010
0.013


478
0.0059
0.001


479
0.0094
0.005


480
0.0057
0.3


481
0.0012
2.2


482
0.0025
0.001


483
0.0056
0.016


484
0.0030
0.42


485
0.0017
0.002


486
0.0043
0.036


487
0.0019
0.72


488
0.0026
0.79


489
0.0007
0.005


490
0.001
0.001


491
0.0018
>5


492
0.0087
>5


493
0.0022
0.27


494
0.0034
0.44


495
0.0016
0.86


496
0.0030
1.1


497
0.0012
0.72


498
0.0018
>5


499
0.029
0.060


500
0.0022
0.71


501
0.0016
2.5


502
0.0077
0.90


503
0.0043
3.5


504
0.0022
3.3


505
0.10
3.4


506
0.0008
0.068


507
0.0023
0.15


508
0.0064
0.11


509
0.041
0.079


510
0.0035
0.29


511
0.066
0.39


512
0.0037
2.1


513
0.0024
1.5


514
0.0026
0.27


515
0.0021
2.2


516
0.0013
1.7


517
0.0028
1.8


518
0.0020
3.3


519
0.0031
0.48


520
0.0049
1.3


521
0.0090
0.33


522
0.0054
>5


523
0.0014
3.6


524
0.0008
1.4


525
0.0014
0.42


526
0.0011
2.3


527
0.0013
0.77


528
0.0002
0.60


529
0.0067
>5


530
0.0031
0.68


531
0.0016
3.2


532
0.0023
0.63


533
0.0040
0.90


534
0.0034
>5


535
0.0010
0.20


536
0.0021
0.65


537
0.0099
0.035


538
0.0013
2.0


539
0.0068
0.47


540
0.0027
>5


541
0.020
0.81


542
0.0057
1.2


543
0.0069
1.9


544
0.034
1.7


545
0.0060
0.33


546
0.0021
1.8


547
0.0045
2.4


548
0.28
>5


549
0.0041
0.028


550
0.010
0.0035


551
0.0015
0.077


552
0.13
0.44


553
0.0007
1.2


554
0.0043
2.4


555
0.031
0.53


556
0.0022
2.0


557
0.0018
0.13


558
0.0064
2.0


559
0.0066
0.45


560
0.0008
0.12


561
0.0043
0.17


562
0.0016
0.75


563
0.0023
0.0023


564
0.0036
0.0005


565
0.0082
0.72


566
0.0011
0.99


567
0.0096
>5


568
0.0028
0.44


569
0.0012
1.6


570
0.0012
1.5


571
0.0060
0.58


572
0.0035
1.6


573
0.0087
1.3


574
0.015
0.55


575
0.48
>5


576
0.0014
0.0015


577
0.0006
0.0002


578
0.0015
0.006


579
0.0058
0.0055


580
0.0036
0.74


581
0.0013
0.010


582
0.0047
0.55


583
0.0038
0.057


584
0.0218
0.66


585
0.0218
1.2


586
0.0098
1.3


587
0.0011
0.60


588
0.0069
0.41


589
0.13
2.6


590
0.0019
1.6


591
0.0105
0.0085


592
0.0071
0.0062


593
0.0033
0.040


594
0.0024
0.0014


595
0.0024
0.013


596
0.0437
0.86


597
0.0015
0.21


598
0.0062
0.59


599
0.0041
0.040


600
0.0078
0.17


601
0.0020
0.17


602
0.0038
0.088


603
0.0039
0.056


604
0.0005
0.015


605
<0.005
0.0019


606
0.0200
0.053


607
0.0133
0.030


608
0.0041
0.0042


609
0.0018
0.028


610
0.0010
0.0003


611
0.0024
0.0059


612
0.0135
0.033


613
0.0118
0.0093


614
0.0060
0.033


615
0.0087
0.0053


616
0.0094
0.020


617
0.0091
0.018


618
0.0010
0.0095


619
0.0094
0.064


620
0.0074
0.0065


621
0.090
0.064


622
0.0084
0.0022


623
0.0115
0.16


624
0.0015
0.0093


625
0.0019
0.012


626
0.0007
0.013


627
0.0086
0.0020


628
0.0047
0.059


629
0.0099
0.67


630
0.0052
1.1


631
0.0100
0.16


632
0.0009
0.0037


633
0.0014
0.0043


634
0.0020
0.0023


635
0.0037
0.0063


636
0.0016
0.0032


637
0.0066
0.0057


638
0.014
0.29


639
0.0058
0.057


640
0.0022
1.2


641
0.0028
1.0


642
0.015
0.57


643
0.0026
0.075


644
0.0021
0.064


645
0.0028
0.19


646
0.016
0.67


647
0.0015
0.022


648
0.0007
0.0041


649
0.0013
0.0078


650
0.011
1.7


651
0.0035
0.78


652
0.0072
0.70


653
0.0033
0.012


654
0.0010
0.012


655
0.0038
0.0012


656
0.0025
0.013


657
0.0020
0.045


658
0.0034
0.0017


659
0.0010
0.0013


660
0.0014
0.029


661
0.0012
0.11


662
0.0040
0.014


663
0.0011
1.7


664
0.0087
0.19


665
<0.010
0.0074


666
0.015
0.015


667
0.063
0.0077


668
0.0088
0.21


669
0.011
0.27


670
0.0065



671
0.0058



672
0.0079
0.005


673
0.0031
0.012


674
0.0068
0.023


675
0.0055
0.005


676
0.013
0.295


677
0.0053
0.230


678
0.011
0.092


679
0.006
0.028


680
0.0028
0.78


681
0.010
1.000


682
0.015
0.001


683
0.013



684
0.007
0.005


685
0.014
0.0014


686
0.013
0.00070


687
0.0018
0.00028


688
0.012
0.0015


689
0.0045
0.0015


690
0.011
0.024


691
0.011
0.011


692
0.0038
0.0028


693
0.0020
0.0025


694
0.0061
0.056


695
0.0035
0.004


696
0.0072
0.0083


697
0.0036
0.0067


698
0.0057
0.0025


699
0.0066
0.0030


700
0.0030
0.00067


701
0.012
0.027


702
0.0085
0.0075


703
0.057
0.099


704
0.0024
0.001


705
0.0006
0.0039


706
0.0094
0.019


707
0.0054
0.13


708
0.011
>1


709
0.014
0.21


710
0.0040
0.49


711
0.0042
3.4


712
0.0021
2.8


713
0.0040
>5


714
0.0064
3.6


715
0.0055
>5


716
0.0057
>5


717
0.0007
0.15


718
0.0009
0.84


719
0.0014
1.9


720
0.0039
>5


721
0.0056
>5






PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE

The compounds of the present invention may be administered to mammals, preferably humans, for the treatment of a variety of conditions and disorders including atherosclerosis, heart failure, lung diseases including asthma, COPD, and cystic fibrosis; neuroinflammatory diseases including multiple sclerosis, Alzheimer’s disease, and stroke; and chronic inflammatory diseases such as inflammatory bowel disease, rheumatoid arthritis, psoriasis, sepsis, and kidney fibrosis.


Unless otherwise specified, the following terms have the stated meanings. The term “subject” refers to any human or other mammalian species that could potentially benefit from treatment with a FPR2 and/or FPR1 agonist as understood by practioners in this field. Some subjects include human beings of any age with risk factors for cardiovascular disease. Common risk factors include age, sex, weight, family history, sleep apnea, alcohol or tobacco use, physical inactivity arrthymia or signs of insulin resistance such as acanthosis nigricans, hypertension, dyslipidemia, or polycystic ovary syndrome (PCOS). The term “patient” means a person suitable for therapy as determined by practitioners in the field. “Treating” or “treatment” cover the treatment of a patient or subject as understood by practitioners in this field. “Preventing” or “prevention” cover the preventive treatment (i.e., prophylaxis and/or risk reduction) of a subclinical disease-state in a patient or subject aimed at reducing the probability of the occurrence of a clinical disease-state as understood by practitioners in this field. Patients are selected for preventative therapy based on factors that are known to increase risk of suffering a clinical disease state compared to the general population. “Therapeutically effective amount” means an amount of a compound that is effective as understood by practitioners in this field.


Another aspect of the invention are pharmaceutical compositions comprising a therapeutically effective amount of a compound of Formulae (I)-(VII) in combination with a pharmaceutical carrier.


Another aspect of the invention are pharmaceutical compositions comprising a therapeutically effective amount of a compound of Formulae (I)-(VII) in combination with at least one other therapeutic agent and a pharmaceutical carrier.


“Pharmaceutical composition” means a composition comprising a compound of the invention in combination with at least one additional pharmaceutically acceptable carrier. A “pharmaceutically acceptable carrier” refers to media generally accepted in the art for the delivery of biologically active agents to animals, in particular, mammals, including, i.e., adjuvant, excipient or vehicle, such as diluents, preserving agents, fillers, flow regulating agents, disintegrating agents, wetting agents, emulsifying agents, suspending agents, sweetening agents, flavoring agents, perfuming agents, anti-bacterial agents, anti-fungal agents, lubricating agents and dispensing agents, depending on the nature of the mode of administration and dosage forms.


Pharmaceutically acceptable carriers are formulated according to a number of factors well within the purview of those of ordinary skill in the art. These include, without limitation: the type and nature of the active agent being formulated; the subject to which the agent-containing composition is to be administered; the intended route of administration of the composition; and the therapeutic indication being targeted. Pharmaceutically acceptable carriers include both aqueous and non-aqueous liquid media, as well as a variety of solid and semi-solid dosage forms. Such carriers can include a number of different ingredients and additives in addition to the active agent, such additional ingredients being included in the formulation for a variety of reasons, e.g., stabilization of the active agent, binders, etc., well known to those of ordinary skill in the art. Descriptions of suitable pharmaceutically acceptable carriers, and factors involved in their selection, are found in a variety of readily available sources such as, for example, Allen, L.V., Jr. et al., Remington: The Science and Practice of Pharmacy (2 Volumes), 22nd Edition, Pharmaceutical Press (2012).


Particularly when provided as a single dosage unit, the potential exists for a chemical interaction between the combined active ingredients. For this reason, when the compound of the present invention and a second therapeutic agent are combined in a single dosage unit they are formulated such that although the active ingredients are combined in a single dosage unit, the physical contact between the active ingredients is minimized (that is, reduced). For example, one active ingredient may be enteric coated. By enteric coating one of the active ingredients, it is possible not only to minimize the contact between the combined active ingredients, but also, it is possible to control the release of one of these components in the gastrointestinal tract such that one of these components is not released in the stomach but rather is released in the intestines. One of the active ingredients may also be coated with a material that affects a sustained-release throughout the gastrointestinal tract and also serves to minimize physical contact between the combined active ingredients. Furthermore, the sustained-released component can be additionally enteric coated such that the release of this component occurs only in the intestine. Still another approach would involve the formulation of a combination product in which the one component is coated with a sustained and/or enteric release polymer, and the other component is also coated with a polymer such as a low viscosity grade of hydroxypropyl methylcellulose (HPMC) or other appropriate materials as known in the art, in order to further separate the active components. The polymer coating serves to form an additional barrier to interaction with the other component.


Another aspect of the invention is a method for treating heart disease comprising administering a therapeutically effective amount of a compound of Formulae (I)-(VII) to a patient.


Another aspect of the invention is a method for treating heart disease wherein the heart disease is selected from the group consisting of angina pectoris, unstable angina, myocardial infarction, heart failure, acute coronary disease, acute heart failure, chronic heart failure, and cardiac iatrogenic damage.


It will be understood that treatment or prophylaxis of heart failure may involve treatment or prophylaxis of a cardiovascular event as well. Treatment or prophylaxis as referred to herein may refer to treatment or prophylaxis of certain negative symptoms or conditions associated with or arising as a result of a cardiovascular event. By way of example, treatment or prophylaxis may involve reducing or preventing negative changes in fractional shortening, heart weight, lung weight, myocyte cross sectional area, pressure overload induced cardiac fibrosis, stress induced cellular senescence, and/or cardiac hypertrophy properties, or any combination thereof, associated with or arising as a result of a cardiovascular event. Treatment may be administered in preparation for or in response to a cardiovascular event to alleviate negative effects. Prevention may involve a pro-active or prophylactic type of treatment to prevent the cardiovascular event or to reduce the onset of negative effects of a cardiovascular event.


In one embodiment, the present invention provides the use of a compound of Formulae (I)-(VII) or a pharmaceutically acceptable salt thereof for the preparation of a pharmaceutical composition for the treatment or prophylaxis of heart failure, for example, heart failure results from hypertension, an ischemic heart disease, a non-ischemic heart disease, exposure to a cardiotoxic compound, myocarditis, Kawasaki’s disease, Type I and Type II diabetes, thyroid disease, viral infection, gingivitis, drug abuse, alcohol abuse, pericarditis, atherosclerosis, vascular disease, hypertrophic cardiomyopathy, dilated cardiomyopathy, myocardial infarction, atrial fibrosis, left ventricular systolic dysfunction, left ventricular diastolic dysfunction, coronary bypass surgery, pacemaker implantation surgery, starvation, an eating disorder, muscular dystrophies, and a genetic defect. Preferably, the heart failure to be treated is diastolic heart failure, heart failure with reduced ejection fraction (HFREF), heart failure with preserved ejection fraction (HFPEF), acute heart failure, and chronic heart failure of ischemic and non-ischemic origin.


In one embodiment, the present invention provides the use of a compound of Formulae (I)-(VII) to treat systolic and/or diastolic dysfunction, wherein the compound is administered in a therapeutically effective amount to increase the ability of the cardiac muscle cells to contract and relax thereby increasing the filling and emptying of both the right and left ventricles, preferably, the left ventricle.


In another embodiment, the present invention provides the use of a compound of Formulae (I)-(VII) to treat heart failure wherein the compound is administered in a therapeutically effective amount to increase ejection fraction in the left ventricle.


In still another embodiment, the present invention provides the use of a compound of Formulae (I)-(VII) to treat heart failure wherein the compound is administered in a therapeutically effective amount to reduce fibrosis in heart tissue.


Another aspect of the invention is a method for treating heart disease wherein the treatment is post myocardial infarction.


Another aspect of the invention is a method for treating heart disease comprising administering a therapeutically effective amount of a compound of Formulae (I)-(VII) to a patient in conjunction with other therapeutic agents.


The compounds of this invention can be administered by any suitable means, for example, orally, such as tablets, capsules (each of which includes sustained release or timed release formulations), pills, powders, granules, elixirs, tinctures, suspensions (including nanosuspensions, microsuspensions, spray-dried dispersions), syrups, and emulsions; sublingually; buccally; parenterally, such as by subcutaneous, intravenous, intramuscular, or intrasternal injection, or infusion techniques (e.g., as sterile injectable aqueous or non-aqueous solutions or suspensions); nasally, including administration to the nasal membranes, such as by inhalation spray; topically, such as in the form of a cream or ointment; or rectally such as in the form of suppositories. They can be administered alone, but generally will be administered with a pharmaceutical carrier selected on the basis of the chosen route of administration and standard pharmaceutical practice.


The dosage regimen for the compounds of the present invention will, of course, vary depending upon known factors, such as the pharmacodynamic characteristics of the particular agent and its mode and route of administration; the species, age, sex, health, medical condition, and weight of the recipient; the nature and extent of the symptoms; the kind of concurrent treatment; the frequency of treatment; the route of administration, the renal and hepatic function of the patient, and the effect desired.


By way of general guidance, the daily oral dosage of each active ingredient, when used for the indicated effects, will range between about 0.01 to about 5000 mg per day, preferably between about 0.1 to about 1000 mg per day, and most preferably between about 0.1 to about 250 mg per day. Intravenously, the most preferred doses will range from about 0.01 to about 10 mg/kg/minute during a constant rate infusion. Compounds of this invention may be administered in a single daily dose, or the total daily dosage may be administered in divided doses of two, three, or four times daily.


Dosage forms (pharmaceutical compositions) suitable for administration may contain from about 1 milligram to about 2000 milligrams of active ingredient per dosage unit. In these pharmaceutical compositions the active ingredient will ordinarily be present in an amount of about 0.1-95% by weight based on the total weight of the composition. A typical capsule for oral administration contains at least one of the compounds of the present invention (250 mg), lactose (75 mg), and magnesium stearate (15 mg). The mixture is passed through a 60 mesh sieve and packed into a No. 1 gelatin capsule. A typical injectable preparation is produced by aseptically placing at least one of the compounds of the present invention (250 mg) into a vial, aseptically freeze-drying and sealing. For use, the contents of the vial are mixed with 2 mL of physiological saline, to produce an injectable preparation.


The compounds of the present invention may be employed in combination with other suitable therapeutic agents useful in the treatment of the aforementioned diseases or disorders including: anti-atherosclerotic agents, anti-dyslipidemic agents, anti-diabetic agents, anti-hyperglycemic agents, anti-hyperinsulinemic agents, anti-thrombotic agents, anti-retinopathic agents, anti-neuropathic agents, anti-nephropathic agents, anti-ischemic agents, anti-hypertensive agents, anti-obesity agents, anti-hyperlipidemic agents, anti-hypertriglyceridemic agents, anti-hypercholesterolemic agents, anti-restenotic agents, anti-pancreatic agents, lipid lowering agents, anorectic agents, memory enhancing agents, anti-dementia agents, cognition promoting agents, appetite suppressants, agents for treating heart failure, agents for treating peripheral arterial disease, agents for treating malignant tumors, and anti-inflammatory agents.


The compounds of the invention may be used with at least one of the following heart failure agents selected from loop diuretics, Angiotensin converting enzyme (ACE) inhibitors, Angiotensin II receptor blockers (ARBs), angiotensin receptor-neprilysin inhibitors (ARNI), beta blockers, mineralocorticoid receptor antagonists, nitroxyl donors, RXFP1 agonists, APJ agonists and cardiotonic agents. These agents include, but are not limited to furosemide, bumetanide, torsemide, sacubitrial-valsartan, thiazide diruetics, captopril, enalapril, lisinopril, carvedilol, metopolol, bisoprolol, serelaxin, spironolactone, eplerenone, ivabradine, candesartan, eprosartan, irbestarain, losartan, olmesartan, telmisartan, and valsartan.


The compounds of the present invention may be employed in combination with at least one of the following therapeutic agents in treating atherosclerosis: anti-hyperlipidemic agents, plasma HDL-raising agents, anti-hypercholesterolemic agents, cholesterol biosynthesis inhibitors (such as HMG CoA reductase inhibitors), LXR agonist, probucol, raloxifene, nicotinic acid, niacinamide, cholesterol absorption inhibitors, bile acid sequestrants (such as anion exchange resins, or quaternary amines (e.g., cholestyramine or colestipol)), low density lipoprotein receptor inducers, clofibrate, fenofibrate, benzofibrate, cipofibrate, gemfibrizol, vitamin B6, vitamin B12, anti-oxidant vitamins, β-blockers, anti-diabetes agents, angiotensin II antagonists, angiotensin converting enzyme inhibitors, platelet aggregation inhibitors, fibrinogen receptor antagonists, aspirin and fibric acid derivatives.


The compounds of the present invention may be employed in combination at least one of the following therapeutic agents in treating cholesterol biosynthesis inhibitor, particularly an HMG-CoA reductase inhibitor. Examples of suitable HMG-CoA reductase inhibitors include, but are not limited to, lovastatin, simvastatin, pravastatin, fluvastatin, atorvastatin, and rosuvastatin.


The compounds of the invention may be used in combination with at least one of the following anti-diabetic agents depending on the desired target therapy. Studies indicate that diabetes and hyperlipidemia modulation can be further improved by the addition of a second agent to the therapeutic regimen. Examples of anti-diabetic agents include, but are not limited to, sulfonylureas (such as chlorpropamide, tolbutamide, acetohexamide, tolazamide, glyburide, gliclazide, glynase, glimepiride, and glipizide), biguanides (such as metformin), thiazolidinediones (such as ciglitazone, pioglitazone, troglitazone, and rosiglitazone), and related insulin sensitizers, such as selective and non-selective activators of PPARα, PPARβ and PPARγ; dehydroepiandrosterone (also referred to as DHEA or its conjugated sulphate ester, DHEA-SO4); anti-glucocorticoids; TNFα inhibitors; dipeptidyl peptidase IV (DPP4) inhibitor (such as sitagliptin, saxagliptin), GLP-1 agonists or analogs (such as exenatide), α-glucosidase inhibitors (such as acarbose, miglitol, and voglibose), pramlintide (a synthetic analog of the human hormone amylin), other insulin secretagogues (such as repaglinide, gliquidone, and nateglinide), insulin, as well as the therapeutic agents discussed above for treating atherosclerosis.


The compounds of the invention may be used in combination with at least one of the following anti-obesity agents selected from phenylpropanolamine, phentermine, diethylpropion, mazindol, fenfluramine, dexfenfluramine, phentiramine, β3-adrenoreceptor agonist agents; sibutramine, gastrointestinal lipase inhibitors (such as orlistat), and leptins. Other agents used in treating obesity or obesity-related disorders include neuropeptide Y, enterostatin, cholecytokinin, bombesin, amylin, histamine H3 receptors, dopamine D2 receptor modulators, melanocyte stimulating hormone, corticotrophin releasing factor, galanin and gamma amino butyric acid (GABA).


The compounds of the present invention are also useful as standard or reference compounds, for example as a quality standard or control, in tests or assays involving the FPR2. Such compounds may be provided in a commercial kit, for example, for use in pharmaceutical research involving FPR2 activity. For example, a compound of the present invention could be used as a reference in an assay to compare its known activity to a compound with an unknown activity. This would ensure the experimenter that the assay was being performed properly and provide a basis for comparison, especially if the test compound was a derivative of the reference compound. When developing new assays or protocols, compounds according to the present invention could be used to test their effectiveness. The compounds of the present invention may also be used in diagnostic assays involving FPR2.


The present invention also encompasses an article of manufacture. As used herein, article of manufacture is intended to include, but not be limited to, kits and packages. The article of manufacture of the present invention, comprises: (a) a first container; (b) a pharmaceutical composition located within the first container, wherein the composition, comprises a first therapeutic agent, comprising a compound of the present invention or a pharmaceutically acceptable salt form thereof; and, (c) a package insert stating that the pharmaceutical composition can be used for the treatment of dyslipidemias and the sequelae thereof. In another embodiment, the package insert states that the pharmaceutical composition can be used in combination (as defined previously) with a second therapeutic agent for the treatment of dyslipidemias and the sequelae thereof. The article of manufacture can further comprise: (d) a second container, wherein components (a) and (b) are located within the second container and component (c) is located within or outside of the second container. Located within the first and second containers means that the respective container holds the item within its boundaries. The first container is a receptacle used to hold a pharmaceutical composition. This container can be for manufacturing, storing, shipping, and/or individual/bulk selling. First container is intended to cover a bottle, jar, vial, flask, syringe, tube (e.g., for a cream preparation), or any other container used to manufacture, hold, store, or distribute a pharmaceutical product. The second container is one used to hold the first container and, optionally, the package insert. Examples of the second container include, but are not limited to, boxes (e.g., cardboard or plastic), crates, cartons, bags (e.g., paper or plastic bags), pouches, and sacks. The package insert can be physically attached to the outside of the first container via tape, glue, staple, or another method of attachment, or it can rest inside the second container without any physical means of attachment to the first container. Alternatively, the package insert is located on the outside of the second container. When located on the outside of the second container, it is preferable that the package insert is physically attached via tape, glue, staple, or another method of attachment. Alternatively, it can be adjacent to or touching the outside of the second container without being physically attached. The package insert is a label, tag, marker, etc. that recites information relating to the pharmaceutical composition located within the first container. The information recited will usually be determined by the regulatory agency governing the area in which the article of manufacture is to be sold (e.g., the United States Food and Drug Administration). Preferably, the package insert specifically recites the indications for which the pharmaceutical composition has been approved. The package insert may be made of any material on which a person can read information contained therein or thereon. Preferably, the package insert is a printable material (e.g., paper, plastic, cardboard, foil, adhesive-backed paper or plastic, etc.) on which the desired information has been formed (e.g., printed or applied).


CHEMISTRY METHODS

Abbreviations as used herein, are defined as follows: “1x” for once, “2x” for twice, “3x” for thrice, “°C” for degrees Celsius, “aq” for aqueous, “Col” for column, “eq” for equivalent or equivalents, “g” for gram or grams, “mg” for milligram or milligrams, “L” for liter or liters, “mL” for milliliter or milliliters, “µL” for microliter or microliters, “N” for normal, “M” for molar, “nM” for nanomolar, “mol” for mole or moles, “mmol” for millimole or millimoles, “min” for minute or minutes, “h” for hour or hours, “rt” for room temperature, “RT” for retention time, “ON” for overnight, “atm” for atmosphere, “psi” for pounds per square inch, “conc.” for concentrate, “aq” for “aqueous”, “sat” or “sat’d” for saturated, “MW” for molecular weight, “mw” or “µwave” for microwave, “mp” for melting point, “Wt” for weight, “MS” or “Mass Spec” for mass spectrometry, “ESI” for electrospray ionization mass spectroscopy, “HR” for high resolution, “HRMS” for high resolution mass spectrometry, “LCMS” for liquid chromatography mass spectrometry, “HPLC” for high pressure liquid chromatography, “RP HPLC” for reverse phase HPLC, “TLC” or “tlc” for thin layer chromatography, “NMR” for nuclear magnetic resonance spectroscopy, “nOe” for nuclear Overhauser effect spectroscopy, “1H” for proton, “δ” for delta, “s” for singlet, “d” for doublet, “t” for triplet, “q” for quartet, “m” for multiplet, “br” for broad, “Hz” for hertz, and “α”, “β”, “R”, “S”, “E”, and “Z” are stereochemical designations familiar to one skilled in the art.










Ac
acetic


AcOH
acetic acid


Acn (or MeCN)
acetonitrile


Bn
benzyl


Boc
tert-butyl carbonyl


Boc2O
di-tert-butyl dicarbonate


Bu
butyl


Dba as in (Pd2(dba)3)
dibenzylideneacetone


Cbz
carboxybenzyl


DCM
dichloromethane


DEA
diethylamine


DIEA or DIPEA
diisopropylethylamine


DMAP
4-dimethylaminopyridine


DMF
dimethylformamide


DMSO
dimethyl sulfoxide


dppf
1,1′-bis(diphenylphosphino)ferrocene


Et
ethyl


EtOH
ethanol


EtOAc
ethyl acetate


HATU
2-(7-Aza-1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluroni



um hexafluorophosphate


HBTU
2-(1H-Benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate


i-Bu
isobutyl


IPA
isopropyl alcohol


i-Pr
isopropyl


LAH
lithium aluminum hydride


Me
methyl


MeOH
methanol


pet
petroleum


Ph
phenyl


Pr
propyl


t-Bu
tert-butyl


TEA
triethylamine


TFA
trifluoroacetic acid


THF
tetrahydrofuran


Ts
tosyl






The disclosed compounds can be made by various methods known in the art including those of the following schemes and in the specific embodiments section. The structure numbering and variable numbering shown in the synthetic schemes are distinct from and should not be confused with the structure or variable numbering in the claims or the rest of the specification. The variables in the schemes are meant only to illustrate how to make some of the compounds of this invention.


A consideration in the planning of any synthetic route in this field is the choice of the protecting group used for protection of the reactive functional groups present in the compounds described in this invention. An authoritative account describing the many alternatives to the trained practitioner is Greene, T.W. et al., Protecting Groups in Organic Synthesis, 4th Edition, Wiley (2007)).


Compounds having the general Formula (I): wherein A, B and C are defined above as Ar1, Ar2 and Ar3, respectively and Formula (II): wherein A, B and Y are defined above as Ar1, Ar2 and alkyl and/or cycloalkyl groups, respectively and can be prepared by the following one or more of the synthetic Schemes.




embedded image - (I)




embedded image - (II)


1-Arylpyrrolidinone compounds of this invention (Formula I) wherein ring A is a substituted phenyl or cycloalkyl ring, ring B is phenyl or heteroaryl ring and ring C is a substituted phenyl or heteroaryl ring can be prepared by the general route shown in Scheme 1. Compound 1a was synthesized as per the procedure reported in the patent literature (WO2015079692). Compound 1a was treated with diphenylphosphoryl azide (DPPA) and a tertiary amine such as triethylamine (TEA). Subsequent addition of benzyl alcohol yielded Cbz protected compound 1b. Removal of the Cbz protecting group from 1b with Pd/C in the presence of hydrogen, followed by amide coupling of the resulting free amine with a suitably substituted phenyl acid provided amides 1c. Other deprotection conditions and protecting groups known to those skilled in the art could also be used in this sequence. Copper or Pd-catalyzed coupling of 1c to a substituted iodobenzene or bromobenzene or other suitable halo aryl or heteroaryl compounds in a suitable solvent such as butanol or dioxane or toluene, in the presence of a base such as potassium carbonate or cesium carbonate and a suitable ligand such as N,N′-dimethylethylenediamine, or Xanthphos can afford desired compounds 1d. Suitable aryl or heteroaryl halides are either commercially available or can be readily obtained from the corresponding readily available starting materials by methods known to one skilled in the art. Additional methods for this transformation include other variations of Ullmann, Goldberg, and Buchwald copper-catalyzed amidation or Buchwald Pd-catalyzed C-N coupling depending on the nature of ring B, using methods known to one skilled in the art for these types of couplings (see for example Yin & Buchwald, Organic Lett. 2000, 2, 1101; Klapers et al., JACS, 2001, 123, 7727; Klapars et al., JACS, 2002, 124, 7421; Yin & Buchwald, JACS. 2002, 124, 6043; Kiyomor, Madoux & Buchwald, Tet. Lett., 1999, 40, 2657). Similarly, 1-arylpyrrolidinone compounds of this invention (Formula I) wherein rings A and C are substituted phenyl rings or heteroaryl or cycloalkyl and ring B is phenyl or heteroaryl can be prepared by the general route shown in Scheme 2.




embedded image - Scheme 1




embedded image - Scheme 2


1-Arylpyrrolidinone compounds of this invention (Formula II) wherein rings A and C are phenyl rings and Y is a substituted benzyl, heteroaryl alkyl, alkyl and or cycloalkyl group, can be prepared by the general route shown in Scheme 3, starting from an intermediate 1c, prepared as shown in Scheme 1.




embedded image - Scheme 3


In the Scheme 3, Y is a C1-6 alkyl group, benzyl, and heteroaryl with an alkyl spacer and X is a leaving group such as chloride, bromide, iodide, a methane sulfonyloxy group, a trifluoromethane sulfonyloxy group or the other known groups. Compound 1e can be obtained by reacting compound 1c with alkylating reagent YX in a solvent in the presence of a suitable base with heating in an appropriate solvent such as DMF or DMSO or obtained by other methods known to one skilled in the art.


Other features of the invention will become apparent in the course of the following descriptions of exemplary embodiments that are given for illustration of the invention and are not intended to be limiting thereof.


The following methods were used in the exemplified Examples, except where noted otherwise. Purification of intermediates and final products was carried out via either normal or reverse phase chromatography. Normal phase chromatography was carried out using prepacked SiO2 cartridges eluting with either gradients of hexanes and ethyl acetate or DCM and MeOH unless otherwise indicated. Reverse phase preparative HPLC was carried out using C18 columns with UV 220 nm or prep LCMS detection eluting with gradients of Solvent A (90% water, 10%MeOH, 0.1% TFA) and Solvent B (10% water, 90% MeOH, 0.1% TFA) or with gradients of Solvent A (95% water, 5% Acn, 0.1% TFA) and Solvent B (5% water, 95% Acn, 0.1% TFA) or with gradients of Solvent A (95% water, 2% Acn, 0.1% HCOOH) and Solvent B (98% Acn, 2% water, 0.1% HCOOH) or with gradients of Solvent A (95% water, 5% Acn, 10 mM NH4OAc) and Solvent B (98% Acn, 2% water, 10 mMNH4OAc) or with gradients of Solvent A (98% water, 2% Acn, 0.1%NH4OH) and Solvent B (98% Acn, 2% water, 0.1% NH4OH).


LC/MS Methods Employed in Characterization of Examples. Reverse phase analytical HPLC/MS was performed on a Waters Acquity system coupled with a Waters MICROMASS® ZQ Mass Spectrometer.

  • Method A: Linear gradient of 0 to 100% B over 3 min, with 0.75 min hold time at 100% B;
    • UV visualization at 220 nm
    • Column: Waters BEH C18 2.1 × 50 mm
    • Flow rate: 1.0 mL/min
    • Solvent A: 0.1% TFA, 95% water, 5% Acn
    • Solvent B: 0.1% TFA, 5% water, 95% Acn
  • Method B: Linear gradient of 0 to 100% B over 3 min, with 0.75 min hold time at 100% B;
    • UV visualization at 220 nm
    • Column: Waters BEH C18 2.1 × 50 mm
    • Flow rate: 1.0 mL/min
    • Solvent A: 10 mM ammonium acetate, 95% water, 5% Acn
    • Solvent B: 10 mM ammonium acetate, 5% water, 95% Acn


Analytical HPLC: Methods Employed in Characterization of Examples

Products were analyzed by reverse phase analytical HPLC: carried out on a Shimadzu Analytical HPLC: system running Discovery VP software. RT = retention time.


Method C: Ascentis Express C18, 2.1 × 50 mm, 2.7 \-µm particles; Solvent A: 95% water, 5% acetonitrile, 0.05% TFA; Solvent B: 95% acetonitrile, 5% water, 0.1% TFA; Temperature: 50° C.; Gradient: 0-100% B over 3 minutes, then a 1-minute hold at 100% B; Flow: 1.1 mL/min.


Method D: Ascentis Express C18, 2.1 × 50 mm, 2.7 \-µm particles; Solvent A: 95% water, 5% acetonitrile with 10 mM ammonium acetate; Solvent B: 95% acetonitrile, 5% water with 10 mM ammonium acetate; Temperature: 50° C.; Gradient: 0-100% B over 3 minutes, then a 1-minute hold at 100% B; Flow: 1.1 mL/min.


The following representative conditions were used to screen compounds for chiral purity. Other conditions were used as well.

  • Columns: Chiralpak IA, 250 × 4.6 mm, 5.0 \-µm particles, Chiralpak IB, 250 × 4.6 mm, 5.0 \- µm particles, Chiralpak IC, 250 × 4.6 mm, 5.0 \-µm particles, Chiralpak ID, 250 × 4.6 mm, 5.0 \- µm particles, Chiralpak IE, 250 × 4.6 mm, 5.0 \-µm particles and Chiralpak IF, 250 × 4.6 mm, 5.0 \- µm particles;
  • Mobile Phase: 0.2% ammonia in Acn—MeOH (1:1).
  • NMR Employed in Characterization of Examples. 1H NMR spectra were obtained with Bruker or JEOL® Fourier transform spectrometers operating at frequencies as follows: 1H NMR: 300 MHz (Bruker or JEOL®) or 400 MHz (Bruker or JEOL®) or 500 MHz (Bruker or JEOL®). 13C NMR: 100 MHz (Bruker or JEOL®). Spectra data are reported in the format: chemical shift (multiplicity, coupling constants, and number of hydrogens). Chemical shifts are specified in ppm downfield of a tetramethylsilane internal standard (δ units, tetramethylsilane = 0 ppm) and/or referenced to solvent peaks, which in 1H NMR spectra appear at 2.49 ppm for CD2HSOCD3, 3.30 ppm for CD2HOD, 1.94 for CD3CN, and 7.24 ppm for CHCl3, and which in 13C NMR spectra appear at 39.7 ppm for CD3SOCD3, 49.0 ppm for CD3OD, and 77.0 ppm for CDCl3. All 13C NMR spectra were proton decoupled.


Intermediate 1: Benzyl ((3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-2-oxopyrrolidin-3-yl)carbamate



embedded image


To a stirred solution of (3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-2-oxopyrrolidine-3-carboxylic acid (6.0 g, 22 mmol), TEA (3.7 mL, 27 mmol) in toluene (60 mL) and acetonitrile (12 mL) was added diphenylphosphoryl azide (5.7 mL, 27 mmol). The mixture was stirred at rt for 3 h, and then at 80° C. for 30 min. After the mixture was cooled to rt, benzyl alcohol (12 mL, 110 mmol) was added, and the mixturewas stirred at 100° C. for 16 h. The reaction mixture was cooled and concentrated under reduced pressure. The residue was purified via column chromatography (pet. ether-ethyl acetate) to afford Intermediate 1 (4.0 g, 11 mmol, 50%) as a colorless liquid. MS (ESI) m/z: 377.3 [M+H]+


Intermediate 2: (3S,4R)-3-amino-4-(2,6-difluoro-4-methoxyphenyl)pyrrolidin-2-one



embedded image


To a degassed solution of Intermediate 1 (4.0 g, 11 mmol) in EtOH (60 mL) was added Pd—C (0.11 g, 1.1 mmol). The reaction mixture was purged with H2 and stirred under an H2 atmosphere for 16 h at rt. The mixture was filtered through a pad of Celite and concentrated under reduced pressure to afford (3S,4R)-3-amino-4-(2,6-difluoro-4-methoxyphenyl)pyrrolidin-2-one (2.5 g, 10.3 mmol, 97 %) as a white solid. The crude material was used in the next synthetic step without further purification. MS (ESI) m/z: 243.2 [M+H]+


Intermediate 3: N-((3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-2-oxopyrrolidin-3-yl)-4-(difluoromethoxy)benzamide



embedded image


To a stirred solution of Intermediate 2 (1.2 g, 5.0 mmol) in DMF (10 mL) under argon atmosphere at rt were added DIEA (1.0 mL, 6.0 mmol), 4-(difluoromethoxy)benzoic acid (1.1 g, 6.0 mmol), and HATU (2.3 g, 6.0 mmol). After 16 h, the reaction mixture was quenched with water (20 mL) and extracted with EtOAc (20 mL x 3). The combined organic layers were washed with water and brine (20 mL each), dried over Na2SO4 and concentrated under reduced pressure to give the crude product, which was purified via column chromatography (pet. ether-ethyl acetate) to afford Intermediate 3 (1.2 g, 2.9 mmol, 59% yield) as a white solid. MS(ESI) m/z: 413.1 [M+H]+. 1H NMR (300 MHz, DMSO-d6) δ 8.85 (d, J = 8.6 Hz, 1H), 8.19 (s, 1H), 7.86 (d, J= 8.6 Hz, 2H), 7.35 (t, J = 75.0 Hz, 1H), 7.26 (d, J = 8.6 Hz, 2H), 6.75 (d, J = 12.0 Hz, 2H), 4.90 - 4.80 (m, 1H), 4.06 - 3.79 (m, 1H), 3.75 (s, 3H), 3.60 - 3.45 (m, 1H), 3.42 -3.32 (m, 1H).


Intermediate 4: N-((3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-2-oxopyrrolidin-3-yl)-4-(trifluoromethoxy)benzamide



embedded image


A similar protocol to the above procedure for Intermediate 3 was followed to synthesize Intermediate 4. MS(ESI) m/z: 431.1 [M+H]+. 1H NMR (300 MHz, CDCl3) δ = 7.77 (d, J= 8.4 Hz, 2H), 7.19 (d, J = 7.9 Hz, 2H), 6.47 (m, 3H), 6.23 (s, 1 H), 5.14 - 4.97 (m, 1H), 4.07 - 3.95 (m, 1H), 3.82 - 3.75 (m, 4H), 3.68 - 3.63 (m, 1H).


Intermediate 5A and 5B: 3-Bromo-4-methyl-1-(3,3,3-trifluoro-2-hydroxypropyl) pyridin-2(1H)-one:



embedded image - 5A Enantiomer-1




embedded image - 5B Enantiomer-2


To a stirred solution of 3-bromo-4-methylpyridin-2(1H)-one (1.5 g, 8.0 mmol) in DMF (15 mL) at rt, were added 3-bromo-1,1,1-trifluoropropan-2-ol (2.3 g, 12 mmol) and K2CO3 (3.3 g, 24 mmol). The reaction mixture was heated at 90° C. for 16 h. The reaction mixture was cooled, filtered through Celite pad, and concentrated under reduced pressure. The crude compound was purified by silica gel chromatography (pet. ether-ethyl acetate) and the enantiomers were separated via chiral SFC separation to yield Intermediate 5A (0.80 g, 2.7 mmol, 33.4% yield) and Intermediate 5B (0.80 g, 2.7 mmol, 33% yield). SFC prep conditions: Column/dimensions: Whelk (R,R)(250 × 4.6) mm, 5µ; CO2:85%, % Co-solvent: 15% of 0.2% DEA in IPA. Total flow: 3.0 g/min, back pressure: 100 bar, temperature: 40° C., UV: 220 nm. Retention time peak 1= 3.2 min and peak 2= 4.4 min. Enantiomer 1: MS(ESI) m/z: 299.9 [M+H]+. 1H NMR (400 MHz, DMSO-d6) δ = 7.60 (d, J = 7.0 Hz, 1H), 6.62 (d, J = 6.5 Hz, 1H), 6.29 (d, J = 7.0 Hz, 1H), 4.42 - 4.29 (m, 2H), 3.87 - 3.79 (m, 1H), 2.28 (s, 3H). Enantiomer 2: MS(ESI) m/z: 299.9 [M+H]+. 1H NMR (400 MHz, DMSO-d6) δ = 7.60 (d, J = 7.0 Hz, 1H), 6.62 (d, J = 6.5 Hz, 1H), 6.29 (d, J = 7.0 Hz, 1H), 4.42 - 4.29 (m, 2H), 3.87 - 3.79 (m, 1H), 2.28 (s, 3H).


Intermediate 6: 2-(2-Methoxyethyl)-5-methylpyridazin-3(2H)-one



embedded image


To a stirred solution of 5-methylpyridazin-3(2H)-one (1.0 g, 9.1 mmol) in DMF (10 mL) at rt, were added potassium carbonate (3.8 g, 27 mmol), and 1-bromo-2-methoxyethane (1.5 g, 11 mmol). The reaction mixture was heated at 70° C. for 15 h. Then, the reaction mixture was cooled, filtered through Celite pad, and concentrated under reduced pressure. The crude residue was purified by silica gel chromatography (pet. ether-ethyl acetate) to yield Intermediate 6 (1.0 g, 6.0 mmol, 66 % yield) as a yellow liquid. MS(ESI) m/z: 169.1 [M+H]+. 1H NMR (400 MHz, DMSO-d6) δ = 7.79 (d, J = 2.0 Hz, 1H), 6.73 (m, 1H), 4.18 (t, J = 5.8 Hz, 2H), 3.64 (t, J = 5.8 Hz, 2H), 3.23 (s, 3H), 2.16 (d, J = 2.0 Hz, 3H).


Intermediate 7: 4-Bromo-2-(2-methoxyethyl)-5-methylpyridazin-3(2H)-one



embedded image


To a stirred solution of 2-(2-methoxyethyl)-5-methylpyridazin-3(2H)-one (500 mg, 3.0 mmol) in acetonitrile (5 mL) at rt, was added NBS (1060 mg, 5.95 mmol). Then, the reaction mixture was heated at 80° C. for 16 h. The reaction mixture was cooled, filtered through Celite pad and the filtrate was concentrated under reduced pressure. The crude compound was purified by silica gel chromatography (pet. ether-ethyl acetate) to afford theIntermediate 7 (350 mg, 1.4 mmol, 48% yield) as an orange solid. MS(ESI) m/z: 249.1 [M+H]+. 1H NMR (400 MHz, DMSO-d6) δ = 7.86 (s, 1H), 4.26 (t, J = 5.5 Hz, 2H), 3.67 (t, J = 5.5 Hz, 2H), 3.22 (s, 3H), 2.27 (s, 3H).


Example 1: N-((3S,4R)-1-(2-cyanopyridin-3-yl)-4-(2,6-difluoro-4-methoxyphenyl)-2-oxopyrrolidin-3-yl)-4-(difluoromethoxy)benzamide



embedded image


To a stirred solution of Intermediate 3 (80 mg, 0.19 mmol) in 1,4-dioxane (2 mL) were added 3-bromopicolinonitrile (43 mg, 0.23 mmol), and Cs2CO3 (130 mg, 0.39 mmol). The reaction mixture was purged with nitrogen for 5 min and charged with xanthphos (22 mg, 0.039 mmol) and Pd2(dba)3 (18 mg, 0.019 mmol). The reaction mixture was again purged with nitrogen for 3 min and heated at 100° C. for 16 h. The reaction mixture was cooled and filtered through a Celite pad. The filtrate was concentrated under reduced pressure, and the crude product was purified by reverse phase HPLC to afford Example 1 (26 mg, 0.051 mmol, 26% yield) as a white solid. MS(ESI) m/z: 515.2 [M+H]+. 1H NMR (400 MHz, DMSO-d6) δ = 9.14 (d, J= 8.3 Hz, 1H), 8.72 (d, J = 4.6 Hz, 1H), 8.24 (d, J = 8.3 Hz, 1H), 7.94 - 7.87 (m, 3H), 7.35 (s, 1H), 7.29 (d, J = 8.8 Hz, 2H), 6.81 (d, J = 10.8 Hz, 2H), 5.16 - 5.02 (m, 1H), 4.34 - 4.22 (m, 2H), 4.18 - 4.09 (m, 1H), 3.78 (s, 3H). RT = 1.725 min, 100% (Method D).


Example 2: N-((3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-1-(1-methyl-6-oxo-1,6-dihydropyridin-3-yl)-2-oxopyrrolidin-3-yl)-4-(difluoromethoxy)benzamide



embedded image


To a stirred solution of Intermediate 3 (60 mg, 0.15 mmol) in 1,4-dioxane (2 mL) at rt were added 5-bromo-1-methylpyridin-2(1H)-one (33 mg, 0.18 mmol), Cs2CO3 (95 mg, 0.29 mmol) and, N,N′-dimethylethylenediamine (2.6 mg, 0.029 mmol). The reaction mixture was purged with nitrogen for 5 min and then charged with copper (I) iodide (5.5 mg, 0.029 mmol), purged with nitrogen for 3 min and heated at 100° C. for 16 h. The reaction mixture was cooled, filtered through Celite pad and concentrated under reduced pressure to give the crude product, which was purified by reverse phase HPLC to afford the Example 2 (32 mg, 0.062 mmol, 42% yield) as a white solid. MS(ESI) m/z: 520.1 [M+H]+. 1H NMR (400 MHz, DMSO-d6) δ = 9.03 (d, J= 8.6 Hz, 1H), 8.01 (d, J= 2.7 Hz, 1H), 7.93 - 7.81 (m, 3H), 7.55 - 7.13 (m, 3H), 6.80 (d, J= 10.8 Hz, 2H), 6.46 (d, J= 10.0 Hz, 1H), 4.98 (m, 1H), 4.18 - 4.07 (m, 1H), 4.00 (t, J = 8.8 Hz, 1H), 3.93 - 3.85 (m, 1H), 3.78 (s, 3H), 3.45 (s, 3H). RT = 1.677 min, 100% (Method D).


Example 3: N-((3S,4R)-1-(cyclopropylmethyl)-4-(2,6-difluoro-4-methoxyphenyl)-2-oxopyrrolidin-3-yl)-4-(difluoromethoxy)benzamide



embedded image


To a stirred solution of Intermediate 3 (60 mg, 0.15 mmol) in DMF (2 mL) under argon atmosphere at 0° C. was added NaH (8.7 mg, 0.22 mmol), and the resulting reaction mixture was stirred for 30 min. Then bromomethyl cyclopropane (24 mg, 0.18 mmol) was added to the reaction mixture, and the mixture was gradually warmed to rt over a period of 2 h. The reaction mixture was quenched with ice/water and extracted with EtOAc (20 mL × 2). The combined organic layers were washed with water (10 mL) and brine (10 mL), dried over Na2SO4 and concentrated under reduced pressure. The crude product was purified by reverse phase HPLC to afford Example 3 (23 mg, 0.049 mmol, 33 % yield) as a white solid. MS(ESI) m/z: 467.1 [M+H]+. 1H NMR (400 MHz, DMSO-d6) δ = 8.91 (d, J= 8.8 Hz, 1H), 7.87 (d, J = 8.8 Hz, 2H), 7.34 (s, 1H), 7.26 (d, J = 8.6 Hz, 2H), 6.76 (d, J = 10.8 Hz, 2H), 4.92 (t, J = 9.5 Hz, 1H), 3.97 - 3.88 (m, 1H), 3.77 (s, 3H), 3.75 - 3.70 (m, 1H), 3.65 - 3.55 (m, 1H), 3.31 - 3.24 (m, 1H), 3.07 (m, 1H), 1.01 - 0.93 (m, 1H), 0.51 (d, J = 8.1 Hz, 2H), 0.32 - 0.20 (m, 2H). RT = 1.810 min, 99.2% (Method D).


Example 4 and 5: N-((3S, 4R)-4-(2, 6-Difluoro-4-methoxyphenyl)-2-oxo-1-(2-oxo-1-(3, 3, 3-trifluoro-2-hydroxypropyl)-1,2-dihydropyridin-3-yl)pyrrolidin-3-yl)-4-(difluoromethoxy)benzamide (Enantiomers 1 and 2)



embedded image - 4 Enantiomer-1




embedded image - 5 Enantiomer-2


To a stirred solution of N-((3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-2-oxopyrrolidin-3-yl)-4-(difluoromethoxy)benzamide (500 mg, 1.2 mmol) in 1,4-dioxane (10 mL) at rt, were added cesium carbonate (790 mg, 2.4 mmol), and 3-bromo-1-(3,3,3-trifluoro-2-hydroxypropyl)pyridin-2(1H)-one (382 mg, 1.34 mmol). The reaction mixture was purged with nitrogen for 5 min and then charged with N,N-dimethylethane-1,2-diamine (21 mg, 0.24 mmol) and copper (I) iodide (23 mg, 0.12 mmol). The reaction mixture was again purged with nitrogen for 3 min and heated at 100° C. for 16 h. The reaction mixture was cooled, filtered through Celite pad, concentrated under reduced pressure. The crude compound, which was purified reverse phase HPLC followed by chiral SFC to yield Example 4 (68 mg, 0.11 mmol, 9.1% yield), and Example 5 (65 mg, 0.10 mmol, 8.7 % yield). SFC prep condition: Column/dimensions: Luxcellulose (250 × 30) mm, 5µ; % CO2: 60%, % Co-solvent: 40% of 4 M methanolic ammonia in MeOH. Total flow: 120.0 g/min, back pressure: 100 bar, temperature: 30° C., UV: 220 nm; Retention time: peak 1 = 4.6 min and peak 2 = 9.7 min. Enantiomer 1: MS(ESI) m/z: 618.2 [M+H]+. 1H NMR (400 MHz, DMSO-d6) δ = 9.01 (br d, J = 8.6 Hz, 1H), 7.93 - 7.81 (m, 2H), 7.70 (dd, J = 6.8, 2.0 Hz, 1H), 7.65 (dd, J = 7.3, 2.0 Hz, 1H), 7.34 (t, J = 73.6 Hz, 1H), 7.27 (m, 2H), 6.76 (d, J = 10.8 Hz, 2H), 6.37 (t, J= 7.1 Hz, 1H), 5.16 - 5.04 (m, 1H), 4.45 (dd, J= 13.1, 2.8 Hz, 1H), 4.39 - 4.27 (m, 1H), 4.17 - 4.06 (m, 1H), 4.06 - 3.98 (m, 1H), 3.97 - 3.88 (m, 1H), 3.88 -3.80 (m, 1H), 3.76 (s, 3H), 3.35 (br s, 1H). Enantiomer 2: MS(ESI) m/z: 618.2 [M+H]+. 1H NMR (400 MHz, DMSO-d6) δ = 9.02 (d, J = 8.8 Hz, 1H), 7.93 - 7.83 (m, 2H), 7.69 (dd, J = 6.7, 2.1 Hz, 1H), 7.64 (dd, J= 7.3, 2.1 Hz, 1H), 7.34 (t, J = 73.6 Hz, 1H), 7.28 (d, J= 8.8 Hz, 2H), 6.77 (d, J = 10.8 Hz, 2H), 6.37 (t, J= 7.0 Hz, 1H), 5.08 (dd, J = 10.9, 8.9 Hz, 1H), 4.44 (dd, J= 13.1, 3.1 Hz, 1H), 4.39 - 4.26 (m, 1H), 4.15 - 3.99 (m, 2H), 3.97 - 3.90 (m, 1H), 3.84 (dd, J = 13.3, 9.4 Hz, 1H), 3.76 (s, 3H), 3.36 (br s, 1H).


The following Examples in Table 2 were made by using analogous procedures as shown in Examples 1-5 and/or modifications thereof known to one skilled in the art.





TABLE 2








Ex
Structure
LCMS (M+H) +
HPLC Method, RT (min.) & Purity

1H NMR





6


embedded image


549.1
Method D, RT = 2.022 min, 96.2%

1H NMR (400 MHz, DMSO-d6) δ = 9.18 (d, J = 8.1 Hz, 1H), 8.50 (d, J = 8.3 Hz, 1H), 7.96 - 7.82 (m, 2H), 7.70 (d, J = 8.1 Hz, 1H), 7.58 - 7.13 (m, 3H), 6.81 (d, J = 10.8 Hz, 2H), 5.06 (m, 1H), 4.46 - 4.33 (m, 1H), 4.31 - 4.20 (m, 1H), 4.17 - 4.08 (m, 1H), 3.78 (s, 3H).



7


embedded image


558.1
Method D, RT = 1.907 min, 97.7%

1H NMR (400 MHz, DMSO-d6) δ = 9.09 (d, J = 8.6 Hz, 1H), 8.94 - 8.85 (m, 1H), 8.39 (dd, J= 1.6, 7.9 Hz, 1H), 7.95 - 7.83 (m, 2H), 7.73 (dd, J = 5.3, 7.7 Hz, 1H), 7.57 - 7.09 (m, 3H), 6.80 (d, J= 10.8 Hz, 2H), 5.14 (m, 1H), 4.28 (m, 1H), 4.14 (m, J= 9.3 Hz, 1H), 4.02 - 3.94 (m, 1H), 3.77 (s, 3H).



8


embedded image


555.1
Method D, RT = 2.153 min, 97.9%

1H NMR (400 MHz, DMSO-d6) δ = 9.18 (d, J = 8.6 Hz, 1H), 8.05 - 7.87 (m, 2H), 7.50 (d, J = 8.1 Hz, 2H), 7.29 (m, 1H), 7.14 (m, 1H), 6.95 (m, 1H), 6.79 (d, J = 10.8 Hz, 2H), 5.13 (m, 1H), 4.24 - 4.13 (m, 1H), 4.05 (t, J = 8.8 Hz, 1H), 4.01 -3.90 (m, 1H), 3.77 (s, 3H), 3.51 (s, 3H).



9


embedded image


510.2
Method D, RT = 1.931 min, 97.7%

1H NMR (400 MHz, DMSO-d6) δ = 9.35 (d, J = 8.3 Hz, 1H), 8.38 (d, J = 4.6 Hz, 1H), 8.03 (d, J = 8.3 Hz, 2H), 7.96 - 7.82 (m, 3H), 7.49 (m, 1H), 6.81 (d, J = 11.0 Hz, 2H), 5.13 (t, J = 9.3 Hz, 1H), 4.33 -4.16 (m, 2H), 4.15 - 4.03 (m, 1H), 3.78 (s, 3H).



10


embedded image


520.1
Method D, RT = 1.583 min, 90.7%

1H NMR (400 MHz, DMSO-d6) δ = 9.13 (d, J = 7.8 Hz, 1H), 7.89 (d, J = 8.8 Hz, 2H), 7.57 - 7.12 (m, 4H), 6.81 (d, J= 10.5 Hz, 2H), 6.46 (d, J = 9.3 Hz, 1H), 6.40 (m, 1H), 4.87 - 4.73 (m, 1H), 4.37 - 4.24 (m, 1H), 4.04 (t, J = 8.7 Hz, 1H), 3.99 -3.92 (m, 1H), 3.78 (s, 3H), 3.45 (br s, 3H).



11


embedded image


538.1
Method D, RT = 1.759 min, 99.2%

1H NMR (400 MHz, DMSO-d6) δ = 9.23 (d, J= 8.1 Hz, 1H), 8.03 - 7.88 (m, 2H), 7.57 - 7.45 (m, 3H), 6.82 (d, J= 10.8 Hz, 2H), 6.50 - 6.44 (m, 1H), 6.40 (dd, J = 1.0, 7.1 Hz, 1H), 4.90 - 4.76 (m, 1H), 4.37 - 4.24 (m, 1H), 4.05 (t, J = 8.8 Hz, 1H), 4.00 - 3.92 (m, 1H), 3.78 (s, 3H), 3.44 (br s, 3H).



12


embedded image


591
Method D, RT = 2.381 min, 92.5%

1H NMR (400 MHz, DMSO-d6) δ = 9.11 (d, J = 8.1 Hz, 1H), 8.20 (s, 1H), 8.11 (s, 1H), 7.95 - 7.83 (m, 2H), 7.69 (s, 1H), 7.55 - 7.12 (m, 3H), 6.81 (d, J=10.8 Hz, 2H), 5.04 (m, 1H), 4.33 - 4.23 (m, 1H), 4.21 - 4.10 (m, 2H), 3.79 (s, 3H).



13


embedded image


584.2
Method D, RT = 1.784 min, 98.7%

1H NMR (400 MHz, DMSO-d6) δ = 9.23 (d, J= 8.1 Hz, 1H), 8.72 (d, J= 12.7 Hz, 1H), 8.59 (m, 1H), 7.96 (d, J = 8.8 Hz, 2H), 7.62 - 7.42 (m, 3H), 6.80 (d, J= 10.5 Hz, 2H), 5.03 (m, 1H), 4.47 (t, J= 9.8 Hz, 1H), 4.18 (m, 1H), 4.09 - 3.99 (m, 1H), 3.79 (s, 3H), 1.75 (s, 3H), 1.70 (s, 3H).



14


embedded image


583.2
Method D, RT = 1.414 min, 99.8%

1H NMR (400 MHz, DMSO-d6) δ = 9.17 (d, J = 8.3 Hz, 1H), 7.95 (d, J = 8.8 Hz, 2H), 7.50 (d, J = 8.3 Hz, 2H), 7.25 (m, 1H), 7.17 (s, 1H), 6.80 (d, J = 10.5 Hz, 2H), 6.70 - 6.61 (m, 1H), 5.06 (m, 1H), 4.66 (m, 1H), 4.23 - 4.05 (m, 2H), 4.04 -3.94 (m, 1H), 3.78 (s, 3H), 1.28 (d, J = 5.9 Hz, 6H).



15


embedded image


533.1
Method D, RT = 1.951 min, 97.8%

1H NMR (400 MHz, DMSO-d6) δ = 9.27 (d, J = 8.1 Hz, 1H), 8.81 (m, 1H), 8.45 (m, 1H), 7.96 (d, J = 8.8 Hz, 2H), 7.57 (m, 1H), 7.51 (d, J= 8.3 Hz, 2H), 6.81 (d, J = 10.8 Hz, 2H), 5.11 (m, 1H), 4.49 -4.37 (m, 1H), 4.26 (q, J = 9.5 Hz, 1H), 4.19 - 4.08 (m, 1H), 3.75 (s, 3H).



16


embedded image


529.2
Method D, RT = 2.370 min, 100.0%

1H NMR (400 MHz, DMSO-d6) δ = 9.08 - 9.02 (m, 1H), 7.89 (d, J = 8.8 Hz, 2H), 7.46 (m, 1H), 7.31 - 7.26 (m, 3H), 7.16 (s, 1H), 6.87 - 6.71 (m, 3H), 5.11 - 4.97 (m, 1H), 4.67 (m, 1H), 4.25 - 4.06 (m, 2H), 4.05 - 3.96 (m, 1H), 3.78 (s, 3H), 1.27 (d, J = 5.9 Hz, 6H).



17


embedded image


597.2
Method D, RT = 1.763 min, 98.4%

1H NMR (400 MHz, DMSO-d6) δ = 9.10 (d, J = 8.3 Hz, 1H), 7.96 (d, J = 8.8 Hz, 2H), 7.71 - 7.60 (m, 2H), 7.52 - 7.42 (m, 4H), 6.75 (d, J= 10.8 Hz, 2H), 5.13 - 4.98 (m, 2H), 4.95 - 4.87 (m, 1H), 4.02 (m, 1H), 3.75 (s, 3H), 3.61 (m, 1H), 3.52 -3.44 (m, 1H), 1.80 (s, 3H), 1.74 (s, 3H).



18


embedded image


579.2
Method D, RT = 1.607 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.00 (d, J= 8.1 Hz, 1H), 7.90 (d, J = 8.8 Hz, 2H), 7.71 - 7.60 (m, 2H), 7.50 - 7.41 (m, 2H), 7.35 (s, 1H), 7.29 (d, J = 8.6 Hz, 2H), 6.75 (d, J = 10.5 Hz, 2H), 5.05 (m, 2H), 4.93 - 4.86 (m, 1H), 4.02 (m, 1H), 3.75 (s, 3H), 3.60 (m, 1H), 3.50 - 3.43 (m, 1H), 1.80 (s, 3H), 1.75 (s, 3H).



19


embedded image


583.1
Method D, RT = 1.723 min, 93.7%

1H NMR (400 MHz, DMSO-d6) δ = 9.21 - 9.06 (m, 1H), 7.95 (d, J = 8.6 Hz, 2H), 7.89 - 7.79 (m, 1H), 7.74 - 7.66 (m, 1H), 7.60 - 7.52 (m, 1H), 7.52 - 7.44 (m, 3H), 6.85 - 6.72 (m, 2H), 5.12 - 4.90 (m, 1H), 4.31 - 4.16 (m, 1H), 4.13 - 3.89 (m, 2H), 3.77 (s, 3H), 1.86 - 1.58 (m, 6H).



20


embedded image


485.1
Method D, RT = 1.965 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.01 (d, J = 8.6 Hz, 1H), 7.93 (d, J = 8.8 Hz, 2H), 7.48 (d, J = 8.3 Hz, 2H), 6.78 (s, 1H), 6.75 (s, 1H), 4.96 - 4.89 (m, 1H), 3.93 (m, 1H), 3.77 (s, 3H), 3.76 - 3.72 (m, 1H), 3.64 - 3.56 (m, 1H), 3.31 - 3.25 (m, 1H), 3.07 (m, 1H), 1.02 - 0.89 (m, 1H), 0.51 (d, J= 8.1 Hz, 2H), 0.30 - 0.20 (m, 2H).



21


embedded image


533.1
Method D, RT = 1.897 min, 96.7%

1H NMR (400 MHz, DMSO-d6) δ = 9.25 (d, J = 8.3 Hz, 1H), 8.72 (m, 1H), 8.25 (m, 1H), 8.02 - 7.93 (m, 2H), 7.90 (m, 1H), 7.51 (d, J = 8.3 Hz, 2H), 6.82 (d, J = 10.8 Hz, 2H), 5.13 (m, 1H), 4.36 - 4.22 (m, 2H), 4.17 - 4.07 (m, 1H), 3.78 (s, 3H).



22


embedded image


584.1
Method D, RT = 1.620 min, 93.1%

1H NMR (400 MHz, DMSO-d6) δ = 9.16 (d, J = 8.1 Hz, 1H), 8.79 - 8.70 (m, 1H), 8.33-8.31 (m, 1H), 7.95 (d, J = 8.8 Hz, 2H), 7.61 (m, 1H), 7.59 - 7.50 (m, 2H), 6.79 (d, J = 10.8 Hz, 2H), 5.10 - 4.94 (m, 1H), 4.33 - 4.23 (m, 1H), 4.15 - 4.08 (m, 1H), 4.06 - 3.97 (m, 1H), 3.78 (s, 3H), 1.91 - 1.68 (m, 6H).



23


embedded image


538.1
Method D, RT = 2.065 min, 94.0%

1H NMR (400 MHz, DMSO-d6) δ = 9.19 (d, J = 8.3 Hz, 1H), 8.25 (d, J = 5.9 Hz, 1H), 8.01 - 7.81 (m, 3H), 7.51 (d, J = 8.3 Hz, 2H), 6.85 (m, 1H), 6.79 (d, J = 10.8 Hz, 2H), 5.08 (m, 1H), 4.44 (m, 1H), 4.12 (m, 1H), 4.03 - 3.94 (m, 1H), 3.85 (s, 3H), 3.78 (s, 3H).



24


embedded image


558.1
Method D, RT = 2.223 min, 92.5%

1H NMR (400 MHz, DMSO-d6) δ = 9.23 (d, J = 8.1 Hz, 1H), 8.50 (d, J = 8.3 Hz, 1H), 8.09 (m, 1H), 7.96 (d, J = 8.6 Hz, 2H), 7.54 - 7.48 (m, 3H), 6.9 (s, 1 H), 6.82 - 6.74 (m, 2H), 5.11 (m, 1H), 4.46 (m, 1H), 4.17 (m, 1H), 4.06 - 3.96 (m, 1H), 3.78 (s, 3H).



25


embedded image


566.2
Method D, RT = 1.594 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.06 (d, J = 7.8 Hz, 1H), 8.82 - 8.68 (m, 1H), 8.41 - 8.28 (m, 1H), 7.89 (d, J = 8.8 Hz, 2H), 7.61 (m, 1H), 7.54 - 7.07 (m, 3H), 6.87 - 6.71 (m, 2H), 5.08 - 4.91 (m, 1H), 4.38 - 4.23 (m, 1H), 4.11 (m, 1H), 4.06 -3.94 (m, 1H), 3.78 (s, 3H), 1.86 - 1.72 (m, 6H).



26


embedded image


538.1
Method D, RT = 1.677 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.13 (d, J = 8.3 Hz, 1H), 8.01 (d, J = 2.9 Hz, 1H), 7.94 (d, J = 8.8 Hz, 2H), 7.87 (m, 1H), 7.50 (d, J = 8.6 Hz, 2H), 6.80 (d, J = 10.8 Hz, 2H), 6.46 (d, J = 9.8 Hz, 1H), 5.08 - 4.91 (m, 1H), 4.12 (m, 1H), 4.00 (m, 1H), 3.94 - 3.87 (m, 1H), 3.78 (s, 3H), 3.45 (s, 3H).



27


embedded image


538.1
Method D, RT = 1.874 min, 93.8%

1H NMR (400 MHz, DMSO-d6) δ = 9.20 (d, J = 8.3 Hz, 1H), 8.19 (d, J = 8.6 Hz, 1H), 7.96 (d, J = 8.8 Hz, 2H), 7.88 (m, 1H), 7.51 (d, J = 8.3 Hz, 2H), 7.29 (d, J = 7.3 Hz, 1H), 6.80 (d, J = 10.8 Hz, 2H), 5.40 (m, 1H), 5.10 (m, 1H), 4.52 (d, J = 5.9 Hz, 2H), 4.44 (m, 1H), 4.12 (q, J = 9.9 Hz, 1H), 4.01 - 3.98 (m, 1H), 3.78 (s, 3H).



28


embedded image


526.1
Method D, RT = 1.926 min, 97.9%

1H NMR (400 MHz, DMSO-d6) δ = 9.22 (d, J = 8.3 Hz, 1H), 8.38 (d, J = 4.4 Hz, 1H), 8.03 - 7.78 (m, 3H), 7.57 - 7.39 (m, 3H), 6.80 (d, J = 10.8 Hz, 2H), 5.11(m, 1H), 4.32 - 4.17 (m, 2H), 4.15 - 4.06 (m, 1H), 3.78 (s, 3H).



29


embedded image


565.2
Method D, RT = 2.289 min, 93.5%

1H NMR (400 MHz, DMSO-d6) δ = 9.07 (d, J = 8.3 Hz, 1H), 7.89 (d, J = 8.8 Hz, 2H), 7.55 - 7.10 (m, 5H), 6.80 (d, J = 10.8 Hz, 2H), 6.69 - 6.60 (m, 1H), 5.05 (m, 1H), 4.66 (m, 1H), 4.24 - 4.04 (m, 2H), 4.02 - 3.92 (m, 1H), 3.78 (s, 3H), 1.28 (d, J = 5.9 Hz, 6H).



30


embedded image


566.2
Method D, RT = 1.529 min, 89.8%

1H NMR (400 MHz, DMSO-d6) δ = 9.02 (d, J = 8.3 Hz, 1H), 8.76 (d, J = 4.4 Hz, 1H), 8.01 - 7.94 (m, 1H), 7.92 - 7.87 (m, 2H), 7.74 - 7.67 (m, 1H), 7.31 - 7.21 (m, 3H), 6.79 - 6.71 (m, 2H), 5.14 (dd, J = 8.7, 10.6 Hz, 1H), 4.27 - 4.18 (m, 1H), 4.12 - 4.00 (m, 2H), 3.77 (s, 3H), 1.70-1.63 (m, 6H).



31


embedded image


565.1
Method D, RT = 1.604 min, 95.1%

1H NMR (400 MHz, DMSO-d6) δ = 9.09 - 8.98 (m, 1H), 7.94 - 7.77 (m, 3H), 7.70 (t, J = 7.8 Hz, 1H), 7.61 - 7.52 (m, 1H), 7.46 (dd, J = 3.4, 7.8 Hz, 1H), 7.35 (s, 1H), 7.31 - 7.15 (m, 3H), 6.82 - 6.71 (m, 1H), 5.09 - 4.94 (m, 1H), 4.29 - 4.18 (m, 1H), 4.12 - 3.89 (m, 2H), 3.77 (s, 3H), 1.83 - 1.68 (m, 6H).



32


embedded image


520.1
Method D, RT = 1.886 min, 94.2%

1H NMR (400 MHz, DMSO-d6) δ = 9.09 (d, J = 8.1 Hz, 1H), 8.25 (d, J = 5.9 Hz, 1H), 7.96 (d, J = 2.2 Hz, 1H), 7.92 - 7.86 (m, 2H), 7.36 (s, 1H), 7.29 (d, J = 8.8 Hz, 2H), 6.85 (m, 1H), 6.79 (d, J = 10.5 Hz, 2H), 5.06 (dd, J = 8.1, 11.0 Hz, 1H), 4.47 - 4.40 (m, 1H), 4.17 - 4.08 (m, 1H), 4.03 - 3.94 (m, 1H), 3.86 (s, 3H), 3.78 (s, 3H).



33


embedded image


508.1
Method D, RT = 1.790 min, 90.9%

1H NMR (400 MHz, DMSO-d6) δ = 9.12 (d, J=8.6 Hz, 1H), 8.38 (d, J=4.6 Hz, 1H), 7.96 - 7.84 (m, 3H), 7.56 - 7.13 (m, 4H), 6.80 (d, J=10.8 Hz, 2H), 5.17 - 5.01 (m, 1H), 4.32 - 4.17 (m, 2H), 4.15 - 4.03 (m, 1H), 3.78 (s, 3H).



34


embedded image


520.2
Method D, RT = 1.564 min, 99.4%

1H NMR (400 MHz, DMSO-d6) δ = 9.01 (d, J = 8.8 Hz, 1H), 7.96 - 7.82 (m, 2H), 7.76 (m, 1H), 7.59 (m, 1H), 7.55 - 7.11 (m, 3H), 6.77 (d, J = 10.8 Hz, 2H), 6.33 (m, 1H), 5.11 (m, 1H), 4.17 - 4.03 (m, 1H), 3.98 (m, 2H), 3.77 (s, 3H), 3.51 (s, 3H).



35


embedded image


618.3
Method D, RT = 1.881 min, 94.8%

1H NMR (400 MHz, DMSO-d6) δ = 9.05 (d, J = 8.3 Hz, 1H), 7.89 (d, J = 8.8 Hz, 2H), 7.55 - 7.13 (m, 4H), 6.79 (d, J = 10.5 Hz, 2H), 6.14 (d, J = 1.5 Hz, 1H), 5.08 (m, 1H), 4.43 (m, 1H), 4.06 (m, 1H), 3.92 - 3.84 (m, 1H), 3.79 (d, J = 7.6 Hz, 6H), 3.48 (m, 4H), 2.49 - 2.35 (m, 4H), 2.25 (s, 3H).



36


embedded image


564.2
Method D, RT = 1.640 min, 97.8%

1H NMR (400 MHz, DMSO-d6) δ = 9.02 (d, J = 8.6 Hz, 1H), 7.93 - 7.83 (m, 2H), 7.67 (dd, J = 6.8, 2.0 Hz, 1H), 7.60 (dd, J = 7.3, 2.0 Hz, 1H), 7.34 (t, J = 73.6 Hz, 1H), 7.27 (d, J = 8.8 Hz, 2H), 6.77 (d, J = 10.8 Hz, 2H), 6.33 (t, J = 7.0 Hz, 1H), 5.12 (dd, J = 11.0, 8.6 Hz, 1H), 4.20 - 4.03 (m, 3H), 4.02 - 3.94 (m, 2H), 3.77 (s, 3H), 3.60 (t, J = 5.3 Hz, 2H), 3.25 (s, 3H).



37


embedded image


582.2
Method D, RT = 1.808 min, 95.8%

1H NMR (400 MHz, DMSO-d6) δ = 9.13 (d, J = 8.6 Hz, 1H), 8.00 - 7.87 (m, 2H), 7.67 (dd, J = 6.8, 2.0 Hz, 1H), 7.60 (dd, J = 7.3 Hz, 2.0, 1H), 7.49 (d, J = 7.8 Hz, 2H), 6.78 (d, J= 10.8 Hz, 2H), 6.33 (t, J= 7.0 Hz, 1H), 5.13 (dd, J = 11.0, 8.6 Hz, 1H), 4.19 - 3.93 (m, 5H), 3.77 (s, 3H), 3.60 (t, J = 5.3 Hz, 2H), 3.25 (s, 3H).



38


embedded image


534.2
Method D, RT = 1.651 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.02 (d, J = 8.6 Hz, 1H), 7.94 - 7.84 (m, 2H), 7.77 (dd, J = 6.8, 2.0 Hz, 1H), 7.58 (dd, J = 7.1, 2.0 Hz, 1H), 7.34 (t, J = 73.6 Hz, 1H), 7.27 (d, J = 8.6 Hz, 2H), 6.77 (d, J = 10.8 Hz, 2H), 6.35 (t, J = 7.0 Hz, 1H), 5.12 (dd, J = 11.0, 8.6 Hz, 1H), 4.16 -4.04 (m, 1H), 4.02 - 3.92 (m, 4H), 3.77 (s, 3H), 1.25 (t, J = 7.1 Hz, 3H).



39


embedded image


488.1
Method D, RT = 1.73 min, 99%

1H NMR (400 MHz, DMSO-d6) δ = 9.14 (d, J = 8.8 Hz, 1H), 8.10 (dd, J= 4.6, 1.2 Hz, 1H), 7.90 - 7.77 (m, 2H), 7.64 (dd, J = 8.4, 1.2 Hz, 1H), 7.61 - 7.53 (m, 2H), 7.44-7.41 (m, 1H), 6.79 (d, J = 10.8 Hz, 2H), 5.22 (dd, J = 11.1, 8.9 Hz, 1H), 4.23 - 4.11 (m, 1H), 4.05 (t, J = 8.9 Hz, 1H), 3.93 - 3.89 (m, 1H), 3.87 (s, 3H) 3.77 (s, 3H).



40


embedded image


598.2
Method D, RT = 1.68 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.11 (d, J = 8.3 Hz, 1H), 7.84 - 7.82 (m, 2H), 7.59 - 7.56 (m, 2H), 7.22 (d, J = 2.0 Hz, 1H), 6.79 (d, J =10.8 Hz, 2H), 5.80 (s, 1H), 5.11 - 5.06 (m, 1H), 4.59 (br s, 1H), 4.45 (t, J= 9.9 Hz, 1H), 4.08 - 3.98 (m, 1H), 3.90 - 3.81 (m, 2H), 3.78 (s, 3H), 3.77 (s, 3H), 3.45 - 3.38 (m, 2H), 3.25 -3.22 - 3.19 (m, 1H), 2.82 - 2.76 (m, 1H), 2.24 (s, 3H), 1.83 - 1.79 (m, 1H), 1.71 -1.63 (m, 1H).



41


embedded image


593.3
Method D, RT = 1.424 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.00 (d, J = 8.8 Hz, 1H), 7.96 - 7.81 (m, 2H), 7.68 (dd, J = 7.0, 1.8, Hz, 1H), 7.55 (dd, J= 7.2, 1.8 Hz, 1H), 7.34 (t, J= 73.6 Hz, 1H), 7.28 (d, J = 8.8 Hz, 2H), 6.76 (d, J = 10.8 Hz, 2H), 6.34 (t, J = 7.1 Hz, 1H), 5.10 (dd, J = 10.8, 8.6 Hz, 1H), 5.01 -4.88 (m, 1H), 4.15 - 4.03 (m, 1H), 4.03 -3.89 (m, 2H), 3.80 - 3.71 (m, 4H), 3.61 (dd, J= 10.5, 4.4 Hz, 1H), 3.34 (br s, 2H), 3.23 (s, 3H), 2.95 - 2.81 (m, 2H).



42


embedded image


634.2
Method D, RT = 2.634 min, 99%

1H NMR (400 MHz, DMSO-d6) δ = 9.13 - 9.04 (m, 1H), 7.93 - 7.84 (m, 2H), 7.70 - 7.57 (m, 1H), 7.34 (t, J = 72 Hz, 1H), 7.29 - 7.27 (m, 2H), 6.89 - 6.74 (m, 3H), 5.16 - 5.07 (m, 1H), 4.26 - 4.15 (m, 2H), 4.06 - 3.93 (m, 3H), 3.76 (s, 3H), 2.56 -2.47 (m, 2H), 2.17 (s, 3H), 2.16 - 2.10 (m, 2H), 1.12 - 1.03 (d, J = 6 Hz, 6H).



43


embedded image


529.15
Method D, RT = 1.97 min, 97%

1H NMR (400 MHz, DMSO-d6) δ = 8.96 (d, J = 8.6 Hz, 1H), 8.07 (dd, J= 4.6, 1.2 Hz, 1H), 7.90 - 7.79 (m, 2H), 7.61 (d, J = 7.3 Hz, 1 H), 7.57 - 7.49 (m, 2H), 7.37 (dd, J = 8.3, 4.6 Hz, 1H), 6.84 - 6.70 (m, 2H), 5.60 (dd, J = 11.5, 8.8 Hz, 1H), 4.74-4.68 (m, 1H), 4.54 - 4.44 (m, 1H), 4.40-4.35 (m, 1H), 3.77 (s, 3H), 1.28 (d, J= 6.0 Hz, 3H), 1.27 (d, J= 6.0 Hz, 3H), 0.90 (d, J= 6.6 Hz, 3H).



44


embedded image


593.3
Method D, RT = 1.427 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.11 (d, J = 8.6 Hz, 1H), 7.95 (d, J = 8.8 Hz, 2H), 7.68 (dd, J = 7.0, 1.8 Hz, 1H), 7.56 (dd, J= 7.1, 1.8 Hz, 1H), 7.34 (t, J= 73.6 Hz, 1H), 7.28 (d, J = 8.8 Hz, 2H), 6.77 (d, J = 10.8 Hz, 2H), 6.34 (t, J = 7.1 Hz, 1H), 5.13 (dd, J = 10.8, 8.8 Hz, 1H), 5.02 - 4.90 (m, 1H), 4.15 - 3.88 (m, 3H), 3.81 - 3.70 (m, 4H), 3.61 (dd, J= 10.8, 4.4 Hz, 1H), 3.35 - 3.33 (br s, 2H), 3.20 (s, 3H), 2.96 - 2.84 (m, 2H).



45


embedded image


570.2
Method D, RT = 1.84 min, 96.7%

1H NMR (400 MHz, DMSO-d6) δ = 9.06 (d, J = 8.8 Hz, 1H), 8.01 - 7.91 (m, 2H), 7.72 (dd, J= 7.0, 1.8 Hz, 1H), 7.66 (dd, J = 7.1, 1.8 Hz, 1H), 7.55 - 7.35 (m, 3H), 6.89 - 6.74 (m, 2H), 6.43 - 6.40 (m, 1H), 6.35 (t, J = 57.6 Hz, 1H), 5.14 (dd, J = 11.4, 8.7 Hz, 1H), 4.49 - 4.43 (m, 2H), 4.20 - 4.09 (m, 1H), 4.07 - 3.97 (m, 1H), 3.76 (s, 3H), 3.75 - 3.67 (m, 1H).



46


embedded image


577.2
Method D, RT = 1.862 min, 99%

1H NMR (400 MHz, DMSO-d6) δ = 9.12 (d, J = 8.3 Hz, 1H), 8.01 - 7.74 (m, 3H), 7.74 - 7.28 (m, 3H), 7.36 (t, J = 72 Hz, 1H), 6.81 (d, J= 10.8 Hz, 2H), 5.11 (m, 1H), 4.33 - 4.15 (m, 2H), 4.12 - 3.98 (m, 1H), 3.78 (s, 3H), 3.76 - 3.57 (m, 2H), 3.13 (t, J = 4.4 Hz, 2H).



47


embedded image


636.2
Method D, RT = 1.904 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.18 - 9.04 (m, 1H), 7.99 - 7.86 (m, 2H), 7.70 (dd, J = 6.8, 2.0 Hz, 1H), 7.66 (dd, J = 7.3, 2.0 Hz, 1H), 7.53 - 7.39 (m, 2H), 6.77 (d, J = 10.8 Hz, 2H), 6.37 (t, J = 7.0 Hz, 1H), 5.16 - 5.02 (m, 1H), 4.45 (dd, J = 13.2, 2.9 Hz, 1H), 4.37 - 4.25 (m, 1H), 4.19 - 3.98 (m, 2H), 3.98 - 3.80 (m, 2H), 3.76 (s, 3H), 3.35 - 3.33 (brs, 1H).



48


embedded image


616.3
Method D, RT = 1.939 min, 99%

1H NMR (400 MHz, DMSO-d6) δ = 9.07 (d, J = 8.3 Hz, 1H), 7.94 - 7.82 (m, 2H), 7.64 - 7.56 (m, 2H), 7.36 (t, J = 72 Hz, 1H), 7.29 - 7.27 (m, 2H), 6.86 - 6.73 (m, 2H), 6.63 (dd, J = 6.1, 2.9 Hz, 1H), 5.07 (dd, J= 11.0, 9.0 Hz, 1H), 4.51 - 4.39 (m, 1H), 4.14 - 3.98 (m, 3H), 3.97 - 3.87 (m, 1H), 3.78 (s, 3H), 3.34 - 3.28 (m, 2H), 2.17 (s, 3H), 2.17 - 2.03 (m, 2H), 1.06 (d, J= 5.9 Hz, 6H).



49


embedded image


612.3
Method D, RT = 1.74 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.11 (d, J = 8.6 Hz, 1H), 7.84 (d, J = 8.4 Hz, 2H), 7.57 (d, J= 8.4 Hz, 2H), 6.90 - 6.69 (m, 3H), 5.85 (s, 1H), 4.99 (dd, J = 10.8, 8.3 Hz, 1H), 4.61 - 4.38 (m, 2H), 3.79 (s, 3H), 3.78 (s, 3H), 3.64-3.61 (m, 2H), 3.45 - 3.42 (m, 1H), 3.23 - 3.21 (m, 1H), 2.80 (dd, J = 9.3, 2.0 Hz, 1H), 2.42-2.44 (m, 1H), 2.25 (s, 3H), 1.92 - 1.77 (m, 1H), 1.71-1.68 (m, 1H), 1.36 (d, J = 5.9 Hz, 3H).



50


embedded image


618.2
Method D, RT = 2.407 min, 96%

1H NMR (400 MHz, DMSO-d6) δ = 9.10 - 9.03 (m, 1H), 7.93 - 7.86 (m, 2H), 7.59 - 7.56 (m, 1H), 7.35 (t, J = 72 Hz, 1H), 7.29 - 7.27 (m, 2H), 6.84 - 6.74 (m, 2H), 6.51 - 6.43 (m, 1H), 5.17 - 5.07 (m, 1H), 4.55 - 4.48 (m, 1H), 4.20 - 4.11 (m, 2H), 4.02 - 3.93 (m, 1H), 3.77 (s, 3H), 3.44 -3.38 (m, 3H), 2.83 - 2.76 (m, 1H), 2.47 -2.39 (m, 1H), 2.25 (s, 3H), 1.87 - 1.82 (m, 1H), 1.74 - 1.69 (m, 1H).



51


embedded image


644.3
Method D, RT = 1.69 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 8.86 (d, J= 8.6 Hz, 1H), 7.93 - 7.82 (m, 2H), 7.35 (t, J = 73.6 Hz, 1H), 7.27 - 7.25 (m, 3H), 6.87 - 6.70 (m, 2H), 5.78 (d, J= 1.7 Hz, 1H), 5.65 (dd, J = 12.8, 8.4 Hz, 1H), 4.94 - 4.83 (m, 1H), 4.58 — 4.53 (m, 1H), 4.26 - 4.21 (m, 1H), 3.77 (s, 3H), 3.76 (s, 3H), 3.43 - 3.37 (m, 1H), 3.40 - 3.36 (m, 1H), 3.26 - 3.24 (m, 1H), 2.79-2.76 (m, 1H), 2.46 - 2.37 (m, 1H), 2.27 (s, 3H), 1.82 - 1.7 (m, 1H), 1.75 - 1.64 (m, 1H), 1.18 (d, J = 6.4 Hz, 3H).



52


embedded image


556.2
Method D, RT = 1.764 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.02 (d, J= 8.6 Hz, 1H), 7.92 (t, J = 59.2 Hz, 1H) 7.92 (t, J= 67.2 Hz, 1H), 7.89 - 7.74 (m, 3H), 7.34 (t, J = 73.6 Hz, 1H) 7.28 (d, J = 8.4 Hz, 2H), 6.78 (d, J = 10.8 Hz, 2H), 6.56 (t, J = 7.2 Hz, 1H), 5.08 (dd, J = 11.0, 8.6 Hz, 1H), 4.20 - 4.07 (m, 1H), 4.06 - 3.94 (m, 2H), 3.77 (s, 3H).



53


embedded image


564.3
Method D, RT = 1.70 min, 94.9%

1H NMR (400 MHz, DMSO-d6) δ = 8.64 (d, J= 8.0 Hz, 1H), 7.81 - 7.55 (m, 4H), 7.50 - 7.23 (m, 3H), 6.79 - 6.57 (m, 2H), 6.36 (t, J = 7.0 Hz, 1H), 5.24 - 5.11 (m, 1H), 4.23 - 4.04 (m, 5H), 3.72 (s, 3H), 3.66 - 3.57 (m, 2H), 3.24 (s, 3H).



54


embedded image


606.2
Method D, RT = 1.805 min, 97%

1H NMR (400 MHz, DMSO-d6) δ = 9.07 (br d, J = 8.1 Hz, 1H), 7.93 - 7.82 (m, 2H), 7.63 (t, J = 9.3 Hz, 1H), 7.34 (t, J = 72 Hz, 1H), 7.29 - 7.6 (m, 2H), 6.86 -6.73 (m, 3H), 5.12 (t, J = 9.4 Hz, 1H), 4.25 - 4.13 (m, 2H), 4.03 - 3.94 (m, 1H), 3.78 (s, 3H), 3.48 - 3.42 (m, 4H), 2.48 -2.36 (m, 4H), 2.25 (s, 3H).



55


embedded image


584.2
Method D, RT = 1.81 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 8.95 (d, J = 8.8 Hz, 1H), 7.96 - 7.85 (m, 2H), 7.77 (dd, J = 6.8, 2.0 Hz, 1H), 7.63 (dd, J= 7.3, 2.0 Hz, 1H), 7.51 (d, J= 8.1 Hz, 1H), 7.35 (t, J= 72.0 Hz, 1H), 7.32 - 7.23 (m, 2H), 6.86 - 6.74 (m, 2H), 6.38 (t, J = 7.1 Hz, 1H), 5.13 (dd, J = 11.5, 8.8 Hz, 1H), 4.30 - 4.09 (m, 3H), 4.04 - 3.94 (m, 1H), 3.74 (s, 3H), 3.73 - 3.64 (m, 1H), 2.84 - 2.70 (m, 2H).



56


embedded image


564.2
Method D, RT = 1.75 min, 98.9%

1H NMR (400 MHz, DMSO-d6) δ = 9.06 (d, J = 8.8 Hz, 1H), 8.04 - 7.88 (m, 2H), 7.65 (dd, J= 6.7, 2.1 Hz, 1H), 7.59 (dd, J = 7.1, 2.0 Hz, 1H), 7.55 - 7.37 (m, 3H), 6.90 - 6.70 (m, 2H), 6.32 (t, J = 7.0 Hz, 1H), 5.14 (dd, J = 11.2, 8.8 Hz, 1H), 4.22 - 4.06 (m, 3H), 4.05 - 3.94 (m, 1H), 3.74 (s, 3H), 3.72 - 3.65 (m, 1H), 3.60 (t, J = 5.3 Hz, 2H), 3.25 (s, 3H).



57


embedded image


556.3
Method D, RT = 1.881 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.05 (t, J = 8.6 Hz, 1H), 8.06 - 7.91 (m, 2H), 7.75 - 7.60 (m, 1H), 7.57 - 7.42 (m, 2H), 7.42 - 7.22 (m, 2H), 6.91 (dd, J = 13.8, 8.7 Hz, 2H), 6.22 (d, J = 6.8 Hz, 1H), 5.28 - 4.66 (m, 1H), 4.14 - 3.78 (2 s, 3H), 3.77 - 3.64 (m, 5H), 2.21 - 2.07 (2 s, 3H), 1.27 - 1.08 (m, 1H), 0.55 - 0.43 (m, 2H), 0.44 - 0.32 (m, 2H). (mixture of interconvertible atropisomers)



58


embedded image


625.2
Method D, RT = 1.87 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.23 (d, J= 8.5 Hz, 1H), 8.07 - 8.00 (m, 1H), 7.99 - 7.87 (m, 3H), 7.55 - 7.45 (m, 2H), 6.80 (d, J = 10.5 Hz, 2H), 5.15-5.10 (m, 1H), 4.33 - 4.18 (m, 4H), 4.12 - 4.04 (m, 1H), 4.02 - 3.88 (m, 4H), 3.90 (s, 3H).



59


embedded image


552.2
Method D, RT = 1.75 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 8.96 (d, J = 8.8 Hz, 1H), 7.96 - 7.86 (m, 2H), 7.72 (dd, J= 6.8, 2.0 Hz, 1H), 7.66 (dd, J = 7.3, 2.0 Hz, 1H), 7.55 - 7.49 (m, 1H), 7.35 (t, J = 73.6 Hz, 1H), 7.33 - 7.25 (m, 2H), 6.85 - 6.75 (m, 2H), 6.42 (t, J= 7.2 Hz, 1H), 6.35 (t, J = 57.6 Hz, 1H), 5.13 (dd, J= 11.4, 8.7 Hz, 1H), 4.53 - 4.37 (m, 2H), 4.20 - 4.10 (m, 1H), 4.05 - 3.95 (m, 1H), 3.74 (s, 3H), 3.70 (t, J= 9.5 Hz, 1H).



60


embedded image


546.2
Method D, RT = 1.69 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.02 (d, J = 8.6 Hz, 1H), 8.08 - 7.91 (m, 2H), 7.64 (dd, J= 6.8, 2.0 Hz, 1H), 7.59 (dd, J = 7.3, 2.0 Hz, 1H), 7.51 - 7.43 (m, 2H), 7.41 - 7.30 (m, 2H), 7.01 - 6.83 (m, 2H), 6.32 (t, J = 7.0 Hz, 1H), 5.02 (dd, J = 11.1, 8.7 Hz, 1H), 4.19 - 4.04 (m, 3H), 3.82 - 3.67 (m, 5H), 3.60 (t, J = 5.3 Hz, 2H), 3.25 (s, 3H).



61


embedded image


502.1
Method D, RT = 1.606 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.19 - 8.95 (m, 1H), 7.90 - 7.80 (m, 2H), 7.71 - 7.62 (m, 1H), 7.60 - 7.44 (m, 2H), 6.82 - 6.69 (m, 2H), 6.25 - 6.16 (m, 1H), 5.34 - 4.84 (m, 1H), 4.27 - 4.05 (m, 2H), 3.79 - 3.70 (2 s, 3H), 3.53 - 3.38 (m, 4H), 2.22 - 1.98 (2 s, 3H). (Mixture of interconvertible atropisomers)



62


embedded image


611.2
Method D, RT = 1.99 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.18 (d, J = 8.6 Hz, 1H), 8.03 - 7.87 (m, 2H), 7.54 - 7.40 (m, 3H), 6.97 (d, J = 5.6 Hz, 1H), 6.79 (d, J = 11.0 Hz, 2H), 6.47 (dd, J= 8.8, 2.7 Hz, 1H), 5.16 - 5.05 (m, 1H), 4.27 - 4.09 (m, 3H), 4.04 - 3.94 (m, 1H), 3.89 (dd, J = 8.8, 5.9 Hz, 1H), 3.85 - 3.77 (m, 1H), 3.76 (s, 3H), 3.73 - 3.69 (m, 1H), 3.51-3.47 (m, 1H), 2.23 - 2.08 (m, 1H), 1.82 - 1.71 (m, 1H).



63


embedded image


550.2
Method D, RT = 1.62 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.04 (d, J = 8.8 Hz, 1H), 8.05 - 7.84 (m, 2H), 7.64 (dd, J= 6.8, 2.0 Hz, 1H), 7.59 (dd, J = 7.3, 2.0 Hz, 1H), 7.54 - 7.43 (m, 3H), 6.89 - 6.71 (m, 2H), 6.31 (t, J = 7.0 Hz, 1H), 5.13 (dd, J= 11.4, 8.7 Hz, 1H), 4.92 (t, J = 5.4 Hz, 1H), 4.18 - 4.09 (m, 1H), 4.05 - 3.92 (m, 1H), 4.07 - 3.92 (m, 2H), 3.74 (s, 3H), 3.71 (br d, J = 9.5 Hz, 1H), 3.68 - 3.59 (m, 2H).



64


embedded image


532.2
Method D, RT = 2.147 min, 99%

1H NMR (400 MHz, DMSO-d6) δ = 9.02 (d, J = 8.5 Hz, 1H), 8.06 - 7.95 (m, 2H), 7.62 (m, 2H), 7.48 (d, J = 8.0 Hz, 2H), 7.40 - 7.31 (m, 2H), 6.95 - 6.85 (m, 2H), 6.36 - 6.28 (m, 1H), 5.06 - 4.95 (m, 1H), 4.93- 4.89 (m, 1H), 4.16 - 3.98 (m, 3H), 3.78 - 3.67 (m, 5H), 3.65 - 3.60 (m, 2H).



65


embedded image


668.2
Method D, RT = 1.68 min, 98.5%

1H NMR (400 MHz, DMSO-d6) δ = 9.06 (br d, J= 8.1 Hz, 1H), 8.34 (d, J = 4.9 Hz, 1H), 7.89 (d, J= 8.8 Hz, 2H), 7.36 (t, J= 73.6 Hz, 1H),7.28 (d, J = 8.4 Hz, 2H), 6.86 (br d, J = 4.9 Hz, 1H), 6.80 (br d, J = 10.8 Hz, 2H), 5.09 - 4.89 (m, 1H), 4.23 - 4.12 (m, 1H), 4.09 - 3.98 (m, 1H), 3.98 - 3.86 (m, 1H), 3.77 (s, 3H), 3.57 - 3.41 (m, 2H), 3.30 - 3.20 (m, 2H), 2.85 - 2.69 (m, 2H), 2.30 (br s, 3H), 1.96 - 1.84 (m, 1H), 1.80 - 1.64 (m, 1H).



66


embedded image


617.2
Method D, RT = 2.009 min, 95%

1H NMR (400 MHz, DMSO-d6) δ = 9.11 (d, J= 8.6 Hz, 1H), 7.97 - 7.81 (m, 3H), 7.58 (dd, J = 2.8, 8.7 Hz, 1H), 7.34 (t, J = 73.6 Hz, 1H), 7.29 - 7.27 (m, 2H), 6.87 - 6.68 (m, 2H), 5.17 - 5.05 (m, 1H), 4.58 (t, J = 3.7 Hz, 1H), 4.28 - 4.14 (m, 2H), 4.09 - 4.03 (m, 1H), 3.77 (s, 3H), 3.68 -3.62 (m, 1H), 2.27 - 2.21 (m, 1H), 1.97 -1.89 (m, 1H), 1.85 - 1.78 (m, 1H), 1.72 -1.63 (m, 1H), 1.56 - 1.37 (m, 2H).



67


embedded image


520.2
Method D, RT = 1.899 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.07 (d, J = 8.6 Hz, 1H), 8.03 - 7.91 (m, 2H), 7.75 (dd, J = 6.6, 2.0 Hz, 1H), 7.58 (dd, J = 7.2, 2.1 Hz, 1H), 7.53 - 7.44 (m, 4H), 7.44 - 7.32 (m, 2H), 6.35 (t, J = 7.0 Hz, 1H), 5.05 (dd, J= 10.9, 8.7 Hz, 1H), 4.22 - 4.11 (m, 1H), 4.04 - 3.88 (m, 2H), 3.88 - 3.70 (m, 2H), 1.24 (t, J= 7.1 Hz, 3H).



68


embedded image


613.2
Method D, RT = 1.76 min, 99%

1H NMR (400 MHz, DMSO-d6) δ = 9.15 (d, J = 8.3 Hz, 1H), 8.43 (d, J = 5.6 Hz, 1H), 7.89 (d, J= 8.8 Hz, 2H), 7.35 (t, J= 73.2 Hz, 1H), 7.27 (d, J = 8.4 Hz, 2H), 7.12 (d, J = 5.4 Hz, 1H), 6.90 - 6.72 (m, 2H), 5.14 - 4.98 (m, 1H), 4.32 - 4.02 (m, 3H), 3.91 (s, 3H), 3.83 - 3.72 (m, 4H), 3.72 - 3.61 (m, 4H), 2.56 (s, 3H).



69


embedded image


556.2
Method D, RT = 1.970 min, 97.7%

1H NMR (400 MHz, DMSO-d6) δ = 9.07 (d, J = 8.6 Hz, 1H), 8.03 - 7.91 (m, 2H), 7.72 (d, J = 6.8 Hz, 1H), 7.66 (td, J = 1.1, 7.2 Hz, 1H), 7.48 (d, J = 8.6 Hz, 4H), 7.44 - 7.29 (m, 2H), 6.42 (m, 1H), 6.34 (t, J = 3.6 Hz, 1 H), 6.40 (t, J = 59.6 Hz, 1H), 5.05 (dd, J= 8.9, 10.9 Hz, 1H), 4.56 - 4.29 (m, 2H), 4.17 (t, J = 7.7 Hz, 1H), 3.89 - 3.72 (m, 2H)



70


embedded image


612.3
Method D, RT = 1.74 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 8.92 (d, J = 8.3 Hz, 1H), 7.91 - 7.74 (m, 2H), 7.63 - 7.47 (m, 2H), 7.26 (s,, 1H), 6.90 -6.68 (m, 2H), 5.78 (d, J = 1.7 Hz, 1H), 5.66-5.63 (m, 1H), 4.96 - 4.79 (m, 1H), 4.58 - 4.53 (m, 1H), 4.25 - 4.20 (m, 1H), 3.77 (s, 3H), 3.76 (s, 3H), 3.42 -3.37 (m, 2H), 3.26 - 3.21 (m, 1H), 2.79-2.77 (m, 1H), 2.41 (d, J = 9.0 Hz, 1H), 2.26 (s, 3H), 1.81-1.79 (m, 1H), 1.72-1.69 (m, 1H), 1.18 (d, J = 6.6 Hz, 3H).



71


embedded image


644.2
Method D, RT = 1.58 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.05 (d, J = 8.6 Hz, 1H), 7.96 - 7.80 (m, 2H), 7.35 (t, J = 73.6 Hz, 1H), 7.29-7.27 (m, 2H), 6.93 - 6.66 (m, 3H), 5.85 (s, 1H), 4.99 (dd, J = 10.8, 8.3 Hz, 1H), 4.58 -4.39 (m, 2H), 3.78 (s, 3H), 3.76 (s, 3H), 3.64-3.61 (m, 1H), 3.45 - 3.42 (m, 1H), 3.37 - 3.29 (m, 1H), 3.23-3.21 (m, 1H), 2.80 (dd, J= 9.0, 1.7 Hz, 1H), 2.44 (br d, J= 9.0 Hz, 1H), 2.25 (s, 3H), 1.90 - 1.78 (m, 1H), 1.71-1.68 (m, 1H), 1.36 (d, J= 5.9 Hz, 3H).



72


embedded image


570.2
Method C, RT = 1.927 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 8.96 (d, J = 8.6 Hz, 1H), 7.97 - 7.87 (m, 2H), 7.77 (dd, J = 6.8, 2.0 Hz, 1H), 7.63 (dd, J= 7.2, 1.8 Hz, 1H), 7.51 - 7.37 (m, 4H), 7.35 (t, J = 73.2 Hz, 1H), 7.30 - 7.32 (m, 2H), 6.38 (t, J = 7.0 Hz, 1H), 5.04 (dd, J = 11.1, 8.7 Hz, 1H), 4.26 - 4.11 (m, 3H), 3.88 - 3.72 (m, 2H), 2.83 - 2.70 (m, 2H).



73


embedded image


588.2
Method D, RT = 2.086 min, 98.8%

1H NMR (400 MHz, DMSO-d6) δ = 9.06 (d, J = 8.6 Hz, 1H), 8.02 - 7.93 (m, 2H), 7.77 (dd, J = 6.8, 2.0 Hz, 1H), 7.63 (dd, J = 7.1, 2.0 Hz, 1H), 7.52 - 7.46 (m, 4H), 7.44 - 7.35 (m, 2H), 6.38 (t, J = 7.0 Hz, 1H), 5.05 (dd, J= 11.0, 8.8 Hz, 1H), 4.26 - 4.15 (m, 3H), 3.89 - 3.71 (m, 2H), 2.85 - 2.71 (m, 2H).



74


embedded image


546.2
Method D, RT = 1.69 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 8.30 (d, J = 5.5 Hz, 1H), 7.68 (dd, J= 7.0, 2.0 Hz, 1H), 7.64 - 7.56 (m, 2H), 7.49 - 7.33 (m, 3H), 6.75 - 6.59 (m, 2H), 6.35 (t, J = 7.0 Hz, 1H), 5.11 (dd, J = 9.0, 5.5 Hz, 1H), 4.90 - 4.87 (m, 1H), 4.63-4.61 (m, 1H), 4.23 - 4.06 (m, 2H), 3.72 (s, 3H), 3.61 (t, J= 5.8 Hz, 2H), 3.25 (s, 3H), 0.70 (d, J= 6.5 Hz, 3H).



75


embedded image


602.2
Method D, RT = 1.98 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.06 (d, J = 8.8 Hz, 1H), 8.04 - 7.89 (m, 2H), 7.77 (dd, J= 6.8, 2.0 Hz, 1H), 7.63 (dd, J = 7.3, 2.0 Hz, 1H), 7.57 - 7.39 (m, 3H), 6.92 - 6.70 (m, 2H), 6.38 (t, J = 7.0 Hz, 1H), 5.14 (dd, J= 11.4, 8.7 Hz, 1H), 4.29 - 4.09 (m, 3H), 4.06 - 3.94 (m, 1H), 3.75 (s, 3H), 3.74 - 3.61 (m, 1H), 2.87 - 2.68 (m, 2H)



76


embedded image


502.2
Method D, RT = 1.78 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 8.95 (d, J = 9.0 Hz, 1H), 8.11 (dd, J= 4.6, 1.5 Hz, 1H), 7.91 - 7.76 (m, 2H), 7.64 (dd, J = 8.3, 1.5 Hz, 1H), 7.59 - 7.49 (m, 2H), 7.42 (dd, J = 4.6, 8.3 Hz, 1H), 6.87 - 6.70 (m, 2H), 5.67 (dd, J = 12.0, 8.6 Hz, 1H), 4.58 - 4.46 (m, 1H), 4.40-4.35 (m, 1H), 3.85 (s, 3H), 3.77 (s, 3H), 0.92 (d, J= 6.8 Hz, 3H).



77


embedded image


534.2
Method D, RT = 1.76 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 8.88 (d, J = 8.8 Hz, 1H), 8.11 (dd, J= 4.6, 1.5 Hz, 1H), 7.95 - 7.83 (m, 2H), 7.64 (dd, J = 8.6, 1.5 Hz, 1H), 7.43-7.40 (m, 1 H), 7.35 (t, J = 73.6 Hz, 1H), 7.26-7.24 (m, 2H), 6.85 - 6.72 (m, 2H), 5.67 (dd, J = 11.7, 8.6 Hz, 1H), 4.60 - 4.48 (m, 1H), 4.41-4.36 (m, 1H), 3.86 (s, 3H), 3.77 (s, 3H), 0.92 (d, J = 6.6 Hz, 3H).



78


embedded image


611.3
Method C, RT = 1.525 min, 97.1%

1H NMR (400 MHz, DMSO-d6) δ = 9.11 (d, J = 8.6 Hz, 1H), 7.95 (d, J = 8.8 Hz, 2H), 7.68 (dd, J = 7.0, 1.7 Hz, 1H), 7.56 (dd, J = 7.1, 1.7 Hz, 1H), 7.48 (d, J = 8.1 Hz, 2H), 6.77 (d, J = 10.8 Hz, 2H), 6.34 (t, J= 7.1 Hz, 1H), 5.13 (dd, J = 10.8, 8.8 Hz, 1H), 5.02 - 4.90 (m, 1H), 4.15 - 3.88 (m, 4H), 3.81 - 3.70 (m, 4H), 3.61 (dd, J = 10.8, 4.4 Hz, 1H), 3.24 - 3.18 (m, 4H), 2.96 - 2.84 (m, 2H).



79


embedded image


514.2
Method D, RT = 1.36 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 8.93 (d, J= 8.8 Hz, 1H), 7.99 - 7.83 (m, 2H), 7.63 (dd, J= 6.7, 2.1 Hz, 1H), 7.58 (dd, J = 7.1, 2.1 Hz, 1H), 7.33 (t, J = 73.6 Hz, 1H), 7.36 - 7.25 (m, 4H), 6.98 - 6.77 (m, 2H), 6.35 - 6.23 (m, 1H), 5.06 - 4.87 (m, 2H), 4.16 - 3.96 (m, 3H), 3.82 - 3.68 (m, 5H), 3.65 (br s, 2H).



80


embedded image


548.2
Method D, RT = 1.68 min, 100%
1H NMR (400 MHz, DMSO-d6) δ = 8.86 (d, J = 8.6 Hz, 1H), 7.90 (d, J = 8.8 Hz, 2H), 7.77 (dd, J = 7.2, 1.8 Hz, 1H), 7.57 (dd, J = 7.2, 1.8 Hz, 1H), 7.35 (t, J = 73.6 Hz, 1H), 7.25 - 7.23 (m, 2H), 6.77 (d, J= 11.5 Hz, 2H), 6.34 (t, J = 7.0 Hz, 1H), 5.66 (dd, J = 12.0, 8.8 Hz, 1H), 4.69 - 4.58 (m, 1H), 4.333-4.28 (m, 1H), 4.14 - 3.98 (m, 1H), 3.98 - 3.87 (m, 1H), 3.76 (s, 3H), 1.25 (t, J = 7.1 Hz, 3H), 0.91 (d, J = 6.8 Hz, 3H).


81


embedded image


546.2
Method D, RT = 1.57 min, 95.1%

1H NMR (400 MHz, DMSO-d6) δ = 8.95 (d, J = 8.8 Hz, 1H), 7.97 - 7.86 (m, 2H), 7.65 (dd, J= 6.6, 2.0 Hz, 1H), 7.59 (dd, J = 7.1, 2.0 Hz, 1H), 7.55 - 7.46 (m, 1H), 7.35 (t, J = 73.6 Hz, 1H), 7.32 - 7.23 (m, 2H), 6.87 - 6.74 (m, 2H), 6.36 - 6.26 (m, 1H), 5.13 (dd, J= 11.4, 8.9 Hz, 1H), 4.19 - 4.05 (m, 3H), 4.04 - 3.95 (m, 1H), 3.74 (s, 3H), 3.73 - 3.65 (m, 1H), 3.60 (t, J = 5.4 Hz, 2H), 3.25 (s, 3H).



82


embedded image


534.2
Method D, RT = 1.77 min, 98.9%

1H NMR (400 MHz, DMSO-d6) δ = 9.05 (d, J = 8.8 Hz, 1H), 8.00 - 7.92 (m, 2H), 7.75 (dd, J= 6.8, 2.0 Hz, 1H), 7.58 (dd, J = 7.3, 2.0 Hz, 1H), 7.54 - 7.43 (m,3H), 6.86 - 6.73 (m, 2H), 6.39 - 6.29 (m, 1H), 5.13 (dd, J = 11.4, 8.9 Hz, 1H), 4.19 -4.09 (m, 1H), 4.04 - 3.93 (m, 3H), 3.74 (s, 3H), 3.73 - 3.64 (m, 1H), 1.24 (t, J = 7.1 Hz, 3H).



83


embedded image


516.2
Method D, RT = 1.58 min, 96.07%

1H NMR (400 MHz, DMSO-d6) δ = 8.95 (d, J = 8.8 Hz, 1H), 7.98 - 7.84 (m, 2H), 7.75 (dd, J = 6.6, 2.0 Hz, 1H), 7.58 - 7.51 (m, 1H), 7.35 (t, 72.0 Hz, 1H), 7.28 - 7.19 (m, 3H), 6.91 - 6.69 (m, 2H), 6.39 - 6.31 (m, 1H), 5.13 (dd, J = 11.5, 8.8 Hz, 1H), 4.20 - 4.08 (m, 1H), 4.06 - 3.89 (m, 3H), 3.74 (s, 3H), 3.73 - 3.61 (m, 1H), 1.24 (t, J= 7.1 Hz, 3H).



84


embedded image


611.2
Method D, RT = 1.99 min, 99%

1H NMR (400 MHz, DMSO-d6) δ = 9.18 (d, J = 8.6 Hz, 1H), 7.99 - 7.86 (m, 2H), 7.54 - 7.41 (m, 3H), 6.96 (d, J = 5.9 Hz, 1H), 6.79 (d, J = 10.8 Hz, 2H), 6.47 (dd, J= 8.9, 2.6 Hz, 1H), 5.16 - 5.05 (m, 1H), 4.28 - 4.18 (m, 1H), 4.18 - 4.07 (m, 2H), 4.03 - 3.94 (m, 1H), 3.89-3.86 (m, 1H), 3.84 - 3.77 (m, 1H), 3.76 (s, 3H), 3.70 (dt, J= 8.1, 5.7 Hz, 1H), 3.51-3.49 (m, 1H), 2.19-2.16 (m, 1H), 1.83 - 1.73 (m, 1H).



85


embedded image


595.3
Method D, RT = 1.651 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.12 (d, J = 8.6 Hz, 1H), 8.01 - 7.89 (m, 2H), 7.70 (dd, J= 2.0, 6.8 Hz, 1H), 7.58 (dd, J = 7.3, 2.0 Hz, 1H), 7.49 (dd, J = 8.8, 1.0 Hz, 2H), 6.84 - 6.72 (m, 2H), 6.32 (t, J = 7.0 Hz, 1H), 5.13 (dd, J = 8.6, 11.0 Hz, 1H), 4.14 - 3.91 (m, 5H), 3.77 (s, 3H), 2.18 (s, 6H), 2.14 - 1.73 (m, 2H).



86


embedded image


602.2
Method D, RT = 1.93 min, 97%

1H NMR (400 MHz, DMSO-d6) δ = 9.26 - 8.96 (m, 1H), 8.04 - 7.84 (m, 2H), 7.74 - 7.58 (m, 1H), 7.55 - 7.37 (m, 2H), 6.90 - 6.68 (m, 2H), 6.51 - 6.12 (m, 2H), 5.38 - 4.83 (m, 1H), 4.52 - 4.31 (m, 2H), 4.30 - 4.00 (m, 2H), 3.82 - 3.73 (m, 3H), 3.59 - 3.49 (m, 1H), 2.26 - 1.97 (2 s, 3H). (mixture of interconvertible atropisomers)



87


embedded image


474.1
Method D, RT = 1.491 min, 95.5%

1H NMR (400 MHz, DMSO-d6) δ = 12.03 (br dd, J = 3.8, 2.3 Hz, 1H), 9.06 (br d, J = 8.8 Hz, 1H), 7.88 - 7.80 (m, 2H), 7.61 (dd, J = 7.1, 2.0 Hz, 1H), 7.59 - 7.51 (m, 2H), 7.40 (dd, J = 1.3, 6.2 Hz, 1H), 6.77 (d, J = 10.8 Hz, 2H), 6.30 (t, J = 6.8 Hz, 1H), 5.12 (dd, J= 10.5, 8.8 Hz, 1H), 4.15 - 3.87 (m, 3H), 3.77 (s, 3H).



88


embedded image


498.2
Method D, RT = 1.519 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 8.92 (d, J = 8.8 Hz, 1H), 7.98 - 7.86 (m, 2H), 7.74 (dd, J= 6.7,2.1 Hz, 1H), 7.57 (dd, J = 7.3, 2.0 Hz, 1H), 7.34 (t, J = 80.0 Hz, 1H), 7.35 - 7.27 (m, 4H), 6.97 - 6.83 (m, 2H), 6.34 (t, J = 7.0 Hz, 1H), 5.01 (dd, J = 11.2, 8.8 Hz, 1H), 4.18 - 4.08 (m, 1H), 4.04 - 3.90 (m, 2H), 3.83 - 3.63 (m, 5H), 1.24 (t, J= 7.2 Hz, 3H).



89


embedded image


582.2
Method D, RT = 1.693 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.11 (d, J = 8.6 Hz, 1H), 8.00 - 7.85 (m, 2H), 7.62 (dd, J= 6.8, 2.0 Hz, 1H), 7.58 (dd, J = 7.2, 2.1 Hz, 1H), 7.53 - 7.39 (m, 2H), 6.76 (d, J= 10.8 Hz, 2H), 6.31 (t, J= 7.1 Hz, 1H), 5.12 (dd, J = 11.0, 8.6 Hz, 1H), 4.94 (br d, J = 5.4 Hz, 1H), 4.16 - 3.88 (m, 5H), 3.76 (s, 3H), 3.65 (dd, J = 13.0, 8.1 Hz, 1H), 1.09 (d, J = 6.1 Hz, 3H).



90


embedded image


584.2
Method D, RT = 1.765 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.15 - 8.90 (m, 1H), 7.99 - 7.83 (m, 2H), 7.74 - 7.59 (m, 1H), 7.35 (t, J = 68 Hz, 1 H), 7.56 - 7.07 (m, 2H), 6.84 - 6.69 (m, 2H), 6.54 - 6.11 (m, 2H), 5.39 - 4.80 (m, 1H), 4.51 - 4.02 (m, 4H), 3.82 - 3.71 (m, 3H), 3.58 - 3.41 (m, 1H), 2.25 - 1.95 (2 s, 3H). (mixture of interconvertible atropisomers)



91


embedded image


534.2
Method D, RT = 1.597 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 8.93 (d, J = 8.8 Hz, 1H), 7.99 - 7.87 (m, 2H), 7.72 (dd, J = 7.0, 2.1 Hz, 1H), 7.66 (dd, J = 7.3, 2.0 Hz, 1H), 7.35 (t, J = 72.4 Hz, 1 H), 7.34 - 7.25 (m, 4H), 6.94 - 6.85 (m, 2H), 6.34 (tt, J = 52.2, 4 Hz, 1H), 6.41 (t, J = 8 Hz, 1H), 5.02 (dd, J= 11.1, 8.9 Hz, 1H), 4.54 - 4.41 (m, 2H), 4.17 - 4.08 (m, 1H), 3.79 - 3.70 (m, 5H).



92


embedded image


635.2
Method D, RT = 1.615 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.01 (d, J = 8.6 Hz, 1H), 7.94 - 7.83 (m, 2H), 7.72 (dd, J= 7.1, 2.0 Hz, 1H), 7.61 (dd, J = 7.2, 1.8 Hz, 1H), 7.34 (t, J = 73.6 Hz, 1H), 7.28 (m, 1H), 6.76 (d, J = 11.0 Hz, 2H), 6.41 (t, J = 7.1 Hz, 1H), 6.07 (dd, J = 8.7, 5.3 Hz, 1H), 5.09 (dd, J= 11.1, 8.7 Hz, 1H), 4.13 - 4.04 (m, 1H), 4.03 - 3.79 (m, 5H), 3.76 (s, 3H), 3.26 (s, 3H), 3.11 (s, 3H), 2.84 (s, 3H).



93


embedded image


566.2
Method D, RT = 1.86 min, 98%

1H NMR (400 MHz, DMSO-d6) δ = 8.97 (d, J = 8.8 Hz, 1H), 8.02 - 7.88 (m, 2H), 7.78 (dd, J= 6.8, 2.0 Hz, 1H), 7.58 (dd, J = 6.8, 2.0 Hz, 1H), 7.45 (d, J = 8.3 Hz, 2H), 6.81 - 6.67 (m, 2H), 6.34 (t, J= 7.0 Hz, 1H), 5.67 (dd, J = 12.0, 8.8 Hz, 1H), 4.71 - 4.56 (m, 1H), 4.33-4.28 (m, 1H), 4.13 - 3.99 (m, 1H), 3.98 - 3.89 (m, 1H), 3.76 (s, 3H), 1.25 (t, J= 7.1 Hz, 3H), 0.91 (d, J= 6.6 Hz, 3H).



94


embedded image


524.1
Method D, RT = 1.789 min, 98.8%

1H NMR (400 MHz, DMSO-d6) δ = 9.07 (br d, J = 8.3 Hz, 1H), 7.92 (t, J = 59.6 Hz, 1H), 7.84 (m, 2H), 7.74 (m, 2H), 7.56 (d, J = 8.3 Hz, 2H), 6.77 (d, J = 10.5 Hz, 2H), 6.56 (t, J = 7.1 Hz, 1H), 5.08 (dd, J = 11.0, 8.8 Hz, 1H), 4.20 - 4.06 (m, 1H), 4.04 - 3.93 (m, 2H), 3.77 (s, 3H).



95


embedded image


506.1
Method D, RT = 1.509 min, 96.5%

1H NMR (400 MHz, DMSO-d6) δ = 12.03 (br s, 1H), 9.00 (br d, J = 7.8 Hz, 1H), 7.94 - 7.84 (m, 2H), 7.61 (dd, J = 7.2, 2.1 Hz, 1H), 7.40 - 7.25 (m, 3H), 7.33 (t, J= 73.6 Hz, 1H), 6.77 (d, J= 10.8 Hz, 2H), 6.30 (t, J = 6.7 Hz, 1H), 5.12 (dd, J= 10.8, 8.6 Hz, 1H), 4.15 - 3.92 (m, 3H), 3.77 (s, 3H).



96


embedded image


610.2
Method D, RT = 1.856 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.00 (d, J = 8.8 Hz, 1H), 7.95 - 7.84 (m, 2H), 7.79 (dd, J = 6.8, 2.0 Hz, 1H), 7.61 (dd, J = 7.3, 2.0 Hz, 1H), 7.33 (t, J = 73.6 Hz, 1H), 7.28 (m, 2H), 6.77 (d, J = 10.5 Hz, 2H), 6.36 (t, J = 7.0 Hz, 1H), 5.11 (dd, J = 10.8, 8.8 Hz, 1H), 4.18 - 4.03 (m, 3H), 4.03 - 3.88 (m, 2H), 3.77 (s, 3H), 2.68 -2.55 (m, 5H).



97


embedded image


577.3
Method D, RT = 1.464 min, 98.5%

1H NMR (400 MHz, DMSO-d6) δ = 9.01 (d, J = 8.8 Hz, 1H), 7.92 - 7.83 (m, 2H), 7.70 (dd, J = 6.7, 2.1 Hz, 1H), 7.58 (dd, J = 7.2, 2.1 Hz, 1H), 7.34 (t, J = 73.6 Hz, 1H), 7.28 (m, 2H), 6.77 (d, J = 10.8 Hz, 2H), 6.32 (t, J = 7.0 Hz, 1H), 5.12 (dd, J = 11.0, 8.6 Hz, 1H), 4.12 - 3.92 (m, 7H), 3.76 (s, 3H), 2.18 (s, 6H).



98


embedded image


502.1
Method D, RT = 1.680 min, 99.7%

1H NMR (400 MHz, DMSO-d6) δ = 9.06 (br d, J = 8.3 Hz, 1H), 7.94 - 7.80 (m, 2H), 7.76 (dd, J = 6.8, 1.7 Hz, 1H), 7.64 - 7.44 (m, 3H), 6.77 (d, J= 10.5 Hz, 2H), 6.35 (t, J = 7.0 Hz, 1H), 5.13 (dd, J = 10.9, 8.7 Hz, 1H), 4.18 - 4.05 (m, 1H), 4.05 - 3.92 (m, 4H), 3.78 (s, 3H), 1.25 (t, J= 7.1 Hz, 3H).



99


embedded image


619.2
Method D, RT = 1.569 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.01 (d, J = 8.6 Hz, 1H), 7.94 - 7.80 (m, 2H), 7.71 (dd, J = 6.6, 2.0 Hz, 1H), 7.59 (dd, J = 7.1, 2.0 Hz, 1H), 7.34 (t, J= 76.0 Hz, 1 H), 7.27 - 7.25 (m, 2H), 6.77 (d, J= 10.8 Hz, 2H), 6.33 (t, J = 7.0 Hz, 1H), 5.12 (dd, J= 10.9, 8.7 Hz, 1H), 4.14 - 3.92 (m, 5H), 3.76 (s, 3H), 3.54 (t, J= 4.5 Hz, 4H), 2.58 (t, J = 6.4 Hz, 2H), 2.43 (m, 4H).



100


embedded image


596.2
Method D, RT = 1.84 min, 98%

1H NMR (400 MHz, DMSO-d6) δ = 8.97 (d, J = 8.8 Hz, 1H), 8.01 - 7.89 (m, 2H), 7.68 (dd, J= 6.7, 2.0 Hz, 1H), 7.60 (dd, J = 6.7, 2.0 Hz, 1H), 7.52 - 7.38 (m, 2H), 6.84 - 6.71 (m, 2H), 6.32 (t, J = 7.0 Hz, 1H), 5.67 (dd, J= 12.1, 8.7 Hz, 1H), 4.69 - 4.57 (m, 1H), 4.32 - 4.27 (m 1H), 4.23-4.18 (m, 1H), 4.10 - 3.99 (m, 1H), 3.76 (s, 3H), 3.60 (t, J = 5.3 Hz, 2H), 3.25 (s, 3H), 0.91 (d, J = 6.8 Hz, 3H).



101


embedded image


620.1
Method D, RT = 1.82 min, 100%
1H NMR (400 MHz, DMSO-d6) δ = 9.11 (d, J = 8.3 Hz, 1H), 8.08 - 7.77 (m, 4H), 7.35 (t, J = 73.6 Hz, 1H), 7.29 - 7.27 (m, 2H), 6.79 (d, J= 10.8 Hz, 2H), 5.18 - 5.04 (m, 1H), 4.30 (s, 1H), 4.27 - 4.20 (m, 3H), 4.11 - 3.97 (m, 3H), 3.77 (s, 3H), 3.55 - 3.46 (m, 1H), 1.26 (d, J = 6.1 Hz, 3H).


102


embedded image


536.2
Method D, RT = 1.730 min, 100%
1H NMR (400 MHz, DMSO-d6) δ = 9.07 (d, J = 8.8 Hz, 1H), 8.04 - 7.88 (m, 2H), 7.64 (dd, J= 6.8, 2.0 Hz, 1H), 7.59 (dd, J = 7.3, 2.0 Hz, 1H), 7.52 - 7.44 (m, 4H), 7.43 - 7.34 (m, 2H), 6.32 (t, J = 7.1 Hz, 1H), 5.04 (dd, J= 10.9, 8.7 Hz, 1H), 4.98 - 4.88 (m, 1H), 4.16 (t, J = 7.6 Hz, 1H), 4.05 - 3.95 (m, 2H), 3.88 - 3.71 (m, 2H), 3.70 - 3.59 (m, 2H).


103


embedded image


596.2
Method D, RT = 1.889 min, 100%
1H NMR (400 MHz, DMSO-d6) δ = 9.11 (d, J = 8.6 Hz, 1H), 7.94 (d, J = 8.8 Hz, 2H), 7.67 - 7.55 (m, 2H), 7.48 (d, J= 8.8 Hz, 2H), 6.77 (d, J = 10.5 Hz, 2H), 6.32 (t, J= 7.0 Hz, 1H), 5.12 (dd, J = 10.8, 8.6 Hz, 1H), 4.15 - 3.92 (m, 4H), 3.92 - 3.82 (m, 1H), 3.76 (s, 3H), 3.65 (dt, J = 6.5, 4.6 Hz, 1H), 3.19 (s, 3H), 1.09 (d, J= 6.1 Hz, 3H).


104


embedded image


564.2
Method D, RT = 1.512 min, 100%
1H NMR (400 MHz, DMSO-d6) δ = 9.00 (d, J = 8.6 Hz, 1H), 7.94 - 7.82 (m, 2H), 7.62 (dd, J= 6.8, 2.0 Hz, 1H), 7.58 (dd, J = 7.2, 2.1 Hz, 1H), 7.34 (t, J = 73.6 Hz, 1H), 7.28 (m, 2H), 6.76 (d, J = 10.8 Hz, 2H), 6.30 (t, J = 7.0 Hz, 1H), 5.11 (dd, J = 11.1, 8.7 Hz, 1H), 4.93 (d, J = 5.6 Hz, 1H), 4.17 - 4.04 (m, 2H), 4.04 - 3.83 (m, 3H), 3.76 (s, 3H), 3.63 (dd, J = 12.8, 8.2 Hz, 1H), 1.09 (d, J= 6.4 Hz, 3H).


105


embedded image


578.3
Method D, RT = 1.66 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 8.87 (d, J= 8.6 Hz, 1H), 7.90 (d, J = 8.8 Hz, 2H), 7.68 (dd, J = 7.1, 2.0 Hz, 1H), 7.59 (dd, J= 7.1, 2.0 Hz, 1H), 7.35 (t, J = 73.6 Hz, 1H), 7.25 - 7.35 (m, 2H), 6.84 - 6.65 (m, 2H), 6.32 (t, J = 7.0 Hz, 1H), 5.66 (dd, J = 12.0, 8.6 Hz, 1H), 4.69 -4.58 (m, 1H), 4.33-4.29 (m, 1H), 4.24-4.18 (m, 1H), 4.09 - 4.03 (m, 1H), 3.76 (s, 3H), 3.60 (t, J = 5.1 Hz, 2H), 3.25 (s, 3H), 0.91 (d, J = 6.6 Hz, 3H).



106


embedded image


547.2
Method D, RT = 1.808 min, 97.5%
1H NMR (400 MHz, DMSO-d6) δ = 9.10 (br d, J = 8.3 Hz, 1H), 7.91 - 7.75 (m, 2H), 7.58 (d, J = 8.6 Hz, 2H), 7.16 (d, J = 2.0 Hz, 1H), 6.79 (d, J = 10.8 Hz, 2H), 6.45 (br dd, J = 0.7, 2.4 Hz, 1H), 5.87 (d, J = 1.7 Hz, 1H), 5.08 (dd, J = 10.9, 8.4 Hz, 1H), 4.67 - 4.56 (m, 1H), 4.40 (t, J = 9.8 Hz, 1H), 4.14 - 3.98 (m, 1H), 3.94 -3.85 (m, 1H), 3.78 (s, 3H), 3.73 (s, 3H), 3.50 (q, J = 5.7 Hz, 2H), 3.31 - 3.25 (m, 1H), 3.18 (d, J= 5.1 Hz, 1H).


107


embedded image


550.2
Method D, RT = 1.891 min, 100%
1H NMR (400 MHz, DMSO-d6) δ = 9.07 (d, J = 8.6 Hz, 1H), 8.04 - 7.89 (m, 2H), 7.65 (dd, J= 6.8, 2.0 Hz, 1H), 7.60 (dd, J = 7.1, 2.0 Hz, 1H), 7.54 - 7.44 (m, 4H), 7.44 - 7.29 (m, 2H), 6.33 (t, J = 7.0 Hz, 1H), 5.05 (dd, J= 10.8, 8.8 Hz, 1H), 4.25 - 4.04 (m, 3H), 3.88 - 3.69 (m, 2H), 3.60 (t, J = 5.4 Hz, 2H), 3.25 (s, 3H).


108


embedded image


546.2
Method D, RT = 1.78 min, 100%
1H NMR (400 MHz, DMSO-d6) δ = 9.14 - 8.93 (m, 1H), 8.07 - 7.91 (m, 3H), 7.57 - 7.26 (m, 4H), 7.05 - 6.79 (m, 3H), 5.27 - 4.71 (m, 2H), 4.54 - 4.01 (m, 3H), 3.98 - 3.84 (m, 2H), 3.81 - 3.67 (m, 5H), 2.31 - 2.19 (2 s, 3H). (mixture of interconvertible atropisomers)


109


embedded image


684.3
Method D, RT = 2.00 min, 100%
1H NMR (400 MHz, DMSO-d6) δ = 9.11 - 8.90 (m, 1H), 8.46 - 8.35 (m, 1H), 7.96 - 7.78 (m, 2H), 7.35 (t, J = 73 Hz, 1H), 7.31 - 7.25 (m, 3H), 6.79 (d, J=11.0 Hz, 2H), 5.18 - 4.97 (m, 1H), 4.44 - 4.35 (m, 1H), 4.28 - 4.13 (m, 1H), 3.76 - 3.74 (m, 1H), 3.73 (s, 3H), 3.00 - 2.70 (m, 3H), 2.35 - 2.26 (m, 3 H) 2.19 (s, 3H), 1.04 (d, J = 6.4 Hz, 6H).


110


embedded image


518.2
Method D, RT = 1.547 min, 97.1%

1H NMR (400 MHz, DMSO-d6) δ = 8.96 (d, J= 9.0 Hz, 1H), 7.99 - 7.84 (m, 2H), 7.64 (dd, J= 7.0, 2.0 Hz, 1H), 7.60 (dd, J = 7.0, 2.0 Hz, 1H), 7.55 - 7.38 (m, 4H), 7.34 (t, J = 73.6 Hz, 1H), 7.29 - 7.24 (m, 2H), 6.32 (t, J = 7.0 Hz, 1H), 5.09 - 5.00 (m, 1H), 4.93 (t, J = 5.3 Hz, 1H), 4.16 (t, J= 7.8 Hz, 1H), 4.05 - 3.96 (m, 2H), 3.89 - 3.72 (m, 2H), 3.68 - 3.60 (m, 2H).



111


embedded image


490.1
Method D, RT = 1.932 min, 95%

1H NMR (400 MHz, DMSO-d6) δ = 9.16 (d, J = 8.8 Hz, 1H), 7.84 (d, J = 8.6 Hz, 2H), 7.80 - 7.72 (m, 1H), 7.58 (d, J= 8.6 Hz, 2H), 7.31 (dd, J = 8.2, 3.3 Hz, 1H), 6.79 (d, J= 10.8 Hz, 2H), 5.15 - 5.04 (m, 1H), 4.31 - 4.16 (m, 2H), 4.12 - 4.01 (m, 1H), 3.78 (s, 3H), 2.47 (s, 3H).



112


embedded image


608.3
Method D, RT = 1.602 min, 98.8%

1H NMR (400 MHz, DMSO-d6) δ = 9.15 - 8.89 (m, 1H), 7.98 - 7.84 (m, 2H), 7.67 - 7.56 (m, 1H), 7.55 - 7.05 (m, 2H), 7.34 (t, J = 73.6 Hz, 1H), 6.76 (dd, J = 5.0, 10.9 Hz, 2H), 6.29 - 6.12 (m, 1H), 5.36 -4.85 (m, 2H), 4.28 - 4.08 (m, 2H), 3. 76 (s, 3H), 3.74 - 3.59 (m, 4H), 3.50 (br s, 1H), 3.25 - 3.21 (2 s, 3H), 2.25 - 2.02 (2 s, 3H), 1.98 - 1.80 (m, 1H). (mixture of interconvertible atropisomers)



113


embedded image


564.2
Method D, RT = 2.304 min, 99.9%

1H NMR (400 MHz, DMSO-d6) δ = 9.01 (d, J = 8.5 Hz, 1H), 7.93 - 7.86 (m, 2H), 7.67 (dd, J= 7.0, 2.0 Hz, 1H), 7.62 - 7.57 (m, 1H), 7.35 (t, J = 72.6 Hz, 1H), 7.30 -7.24 (m, 2H), 6.77 (d, J = 10.5 Hz, 2H), 6.33 (t, J = 7.0 Hz, 1H), 5.12 (dd, J = 11.0, 9.0 Hz, 1H), 4.17 - 4.04 (m, 3H), 4.02 - 3.93 (m, 2H), 3.77 (s, 3H), 3.60 (t, J = 5.3 Hz, 2H), 3.25 (s, 3H).



114


embedded image


597.2
Method D, RT = 1.88 min, 97%

1H NMR (400 MHz, DMSO-d6) δ = 9.22 (d, J = 8.8 Hz, 1H), 8.05 - 7.83 (m, 3H), 7.57 (dd, J = 2.6, 8.9 Hz, 1H), 7.50 (d, J = 8.3 Hz, 2H), 6.79 (d, J = 10.8 Hz, 2H), 5.10 (br dd, J = 8.8, 10.3 Hz, 1H), 4.30 -4.16 (m, 2H), 4.09-4.03 (m, 1H), 3.77 (s, 3H), 3.27 (s, 3H), 2.07 (s, 3H).



115


embedded image


582.3
Method D, RT = 2.369 min, 99.5%

1H NMR (400 MHz, DMSO-d6) δ = 9.26 - 9.02 (m, 1H), 8.02 - 7.89 (m, 2H), 7.61 - 7.42 (m, 3H), 6.83 - 6.71 (m, 2H), 6.27 - 6.14 (m, 1H), 5.41 - 4.85 (m, 2H), 4.33 - 3.87 (m, 4H), 3.83 - 3.72 (m, 3H), 3.70 - 3.58 (m, 2H), 3.56 - 3.44 (m, 1H), 2.24 - 2.02 (2 s, 3H). (mixture of interconvertible atropisomers)



116


embedded image


548.2
Method D, RT = 1.787 min, 99.6%

1H NMR (400 MHz, DMSO-d6) δ = 9.23 (d, J = 8.6 Hz, 1H), 8.02 (d, J = 8.3 Hz, 2H), 7.88 (d, J= 8.3 Hz, 2H), 7.62 - 7.57 (m, 2H), 6.78 (d, J = 10.8 Hz, 2H), 6.30 (t, J = 7.1 Hz, 1H), 5.14 (dd, J= 11.0, 8.8 Hz, 1H), 4.18 - 4.06 (m, 1H), 4.04 - 3.94 (m, 2H), 3.77 (s, 3H), 3.43 - 3.38 (m, 1H), 1.10 - 0.98 (m, 2H), 0.93 - 0.80 (m, 2H).



117


embedded image


599.2
Method D, RT = 2.095 min, 93%

1H NMR (400 MHz, DMSO-d6) δ = 9.07 (d, J = 8.5 Hz, 1H), 7.88 (d, J = 9.0 Hz, 2H), 7.74 (t, J = 9.0 Hz, 1H), 7.34 (t, J = 76.0 Hz, 1 H), 7.29 - 7.26 (m, 2H), 6.79 (d, J = 10.5 Hz, 2H), 6.59 (dd, J = 8.5, 2.5 Hz, 1H), 5.16 - 5.03 (m, 1H), 4.46 -4.33 (m, 4H), 4.25 - 4.14 (m, 2H), 4.02 -3.90 (m, 1H), 3.77 (s, 3H).



118


embedded image


562.2
Method D, RT = 1.612 min, 95.8%

1H NMR (400 MHz, DMSO-d6) δ = 8.98 (d, J = 8.8 Hz, 1H), 7.92 (d, J = 9.0 Hz, 2H), 7.69 (dd, J= 7.1, 2.0 Hz, 1H), 7.56 (dd, J= 7.3, 2.0 Hz, 1H), 7.50 - 7.37 (m, 4H), 7.34 (t, J= 73.6 Hz, 1H), 7.32 - 7.19 (m, 2H), 6.34 (t, J = 7.1 Hz, 1H), 5.13 -5.00 (m, 3H), 4.16 (t, J = 7.9 Hz, 1H), 3.86 - 3.60 (m, 6H), 3.23 (s, 3H).



119


embedded image


617.2
Method D, RT = 2.014 min, 94%

1H NMR (400 MHz, DMSO-d6) δ = 9.09 (d, J= 8.3 Hz, 1H), 7.97 - 7.80 (m, 3H), 7.59 (dd, J = 8.7, 2.8 Hz, 1H), 7.34 (t, J = 73.6 Hz, 1H), 7.29 - 7.27 (m, 2H), 6.79 (d, J = 10.8 Hz, 2H), 5.13 - 5.09 (m, 1H), 4.60 - 4.58 (m, 1H), 4.30 - 4.18 (m, 2H), 4.05 - 3.98 (m, 1H), 3.77 (s, 3H), 3.67 -3.64 (m, 1H), 2.31 - 2.22 (m, 1H), 1.95 -1.88 (m, 1H), 1.85 - 1.79 (m, 1H), 1.69 -1.64 (m, 1H), 1.56 - 1.35 (m, 2H).



120


embedded image


552.3
Method D, RT = 1.777 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.04 (d, J = 8.6 Hz, 1H), 8.03 - 7.93 (m, 2H), 7.72 (dd, J= 6.8, 2.0 Hz, 1H), 7.66 (dd, J = 7.3, 2.0 Hz, 1H), 7.48 (d, J = 7.8 Hz, 2H), 7.39 - 7.26 (m, 2H), 6.97 - 6.82 (m, 2H), 6.42 (t, J = 7 Hz, 1H), 6.35 (tt, J = 56.2, 3.5 Hz, 1H), 5.03 (dd, J= 11.1, 8.7 Hz, 1H), 4.53 - 4.35 (m, 2H), 4.19 - 4.09 (m, 1H), 3.81 - 3.68 (m, 5H).



121


embedded image


566.2
Method D, RT = 1.817 min, 99%

1H NMR (400 MHz, DMSO-d6) δ = 9.05 (dd, J= 16.0, 8.7 Hz, 1H), 8.04 - 7.91 (m, 2H), 7.77 - 7.18 (m, 5H), 7.01 - 6.67 (m, 2H), 6.48 - 6.10 (m, 2H), 5.35 - 4.62 (m, 1H), 4.53 - 4.26 (m, 2H), 4.12 - 3.77 (m, 2H), 3.77 - 3.62 (m, 4H), 3.57 - 3.36 (m, 1H), 2.27 - 1.98 (2 s, 3H). (mixture of interconvertible atropisomers)



122


embedded image


593.3
Method D, RT = 1.82 min, 98%

1H NMR (400 MHz, DMSO-d6) δ = 9.07 (d, J= 8.6 Hz, 1H), 7.95 - 7.81 (m, 2H), 7.53 - 7.48 (m, 1H), 7.35 (t, J= 73.6 Hz, 1H), 7.28 - 7.26 (m, 2H) 6.96 (d, J = 5.9 Hz, 1H), 6.78 (d, J = 10.8 Hz, 2H), 6.46 (dd, J= 2.6, 8.9 Hz, 1H), 5.19 - 5.03 (m, 1H), 4.31 - 4.19 (m, 1H), 4.19 - 4.07 (m, 2H), 4.04 - 3.94 (m, 1H), 3.87-3.86 (m, 1H), 3.84 - 3.77 (m, 1H), 3.76 (s, 3H), 3.70 (dt, J = 5.7, 8.1 Hz, 1H), 3.50-3.49 (m, 1H), 2.19-2.16 (m, 1H), 1.83 - 1.70 (m, 1H).



123


embedded image


524.1
Method D, RT = 1.794 min, 94.4%

1H NMR (400 MHz, DMSO-d6) δ = 9.10 (d, J = 8.6 Hz, 1H), 7.93 (t, J = 59.6 Hz, 1H), 7.86 - 7.66 (m, 4H), 7.63 - 7.47 (m, 2H), 6.78 (d, J = 10.8 Hz, 2H), 6.56 (t, J = 7.1 Hz, 1H), 5.09 (dd, J= 10.9, 8.7 Hz, 1H), 4.19 - 4.06 (m, 1H), 4.03 - 3.92 (m, 2H), 3.77 (s, 3H).



124


embedded image


639.2
Method D, RT = 2.01 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.20 (br d, J = 8.6 Hz, 1H), 8.02 - 7.87 (m, 4H), 7.49 (d, J = 8.3 Hz, 2H), 6.80 (d, J = 11.0 Hz, 2H), 5.17 - 5.07 (m, 1H), 4.33 - 4.20 (m, 4H), 4.12 - 3.98 (m, 3H), 3.77 (s, 3H), 3.57 - 3.49 (m, 1H), 1.26 (d, J = 6.1 Hz, 3H).



125


embedded image


611.2
Method D, RT = 1.88 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.09 (br d, J = 8.8 Hz, 1H), 8.32 - 8.21 (m, 1H), 7.91 - 7.78 (m, 2H), 7.65 - 7.51 (m, 2H), 6.97 - 6.85 (m, 1H), 6.78 (d, J= 10.8 Hz, 2H), 6.13 - 5.95 (m, 1H), 5.21 - 5.02 (m, 1H), 4.37 - 4.11 (m, 3H), 3.95 - 3.83 (m, 2H), 3.82 (s, 3H), 3.79 - 3.64 (m, 3H), 2.31 - 2.19 (m, 1H), 2.04 - 1.89 (m, 1H).



126


embedded image


562.2
Method D, RT = 1.95 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 8.90 (d, J= 8.6 Hz, 1H), 8.07 (dd, J = 4.6, 1.2 Hz, 1H), 7.99 - 7.81 (m, 2H), 7.61 (d, J= 7.3 Hz, 1H), 7.39 - 7.35 (m, 1H), 7.35 (t, J = 73.6 Hz, 1H), 7.27 - 7.24 (m, 2H), 6.87 - 6.67 (m, 2H), 5.60 (dd, J = 11.5, 8.6 Hz, 1H), 4.77-4.68 (m, 1H), 4.56 -4.43 (m, 1H), 4.40-4.35 (m, 1H), 3.77 (s, 3H), 1.30 (d, J = 5.5 Hz, 3H), 1.26 (d, J = 5.5 Hz, 3H), 0.90 (d, J = 6.4 Hz, 3H).



127


embedded image


578.3
Method D, RT = 1.67 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 8.98 (d, J = 8.6 Hz, 1H), 7.93 - 7.82 (m, 2H), 7.69 (dd, J = 6.8, 2.0 Hz, 1H), 7.48-7.45 (m, 1H ),7.35 (t, J = 73.6 Hz, 1H), 7.28 -7.26 (m, 2H), 6.87 - 6.70 (m, 2H), 6.34 (t, J = 7.0 Hz, 1H), 5.11 (dd, J = 11.1, 8.4 Hz, 1H), 4.53- 5.09 (m, 1H), 4.17 - 4.08 (m, 2H), 3.77 (s, 3H), 3.76-3.74 (m, 1H), 3.63 - 3.57 (m, 2H), 3.24 (s, 3H), 0.99 (d, J= 6.1 Hz, 3H).



128


embedded image


516.2
Method D, RT = 1.7 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.03 (d, J = 8.8 Hz, 1H), 8.05 - 7.92 (m, 2H), 7.75 (dd, J = 6.6, 2.0 Hz, 1H), 7.58 (dd, J = 7.3, 2.0 Hz, 1H), 7.48 (d, J = 8.1 Hz, 2H), 7.39 - 7.28 (m, 2H), 7.00 - 6.83 (m, 2H), 6.35 (t, J = 7.0 Hz, 1H), 5.02 (dd, J = 11.1, 8.7 Hz, 1H), 4.18 - 4.08 (m, 1H), 4.05 - 3.92 (m, 2H), 3.83 - 3.68 (m, 5H), 1.25 (t, J= 7.1 Hz, 3H).



129


embedded image


631.2
Method D, RT = 1.75 min, 98.77%

1H NMR (400 MHz, DMSO-d6) δ = 9.06 - 8.99 (m, 1H), 8.24 - 8.14 (m, 1H), 7.94 - 7.81 (m, 2H), 7.33 (t, J = 73.6 Hz, 1H), 7.28 - 7.24 (m, 2H), 6.93 - 6.81 (m, 1H), 6.77 (d, J = 10.5 Hz, 2H), 6.28 (br d, J = 4.9 Hz, 1H), 5.16 - 4.93 (m, 2H), 4.32 -4.10 (m, 2H), 3.92 - 3.82 (m, 1H), 3.76 (s, 3H), 3.75 - 3.68 (m, 1H), 3.47 - 3.39 (m, 2H), 1.18 - 1.04 (m, 3H). (mixture of interconvertible atropisomers)



130


embedded image


518.2
Method D, RT = 1.467 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.07 (d, J = 8.6 Hz, 1H), 7.83 (d, J = 8.6 Hz, 2H), 7.65 (dd, J = 6.8, 2.0 Hz, 1H), 7.62 - 7.43 (m, 3H), 6.77 (d, J= 10.8 Hz, 2H), 6.31 (t, J = 7.0 Hz, 1H), 5.12 (dd, J = 11.0, 8.8 Hz, 1H), 5.02 - 4.88 (m, 1H), 4.19 - 3.88 (m, 5H), 3.76 (s, 3H), 3.69 -3.60 (m, 2H).



131


embedded image


691.2
Method D, RT = 1.732 min, 99%

1H NMR (400 MHz, DMSO-d6) δ = 9.14 - 8.91 (m, 1H), 7.97 - 7.80 (m, 2H), 7.69 - 7.55 (m, 1H), 7.35 (t, J = 73.6 Hz, 1H), 7.28 (m, 1H), 6.86 - 6.69 (m, 2H), 6.40 -6.25 (m, 1H), 6.08 - 5.99 (m, 1H), 5.37 -4.87 (m, 2H), 3.91 - 3.77 (m, 4H), 3.77 -3.73 (m, 3H), 3.63 - 3.37 (m, 4H), 3.30 -3.22 (m, 3H), 2.83 - 2.58 (m, 3H), 2.26 -2.03 (m, 3H), 1.81 (br s, 2H). (mixture of interconvertible atropisomers)



132


embedded image


572.3
Method D, RT = 1.72 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.14 - 8.91 (m, 1H), 8.06 - 7.96 (m, 2H), 7.53 (td, J = 3.5, 7.1 Hz, 1H), 7.50 - 7.43 (m, 2H), 7.43 - 7.34 (m, 1H), 7.32 (d, J= 8.8 Hz, 1H), 7.01 - 6.79 (m, 2H), 6.28 (dd, J = 3.1, 7.2 Hz, 1H), 5.43 - 5.31 (m, 1H), 5.28 - 4.61 (m, 1H), 4.16 - 4.02 (m, 1H), 3.97 - 3.64 (m, 5H), 3.47 (t, J = 9.4 Hz, 1H), 2.98 - 2.83 (m, 2H), 2.19 - 2.05 (2 s, 3H), 2.03 - 1.83 (m, 1H), 1.19 - 1.13 (m, 2H). (mixture of interconvertible atropisomers)



133


embedded image


594.2
Method D, RT = 1.526 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.01 (d, J = 8.6 Hz, 1H), 7.95 - 7.83 (m, 2H), 7.70 (dd, J = 6.8, 2.0 Hz, 1H), 7.56 (dd, J = 7.2, 1.8 Hz, 1H), 7.34 (t, J = 73.6 Hz, 1H), 7.28 (m, 2H), 6.76 (d, J = 10.5 Hz, 2H), 6.34 (t, J = 7.0 Hz, 1H), 5.17 - 5.04 (m, 3H), 4.14 - 4.03 (m, 1H), 4.03 - 3.92 (m, 2H), 3.81 - 3.65 (m, 6H), 3.65 - 3.56 (m, 1H), 3.23 (s, 3H).



134


embedded image


653.3
Method D, RT = 1.790 min, 98.6%

1H NMR (400 MHz, DMSO-d6) δ = 9.12 (d, J = 8.3 Hz, 1H), 8.00 - 7.88 (m, 2H), 7.72 (dd, J= 7.0, 1.8 Hz, 1H), 7.61 (dd, J = 7.2, 1.8 Hz, 1H), 7.48 (dd, J= 1.0, 8.8 Hz, 2H), 6.77 (d, J = 10.8 Hz, 2H), 6.41 (t, J = 7.2 Hz, 1H), 6.08 (dd, J = 8.8, 5.1 Hz, 1H), 5.10 (dd, J = 11.0, 8.6 Hz, 1H), 4.16 - 4.04 (m, 1H), 4.02 - 3.91 (m, 2H), 3.89 - 3.80 (m, 2H), 3.76 (s, 3H), 3.27 (s, 3H), 3.11 (s, 3H), 2.85 (s, 3H).



135


embedded image


607.2
Method D, RT = 1.66 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.12 (d, J= 8.6 Hz, 1H), 8.28 (dd, J= 9.0, 3.2 Hz, 1H), 7.94 (t, J = 9.0 Hz, 1H), 7.91 -7.83 (m, 2H), 7.35 (t, J = 73.6 Hz, 1H), 7.28 - 7.26 (m, 2H), 6.80 (d, J= 10.8 Hz, 2H), 5.86 (br d, J = 6.1 Hz, 1H), 5.17 -5.05 (m, 1H), 4.46 - 4.35 (m, 1H), 4.30 -4.17 (m, 2H), 4.12 - 3.90 (m, 2H), 3.77 (s, 3H), 3.75 - 3.60 (m, 1H), 2.43 - 2.34 (m, 1H), 1.88 - 1.75 (m, 1H).



136


embedded image


576.3
Method D, RT = 1.606 min, 98%

1H NMR (400 MHz, DMSO-d6) δ = 9.05 - 8.98 (m, 1H), 7.98 (d, J = 8.3 Hz, 2H), 7.70 - 7.65 (m, 1H), 7.61 - 7.52 (m, 1H), 7.51 - 7.39 (m, 2H), 7.34 (d, J = 8.3 Hz, 2H), 6.90 (d, J= 8.3 Hz, 2H), 6.34 (t, J= 6.8 Hz, 1H), 5.12 - 4.96 (m, 3H), 4.15 -4.06 (m, 1H), 3.79 - 3.60 (m, 9H), 3.23 (s, 3H). (NMR not clean)



137


embedded image


532.1
Method D, RT = 1.666 min, 99.6%

1H NMR (400 MHz, DMSO-d6) δ = 9.06 (d, J = 8.8 Hz, 1H), 7.93 - 7.76 (m, 2H), 7.66 (dd, J= 6.8, 2.0 Hz, 1H), 7.63 - 7.48 (m, 3H), 6.77 (d, J = 10.5 Hz, 2H), 6.33 (t, J= 7.0 Hz, 1H), 5.12 (dd, J= 11.0, 8.6 Hz, 1H), 4.23 - 4.04 (m, 2H), 4.02 - 3.94 (m, 2H), 3.93 - 3.89 (m, 1H), 3.77 (s, 3H), 3.61 (t, J= 5.3 Hz, 2H), 3.26 (s, 3H).



138


embedded image


596.2
Method D, RT = 1.869 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.11 (d, J = 8.6 Hz, 1H), 8.00 - 7.83 (m, 2H), 7.61 (dt, J = 2.0, 7.1 Hz, 2H), 7.48 (d, J = 8.1 Hz, 2H), 6.77 (d, J = 10.8 Hz, 2H), 6.32 (t, J = 7.0 Hz, 1H), 5.13 (dd, J = 10.6, 8.7 Hz, 1H), 4.15 - 3.97 (m, 3H), 3.97 - 3.81 (m, 2H), 3.76 (s, 3H), 3.68 -3.59 (m, 1H), 3.18 (s, 3H), 1.09 (d, J = 6.1 Hz, 3H).



139


embedded image


536.3
Method D, RT = 1.386 min, 97.2%

1H NMR (400 MHz, DMSO-d6) δ = 11.94 - 11.70 (m, 1H), 9.00 (d, J = 8.6 Hz, 1H), 7.95 - 7.84 (m, 2H), 7.63 - 7.55 (m, 1H), 7.34 (t, J = 73.6 Hz, 1H), 7.28 (m, 2H), 6.77 (d, J = 10.8 Hz, 2H), 6.26 (dt, J= 1.1, 2.9 Hz, 1H), 5.56 - 5.43 (m, 1H), 5.17 - 5.03 (m, 1H), 4.41 - 4.23 (m, 2H), 4.12 - 3.88 (m, 3H), 3.76 (s, 3H).



140


embedded image


502.2
Method D, RT = 1.605 min, 98.6%

1H NMR (400 MHz, DMSO-d6) δ = 9.07 (d, J = 8.6 Hz, 1H), 7.89 - 7.78 (m, 2H), 7.62 - 7.52 (m, 2H), 7.46 (d, J = 7.3 Hz, 1H), 6.77 (d, J= 10.5 Hz, 2H), 6.28 - 6.18 (m, 1H), 5.12 (dd, J = 11.1, 8.7 Hz, 1H), 4.16 - 4.02 (m, 1H), 3.99 - 3.86 (m, 2H), 3.76 (s, 3H), 3.49 (s, 3H), 2.39 (s, 3H)



141


embedded image


564.2
Method D, RT = 1.508 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.00 (d, J = 8.6 Hz, 1H), 7.97 - 7.81 (m, 2H), 7.62 (dd, J= 6.7, 2.1 Hz, 1H), 7.58 (dd, J = 7.1, 2.0 Hz, 1H), 7.34 (t, J = 73.6 Hz, 1H), 7.28 (m, 2H), 6.76 (d, J = 10.8 Hz, 2H), 6.31 (t, J = 7.1 Hz, 1H), 5.11 (dd, J = 10.9, 8.7 Hz, 1H), 4.94 (d, J = 5.4 Hz, 1H), 4.15 - 3.85 (m, 5H), 3.76 (s, 3H), 3.64 (dd, J = 12.8, 8.2 Hz, 1H), 1.09 (d, J = 6.4 Hz, 3H).



142


embedded image


594.3
Method D, RT = 1.528 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.00 (d, J = 8.8 Hz, 1H), 7.94 - 7.82 (m, 2H), 7.70 (dd, J = 2.0, 7.1 Hz, 1H), 7.56 (dd, J = 2.0, 7.1 Hz, 1H), 7.34 (t, J = 73.6 Hz, 1H), 7.28 (m, 2H), 6.76 (d, J = 10.8 Hz, 2H), 6.34 (t, J = 7.0 Hz, 1H), 5.17 - 4.98 (m, 3H), 4.15 - 4.04 (m, 1H), 4.01 - 3.91 (m, 2H), 3.77(s, 3H), 3.77 - 3.58 (m, 4H), 3.23 (s, 3H).



143


embedded image


532.2
Method D, RT = 1.44 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 8.95 (d, J= 9.0 Hz, 1H), 7.99 - 7.87 (m, 2H), 7.63 (dd, J= 6.8, 2.0 Hz, 1H), 7.59 (dd, J = 7.1, 2.0 Hz, 1H), 7.51 (d, J = 9.3 Hz, 1H), 7.35 (t, J = 73.6 Hz, 1H), 7.26 (d, J = 8.8 Hz, 2H), 6.88 - 6.75 (m, 2H), 6.31 (t, J = 7.0 Hz, 1H), 5.12 (dd, J= 11.2, 8.8 Hz, 1H), 4.93 (t, J = 5.4 Hz, 1H), 4.17 -4.09 (m, 1H), 4.06 - 3.93 (m, 3H), 3.74 (s, 3H), 3.72 - 3.58 (m, 3H).



144


embedded image


612.3
Method D, RT = 1.698 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.11 (d, J = 8.6 Hz, 1H), 8.07 - 7.89 (m, 2H), 7.70 (dd, J = 6.8, 2.0 Hz, 1H), 7.56 (dd, J = 7.1, 2.0 Hz, 1H), 7.52 - 7.41 (m, 2H), 6.77 (d, J= 10.8 Hz, 2H), 6.34 (t, J= 7.1 Hz, 1H), 5.22 - 4.95 (m, 3H), 4.20 - 4.03 (m, 1H), 4.03 - 3.90 (m, 2H), 3.83 - 3.61 (m, 4H), 3.76 (s, 3H), 3.23 (s, 3H).



145


embedded image


570.2
Method D, RT = 1.708 min, 97%

1H NMR (400 MHz, DMSO-d6) δ = 9.02 (d, J = 8.6 Hz, 1H), 7.89 (d, J = 8.8 Hz, 2H), 7.74 (dd, J = 6.8, 1.7 Hz, 1H), 7.66 (dd, J= 7.2, 1.7 Hz, 1H), 7.34 (t, J= 76.0 Hz, 1 H), 7.28 - 7.25 (m, 2H), 6.77 (d, J = 10.8 Hz, 2H), 6.53 - 6.18 (m, 2H), 6.42 (t, J = 7 Hz, 1H), 6.35 (tt, J = 56.2, 3.5 Hz, 1H), 5.11 (dd, J = 10.6, 8.7 Hz, 1H), 4.56 - 4.34 (m, 2H), 4.16 - 4.06 (m, 1H), 4.03 - 3.92 (m, 2H), 3.77 (s, 3H).



146


embedded image


565.2
Method D, RT = 1.70 min, 98%

1H NMR (400 MHz, DMSO-d6) δ = 10.61 (s, 1H), 9.11 (d, J = 8.6 Hz, 1H), 8.04 (br d, J = 3.4 Hz, 1H), 7.93 - 7.70 (m, 3H), 7.35 (t, J = 73.6 Hz, 1H), 7.29 -7.27 (m, 2H), 6.80 (d, J = 10.8 Hz, 2H), 5.06 (dd, J = 10.5, 8.6 Hz, 1H), 4.27 -4.04 (m, 3H), 3.77 (s, 3H), 2.09 (s, 3H).



147


embedded image


650.2
Method D, RT = 2.091 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.14 (d, J = 8.6 Hz, 1H), 7.95 (d, J = 8.8 Hz, 2H), 7.73 - 6.67 (m, 2H), 7.48 (d, J= 8.8 Hz, 2H), 6.77 (d, J = 10.8 Hz, 2H), 6.39 (t, J = 7.1 Hz, 1H), 5.13 (dd, J= 10.5, 8.8 Hz, 1H), 4.42 (dd, J = 13.2, 3.4 Hz, 1H), 4.33 - 4.19 (m, 1H), 4.16 - 3.87 (m, 4H), 3.76 (s, 3H), 3.34 (s, 3H).



148


embedded image


588.2
Method D, RT = 1.883 min, 96%

1H NMR (400 MHz, DMSO-d6) δ = 9.13 (d, J = 8.6 Hz, 1H), 7.95 (d, J = 8.8 Hz, 2H), 7.74 (dd, J = 7.0, 1.6 Hz, 1H), 7.67 (dd, J = 7.2, 1.8 Hz, 1H), 7.49 (d, J = 8.3 Hz, 2H), 6.78 (d, J = 10.8 Hz, 2H), 6.42 (t, J = 7 Hz, 1H), 6.35 (tt, J = 56.2, 3.5 Hz, 1H), 5.12 (dd, J = 8.6, 11.0 Hz, 1H), 4.54 - 4.36 (m, 2H), 4.18 - 4.05 (m, 1H), 4.03 - 3.93 (m, 2H), 3.77 (s, 3H).



149


embedded image


631.3
Method D, RT = 1.716 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.08 - 8.96 (m, 1H), 8.03 - 7.89 (m, 2H), 7.54 - 7.44 (m, 2H), 7.40 - 7.20 (m, 2H), 6.90 (m, 2H), 6.28 (d, J = 7.3 Hz, 1H), 6.09 -6.03 (m, 1H), 5.23 - 4.73 (m, 1H), 4.13 -4.03 (m, 1H), 3.94 - 3.78 (m, 4H), 3.74 -3.61 (2 s, 3H), 3.60 - 3.52 (m, 1H), 3.27 -3.24 (2 s, 3H), 3.14 - 3.07 (m, 3H), 2.82 -2. 37 (2 s, 3H), 2.86 - 2.81 (2 s, 3H). (mixture of interconvertible atropisomers)



150


embedded image


502.2
Method D, RT = 1.715 min, 98.1%

1H NMR (400 MHz, DMSO-d6) δ = 8.96 (d, J = 8.5 Hz, 1H), 8.00 - 7.84 (m, 2H), 7.75 (dd, J= 6.8, 1.8 Hz, 1H), 7.59 (dd, J = 7.5, 1.8 Hz, 1H), 7.51 - 7.39(m, 4H), 7.34 (t, J = 73.6 Hz, 1H), 7.27 (d, J = 8.2HZ, 2H), 6.35 (t, J = 6.8 Hz, 1H), 5.04 (dd, J= 8.8, 10.8 Hz, 1H), 4.17 (t, J= 7.8 Hz, 1H), 4.07 - 3.93 (m, 2H), 3.90 - 3.64 (m, 2H), 1.25 (t, J = 7.3 Hz, 3H).



151


embedded image


592.3
Method D, RT = 2.017 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.25 - 8.95 (m, 1H), 8.05 - 7.86 (m, 2H), 7.76 - 7.62 (m, 1H), 7.53 - 7.38 (m, 2H), 6.77 (dd, J= 10.8, 5.9 Hz, 2H), 6.30 - 6.15 (m, 1H), 5.40 - 4.84 (m, 1H), 4.29 - 4.08 (m, 2H), 3.90 - 3.65 (m, 5H), 3.53 - 3.49(m, 1H), 2.19 - 1.06 (2 s, 3H), 1.23 - 1.18 (m, 1H), 0.53 - 0.43 (m, 2H), 0.42 - 0.30 (m, 2H). (mixture of interconvertible atropisomers)



152


embedded image


684.3
Method D, RT = 1.97 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.06 (d, J = 8.3 Hz, 1H), 8.49 (br d, J= 4.6 Hz, 1H), 7.88 (d, J = 8.8 Hz, 2H), 7.35 (t, J = 73.6 Hz, 1H), 7.28 (d, J = 8.8 Hz, 2H), 7.13 -7.08 (m, 1H), 6.79 (d, J= 10.8 Hz, 2H), 5.08 - 4.94 (m, 1H), 4.22 (q, J= 10.0 Hz, 1H), 4.14 - 4.01 (m, 1H), 3.97 - 3.87 (m, 1H), 3.76 (s, 3H), 3.53 (br d, J = 12.5 Hz, 2H), 2.88 - 2.69 (m, 2H), 2.31 - 2.16 (m, 2H), 2.15 (s, 3H), 1.05 (s, 3H), 1.03 (s, 3H).



153


embedded image


612.2
Method D, RT = 1.702 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.12 (d, J = 8.6 Hz, 1H), 8.02 - 7.86 (m, 2H), 7.70 (dd, J= 7.1, 2.0 Hz, 1H), 7.57 (dd, J = 7.3, 2.0 Hz, 1H), 7.52 - 7.41 (m, 2H), 6.77 (d, J= 10.8 Hz, 2H), 6.34 (t, J= 7.1 Hz, 1H), 5.22 - 4.97 (m, 3H), 4.19 - 4.03 (m, 1H), 4.03 - 3.88 (m, 2H), 3.83 - 3.57 (m, 4H), 3.76 (s, 3H), 3.23 (s, 3H).



154


embedded image


580.2
Method D, RT = 1.794 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.07 (d, J = 8.6 Hz, 1H), 7.98 (d, J = 8.8 Hz, 2H), 7.69 (dd, J = 6.8, 2.0 Hz, 1H), 7.57 (dd, J= 7.1, 2.0 Hz, 1H), 7.48 (d, J = 8.3 Hz, 4H), 7.43 - 7.35 (m, 2H), 6.34 (t, J = 7.0 Hz, 1H), 5.11 - 4.95 (m, 3H), 4.17 (t, J = 8.1 Hz, 1H), 3.85 - 3.62 (m, 6H), 3.23 (s, 3H).



155


embedded image


636.2
Method D, RT = 1.887 min, 96.2%

1H NMR (400 MHz, DMSO-d6) δ = 9.12 (d, J = 8.6 Hz, 1H), 8.00 - 7.88 (m, 2H), 7.70 (dd, J = 6.8, 2.0 Hz, 1H), 7.64 (dd, J = 7.2, 2.0 Hz, 1H), 7.48 (d, J = 8.1 Hz, 2H), 6.77 (d, J = 10.8 Hz, 2H), 6.37 (t, J = 7.0 Hz, 1H), 5.10 (dd, J = 10.4, 8.9 Hz, 1H), 4.44 (dd, J= 2.8, 13.1 Hz, 1H), 4.39 - 4.27 (m, 1H), 4.16 - 3.99 (m, 2H), 3.97 - 3.89 (m, 2H), 3.85 (dd, J = 13.1, 9.4 Hz, 1H), 3.76 (s, 3H).



156


embedded image


650.2
Method D, RT = 2.067 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.14 (d, J = 8.6 Hz, 1H), 8.01 - 7.86 (m, 2H), 7.71 (dd, J = 6.8, 2.0 Hz, 1H), 7.67 (dd, J = 7.3, 2.0 Hz, 1H), 7.48 (d, J = 8.1 Hz, 2H), 6.77 (d, J = 10.8 Hz, 2H), 6.39 (t, J = 7.1 Hz, 1H), 5.12 (dd, J= 10.9, 8.7 Hz, 1H), 4.42 (dd, J = 13.4, 3.4 Hz, 1H), 4.38 - 4.26 (m, 1H), 4.15 - 3.93 (m, 4H), 3.76 (s, 3H), 3.34 (S, 3H).



157


embedded image


576.2
Method D, RT = 1.815 min, 99%

1H NMR (400 MHz, DMSO-d6) δ = 9.05 (d, J= 8.5 Hz, 1H), 8.15 (dd, J = 5.0, 2.0 Hz, 1H), 7.97 - 7.87 (m, 2H), 7.79 (dd, J = 7.5, 2.0 Hz, 1H), 7.35 (t, J = 72.0 Hz, 1H), 7.28 - 7.26 (m, 2H), 7.12 (dd, J = 7.8, 4.8 Hz, 1H), 6.80 (d, J = 10.5 Hz, 2H), 5.60 (dt, J = 4.4, 2.3 Hz, 1H), 5.05 (dd, J= 8.5, 11.0 Hz, 1H), 4.19 - 4.12 (m, 1H), 4.05 - 3.94 (m, 2H), 3.94 - 3.81 (m, 3H), 3.80 - 3.72 (m, 4H), 2.31 - 2.20 (m, 1H), 2.11 - 2.01 (m, 1H).



158


embedded image


626.2
Method D, RT = 1.81 min, 98%

1H NMR (400 MHz, DMSO-d6) δ = 9.11 (d, J = 8.6 Hz, 1H), 7.97 - 7.78 (m, 3H), 7.35 (t, J = 73.6 Hz, 1H), 7.29 - 7.27 (m, 2H), 7.13 (dd, J = 8.9, 2.6 Hz, 1H), 6.80 (d, J = 10.8 Hz, 2H), 5.19 - 5.04 (m, 1H), 4.29 - 4.14 (m, 2H), 4.09 - 3.97 (m, 1H), 3.92 m3.85 (m, 2H), 3.77 (s, 3H), 3.59 (t, J = 7.2 Hz, 2H), 2.41 - 2.37 (m, 2H).



159


embedded image


536.2
Method D, RT = 1.791 min, 97.8%

1H NMR (400 MHz, DMSO-d6) δ = 9.24 (d, J = 8.8 Hz, 1H), 8.02 (d, J = 8.3 Hz, 2H), 7.88 (d, J= 8.3 Hz, 2H), 7.77 (dd, J = 6.7, 2.1 Hz, 1H), 7.59 (dd, J = 7.1, 2.1 Hz, 1H), 6.78 (d, J = 10.5 Hz, 2H), 6.36 (t, J= 7.0 Hz, 1H), 5.15 (dd, J= 11.1, 8.7 Hz, 1H), 4.17 - 4.06 (m, 1H), 4.04 - 3.94 (m, 4H), 3.77 (s, 3H), 1.25 (t, J= 7.2 Hz, 3H).



160


embedded image


593.2
Method D, RT = 1.61 min, 98%

1H NMR (400 MHz, DMSO-d6) δ = 9.19 (d, J = 8.8 Hz, 1H), 8.12 (d, J = 6.4 Hz, 1H), 7.84 (d, J = 8.6 Hz, 2H), 7.58 (d, J = 8.6 Hz, 2H), 6.84 - 6.69 (m, 3H), 5.16 (dd, J = 8.8, 10.5 Hz, 1H), 4.77(br s, 1H), 4.24 - 4.04 (m, 3H), 3.76 (s, 3H), 3.72 -3.70(m, 1H), 3.56 - 3.51 (m, 2H), 2.85 (d, J = 9.0 Hz, 1H), 2.58 (d, J= 9.0, Hz, 1H), 2.30 (s, 3H), 1.94 (br d, J= 9.5 Hz, 1H), 1.83 (br d, J= 9.5 Hz, 1H).



161


embedded image


632.2
Method D, RT = 1.930 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.02 (d, J = 8.3 Hz, 1H), 7.88 (d, J = 8.8 Hz, 2H), 7.73 - 7.68 (m, 2H), 7.34 (t, J= 73.6 Hz, 1H), 7.29 -7.26 (m, 2H), 6.77 (d, J= 10.8 Hz, 2H), 6.39 (t, J = 7.0 Hz, 1H), 5.12 (dd, J = 10.5, 8.8 Hz, 1H), 4.42 (dd, J = 13.4, 3.4 Hz, 1H), 4.35 - 4.22 (m, 1H), 4.15 - 3.92 (m, 4H), 3.76 (s, 3H), 3.36 (s, 3H).



162


embedded image


532.2
Method D, RT = 1.711 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 8.97 (d, J = 8.6 Hz, 1H), 7.97 - 7.87 (m, 2H), 7.65 (dd, J= 6.8, 2.0 Hz, 1H), 7.59 (dd, J = 7.3, 2.0 Hz, 1H), 7.52 - 7.39 (m, 4H), 7.34 (t, J = 73.6 Hz, 1H), 7.26 (d, J = 8.0 Hz, 2H), 6.33 (t, J = 7.0 Hz, 1H), 5.10 -4.95 (m, 1H), 4.20 - 4.08 (m, 3H), 3.86 -3.71 (m, 2H), 3.60 (t, J = 5.3 Hz, 2H), 3.25 (s, 3H).



163


embedded image


581.2
Method D, RT = 2.03 min, 98.4%

1H NMR (400 MHz, DMSO-d6) δ = 9.09 (br d, J = 8.8 Hz, 1H), 8.32 - 8.21 (m, 1H), 7.91 - 7.78 (m, 2H), 7.65 - 7.51 (m, 2H), 7.14 (t, J = 5.6 Hz, 1H), 6.93 - 6.84 (m, 1H), 6.78 (d, J = 10.8 Hz, 2H), 5.21 - 5.02 (m, 1H), 4.34 - 4.26 (m, 1H), 4.22 - 4.09 (m, 1H), 3.78 (s, 3H), 3.77 - 3.66 (m, 1H), 2.27 - 2.23 (m, 1H), 0.85 - 0.76 (m, 2H), 0.62 - 0.55 (m, 2H).



164


embedded image


631.3
Method D, RT = 1.459 min, 98.3%

1H NMR (400 MHz, DMSO-d6) δ = 9.01 (d, J = 8.8 Hz, 1H), 7.89 (d, J = 8.8 Hz, 2H), 7.69 - 7.55 (m, 2H), 7.34 (t, J= 73.6 Hz, 1H), 7.28 (m, 2H), 6.77 (d, J = 10.8 Hz, 2H), 6.31 (t, J = 7.1 Hz, 1H), 5.11 (dd, J = 10.9, 8.7 Hz, 1H), 4.57 (s, 4H), 4.15 - 4.05 (m, 1H), 4.00 - 3.92 (m, 2H), 3.90 - 3.82 (m, 2H), 3.76 (s, 3H), 3.29 (s, 4H), 2.65 - 2.57 (m, 2H).



165


embedded image


530.2
Method D, RT = 1.67 min, 98.58%

1H NMR (400 MHz, DMSO-d6) δ = 8.99 - 8.94 (m, 1H), 8.00 - 7.83 (m, 2H), 7.68 - 7.74 (tm, 1H), 7.37 - 7.52 (m, 1H), 7.27 - 7.22 (m, 1H), 7.57 - 7.10 (m, 2H), 6.90 - 6.71 (m, 2H), 6.22 (d, J = 6.8 Hz, 1H), 5.43 - 4.74 (m, 1H), 4.21 - 3.85 (m, 5H), 3.74 (2 s, 3H), 2.21 - 2.05 (2 s, 3H), 1.31 -1.11 (m, 3H). (mixture of interconvertible atropisomers)



166


embedded image


613.2
Method D, RT = 1.87 min, 98.43%

1H NMR (400 MHz, DMSO-d6) δ = 9.09 (d, J = 8.8 Hz, 1H), 8.25 - 8.13 (m, 1H), 7.90 - 7.75 (m, 2H), 7.56 (d, J = 8.6 Hz, 2H), 6.96 - 6.84 (m, 1H), 6.78 (d, J= 10.8 Hz, 2H), 5.95 (br s, 1H), 5.14 (br dd, J = 11.0, 8.8 Hz, 1H), 4.35 - 4.28 (m, 1H), 4.26 - 4.14 (m, 2H), 3.77 (s, 3H), 3.76 -3.71 (m, 1H), 3.25 - 3.13 (m, 2H), 1.17 (s, 3H), 1.15 (s, 3H).



167


embedded image


609.3
Method D, RT = 1.88 min, 98%

1H NMR (400 MHz, DMSO-d6) δ = 10.08 (br s, 1H), 9.20 (d, J = 8.6 Hz, 1H), 8.43 (d, J = 5.9 Hz, 1H), 7.84 (d, J = 8.6 Hz, 2H), 7.58 (d, J = 8.6 Hz, 2H), 6.80 (d, J = 10.8 Hz, 2H), 5.10 (dd, J = 10.8, 8.8 Hz, 1H), 4.40 - 4.28 (m, 1H), 4.26 -4.18 (m, 1H), 4.13 - 4.01 (m, 3H), 3.77 (s, 3H), 3.55 - 3.50 (m, 2H), 3.33 - 3.23 (m, 2H), 2.78 (s, 3H), 1.45 - 1.21 (m, 6H).



168


embedded image


588.2
Method D, RT = 1.850 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 8.99 (br d, J= 8.6 Hz, 1H), 8.46 (s, 1H), 7.95 - 7.73 (m, 3H), 7.34 (t, J = 73.6 Hz, 1H), 7.30 - 7.24 (m, 2H), 6.77 (d, J= 10.8 Hz, 2H), 5.10 (dd, J = 10.8, 8.6 Hz, 1H), 4.22 - 3.95 (m, 3H), 3.77 (s, 3H), 3.58 (s, 3H).



169


embedded image



Method D, RT = 1.424 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.00 (d, J = 8.5 Hz, 1H), 7.93 - 7.85 (m, 2H), 7.76 (dd, J= 6.5, 2.0 Hz, 1H), 7.58 (dd, J = 7.5, 2.0 Hz, 1H), 7.35 (t, J = 73.6 Hz, 1H), 7.29 - 7.27 (m, 2H), 6.77 (d, J= 11.0 Hz, 2H), 6.35 (t, J=7.0 Hz, 1H), 5.11 (dd, J = 10.8, 8.8 Hz, 1H), 4.14 - 4.05 (m, 1H), 4.03 - 3.94 (m, 4H), 3.77 (s, 3H), 1.25 (t, J= 7.3 Hz, 3H).



170


embedded image


530.2
Method D, RT = 1.749 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.12 - 9.89 (m, 1H), 8.12 - 7.89 (m, 2H), 7.75 - 7.52 (m, 1H), 7.52 - 7.42 (m, 2H), 7.42 - 7.16 (m, 2H), 6.99 - 6.65 (m, 2H), 6.31 - 6.09 (m, 1H), 5.32 - 4.68 (m, 1H), 4.16 - 3.77 (m, 4H), 3.76 - 3.51 (m, 4H), 2.23 - 1.94 (2 s, 3H), 1.34 - 1.15 (m, 3H). (mixture of interconvertible atropisomers)



171


embedded image


522.1
Method D, RT = 1.88 min, 99%

1H NMR (400 MHz, DMSO-d6) δ = 9.05 - 8.92 (m, 1H), 8.41 (br d, J = 4.9 Hz, 1H), 7.98 - 7.78 (m, 3H), 7.52-7.49 (m, 1H), 7.35 (t, J= 73.6 Hz, 1H), 7.27 - 7.25 (m, 2H), 6.86 - 6.72 (m, 2H), 5.61 - 5.48 (m, 1H), 4.86 - 4.77 (m, 1H), 4.40-4.35 (m, 1H), 3.78 (s, 3H), 0.99 (d, J= 6.8 Hz, 3H).



172


embedded image


635.3
Method D, RT = 1.614 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.01 (d, J = 8.6 Hz, 1H), 7.94 - 7.83 (m, 2H), 7.72 (dd, J = 7.1, 2.0 Hz, 1H), 7.61 (dd, J = 7.2, 2.0 Hz, 1H), 7.34 (t, J = 73.6 Hz, 1H), 7.29 - 7.24 (m, 1H), 6.76 (d, J= 11.0 Hz, 2H), 6.41 (t, J = 7.1 Hz, 1H), 6.07 (dd, J = 8.7, 5.3 Hz, 1H), 5.09 (dd, J = 11.1, 8.7 Hz, 1H), 4.13 - 4.04 (m, 1H), 4.03 - 3.79 (m, 5H), 3.76 (s, 3H), 3.26 (s, 3H), 3.11 (s, 3H), 2.84 (s, 3H).



173


embedded image


582.2
Method D, RT = 1.690 min, 98.6%

1H NMR (400 MHz, DMSO-d6) δ = 9.11 (d, J = 8.6 Hz, 1H), 7.99 - 7.86 (m, 2H), 7.63 - 7.58 (m, 2H), 7.53 - 7.37 (m, 2H), 6.76 (d, J= 10.8 Hz, 2H), 6.31 (t, J= 7.1 Hz, 1H), 5.12 (dd, J = 11.0, 8.6 Hz, 1H), 4.94 (br d, J = 5.1 Hz, 1H), 4.17 - 4.03 (m, 2H), 4.03 - 3.83 (m, 3H), 3.76 (s, 3H), 3.63 (dd, J= 12.8, 8.2 Hz, 1H), 1.09 (d, J= 6.4 Hz, 3H).



174


embedded image


568.1
Method D, RT = 2.171 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.12 (d, J = 8.5 Hz, 1H), 7.99 - 7.90 (m, 2H), 7.65 (dd, J= 6.5, 2.0 Hz, 1H), 7.59 (dd, J = 7.3, 2.0 Hz, 1H), 7.49 (d, J = 8.0 Hz, 2H), 6.77 (d, J= 10.5 Hz, 2H), 6.35 - 6.29 (m, 1H), 5.12 (dd, J = 11.3, 8.8 Hz, 1H), 4.97 - 4.92 (m, 1H), 4.14 - 4.05 (m, 1H), 4.03 - 3.95 (m, 4H), 3.77 (s, 3H), 3.67 -3.62 (m, 2H).



175


embedded image


626.2
Method D, RT = 1.72 min, 99%

1H NMR (400 MHz, DMSO-d6) δ = 8.97 (br d, J= 8.1 Hz, 1H), 7.96 (d, J= 8.6 Hz, 2H), 7.74 - 7.66 (m, 1H), 7.56 (dd, J = 7.0, 1.3 Hz, 1H), 7.45 (d, J = 8.6 Hz, 2H), 6.77 (d, J = 11.5 Hz, 2H), 6.33 (t, J = 7.0 Hz, 1H), 5.71 - 5.61 (m, 1H), 5.14 - 4.97 (m, 2H), 4.67 - 4.56 (m, 1H), 4.29 (dd, J = 8.3, 11.7 Hz, 1H), 3.83 - 3.69, (m, 5H), 3.65 (td, J = 5.4, 10.9 Hz, 2H), 3.23 (s, 3H), 0.91 (br d, J = 6.8 Hz, 3H).



176


embedded image


578.2
Method D, RT = 1.584 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.11 - 8.92 (m, 1H), 7.88 (d, J = 9.0 Hz, 2H), 7.52 (s, 1H), 7.34 (t, J= 72 Hz, 1H), 7.28 - 7.11 (m, 1H), 6.77 (br d, J = 10.8 Hz, 2H), 6.24 - 6.14 (m, 1H), 5.40 - 5.28 (m, 1H), 4.97 - 4.84 (m, 2H), 4.30 - 3.98 (m, 3H), 3.93 - 3.84 (m, 1H), 3.80 - 3.71 (2 s, 3H), 3.62 - 3.43 (m, 2H), 2.23 - 2.01 (2 s, 3H), 1.08 (d, J = 6.4 Hz, 3H). (mixture of interconvertible atropisomers)



177


embedded image


579.3
Method D, RT = 1.69 min, 94%

1H NMR (400 MHz, DMSO-d6) δ = 9.10 (d, J = 8.6 Hz, 1H), 7.96 (t, J = 8.9 Hz, 1H), 7.92 - 7.84 (m, 2H), 7.56 (dd, J = 8.4, 2.6 Hz, 1H), 7.34 (t, J = 73.6 Hz, 1H), 7.27 - 7.25 (m, 2H), 6.79 (d, J= 10.8 Hz, 2H), 5.14 - 5.04 (m, 1H), 4.29 - 4.13 (m, 2H), 4.11 - 4.01 (m, 1H), 3.77 (s, 3H), 3.27 (s, 3H), 2.07 (s, 3H).



178


embedded image


560.3
Method D, RT = 1.738 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.09 - 8.98 (m, 1H), 8.06 - 7.91 (m, 2H), 7.59 - 7.52 (m, 1H), 7.51 - 7.48 (m, 2H), 7.41 - 7.35 (m, 1H), 7.32 (d, J = 8.6 Hz, 1H), 6.93 - 6.89 (m, 2H), 6.20 (d, J= 7.1 Hz, 1H), 5.27 - 4.66 (m, 1H), 4.19 - 3.99 (m, 2H), 3.95 - 3.80 (m, 2H), 3.74 - 3.68 (2 s, 3H), 3.66 - 3.45 (m, 3H), 3.24 (s, 3H), 2.23 - 2.03 (2 s, 3H). (mixture of interconvertible atropisomers)



179


embedded image


608.2
Method D, RT = 1.506 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.06 - 8.98 (m, 1H), 7.93 - 7.85 (m, 2H), 7.69 - 7.61 (m, 2H), 7.34 (t, J = 73.6 Hz, 1H), 7.28 (m, 2H), 6.77 (d, J = 10.8 Hz, 2H), 6.40 (t, J = 7.0 Hz, 1H), 5.14 (dd, J = 11.1, 8.4 Hz, 1H), 4.74 (t, J = 5.4 Hz, 2H), 4.15 - 4.04 (m, 1H), 4.03 - 3.89 (m, 4H), 3.76 (s, 3H), 3.24 - 3.11 (m, 4H), 0.78 (s, 3H).



180


embedded image


614.2
Method C, RT = 1.75 min, 89.7%

1H NMR (400 MHz, DMSO-d6) δ = 9.12 (br d, J = 8.3 Hz, 1H), 7.91 - 7.75 (m, 2H), 7.58 (br d, J = 8.6 Hz, 2H), 7.43 (s, 1H), 6.90 - 6.71 (m, 2H), 6.34 (s, 1H), 5.08 - 4.97 (m, 1H), 4.55 - 4.38 (m, 1H), 4.15 - 4.00 (m, 1H), 3.94 - 3.83 (m, 1H), 3.82 (s, 3H), 3.78 (s, 3H), 3.45 - 3.37 (m, 2H), 3.33 - 3.28 (m, 2H), 2.93 - 2.82 (m, 2H), 2.79 (s, 3H) 1.34 (d, J= 6.4 H, 6H).



181


embedded image


652.2
Method D, RT = 2.04 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.09 (br d, J = 8.6 Hz, 1H), 8.49 - 8.35 (m, 1H), 7.81 (br d, J = 6.8 Hz, 2H), 7.60 -7.51 (m, 2H), 7.18 (br d, J= 5.9 Hz, 1H), 6.78 (d, J= 10.8 Hz, 2H), 5.18 - 5.00 (m, 1H), 4.44 - 4.05 (m, 2H), 3.88 - 3.75 (m, 1H) 3.74 (s, 3H), 3.44 - 3.37 (m, 2H), 2.92 - 2.69 (m, 2H), 2.37 -2.22 (m, 2H), 2.21 (s, 3H), 1.05 (d, J= 6.4 Hz, 6H).



182


embedded image


584.2
Method D, RT = 1.91 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.12 - 9.89 (m, 1H), 8.06 - 7.89 (m, 2H), 7.69 - 3.61 (m, 1H), 7.58 - 7.40 (m, 3H), 6.91 - 6.71 (m, 2H), 6.38 - 6.35 (m, 1H), 6.32 (t, J= 57.2 Hz, 1H), 5.40 - 4.78 (m, 1H), 4.54 - 4.33 (m, 2H), 4.17 - 3.98 (m, 1H), 3.74 - 3.70 (2 s, 3H), 3.65 - 3.56 (m, 1H), 3.47 - 3.38 (m, 1H), 2.24 - 2.08 (2 s, 3H). (mixture of interconvertible atropisomers)



183


embedded image


548.2
Method D, RT = 1.81 min, 94.5%

1H NMR (400 MHz, DMSO-d6) δ = 9.12 -9.02 (m, 1H), 8.02 - 7.88 (m, 2H), 7.69 -7.62 (m, 1H), 7.57 - 7.39 (m, 3H), 6.88 -6.70 (m, 2H), 6.26 - 6.21 (m, 1H), 5.40 -4.78 (m, 1H), 4.17 - 3.89 (m, 3H), 3.74 -3.70 (2 s, 3H), 3.61 - 3.58 (m, 1H), 3.42 -3.37 (m, 1H), 2.22 - 2.02 (2 s, 3H), 1.28 -1.18 (m, 3H). (mixture of interconvertible atropisomers)



184


embedded image


573.1
Method D, RT = 2.24 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.17 (d, J= 8.6 Hz, 1H), 7.95 (d, J= 8.6 Hz, 2H), 7.71 (s, 1H), 7.62 - 7.55 (m, 1H), 7.51 - 7.46 (m, 3H), 7.26 (t, J= 76.2 Hz, 1H), 7.02 - 6.96 (m, 1H), 6.80 (d, J= 10.8 Hz, 2H), 5.11 - 4.98 (m, 1H), 4.24 - 4.07 (m, 2H), 4.05 - 3.96 (m, 1H), 3.78 (s, 3H).



185


embedded image


596.2
Method D, RT = 1.850 min, 98.6%

1H NMR (400 MHz, DMSO-d6) δ = 9.25 - 9.01 (m, 1H), 8.06 - 7.89 (m, 2H), 7.64 - 7.52 (m, 1H), 7.52 - 7.38 (m, 2H), 6.77 (dd, J= 10.8, 5.9 Hz, 2H), 6.26 - 6.12 (m, 1H), 5.39 - 4.84 (m, 1H), 4.30 - 3.99 (m, 4H), 3.79 - 3.71 (m, 3H), 3.62 - 3.54 (m, 2H), 3.54 - 3.44 (m, 1H), 3.26 - 3.21 (2 s, 3H), 2.23 - 1.99 (m, 3H). (mixture of interconvertible atropisomers)



186


embedded image


632.3
Method C, RT = 1.911 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.02 (d, J = 8.3 Hz, 1H), 7.89 (d, J= 8.8 Hz, 2H), 7.76 - 7.61 (m, 2H), 7.34 (t, J= 73.6 Hz, 1H), 7.28 (m, 2H), 6.77 (d, J= 10.8 Hz, 2H), 6.39 (t, J = 7.1 Hz, 1H), 5.17 -5.03 (m, 1H), 4.42 (dd, J= 13.4, 3.4 Hz, 1H), 4.38 - 4.26 (m, 1H), 4.16 - 3.92 (m, 4H), 3.76 (s, 3H), 3.36 (s, 3H).



187


embedded image


626.2
Method D, RT = 1.788 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.17 - 9.09 (m, 1H), 8.00 - 7.92 (m, 2H), 7.71 - 7.62 (m, 2H), 7.53 - 7.46 (m, 2H), 6.77 (d, J = 10.8 Hz, 2H), 6.40 (t, J = 7.1 Hz, 1H), 5.15 (dd, J= 11.1, 8.4 Hz, 1H), 4.74 (br t, J= 5.4 Hz, 2H), 4.17 - 4.04 (m, 1H), 4.02 - 3.88 (m, 4H), 3.76 (s, 3H), 3.23 -3.10 (m, 4H), 0.78 (s, 3H).



188


embedded image


574.2
Method D, RT = 1.940 min, 98.8%

1H NMR (400 MHz, DMSO-d6) δ = 9.12 (d, J= 8.6 Hz, 1H), 7.95 - 7.70 (m, 4H), 7.92 (t, J= 59.6 Hz, 1H), 7.49 (d, J= 8.3 Hz, 2H), 6.78 (d, J = 10.8 Hz, 2H), 6.56 (t, J= 7.2 Hz, 1H), 5.09 (dd, J= 11.0, 8.6 Hz, 1H), 4.18 - 4.08 (m, 1H), 4.06 - 3.94 (m, 2H), 3.77 (s, 3H).



189


embedded image


522
Method D, RT = 1.730 min, 99.3%

1H NMR (400 MHz, DMSO-d6) δ = 9.07 (d, J = 8.3 Hz, 1H), 8.07 (d, J= 2.9 Hz, 1H), 7.88 - 7.78 (m, 2H), 7.70 (d, J= 2.9 Hz, 1H), 7.63 - 7.50 (m, 2H), 6.78 (d, J = 10.8 Hz, 2H), 5.10 (dd, J= 10.5, 8.8 Hz, 1H), 4.15 - 3.92 (m, 3H), 3.76 (s, 3H), 3.49 (s, 3H).



190


embedded image


588.2
Method D, RT = 1.803 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.03 (d, J= 8.6 Hz, 1H), 7.94 - 7.83 (m, 2H), 7.78 - 7.72 (m, 1H), 7.68 (dd, J= 7.2, 1.8 Hz, 1H), 7.34 (t, J = 73.6 Hz, 1H), 7.28 (m, 2H), 6.77 (d, J = 10.8 Hz, 2H), 6.46 (t, J= 7.1 Hz, 1H), 5.12 (dd, J= 11.2, 8.6 Hz, 1H), 5.03 - 4.86 (m, 2H), 4.17 - 4.06 (m, 1H), 4.03 - 3.90 (m, 2H), 3.76 (s, 3H).



191


embedded image


606.2
Method D, RT = 1.972 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.13 (d, J= 8.6 Hz, 1H), 7.99 - 7.84 (m, 2H), 7.80 - 7.71 (m, 1H), 7.68 (dd, J= 7.1, 2.0 Hz, 1H), 7.55 - 7.36 (m, 2H), 6.78 (d, J= 10.8 Hz, 2H), 6.46 (t, J = 7.1 Hz, 1H), 5.13 (dd, J = 11.1, 8.7 Hz, 1H), 5.03 -4.84 (m, 2H), 4.17 - 4.05 (m, 1H), 4.04 -3.88 (m, 2H), 3.77 (s, 3H).



192


embedded image


556.3
Method D, RT = 1.81 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.03 - 9.86 (m, 1H), 8.01 - 7.84 (m, 2H), 7.72 - 8.65 (m, 1H), 7.60 - 7.39 (m, 1H), 7.35 (t, J = 73 Hz, 1H), 7.26 - 7.19 (m, 2H), 6.90 - 6.72 (m, 2H), 6.22 (d, J = 6.8 Hz, 1H), 5.43 - 4.76 (m, 1H), 4.20 - 3.93 (m, 2H), 3.90 - 3.74 (m, 2H), 3.72 - 3.66 (2 s, 3H), 3.42 - 3.37 (m, 1H), 2.23 - 1.99 (2 s, 3H), 1.31 - 1.15 (m, 1H), 0.55 - 0.45 (m, 2H), 0.41 - 0.30 (m, 2H). (mixture of interconvertible atropisomers)



193


embedded image


488.2
Method D, RT = 2.126 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.09 (br d, J = 8.0 Hz, 1H), 7.92 - 7.71 (m, 3H), 7.61 - 3.52 (m, 3H), 6.78 (br d, J = 11.0 Hz, 2H), 6.33 (br t, J= 6.8 Hz, 1H), 5.12 (br t, J= 9.3 Hz, 1H), 4.09 (br d, J= 8.5 Hz, 1H), 3.97 (br d, J= 8.5 Hz, 2H), 3.77 (s, 3H), 3.51 (br s, 3H).



194


embedded image


611.3
Method C, RT = 1.510 min, 96.6%

1H NMR (400 MHz, DMSO-d6) δ = 9.11 (br d, J = 7.6 Hz, 1H), 7.98 - 7.91 (m, 2H), 7.68 (br d, J = 7.1 Hz, 1H), 7.56 (dt, J= 1.1, 6.9 Hz, 1H), 7.51 - 7.41 (m, 2H), 6.81 - 6.70 (m, 2H), 6.40 - 6.31 (m, 1H), 5.12 - 4.97 (m, 2H), 4.12 - 4.07 (m, 2H), 4.02 - 3.92 (m, 2H), 3.76 (s, 3H), 3.65 -3.61 (m, 1H), 3.34 - 3.31 (m, 1H), 3.25 -3.16 (m, 4H), 3.06 - 3.01 (m, 2H).



195


embedded image


574.3
Method D, RT = 1.86 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.18 - 8.77 (m, 1H), 8.02 - 7.63 (m, 3H), 7.33 (t, J = 76 Hz, 1H), 7.28 - 7.24 (m, 2H), 6.81 - 6.72 (m, 2H), 6.32 - 6.10 (m, 1H), 5.42 - 4.80 (m, 1H), 4.32 - 4.04 (m, 2H), 3.93 - 3.66 (m, 5H), 3.55 - 3.43 (m, 1H), 2.24 - 1.99 (2 s, 3H), 1.29 - 1.11 (m, 1H), 0.55 - 0.42 (m, 2H), 0.42 - 0.30 (m, 2H). (mixture of atrop isomsers)



196


embedded image


522.2
Method D, RT = 1.680 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.19 - 9.00 (m, 1H), 7.92 - 7.75 (m, 3H), 7.64 - 7.47 (m, 2H), 6.77 (d, J= 10.8 Hz, 2H), 6.53 (dd, J= 7.3, 8.6 Hz, 1H), 5.37 - 5.09 (m, 1H), 4.25 - 4.11 (m, 1H), 4.04 - 3.89 (m, 1H), 3.76 (s, 3H), 3.64 - 3.56 (m, 1H), 3.52 - 3.47 (2 s, 3H). (mixture of interconvertible atropisomers)



197


embedded image


548.2
Method D, RT = 1.695 min, 98%

1H NMR (400 MHz, DMSO-d6) δ = 9.13 - 8.88 (m, 1H), 7.96 - 7.76 (m, 2H), 7.71 - 7.64 (m, 1H), 7.34 (t, J = 76 Hz, 1H), 7.28 - 7.24 (m, 2H), 6.84 - 6.66 (m, 2H), 6.31 - 6.16 (m, 1H), 5.36 - 4.82 (m, 1H), 4.29 - 4.07 (m, 2H), 4.02 - 3.83 (m, 2H), 3.80 - 3.72 (2 s, 3H), 3.53 - 3.45 (m, 1H), 2.23 - 1.99 (2 s, 3H), 1.26 - 1.17 (m, 3H). (mixture of interconvertible atropisomers)



198


embedded image


529.3
Method D, RT = 2.851 min, 99%

1H NMR (400 MHz, DMSO-d6) δ = 9.16 - 9.03 (m, 1H), 8.02 - 7.87 (m, 2H), 7.83 - 7.73 (m, 1H), 7.68 - 7.57 (m, 1H), 7.52 - 7.42 (m, 2H), 6.83 - 6.71 (m, 2H), 6.46 - 6.30 (m, 1H), 5.15 - 5.06 (m, 1H), 4.26 - 4.17 (m, 2H), 4.14 - 4.05 (m, 1H), 4.02 - 3.94 (m, 2H), 3.76 (s, 3H), 2.84 - 2.69 (m, 2H).



199


embedded image


607.2
Method D, RT = 1.66 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.11 (d, J = 8.3 Hz, 1H), 8.29 (dd, J = 8.9, 3.1 Hz, 1H), 7.94 (t, J = 9.2 Hz, 1H), 7.91 -7.83 (m, 2H), 7.35 (t, J = 73.6 Hz, 1H), 7.28 - 7.26 (m, 2H), 6.80 (d, J= 10.8 Hz, 2H), 5.94 - 5.77 (m, 1H), 5.10 (dd, J = 10.5, 8.6 Hz, 1H), 4.39 (br t, J = 8.4 Hz, 1H), 4.30 - 4.17 (m, 2H), 4.12 - 3.96 (m, 2H), 3.77 (s, 3H), 3.68-3.66 (m, 1H), 2.44 - 2.34 (m, 1H), 1.89 - 1.74 (m, 1H).



200


embedded image


596.3
Method D, RT = 1.86 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.08 (d, J= 8.6 Hz, 1H), 8.01 - 7.85 (m, 2H), 7.69 (dd, J= 6.8, 2.0 Hz, 1H), 7.53 - 7.39 (m, 3H), 6.87 - 6.71 (m, 2H), 6.34 (t, J= 7.0 Hz, 1H), 5.12 (dd, J = 11.2, 8.6 Hz, 1H), 4.53-4.49 (m, 1H), 4.19 - 4.04 (m, 2H), 3.77 (s, 3H), 3.67 - 3.54 (m, 3H), 3.24 (s, 3H), 0.99 (d, J = 6.1 Hz, 3H).



201


embedded image


576.2
Method D, RT = 1.591 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 7.94 - 7.85 (m, 2H), 7.64 (dd, J= 6.8, 2.0 Hz, 1H), 7.59 (dd, J= 7.2, 2.0 Hz, 1H), 7.36 (t, J= 72.2 Hz, 1H), 7.27 - 7.25 (m, 3H), 6.77 (d, J= 10.8 Hz, 2H), 6.41 (t, J = 7.1 Hz, 1H), 5.47 - 5.38 (m, 1H), 5.10 (d, J = 11.2 Hz, 1H), 4.18 - 3.92 (m, 4H), 3.90 -3.82 (m, 2H), 3.81 - 3.73 (m, 4H), 2.47 -2.42 (m, 1H), 2.04 - 1.92 (m, 1H).



202


embedded image


631.3
Method D, RT = 1.580 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.05 (d, J= 8.6 Hz, 1H), 8.13 (dd, J = 5.0, 2.0 Hz, 1H), 7.95 - 7.86 (m, 2H), 7.79 (dd, J = 7.6, 2.0 Hz, 1H), 7.34 (t, J = 73.6 Hz, 1H), 7.28 (m, 2H), 7.10 (dd, J= 7.6, 5.1 Hz, 1H), 6.80 (d, J = 10.8 Hz, 2H), 5.12 (dd, J= 11.2, 8.6 Hz, 1H), 4.58 (s, 4H), 4.33 - 4.12 (m, 4H), 3.99 (br d, J= 10.0 Hz, 2H), 3.77 (s, 3H), 3.36 (m, 3H), 2.71 (t, J = 5.5 Hz, 2H).



203


embedded image


502.2
Method D, RT = 1.79 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.16 (d, J= 9.0 Hz, 1H), 8.12 (dd, J= 4.6, 1.2 Hz, 1H), 7.92 - 7.79 (m, 2H), 7.65 (dd, J = 8.3, 4.6 Hz, 1H), 7.60 - 7.52 (m, 2H), 7.44 (dd, J= 8.3, 4.6 Hz, 1H), 6.88 - 6.68 (m, 2H), 5.29 (dd, J= 11.5, 8.8 Hz, 1H), 4.37 - 4.24 (m, 1H), 3.87 (s, 3H), 3.77 (s, 3H), 3.70 (t, J= 10.6 Hz, 1H), 1.01 (d, J = 6.1 Hz, 3H).



204


embedded image


572.1
Method D, RT = 2.12 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.02 - 8.87 (m, 1H), 8.10 - 7.99 (m, 1H), 7.80 (br d, J = 8.1 Hz, 1H), 7.66 (br d, J= 8.6 Hz, 2H), 7.35 (t, J = 72.0 Hz, 1H), 7.17 (d, J = 8.4 Hz, 2H), 6.71 - 6.57 (m, 2H), 5.28 - 5.18 (m, 1H), 4.44 - 4.26 (m, 3H), 3.70 (s, 3H), 2.39 (s, 3H).



205


embedded image


552.2
Method D, RT = 1.708 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.01 (d, J= 8.6 Hz, 1H), 8.05 (dd, J= 4.4, 3.3 Hz, 1H), 7.93 - 7.83 (m, 2H), 7.78 (dd, J = 8.4, 3.3 Hz, 1H), 7.34 (t, J = 76 Hz, 1H), 7.28 - 7.25 (m, 2H), 6.77 (d, J= 10.8 Hz, 2H), 5.12 (dd, J= 10.6, 8.7 Hz, 1H), 4.18 - 4.04 (m, 2H), 4.03 - 3.88 (m, 3H), 3.77 (s, 3H), 1.25 (t, J= 7.1 Hz, 3H).



206


embedded image


583.2
Method C, RT = 1.87 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 10.61 (s, 1H), 9.21 (d, J = 8.3 Hz, 1H), 8.11 - 7.98 (m, 1H), 7.97 - 7.90 (m, 2H), 7.86 (t, J= 8.9 Hz, 1H), 7.50 (d, J= 8.6 Hz, 2H), 6.80 (d, J= 11.0 Hz, 2H), 5.07 (dd, J= 10.3, 8.6 Hz, 1H), 4.29 - 4.03 (m, 3H), 3.77 (s, 3H), 2.09 (s, 3H).



207


embedded image


513.1
Method D, RT = 1.650 min, 99.4%

1H NMR (400 MHz, DMSO-d6) δ = 9.08 (d, J = 8.3 Hz, 1H), 8.66 (d, J= 2.4 Hz, 1H), 7.88 (d, J= 2.4 Hz, 1H), 7.86 - 7.75 (m, 2H), 7.62 - 7.53 (m, 2H), 6.82 - 6.68 (m, 2H), 5.10 (dd, J= 11.1, 8.7 Hz, 1H), 4.16 - 4.06 (m, 1H), 4.03 - 3.97 (m, 1H), 3.96 - 3.89 (m, 1H), 3.77 (s, 3H), 3.53 (s, 3H)



208


embedded image


560.2
Method D, RT = 1.65 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.04 - 8.93 (t, J= 8.4 Hz, 1H), 8.00 -7.81 (m, 2H), 7.61 - 7.50 (m, 2H), 7.35 (t, J = 72 Hz, 1H), 7.28 - 7.23 (m, 2H), 6.90 - 6.73 (m, 2H), 6.20 (d, J= 6.8 Hz, 1H), 5.42 -4.74 (m, 1H), 4.21 - 3.92 (m, 4H), 3.74 -3.70 (2S, 3H), 3.61 - 3.55 (m, 3H), 3.24 (s, 3H), 2.22 - 2.03 (2 s, 3H). (mixture of interconvertible atropisomers)



209


embedded image


605.2
Method D, RT = 1.845 min, 97%

1H NMR (400 MHz, DMSO-d6) δ = 9.09 (d, J = 8.3 Hz, 1H), 7.89 (d, J= 8.8 Hz, 2H), 7.64 (t, J = 9.2 Hz, 1H), 7.35 (t, J = 76 Hz, 1H),7.29 - 7.27 (m, 2H), 6.80 (br d, J= 10.8 Hz, 2H), 6.40 (dd, J= 9.0, 2.2 Hz, 1H), 5.17 - 5.05 (m, 1H), 4.71 (s, 4H), 4.24 - 4.02 (m, 6H), 4.00 - 3.94 (m, 1H), 3.78 (s, 3H).



210


embedded image


649.3
Method D, RT = 1.626 min, 95.6%

1H NMR (400 MHz, DMSO-d6) δ = 9.10 (d, J= 8.6 Hz, 1H), 8.00 - 7.88 (m, 2H), 7.64 (dd, J= 6.8, 2.0 Hz, 1H), 7.58 (dd, J = 7.1, 2.0 Hz, 1H), 7.49 (d, J = 8.1 Hz, 2H), 6.77 (d, J = 10.8 Hz, 2H), 6.31 (t, J = 7.0 Hz, 1H), 5.12 (dd, J= 11.1, 8.7 Hz, 1H), 4.57 (s, 4H), 4.15 - 4.04 (m, 1H), 4.01 - 3.92 (m, 2H), 3.88 - 3.84 (m, 2H), 3.77 (s, 3H), 3.29 (s, 4H), 2.61 (t, J= 6.0 Hz, 2H).



211


embedded image


587.2
Method D, RT = 1.964 min, 94%

1H NMR (400 MHz, DMSO-d6) δ = 8.75 (d, J = 7.8 Hz, 1H), 7.71 (d, J = 8.3 Hz, 2H), 7.68 - 7.61 (m, 1H), 7.61 - 7.54 (m, 1H), 7.33 (t, J= 72.6 Hz, 1H), 7.19 - 7.15 (m, 2H), 6.62 (d, J = 11.0 Hz, 2H), 6.31 (d, J = 7.8 Hz, 1H), 5.28 (t, J = 8.4 Hz, 1H), 4.85 - 4.81 (m, 1H), 4.67 - 4.62 (m, 1H), 4.40 - 4.19 (m, 3H), 3.82 - 3.68 (m, 4H), 3.65 (d, J= 7.6 Hz, 1H), 3.44 (br d, J= 9.8 Hz, 1H), 3.24 (m, 1H), 1.94 - 1.76 (m, 2H).



212


embedded image


611.2
Method D, RT = 2.05 min, 95.7%

1H NMR (400 MHz, DMSO-d6) δ = 9.09 (d, J = 8.1 Hz, 1H), 7.83 - 7.77 (m, 3H), 7.59 - 7.55 (m, 2H), 7.13 (d, J = 8 Hz, 1H), 6.79 (d, J= 10.8 Hz, 2H), 5.39 - 5.25 (m, 1H), 5.11 - 5.06 (m, 1H), 4.97 (d, J = 3.2 Hz, 1H), 4.39 (br d, J= 2.7 Hz, 1H), 4.30 - 4.20 (m, 1H), 3.90 - 3.79 (m, 1H), 3.76 (s, 3H), 3.65 - 3.50 (m, 4H), 2.02 -1.83 (m, 2H).



213


embedded image


616.2
Method D, RT = 1.903 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 8.74 (d, J= 7.8 Hz, 1H), 7.78 - 7.63 (m, 3H), 7.63 - 7.55 (m, 1H), 7.33 (t, J = 76 Hz, 1H), 7.18 - 7.14 (m, 2H), 6.70 - 6.54 (m, 3H), 5.29 (t, J = 8.4 Hz, 1H), 4.42 - 4.24 (m, 4H), 4.12 - 3.98 (m, 2H), 3.70 (s, 3H), 2.17 (s, 3H), 2.16 - 2.08 (m, 3H), 1.07 (d, J= 6.1 Hz, 6H).



214


embedded image


646.3
Method D, RT = 1.97 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.05 (d, J= 8.3 Hz, 1H), 7.88 (d, J= 9.2 Hz, 2H), 7.35 (t, J= 73.6 Hz, 1H), 7.33 -7.27 (m, 4H), 6.79 (d, J= 10.8 Hz, 2H), 5.08 - 5.03 (m, 1H), 4.49 - 4.38 (m, 1H), 4.17 - 3.98 (m, 3H), 3.93 - 3.84 (m, 1H), 3.80 (s, 3H), 3.78 (s, 3H), 2.48 (s, 3H), 2.30 -2.01 (m, 4H), 1.15 - 1.02 (m, 6H).



215


embedded image


482.2
Method D, RT = 1.557 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 8.89 (d, J= 8.8 Hz, 1H), 7.76 (dd, J= 6.7, 2.1 Hz, 1H), 7.73 (d, J = 8.3 Hz, 2H), 7.57 (dd, J= 7.2, 2.1 Hz, 1H), 7.28 (d, J= 8.1 Hz, 2H), 6.77 (d, J= 10.8 Hz, 2H), 6.35 (t, J= 7.0 Hz, 1H), 5.12 (dd, J= 11.1, 8.7 Hz, 1H), 4.18 - 4.04 (m, 1H), 4.04 - 3.89 (m, 4H), 3.76 (s, 3H), 2.35 (s, 3H), 1.25 (t, J= 7.1 Hz, 3H).



216


embedded image


621.2
Method D, RT = 2.24 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.10 (d, J= 8.6 Hz, 1H), 8.02 - 7.81 (m, 4H), 7.34 (t, J= 73.6 Hz, 1H),7.29 - 7.27 (m, 2H), 6.80 (d, J= 10.8 Hz, 2H), 5.16 - 5.03 (m, 1H), 4.33 - 4.19 (m, 4H), 4.10 - 3.96 (m, 3H), 3.77 (s, 3H), 3.60 - 3.48 (m, 1H), 1.26 (d, J = 6.1 Hz, 3H).



217


embedded image


608.3
Method D, RT = 1.54 min, 97%

1H NMR (400 MHz, DMSO-d6) δ = 8.87 (br d, J = 8.3 Hz, 1H), 7.96 - 7.84 (m, 2H), 7.71 (dd, J= 7.1, 2.0 Hz, 1H), 7.56 (dd, J= 7.1, 2.0 Hz, 1H), 7.33 (t, J= 73.6 Hz, 1H), 7.25- 7.23 (m, 2H),6.77 (d, J = 11.5 Hz, 2H), 6.33 (t, J = 7.1 Hz, 1H), 5.65 (dd, J = 11.7, 8.6 Hz, 1H), 5.14 -4.93 (m, 2H), 4.70 - 4.52 (m, 1H), 4.32 -4.27 (m, 1H), 3.76 (s, 3H), 3.75 - 3.69 (m, 4H), 3.23 (s, 3H), 0.91 (br d, J= 6.6 Hz, 3H).



218


embedded image


608.3
Method D, RT = 1.522 min, 97.4%

1H NMR (400 MHz, DMSO-d6) δ = 9.06 - 8.98 (m, 1H), 7.93 - 7.85 (m, 2H), 7.69 - 7.61 (m, 2H), 7.34 (t, J = 73.6 Hz, 1H), 7.28 (m, 2H), 6.77 (d, J= 10.8 Hz, 2H), 6.40 (t, J = 7.0 Hz, 1H), 5.14 (dd, J = 11.1, 8.4 Hz, 1H), 4.74 (t, J = 5.4 Hz, 2H), 4.15 - 4.04 (m, 1H), 4.03 - 3.89 (m, 4H), 3.76 (s, 3H), 3.24 - 3.11 (m, 4H), 0.78 (s, 3H).



219


embedded image


550.2
Method D, RT = 1.700 min, 98.8%

1H NMR (400 MHz, DMSO-d6) δ = 8.99 (br d, J = 8.6 Hz, 1H), 8.02 - 7.83 (m, 2H), 7.65 (dd, J= 6.6, 2.0 Hz, 1H), 7.59 (dd, J= 7.1, 2.0 Hz, 1H), 7.34 (t, J= 73.6 Hz, 1H), 7.28 (m, 2H), 6.77 (d, J= 10.8 Hz, 2H), 6.32 (t, J = 7.0 Hz, 1H), 5.12 (dd, J= 10.9, 8.7 Hz, 1H), 4.93 (t, J = 5.3 Hz, 1H), 4.17 - 4.05 (m, 1H), 4.05 - 3.90 (m, 4H), 3.77 (s, 3H), 3.70 - 3.59 (m, 2H).



220


embedded image


546.2
Method D, RT = 1.71 min, 95%

1H NMR (400 MHz, DMSO-d6) δ = 9.03 (d, J= 8.6 Hz, 1H), 7.88 - 7.77 (m, 2H), 7.68 (dd, J= 6.7, 1.8 Hz, 1H), 7.58 - 7.49 (m, 2H), 7.46 (dd, J= 6.7, 1.8 Hz, 1H), 6.87 - 6.72 (m, 2H), 6.34 (t, J= 7.1 Hz, 1H), 5.18 - 5.00 (m, 1H), 4.57 - 4.42 (m, 1H), 4.23 - 4.05 (m, 2H), 3.78 (s, 3H), 3.67 - 3.56 (m, 3H), 3.25 (m, 3H), 0.99 (d, J = 6.4 Hz, 3H).



221


embedded image


570.2
Method D, RT = 1.801 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.12 (d, J= 8.6 Hz, 1H), 8.03 - 7.87 (m, 2H), 7.72 (dd, J= 6.7, 1.8 Hz, 1H), 7.64 (dd, J = 7.3, 1.8 Hz, 1H), 7.49 (d, J = 8.3 Hz, 2H), 6.77 (d, J= 10.8 Hz, 2H), 6.37 (t, J = 7.0 Hz, 1H), 5.13 (dd, J= 10.9, 8.7 Hz, 1H), 4.71 (dt, J= 48.6, 4.6 Hz, 2H), 4.38 - 4.29 (m, 1H), 4.29 - 4.20 (m, 1H), 4.16 - 4.05 (m, 1H), 4.04 - 3.94 (m, 2H), 3.77 (s, 3H).



222


embedded image


526.1
Method D, RT = 1.94 min, 95.6%

1H NMR (400 MHz, DMSO-d6) δ = 9.14 (br d, J= 8.1 Hz, 1H), 8.90 (dd, J= 4.6, 1.2 Hz, 1H), 8.39 (dd, J = 7.8, 1.2 Hz, 1H), 7.91 - 7.79 (m, 2H), 7.73 (dd, J = 7.7, 4.8 Hz, 1H), 7.62 - 7.51 (m, 2H), 6.80 (d, J= 10.8 Hz, 2H), 5.14 (dd, J= 11.1, 8.7 Hz, 1H), 4.29 - 4.23 (m, 1H), 4.18 - 4.06 (m, 1H), 4.02 - 3.94 (m, 1H), 3.78 (s, 3H).



223


embedded image


617.2
Method D, RT = 1.75 min,93%

1H NMR (400 MHz, DMSO-d6) δ = 9.04 (d, J= 8.6 Hz, 1H), 7.95 - 7.84 (m, 2H), 7.57 - 7.52 (m, 1H), 7.34 (t, J = 76 Hz, 1H), 7.28 - 7.25 (m, 2H), 6.77 (d, J= 10.8 Hz, 2H), 6.44 (d, J = 8.8 Hz, 1H), 5.22 (dd, J = 11.1, 8.9 Hz, 1H), 4.71 (s, 4H), 4.18 - 3.91 (m, 6H), 3.88 - 3.81 (m, 1H), 3.76 (s, 3H), 3.75 (s, 3H).



224


embedded image


688.2
Method D, RT = 1.94 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.10 (br d, J= 8.1 Hz, 1H), 8.53 (br d, J= 6.6 Hz, 1H), 7.94 - 7.75 (m, 2H), 7.62 - 7.50 (m, 2H), 7.29 (br d, J= 5.4 Hz, 1H), 6.79 (d, J= 10.8 Hz, 2H), 5.20 - 5.03 (m, 1H), 4.46 - 4.12 (m, 2H), 3.90 - 3.74 (m, 1H), 3.72 (s, 3H), 3.32 - 3.18 (m, 6H), 2.95 (s, 3H), 2.64 - 2.53 (m, 2H).



225


embedded image


646.3
Method D, RT = 1.81 min,97%

1H NMR (400 MHz, DMSO-d6) δ = 9.03 (br d, J = 9.0 Hz, 1H), 7.96 - 7.82 (m, 2H), 7.54 - 7.52 (m, 1H), 7.34 (t, J= 76.0 Hz, 1H), 7. 28 - 7.26 (m, 2H), 6.88 (d, J = 8.8 Hz, 1H), 6.77 (d, J= 10.8 Hz, 2H), 5.21 (dd, J = 11.1, 8.9 Hz, 1H), 4.23 -4.10 (m, 1H), 4.10 - 3.93 (m, 3H), 3.89 -3.82 (m, 1H), 3.77 (s, 3H), 3.76 (s, 3H), 2.49 - 2.43 (m, 1H), 2.39 - 2.06 (m, 6H), 1.11 (br d, J= 6.4 Hz, 6H).



226


embedded image


516.2
Method D, RT = 1.53 min, 95.1%

1H NMR (400 MHz, DMSO-d6) δ = 8.51 (d, J= 8.5 Hz, 1H), 7.93 (d, J = 9.0 Hz, 1H), 7.78 (dd, J= 6.5, 2.0 Hz, 1H), 7.76 - 7.66 (m, 2H), 7.64 (dd, J= 7.0, 2.0 Hz, 1H), 7.35 (t, J= 72.0 Hz, 1H), 7.23 - 7.16 (m, 2H), 6.82 - 6.63 (m, 2H), 6.38 (t, J = 7.0 Hz, 1H), 5.15 - 5.05 (m, 1H), 4.17 -4.06 (m, 1H), 4.04 - 3.94 (m, 3H), 3.82 -3.74 (m, 1H), 3.72 (s, 3H), 1.25 (t, J= 7.1 Hz, 3H).



227


embedded image


568.2
Method D, RT = 1.64 min, 96%

1H NMR (400 MHz, DMSO-d6) δ = 9.11 (d, J= 8.6 Hz, 1H), 8.02 - 7.86 (m, 2H), 7.56 (d, J= 7.6 Hz, 1H), 7.52 - 7.36 (m, 2H), 6.85 - 6.68 (m, 2H), 6.40 (d, J= 7.6 Hz, 1H), 5.67 (t, J = 5.6 Hz, 1H), 5.12 (dd, J= 11.1, 8.7, Hz, 1H), 4.49 (d, J= 5.4 Hz, 2H), 4.18 - 4.04 (m, 1H), 4.02 -3.89 (m, 2H), 3.76 (s, 3H), 3.49 (s, 3H).



228


embedded image


566.2
Method D, RT = 1.886 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.26 - 8.95 (m, 1H), 8.02 - 7.83 (m, 2H), 7.76 - 7.60 (m, 1H), 7.56 - 7.33 (m, 2H), 6.79 - 6.72 (m, 2H), 6.30 - 6.14 (m, 1H), 5.38 - 4.79 (m, 1H), 4.30 - 4.06 (m, 2H), 4.04 - 3.84 (m, 2H), 3.80 - 3.69 (2 s, 3H), 3.53 - 3.44 (m, 1H), 2.22 - 1.97 (2 s, 3H), 1.29 - 1.15 (m, 3H). (mixture of interconvertible atropisomers).



229


embedded image


560.2
Method D, RT = 1.78 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.00 (d, J= 8.6 Hz, 1H), 7.96 - 7.85 (m, 2H), 7.79 (dd, J= 6.6, 2.0 Hz, 1H), 7.59 (dd, J = 7.3, 2.0 Hz, 1H), 7.34 (t, J = 72 Hz, 1H), 7.27 - 7.25 (m, 2H), 6.77 (d, J= 10.8 Hz, 2H), 6.35 (t, J = 7.0 Hz, 1H), 5.12 (dd, J= 10.9, 8.7 Hz, 1H), 4.17 - 4.04 (m, 1H), 4.04 - 3.91 (m, 2H), 3.87 - 3.78 (m, 2H), 3.77 (s, 3H), 1.31 - 1.16 (m, 1H), 0.55 - 0.43 (m, 2H), 0.43 - 0.33 (m, 2H).



230


embedded image


570.2
Method D, RT = 1.89 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.12 (d, J= 8.6 Hz, 1H), 8.05 (dd, J= 4.5, 3.3 Hz, 1H), 7.98 - 7.90 (m, 2H), 7.78 (dd, J = 8.4, 3.3 Hz, 1H), 7.49 (d, J = 8.9 Hz, 2H), 6.78 (d, J= 10.8 Hz, 2H), 5.14 (m, 1H), 4.19 - 4.04 (m, 2H), 4.03 - 3.88 (m, 3H), 3.77 (s, 3H), 1.25 (t, J= 7.1 Hz, 3H)



231


embedded image


668.2
Method D, RT = 1.69 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.11 - 9.00 (m, 1H), 8.24 - 8.06 (m, 1H), 7.95 - 7.78 (m, 2H), 7.35 (t, J= 72 Hz, 1H), 7.31 - 7.25 (m, 2H), 7.01 - 6.83 (m, 1H), 6.82 - 6.68 (m, 2H), 5.16 - 5.01 (m, 1H), 4.58 - 4.43 (m, 1H), 4.38 - 4.27 (m, 1H), 4.25 - 4.08 (m, 1H), 3.86 - 3.77 (m, 1H), 3.76 (s, 3H), 3.64 - 3.55 (m, 1H), 3.50 -3.40 (m, 1H), 3.28 - 3.21 (m, 1H), 2.83 -2.63 (m, 2H), 2.27 (s, 3H), 2.00 - 1.87 (m, 1H), 1.81 (m, 1H).



232


embedded image


578.2
Method D, RT = 1.686 min, 99.4%

1H NMR (400 MHz, DMSO-d6) δ = 9.18 - 8.82 (m, 1H), 8.02 - 7.83 (m, 2H), 7.66 - 7.48 (m, 1H), 7.34 (t, J = 73.6 Hz, 1H), 7.28 (m, 2H), 6.88 - 6.61 (m, 2H), 6.28 -6.12 (m, 1H), 5.38 - 4.81 (m, 1H), 4.32 -3.94 (m, 4H), 3.82 - 3.72 (2 s, 3H), 3.62 -3.44 (m, 3H), 3.27 - 3.19 (2 s, 3H), 2.25 -2.02 (m, 3H). (mixture of interconvertible atropisomers)



233


embedded image


586.2
Method D, RT = 1.92 min, 97.4%

1H NMR (400 MHz, DMSO-d6) δ = 9.13 (br d, J= 8.1 Hz, 1H), 7.83 (br d, J = 8.6 Hz, 2H), 7.58 (br d, J = 8.3 Hz, 2H), 7.41 (s, 1H), 6.80 (br d, J= 10.8 Hz, 2H), 6.28 (s, 1H), 5.10 - 4.98 (m, 1H), 4.50 - 4.23 (m, 3H), 4.13 - 4.04 (m, 1H), 3.93 - 3.85 (m, 2H), 3.82 (s, 3H), 3.75 (s, 3H), 3.15 - 2.95 (m, 5H), 2.83 (s, 3H).



234


embedded image


631.3
Method D, RT = 1.74 min, 98.5%

1H NMR (400 MHz, DMSO-d6) δ = 9.06 - 8.99 (m, 1H), 8.24 - 8.14 (m, 1H), 7.94 -7.81 (m, 2H), 7.33 (t, J= 73.6 Hz, 1H), 7.28 - 7.24 (m, 2H), 6.93 - 6.81 (m, 1H), 6.77 (d, J= 10.5 Hz, 2H), 6.28 (br d, J= 4.9 Hz, 1H), 5.16 - 4.93 (m, 2H), 4.32 -4.10 (m, 2H), 3.92 - 3.82 (m, 1H), 3.76 (s, 3H), 3.75 - 3.68 (m, 1H), 3.47 - 3.39 (m, 2H), 1.18 - 1.04 (m, 3H). (mixture of interconvertible atropisomers)



235


embedded image


594.2
Method D, RT = 1.972 min, 95%

1H NMR (400 MHz, DMSO-d6) δ = 9.15 (d, J = 8.6 Hz, 1H), 8.15 (dd, J = 5.0, 1.8 Hz, 1H), 8.02 - 7.88 (m, 2H), 7.79 (dd, J = 7.7, 1.8 Hz, 1H), 7.56 - 7.42 (m, 2H), 7.12 (dd, J = 7.6, 4.9 Hz, 1H), 6.80 (d, J = 10.8 Hz, 2H), 5.60 (br dd, J = 6.2, 4.5 Hz, 1H), 5.07 (dd, J = 11.0, 8.3 Hz, 1H), 4.16 (br d, J = 10.0 Hz, 1H), 4.05 - 3.88 (m, 3H), 3.87 - 3.80 (m, 2H), 3.77 (s, 3H), 3.76 - 3.73 (m, 1H), 2.30 - 2.21 (m, 1H), 2.12 - 2.03 (m, 1H).



236


embedded image


538.2
Method D, RT = 1.793 min, 96.3%

1H NMR (400 MHz, DMSO-d6) δ = 8.96 (d, J = 8.5 Hz, 1H), 7.98 - 7.85 (m, 2H), 7.72 (dd, J= 2.0, 7.0 Hz, 1H), 7.67 (dd, J = 2.0, 7.5 Hz, 1H), 7.59 - 7.07 (m, 5H), 7.38 (t, J= 58.4 Hz, 1H), 7.34 (t, J = 73.6 Hz, 1H), 6.42 (t, J = 8.0 Hz, 1H), 6.35 (tt, J= 56.2 Hz, 1H), 5.05 (dd, J = 8.8, 10.8 Hz, 1H), 4.54 - 4.36 (m, 2H), 4.18 (t, J = 7.8 Hz, 1H), 3.91 - 3.65 (m, 2H).



237


embedded image


506.2
Method D, RT = 1.655 min, 96%

1H NMR (400 MHz, DMSO-d6) δ = 9.17 (d, J = 8.3 Hz, 1H), 7.95 - 7.75 (m, 3H), 7.65 - 7.55 (m, 2H), 7.50 (dd, J = 8.3, 3.4 Hz, 1H), 6.80 (d, J = 10.8 Hz, 2H), 5.55 (t, J = 5.9 Hz, 1H), 5.19 - 4.98 (m, 1H), 4.54 (d, J = 5.9 Hz, 2H), 4.27 - 4.13 (m, 2H), 4.11 - 4.00 (m, 1H), 3.77 (s, 3H).



238


embedded image


556.2
Method D, RT = 2.691 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.06 (d, J = 8.3 Hz, 1H), 8.47 (d, J = 1.2 Hz, 1H), 7.92 - 7.80 (m, 3H), 7.65 - 7.53 (m, 2H), 6.78 (d, J = 10.8 Hz, 2H), 5.11 (dd, J = 8.6, 10.8 Hz, 1H), 4.19 - 3.96 (m, 3H), 3.77 (s, 3H), 3.57 (s, 3H).



239


embedded image


645.2
Method D, RT = 1.84 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.02 (d, J = 8.8 Hz, 1H), 8.26 - 8.14 (m, 1H), 7.94 - 7.81 (m, 2H), 7.35 (t, J = 72.2 Hz, 1H), 7.34 - 7.25 (m, 2H), 6.94 - 6.83 (m, 1H), 6.78 (d, J= 10.5 Hz, 2H), 5.98 - 5.91 (m, 1H), 5.16 - 5.05 (m, 1H), 4.87 (s, 1H), 4.36 - 4.14 (m, 2H), 3.76 (s, 3H), 3.75 - 3.67 (m, 1H) 3.22 - 3.13 (m, 2H), 1.17 (s, 3H), 1.15 (s, 3H).



240


embedded image


554.2
Method D, RT = 1.572 min, 98.7%

1H NMR (400 MHz, DMSO-d6) δ = 11.91 - 11.48 (m, 1H), 9.11 (d, J = 8.8 Hz, 1H), 8.03 - 7.84 (m, 2H), 7.57 (d, J = 7.3 Hz, 1H), 7.48 (dd, J = 9.0, 1.0 Hz, 2H), 6.77 (d, J = 10.8 Hz, 2H), 6.26 (d, J = 7.3 Hz, 1H), 5.56 - 550 (brs, 1H), 5.13 (dd, J = 11.0, 8.6 Hz, 1H), 4.31 (s, 2H), 4.15 - 3.87 (m, 3H), 3.76 (s, 3H).



241


embedded image


602.2
Method D, RT = 1.838 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.08 - 8.95 (m, 1H), 7.89 (d, J = 8.8 Hz, 2H), 7.82 - 7.59 (m, 2H), 7.34 (t, J = 76.0 Hz, 1H), 7.28 - 7.26 (m, 2H), 6.77 (d, J= 10.8 Hz, 2H), 6.38 (t, J = 8.2 Hz, 1H), 5.19 -5.05 (m, 1H), 4.27 - 4.17 (m, 2H), 4.14 -4.03 (m, 1H), 4.03 - 3.92 (m, 2H), 3.77 (s, 3H), 2.85 - 2.69 (m, 2H).



242


embedded image


566.2
Method D, RT = 1.87 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.08 (d, J = 8.6 Hz, 1H), 7.99 - 7.87 (m, 2H), 7.79 (dd, J = 6.8, 2.0 Hz, 1H), 7.53 - 7.37 (m, 3H), 6.84 - 6.71 (m, 2H), 6.36 (t, J = 7.0 Hz, 1H), 5.13 (dd, J = 11.2, 8.6 Hz, 1H), 4.54 - 4.44 (m, 1H), 4.04 - 3.90 (m, 2H), 3.77 (s, 3H), 3.62 (t, J = 10.5 Hz, 1H), 1.24 (t, J= 7.1 Hz, 3H), 0.99 (d, J = 6.1 Hz, 3H).



243


embedded image


550.2
Method D, RT = 1.455 min, 94%

1H NMR (400 MHz, DMSO-d6) δ = 9.00 (d, J = 8.6 Hz, 1H), 7.96 - 7.81 (m, 2H), 7.55 (d, J = 7.6 Hz, 1H), 7.34 (t, J = 76 Hz, 1H), 7.27 - 7.16 (m, 2H), 6.77 (d, J = 10.8 Hz, 2H), 6.40 (d, J = 7.6 Hz, 1H), 5.67 (br s, 1H), 5.11 (dd, J= 11.0, 8.6 Hz, 1H), 4.49 (s, 2H), 4.15 - 3.90 (m, 3H), 3.76 (s, 3H), 3.49 (s, 3H).



244


embedded image


534.2
Method D, RT = 1.669 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 8.99 (br d, J = 8.3 Hz, 1H), 7.97 - 7.78 (m, 2H), 7.56 (s, 1H), 7.54 - 7.03 (m, 3H), 7.34 (t, J= 73.6 Hz, 1H), 6.77 (d, J = 10.5 Hz, 2H), 5.09 (dd, J = 11.0, 8.6 Hz, 1H), 4.11 (q, J= 10.3 Hz, 1H), 3.97 (br d, J = 9.5 Hz, 2H), 3.77 (s, 3H), 3.46 (s, 3H), 2.08 (s, 3H).



245


embedded image


621.2
Method D, RT = 1.876 min, 97.5%

1H NMR (400 MHz, DMSO-d6) δ = 9.08 (br d, J = 8.3 Hz, 1H), 8.06 - 7.89 (m, 2H), 7.75 - 7.66 (m, 1H), 7.61 (dd, J = 7.2, 1.8 Hz, 1H), 7.52 - 7.44 (m, 3H), 7.43 - 7.34 (m, 2H), 6.41 (t, J = 7.2 Hz, 1H), 6.07 (dd, J = 8.8, 5.1 Hz, 1H), 5.08 - 4.94 (m, 1H), 4.14 - 4.05 (m, 2H), 3.91 - 3.75 (m, 4H), 3.26 (s, 3H), 3.10 (s, 3H), 2.84 (s, 3H).



246


embedded image


639.2
Method D, RT = 1.86 min, 96%

1H NMR (400 MHz, DMSO-d6) δ = 9.21 (d, J = 8.6 Hz, 1H), 8.25 (dd, J = 9.0, 3.2 Hz, 1H), 8.00 - 7.82 (m, 3H), 7.50 (d, J = 8.1 Hz, 2H), 6.80 (d, J = 10.8 Hz, 2H), 5.09 (dd, J = 10.3, 8.6 Hz, 1H), 4.86 (t, J = 5.6 Hz, 1H), 4.63-4.61 (m, 1H), 4.27-4.20 (m, 2H), 4.08 - 3.97 (m, 1H), 3.77 (s, 3H), 3.73-3.71 (m, 1H), 3.61-3.59 (m, 1H), 2.80 - 2.67 (m, 1H), 2.46 - 2.35 (m, 1H), 2.24 - 2.09 (m, 1H), 2.09 - 1.96 (m, 1H).



247


embedded image


572.2
Method D, RT = 1.99 min, 94.3%

1H NMR (400 MHz, DMSO-d6) δ = 9.09 (d, J= 8.6 Hz, 1H), 8.25 (d, J = 8.3 Hz, 1H), 7.94 - 7.84 (m, 2H), 7.69 (d, J = 8.8 Hz, 1H), 7.35 (t, J = 76.2 Hz, 1H), 7.28 (d, J = 8.2 Hz, 2H), 6.80 (d, J = 10.8 Hz, 2H), 5.16 (dd, J = 11.0, 8.8 Hz, 1H), 4.26 (q, J = 9.9 Hz, 1H), 4.10 (br t, J = 8.6 Hz, 1H), 3.99 - 3.88 (m, 1H), 3.77 (s, 3H), 2.61 (s, 3H).



248


embedded image


667.3
Method D, RT = 1.839 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.25 - 8.87 (m, 1H), 8.05 - 7.84 (m, 2H), 7.75 - 7.57 (m, 1H), 7.54 - 7.34 (m, 2H), 6.77 (dd, J= 5.6, 10.8 Hz, 1H), 6.35 - 6.19 (m, 1H), 6.11 - 5.92 (m, 1H), 5.39 - 4.82 (m, 1H), 4.30 - 3.96 (m, 3H), 3.92 - 3.68 (m, 5H), 3.59 - 3.45 (m, 1H), 3.29 - 3.23 (2 s, 3H), 3.16 - 3.06 (m, 3H), 2.86 - 2.80 (2 s, 3H), 2.22 - 1.95 (2 s, 3H). (Mixture of interconvertible atropisomers)



249


embedded image


534.2
Method D, RT = 1.77 min, 98.9%

1H NMR (400 MHz, DMSO-d6) δ = 9.05 (d, J = 8.8 Hz, 1H), 8.00 - 7.92 (m, 2H), 7.75 (dd, J = 6.8, 2.0 Hz, 1H), 7.58 (dd, J = 7.3, 2.0 Hz, 1H), 7.54 - 7.43 (m, 3H), 6.86 - 6.78 (m, 2H), 6.39 - 6.29 (m, 1H), 5.13 (dd, J = 11.4, 8.9 Hz, 1H), 4.19 -4.11 (m, 1H), 4.04 - 3.93 (m, 3H), 3.75 (s, 3H), 3.73 - 3.64 (m, 1H), 1.24 (t, J = 7.1 Hz, 3H).



250


embedded image


624.2
Method D, RT = 1.89 min, 96.4%

1H NMR (400 MHz, DMSO-d6) δ = 9.11 (br d, J = 7.8 Hz, 1H), 8.45 - 8.41 (m, 1H), 7.89 - 7.79 (m, 2H), 7.59 - 7.54 (m, 2H), 7.20 (br d, J = 5.9 Hz, 1H), 6.79 (br d, J = 10.8 Hz, 2H), 5.18 - 5.02 (m, 1H), 4.41 - 4.15 (m, 2H), 3.78 (s, 3H), 3.77 -3.71 (m, 1H), 3.27 - 3.01 (m, 4H), 2.49 -2.37 (m, 4H), 2.22 (s, 3H).



251


embedded image


513.2
Method D, RT = 1.653 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.17 (d, J = 8.8 Hz, 1H), 8.02 (d, J = 7.1 Hz, 1H), 7.92 - 7.81 (m, 2H), 7.65 - 7.48 (m, 2H), 6.79 (d, J = 11.0 Hz, 2H), 6.70 (d, J = 7.1 Hz, 1H), 5.23 (dd, J = 11.5, 8.6 Hz, 1H), 4.26 - 4.11 (m, 2H), 3.77 (s, 3H), 3.75 - 3.70 (m, 1H), 3.56 (s, 3H).



252


embedded image


558.3
Method D, RT = 1.421 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 8.96 - 8.87 (m, 1H), 7.93 (d, J = 8.6 Hz, 2H), 7.68 (dd, J= 6.7, 1.8 Hz, 1H), 7.56 (dd, J = 7.5, 1.8 Hz, 1H), 7.34 (t, J = 76 Hz, 1H), 7.33 - 7.27 (m, 2H), 7.29 - 7.22 (m, 2H), 6.90 (d, J = 8.6 Hz, 2H), 6.34 (t, J = 7.1 Hz, 1H), 5.10 - 4.99 (m, 3H), 4.13 -4.06 (m, 2H), 3.79 - 3.64 (m, 7H), 3.23 (s, 3H), 3.17 (d, J = 4.9 Hz, 1H).



253


embedded image


578.3
Method D, RT = 1.692 min, 93.2%

1H NMR (400 MHz, DMSO-d6) δ = 9.01 (d, J = 8.6 Hz, 1H), 7.93 - 7.81 (m, 2H), 7.61 (dt, J = 7.2, 1.7 Hz, 2H), 7.34 (t, J = 73.6 Hz, 1H), 7.28 (m, 2H), 6.76 (d, J = 10.8 Hz, 2H), 6.32 (t, J = 7.0 Hz, 1H), 5.12 (dd, J = 11.0, 8.6 Hz, 1H), 4.14 -3.79 (m, 5H), 3.76 (s, 3H), 3.68 - 3.61 (m, 1H), 3.18 (s, 3H), 1.09 (d, J = 6.1 Hz, 3H).



254


embedded image


626.2
Method D, RT = 1.700 min, 98.8%

1H NMR (400 MHz, DMSO-d6) δ = 9.06 - 8.98 (m, 1H), 7.93 - 7.85 (m, 2H), 7.69 - 7.61 (m, 2H), 7.56 - 7.13 (m, 2H), 6.77 (d, J = 10.8 Hz, 2H), 6.40 (t, J = 7.0 Hz, 1H), 5.14 (dd, J = 11.1, 8.4 Hz, 1H), 4.74 (t, J = 5.4 Hz, 2H), 4.15 - 4.04 (m, 1H), 4.03 - 3.89 (m, 4H), 3.76 (s, 3H), 3.24 -3.11 (m, 4H), 0.78 (s, 3H).



255


embedded image


548.2
Method D, RT = 1.70 min, 96%

1H NMR (400 MHz, DMSO-d6) δ = 9.01 (d, J = 8.6 Hz, 1H), 7.88 (d, J = 8.8 Hz, 2H), 7.78 (dd, J = 6.6, 2.0 Hz, 1H), 7.46-7.44 (m, 1H) 7.34 (t, J = 73.6 Hz, 1H), 7.27- 7.25 (m, 2H), 6.78 (d, J = 11.0 Hz, 2H), 6.36 (t, J = 7.0 Hz, 1H), 5.14-5.09 (m, 1H), 4.54 - 4.47 (m, 1H), 4.04 - 3.91 (m, 2H), 3.77 (s, 3H), 3.67-3.60 (m, 1H), 1.24 (t, J= 7.1 Hz, 3H), 0.98 (d, J = 6.1 Hz, 3H).



256


embedded image


605.2
Method D, RT = 1.904 min, 95%

1H NMR (400 MHz, DMSO-d6) δ = 9.06 (d, J = 8.6 Hz, 1H), 7.96 - 7.81 (m, 2H), 7.61 (t, J = 9.2 Hz, 1H), 7.34 (t, J = 72 Hz, 1 H), 7.29 - 7.26 (m, 2H), 6.79 (d, J = 10.8 Hz, 2H), 6.53 (dd, J= 2.2, 9.0 Hz, 1H), 5.20 - 5.08 (m, 1H), 4.83 - 4.78 (m, 1H), 4.68 - 4.62 (m, 1H), 4.25 - 4.13 (m, 2H), 4.04 - 3.92 (m, 1H), 3.78 (s, 4H), 3.64 (d, J = 7.3 Hz, 1H), 3.44 (d, J = 9.5 Hz, 1H), 3.23 (d, J = 10.3 Hz, 1H), 1.95 - 1.78 (m, 2H).



257


embedded image


649.3
Method D, RT = 1.672 min, 97.1%

1H NMR (400 MHz, DMSO-d6) δ = 9.18 - 8.91 (m, 1H), 7.98 - 7.80 (m, 2H), 7.69 - 7.56 (m, 1H), 7.55 - 6.92 (m, 2H), 7.34 (t, J = 73.6 Hz, 1H), 6.78 - 6.70 (m, 1H), 6.38 - 6.25 (m, 1H), 6.10 - 5.92 (m, 1H), 5.39 - 4.81 (m, 1H), 4.31 - 4.04 (m, 2H), 3.90 - 3.73 (m, 5H), 3.56 - 3.49 (m, 1H), 3.28 - 3.24 (2 s, 3H), 3.19 - 3.03 (m, 3H), 2.99 - 2.89 (m, 1H), 2.86 - 2.81 (2 s, 3H), 2.23 - 2.04 (2 s, 3H). (mixture of interconvertible atropisomers)



258


embedded image


552.2
Method D, RT = 1.625 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.02 (d, J = 8.6 Hz, 1H), 7.83-7.95 (m, 2H), 7.72 (dd, J = 6.8, 2.0 Hz, 1H), 7.63 (dd, J = 7.1, 2.0 Hz, 1H), 7.35 (t, J = 72 Hz, 1 H), 7.28-7.26 (m, 2H), 6.77 (d, J = 10.8 Hz, 2H), 6.37 (t, J = 7.0 Hz, 1H), 5.12 (dd, J = 11.0, 8.6 Hz, 1H), 4.71 (dt, J = 48.6, 4.6 Hz, 2H), 4.29 - 4.37 (m, 1H), 4.26 (dt, J = 4.6, 2.2 Hz, 1H), 4.04 - 4.14 (m, 1H), 3.94 - 4.02 (m, 2H), 3.76 (s, 3H).



259


embedded image


598.3
Method D, RT = 1.48 min, 97%

1H NMR (400 MHz, DMSO-d6) δ = 9.12 (d, J = 8.8 Hz, 1H), 7.84 (d, J = 8.8 Hz, 2H), 7.62 (d, J = 8.8 Hz, 2H), 7.49 (d, J = 9.0 Hz, 1H), 6.84 - 6.70 (m, 2H), 6.51 (d, J = 9.0 Hz, 1H), 5.22 (dd, J = 11.4, 8.9 Hz, 1H), 4.48 - 7.43 (m, 1H), 4.17 -4.05 (m, 1H), 4.01 (br t, J = 8.8 Hz, 1H), 3.90 - 3.83 (m, 1H), 3.76 (s, 3H), 3.74 (s, 3H), 3.44 - 3.33 (m, 2H), 3.25-3.24 (m, 1H), 2.83 - 2.78 (m, 1H), 2.46-2.43 (m, 1H), 2.25 (s, 3H), 1.87-1.82 (m, 1H), 1.71-1.69 (m, 1H).



260


embedded image


542.3
Method D, RT = 1.56 min, 94%

1H NMR (400 MHz, DMSO-d6) δ = 8.98 - 8.90 (m, 1H), 8.00 - 7.85 (m, 2H), 7.58 - 7.51 (m, 1H), 7.41 - 7.16 (m, 5H), 6.97 - 6.85 (m, 2H), 6.24 - 6.18 (m, 1H), 5.27 - 4.60 (m, 1H), 4.20 - 3.97 (m, 3H), 3.93 - 3.79 (m, 2H), 3.75 - 3.71 (2 s, 3H), 3.61 - 3.53 (m, 2H), 3.24 (s, 3H), 2.20 - 2.07 (2 s, 3H). (mixture of interconvertible atropisomers isomsers)



261


embedded image


587.2
Method D, RT = 1.83 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.03 (br d, J = 8.8 Hz, 1H), 8.29 - 8.13 (m, 1H), 7.99 - 7.78 (m, 2H), 7.35 (t, J = 72 Hz, 1H), 7.31 - 7.25 (m, 2H), 6.85 - 6.65 (m, 4H), 5.22 - 5.02 (m, 1H), 4.34 - 4.05 (m, 2H), 3.82 (s, 3H), 3.80 - 3.68 (s, 1H), 2.85 (d, J = 4.4 Hz, 3H).



262


embedded image


564.3
Method D, RT = 1.508 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.18 - 8.88 (m, 1H), 7.96 - 7.91 (m, 2H), 7.64 -7.07 (m, 4H), 6.77 (dd, J = 10.8, 4.9 Hz, 2H), 6.29 - 6.13 (m, 1H), 5.38 - 4.79 (m, 2H), 4.31 - 3.87 (m, 3H), 3.81 - 3.58 (m, 5H), 3.55 - 3.44 (m, 2H), 2.27 - 1.93 (2 s, 3H). (mixture of interconvertible atropisomers)



263


embedded image


611.2
Method D, RT = 1.88 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.09 (br d, J = 8.8 Hz, 1H), 8.32 - 8.21 (m, 1H), 7.91 - 7.78 (m, 2H), 7.65 - 7.51 (m, 2H), 6.97 - 6.85 (m, 1H), 6.78 (d, J= 10.8 Hz, 2H), 6.13 - 5.95 (m, 1H), 5.21 - 5.02 (m, 1H), 4.37 - 4.11 (m, 3H), 3.95 - 3.83 (m, 2H), 3.82 (s, 3H), 3.79 - 3.64 (m, 3H), 2.31 - 2.19 (m, 1H), 2.04 - 1.89 (m, 1H). (mixture of interconvertible atropisomers).



264


embedded image


582.3
Method D, RT = 1.80 min, 94%

1H NMR (400 MHz, DMSO-d6) δ = 9.09 (d, J = 8.8 Hz, 1H), 7.94 (d, J = 8.8 Hz, 2H), 7.68 (dd, J = 6.6, 2.0 Hz, 1H), 7.53 - 7.39 (m, 3H), 6.79 (d, J = 11.0 Hz, 2H), 6.33 (t, J = 7.0 Hz, 1H), 5.13 (dd, J = 11.4, 8.4 Hz, 1H), 4.99 - 4.90 (m, 1H), 4.55 - 4.44 (m, 1H), 4.06 - 3.98 (m, 2H), 3.77 (s, 3H), 3.68 - 3.56 (m, 3H), 0.99 (d, J = 5.9 Hz, 3H).



265


embedded image


554.3
Method D, RT = 1.541 min, 96%

1H NMR (400 MHz, DMSO-d6) δ = 9.02 - 8.81 (m, 1H), 7.98 - 7.83 (m, 2H), 7.58 - 7.48 (m, 1H), 7.42 - 7.07 (m, 5H), 6.99 - 6.80 (m, 2H), 6.32 - 6.24 (m, 1H), 5.43 - 5.30 (m, 1H), 5.26 - 4.63 (m, 1H), 4.14 - 3.99 (m, 2H), 3.94 - 3.63 (m, 7H), 3.46 (t, J = 9.7 Hz, 1H), 2.47 - 2.38 (m, 1H), 2.22 - 2.07 (2 s, 3H), 2.02 - 1.88 (m, 1H). (mixture of interconvertible atropisomers).



266


embedded image


621.1
Method D, RT = 1.80 min, 98%

1H NMR (400 MHz, DMSO-d6) δ = 9.10 (d, J = 8.0 Hz, 1H), 8.25 (dd, J = 9.0, 3.0 Hz, 1H), 7.92 - 7.87 (m, 3H), 7.35 (t, J = 73.6 Hz, 1H), 7.29 - 7.27 (m, 2H), 6.79 (d, J = 11.0 Hz, 2H), 5.08 (dd, J = 10.0, 8.5 Hz, 1H), 4.85 (t, J = 5.8 Hz, 1H), 4.61- 4.58 (m, 1H), 4.32 - 4.14 (m, 2H), 4.05 - 3.96 (m, 1H), 3.77 (s, 3H), 3.75 -3.66 (m, 1H), 3.64 - 3.60 (m, 1H), 2.74 -2.67 (m, 1H), 2.42 - 2.40 (m, 1H), 2.33 -2.30 (m,1H), 2.10 - 2.04 (m, 1H).



267


embedded image


533.2
Method D, RT = 1.989 min, 93.4%

1H NMR (400 MHz, DMSO-d6) δ = 9.17 - 9.08 (m, 1H), 7.85 (d, J = 8.8 Hz, 2H), 7.63 - 7.48 (m, 4H), 7.11 (dd, J = 10.4, 1.3 Hz, 1H), 6.81 (d, J = 10.8 Hz, 2H), 5.18 (d, J = 1.5 Hz, 1H), 5.06 (dd, J= 8.1, 10.0 Hz, 1H), 4.24 - 4.05 (m, 2H), 4.04 -3.99 (m, 1H), 3.79 (s, 3H), 1.44 (s, 6H).



268


embedded image


582.2
Method D, RT = 1.640 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.01 (d, J = 8.6 Hz, 1H), 7.93 (dd, J = 4.5, 3.3 Hz, 1H), 7.91 - 7.85 (m, 2H), 7.80 (dd, J = 8.4, 3.3 Hz, 1H), 7.34 (t, J = 73.6 Hz, 1H), 7.28 (m, 2H), 6.77 (d, J = 10.8 Hz, 2H), 5.12 (dd, J = 10.8, 8.6 Hz, 1H), 4.18 - 4.03 (m, 4H), 3.97 (s, 1H), 3.77 (s, 3H), 3.61 (t, J= 5.4 Hz, 2H), 3.26 (s, 3H).



269


embedded image


628.2
Method D, RT = 2.016 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.11 (d, J = 8.6 Hz, 1H), 8.01 - 7.89 (m, 2H), 7.79 (dd, J = 6.6, 2.0 Hz, 1H), 7.61 (dd, J = 7.1, 2.0 Hz, 1H), 7.49 (d, J = 8.1 Hz, 2H), 6.77 (d, J = 10.8 Hz, 2H), 6.36 (t, J = 7.0 Hz, 1H), 5.13 (dd, J= 10.8, 8.6 Hz, 1H), 4.20 - 4.05 (m, 3H), 4.05 - 3.91 (m, 2H), 3.77 (s, 3H), 2.69 - 2.55 (m, 4H), 2.48 - 2.41 (m, 1H).



270


embedded image


641.2
Method D, RT = 1.698 min, 94.4%

1H NMR (400 MHz, DMSO-d6) δ = 9.08 (d, J = 8.8 Hz, 1H), 8.27 (d, J = 8.3 Hz, 1H), 7.89 (d, J = 8.8 Hz, 2H), 7.57 (d, J = 8.1 Hz, 1H), 7.54 - 7.11 (m, 3H), 7.34 J= 73.6 Hz, 1H), 6.79 (d, J= 10.8 Hz, 2H), 5.23 - 5.12 (m, 1H), 4.31 - 4.19 (m, 1H), 4.13 (br t, J = 9.8 Hz, 1H), 3.96 (br t, J = 9.8 Hz, 1H), 3.77 (s, 3H), 3.08 (br d, J= 12.0 Hz, 2H), 2.95 - 3.90 (m, 1H), 2.68 - 2.61 (m, 2H), 1.85 - 2.80 (m, 2H), 1.72 - 1.60 (m, 2H).



271


embedded image


593.3
Method D, RT = 1.83 min, 98%

1H NMR (400 MHz, DMSO-d6) δ = 9.07 (d, J = 8.8 Hz, 1H), 7.93 - 7.83 (m, 2H), 77.53 - 7.48 (m, 1H), 7.35 (t, J= 73.6 Hz, 1H), 7.28 - 7.26 (m, 2H), 6.96 (d, J= 5.9 Hz, 1H), 6.87 - 6.64 (m, 2H), 6.46 (dd, J = 8.9, 2.6 Hz, 1H), 5.17 - 5.05 (m, 1H), 4.29 - 4.19 (m, 1H), 4.19 - 4.08 (m, 2H), 4.02 - 3.93 (m, 1H), 3.90 - 3.88 (m, 1H), 3.85 - 3.77 (m, 1H), 3.76 (s, 3H), 3.73-3.71 (m, 1H), 3.51-3.49 (m, 1H), 2.18-2.13 (m, 1H), 1.86 - 1.70 (m, 1H).



272


embedded image


578.2
Method D, RT = 1.946 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.11 (d, J = 8.8 Hz, 1H), 8.03 - 7.87 (m, 2H), 7.79 (dd, J = 6.6, 2.0 Hz, 1H), 7.59 (dd, J = 7.1, 2.0 Hz, 1H), 7.49 (d, J = 8.1 Hz, 2H), 6.77 (d, J = 10.5 Hz, 2H), 6.35 (t, J = 7.0 Hz, 1H), 5.14 (dd, J = 11.0, 8.6 Hz, 1H), 4.17 - 4.05 (m, 1H), 4.05 - 3.92 (m, 2H), 3.89 - 3.73 (m, 2H), 3.72 (s, 3H), 1.31 - 1.18 (m, 1H), 0.55 - 0.45 (m, 2H), 0.43 - 0.34 (m, 2H).



273


embedded image


498.3
Method D, RT = 1.692 min, 93.2%

1H NMR (400 MHz, DMSO-d6) δ = 8.87 (d, J = 8.5 Hz, 1H), 7.79 - 7.69 (m, 2H), 7.65 (dd, J= 6.8, 1.8 Hz, 1H), 7.58 (dd, J = 7.5, 2.0 Hz, 1H), 7.28 (d, J = 8.5 Hz, 2H), 6.76 (d, J = 10.5 Hz, 2H), 6.35 - 6.27 (m, 1H), 5.11 (dd, J = 11.0, 8.5 Hz, 1H), 4.98 - 4.89 (m, 1H), 4.14 - 4.06 (m, 1H), 4.03 - 3.94 (m, 4H), 3.76 (s, 3H), 3.65 (d, J = 5.5 Hz, 2H), 2.35 (s, 3H).



274


embedded image


626.2
Method D, RT = 1.700 min, 98.8%

1H NMR (400 MHz, DMSO-d6) δ = 9.01 (d, J = 8.6 Hz, 1H), 7.88 (d, J = 8.8 Hz, 2H), 7.63 - 7.58 (m, 2H), 7.34 (t, J= 73.6 Hz, 1H), 7.28 (m, 2H), 6.76 (d, J = 10.8 Hz, 2H), 6.32 (t, J = 7.0 Hz, 1H), 5.10 (dd, J = 10.9, 8.9 Hz, 1H), 4.15 - 3.82 (m, 5H), 3.76 (s, 3H), 3.67 - 3.63 (m, 1H), 3.19 (s, 3H), 1.09 (d, J = 6.1 Hz, 3H).



275


embedded image


626.2
Method D, RT = 1.77 min, 97.5%

1H NMR (400 MHz, DMSO-d6) δ = 9.10 (d, J = 8.5 Hz, 1H), 8.39 - 8.25 (m, 1H), 8.23 - 8.13 (m, 1H), 7.90 - 7.75 (m, 2H), 7.62 - 7.49 (m, 2H), 6.79 (d, J = 10.5 Hz, 2H), 6.73 -6.61 (m, 1H), 6.43 - 6.27 (m, 1H), 5.21 - 5.02 (m, 1H), 4.38 - 4.05 (m, 3H), 3.85 - 3.79 (m, 1H), 3.77 (s, 3H), 2.66 (d, J = 8 Hz, 3H), 1.32 (d, J = 4.2 Hz, 3H).



276


embedded image


528.3
Method D, RT = 1.509 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 8.92 (d, J = 8.6 Hz, 1H), 7.99 - 7.90 (m, 2H), 7.64 (dd, J = 6.8, 2.0 Hz, 1H), 7.59 (dd, J = 7.2, 2.0 Hz, 1H), 7.33 (t, J = 80.0 Hz, 1H), 7.36 - 7.27 (m, 4H), 6.96 - 6.80 (m, 2H), 6.32 (t, J = 7.0 Hz, 1H), 5.01 (dd, J = 10.9, 8.9 Hz, 1H), 4.18 - 4.06 (m, 3H), 3.81 - 3.68 (m, 5H), 3.60 (t, J = 5.4 Hz, 2H), 3.25 (s, 3H).



277


embedded image


566.2
Method D, RT = 1.782 min, 99.6%

1H NMR (400 MHz, DMSO-d6) δ = 9.23 (d, J = 8.3 Hz, 1H), 8.02 (d, J = 8.1 Hz, 2H), 7.88 (d, J = 8.1 Hz, 2H), 7.67 (dd, J = 6.8, 2.0 Hz, 1H), 7.61 (dd, J = 7.3, 2.0 Hz, 1H), 6.77 (d, J = 10.8 Hz, 2H), 6.33 (t, J = 7.0 Hz, 1H), 5.15 (dd, J = 11.0, 8.6 Hz, 1H), 4.22 - 4.06 (m, 3H), 4.04 - 3.94 (m, 2H), 3.77 (s, 3H), 3.61 (t, J= 5.3 Hz, 2H), 3.26 (s, 3H).



278


embedded image


637.3
Method D, RT = 1.504 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.12 (d, J = 8.6 Hz, 1H), 7.86 - 8.00 (m, 2H), 7.72 (dd, J = 6.8, 2.0 Hz, 1H), 7.59 (dd, J = 7.3, 2.0 Hz, 1H), 7.49 (dd, J = 8.9, 0.9 Hz, 2H), 6.69 - 6.84 (m, 2H), 6.33 (t, J = 7.0 Hz, 1H), 5.13 (dd, J = 11.1, 8.7 Hz, 1H), 3.91 - 4.15 (m, 5H), 3.76 (s, 3H), 3.54 (t, J= 4.5 Hz, 4H), 2.57 (s, 2H), 2.36 - 2.48 (m, 4H).



279


embedded image


656.3
Method D, RT = 1.71 min, 97.5%

1H NMR (400 MHz, DMSO-d6) δ = 9.06 (br d, J = 8.8 Hz, 1H), 8.62 - 8.51 (m, 1H), 7.92 - 7.80 (m, 2H), 7.35 (t, J = 72 Hz, 1H), 7.34 - 7.23 (m, 3H), 6.80 (d, J = 10.8 Hz, 2H), 5.15 - 4.99 (m, 1H), 4.46 - 4.38 (m, 1H), 4.32 - 4.16 (m, 1H), 3.90 - 3.78 (m, 1H), 3.77 (s, 3H), 3.49 - 3.37 (m, 4H), 3.30 - 3.05 (m, 4H), 2.89 (s, 3H).



280


embedded image


591.2
Method D, RT = 1.82 min, 98%

1H NMR (400 MHz, DMSO-d6) δ = 9.12 (d, J = 8.6 Hz, 1H), 8.27 (dd, J = 9.2, 3.1 Hz, 1H), 7.95 - 7.85 (m, 3H), 7.35 (t, J = 73.6 Hz, 1H), 7.29 - 7.27 (m, 2H), 6.80 (d, J= 10.8 Hz, 2H), 5.11 (br dd, J= 10.4, 8.2 Hz, 1H), 4.31 - 4.17 (m, 2H), 4.10 -3.91 (m, 3H), 3.78 (s, 3H), 2.59 (t, J= 8.1 Hz, 2H), 2.09 - 1.98 (m, 2H).



281


embedded image


638.3
Method C, RT = 1.71 min, 98.5%

1H NMR (400 MHz, DMSO-d6) δ = 9.13 - 8.95 (m, 1H), 8.29 - 8.20 (m, 2H), 7.91 - 7.75 (m, 2H), 7.61 - 7.56 (m, 2H), 6.81 - 6.76 (m, 2H), 6.75 - 6.68 (m, 1H), 6.58 - 6.51 (m, 1H), 5.19 - 4.98 (m, 1H), 4.35 - 4.26 (m, 1H), 4.25 - 4.10 (m, 1H), 3.89 - 3.75 (m, 2H), 3.80 (s, 3H), 3.78 - 3.74 (m, 1H), 2.64 - 2.68 (m, 1H), 0.68 - 0.62 (m, 2H), 0.46 - 0.42 (m, 2H).



282


embedded image


720.2
Method D, RT = 1.88 min, 97.8%

1H NMR (400 MHz, DMSO-d6) δ = 9.09 - 8.98 (m, 1H), 8.57 - 8.49 (m, 1H), 7.87 (td, J = 7.4, 0.9 Hz, 2H), 7.35 (t, J = 72 Hz, 1H), 7.32 - 7.25 (m, 3H), 6.79 (d, J = 10.8 Hz, 2H), 5.17 - 5.06 (m, 1H), 4.45 -4.35 (m, 1H), 4.29 - 4.18 (m, 1H), 3.90 -3.80 (m, 1H), 3.77 (s, 3H), 3.41 - 3.25 (m, 8H), 2.96 (s, 3H).



283


embedded image


653.3
Method D, RT = 1.790 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.11 (d, J = 8.8 Hz, 1H), 8.00 - 7.87 (m, 2H), 7.72 (dd, J = 7.1, 2.0 Hz, 1H), 7.62 (dd, J = 7.2, 2.0 Hz, 1H), 7.54 - 7.40 (m, 2H), 6.77 (d, J = 10.8 Hz, 2H), 6.4 (t, J = 7.1 Hz, 1H), 6.06 (dd, J = 8.6, 5.1 Hz, 1H), 5.13 (dd, J = 11.1, 8.7 Hz, 1H), 4.15 -3.96 (m, 2H), 3.96 - 3.79 (m, 3H), 3.76 (s, 3H), 3.27 (s, 3H), 3.12 (s, 3H), 2.85 (s, 3H).



284


embedded image


614.3
Method D, RT = 1.53 min, 99%

1H NMR (400 MHz, DMSO-d6) δ = 9.11 (d, J = 9.0 Hz, 1H), 7.84 (d, J = 8.6 Hz, 2H), 7.61 - 7.54 (m, 2H), 7.52 (d, J = 8.8 Hz, 1H), 6.86 (d, J = 8.8 Hz, 1H), 6.82 -6.71 (m, 2H), 5.21 (dd, J = 9.2, 10.9 Hz, 1H), 4.18 - 4.01 (m, 2H), 3.99 - 3.90 (m, 2H), 3.88 - 3.82 (m, 1H), 3.76 (s, 6H), 2.47 - 2.39 (m, 2H), 2.23 - 2.11 (m, 5H), 1.12 - 1.01 (m, 6H).



285


embedded image


630.2
Method D, RT = 1.73 min, 96.8%

1H NMR (400 MHz, DMSO-d6) δ = 9.06 (d, J = 8.8 Hz, 1H), 7.88 (d, J = 8.8 Hz, 2H), 7.36 (t, J = 73.6 Hz, 1H), 7.30 - 7.26 (m, 3H), 6.80 (d, J = 10.8 Hz, 2H), 5.84 (s, 1H), 5.08 (dd, J = 11.1, 8.4 Hz, 1H), 4.70 - 4.60 (m, 1H), 4.52 - 4.40 (m, 1H), 4.12 - 4.01 (m, 1H), 3.91 - 3.83 (m, 2H), 3.81 (s, 3H) 3.78 (s, 3H), 3.67 - 3.56 (m, 1H), 3.46 (m, 1H), 2.92 - 2.85 (m, 1H), 2.46 - (s, 3H), 1.97 - 1.85 (m, 2H), 1.79 - 1.75 (m, 1H).



286


embedded image


554.1
Method D, RT = 1.659 min, 97.8%

1H NMR (400 MHz, DMSO-d6) δ = 9.13 - 8.93 (m, 1H), 7.97 - 7.78 (m, 3H), 7.34 (t, J = 73.6 Hz, 1H), 7.28 (m, 2H), 6.77 (d, J = 10.8 Hz, 2H), 6.53 (dd, J = 7.3, 8.6 Hz, 1H), 5.35 - 5.07 (m, 1H), 4.24 -4.09 (m, 1H), 4.05 - 3.89 (m, 1H), 3.76 (s, 3H), 3.64 - 3.53 (m, 1H), 3.50 (d, J = 5.6 Hz, 3H). (mixture of interconvertible atropisomers)



287


embedded image


581.3
Method D, RT = 1.76 min, 94%

1H NMR (400 MHz, DMSO-d6) δ = 9.19 (d, J = 8.6 Hz, 1H), 8.33 (d, J = 5.9 Hz, 1H), 7.87 - 7.78 (m, 2H), 7.61 - 7.53 (m, 2H), 7.00 (d, J = 6.4 Hz, 1H), 6.80 (d, J = 10.8 Hz, 2H), 5.10 (dd, J = 10.8, 8.6 Hz, 1H), 4.38 - 4.30 (m, 1H), 4.20 (q, J = 9.9 Hz, 1H), 4.06 - 3.96 (m, 1H), 3.77 (s, 3H), 3.57 - 3.45 (m, 4H),2.51 - 2.44 (m, 4H), 2.26 (s, 3H).



288


embedded image


578.2
Method D, RT = 1.83 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.17 - 9.00 (m, 1H), 8.09 - 7.87 (m, 2H), 7.66 - 7.35 (m, 4H), 6.94 - 6.66 (m, 2H), 6.20 (d, J = 6.8 Hz, 1H), 5.41 - 4.78 (m, 1H), 4.22 - 3.89 (m, 4H), 3.78 - 3.72 (2 s, 3H), 3.63 - 3.37 (2 s, 3H), 3.24 (s, 3H), 2.21 -2.06 (2 s, 3H). (mixture of interconvertible atropisomers isomers)



289


embedded image


644.1
Method D, RT = 1.99 min, 94%

1H NMR (400 MHz, DMSO-d6) δ = 9.21 (d, J = 8.3 Hz, 1H), 7.99 - 7.82 (m, 3H), 7.50 (d, J= 8.8 Hz, 2H), 7.13 (dd, J= 9.3, 2.4 Hz, 1H), 6.80 (d, J = 10.8 Hz, 2H), 5.17 - 5.07 (m, 1H), 4.28 - 4.16 (m, 2H), 4.09 - 3.99 (m, 1H), 3.94 - 3.82 (m, 2H), 3.77 (s, 3H), 3.59 (t, J= 7.2 Hz, 2H), 2.43 - 2.38 (m, 2H).



290


embedded image


626.2
Method D, RT = 1.77 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.10 (d, J = 8.5 Hz, 1H), 8.39 - 8.25 (m, 1H), 8.23 - 8.13 (m, 1H), 7.90 - 7.75 (m, 2H), 7.62 - 7.49 (m, 2H), 6.79 (d, J = 10.5 Hz, 2H), 6.73 -6.61 (m, 1H), 6.43 - 6.27 (m, 1H), 5.21 - 5.02 (m, 1H), 4.38 - 4.05 (m, 3H), 3.85 - 3.79 (m, 1H), 3.77 (s, 3H), 2.69 - 2.64 (2 s, 3H), 1.43 - 1.32 (m, 3H). (mixture of interconvertible atropisomers)



291


embedded image


552.2
Method D, RT = 1.761 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.25 - 8.95 (m, 1H), 8.01 - 7.86 (m, 2H), 7.73 - 7.57 (m, 1H), 7.54 - 7.36 (m, 2H), 6.88 - 6.66 (m, 2H), 6.28 - 6.15 (m, 1H), 5.38 - 4.84 (m, 1H), 4.30 - 4.05 (m, 2H), 3.80 - 3.72 (2 s, 3H), 3.55 - 3.40 (m, 4H), 2.23 - 2.01 (2 s, 3H). (mixture of interconvertible atropisomers)



292


embedded image


512.3
Method D, RT = 1.560 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 8.89 (d, J = 8.8 Hz, 1H), 7.77 - 7.69 (m, 2H), 7.66 (dd, J = 6.8, 2.0 Hz, 1H), 7.59 (dd, J = 7.3, 2.0 Hz, 1H), 7.28 (d, J = 8.1 Hz, 2H), 6.77 (d, J = 10.8 Hz, 2H), 6.32 (t, J = 7.0 Hz, 1H), 5.12 (dd, J = 8.7, 11.1 Hz, 1H), 4.20 - 4.04 (m, 3H), 3.97 (br d, J = 9.5 Hz, 2H), 3.76 (s, 3H), 3.60 (t, J = 5.3 Hz, 2H), 3.25 (s, 3H), 2.35 (s, 3H).



293


embedded image


626.2
Method D, RT = 1.72 min, 94%

1H NMR (400 MHz, DMSO-d6) δ = 8.97 (br d, J = 8.1 Hz, 1H), 7.96 (d, J= 8.6 Hz, 2H), 7.74 - 7.66 (m, 1H), 7.56 (dd, J = 7.0, 1.3 Hz, 1H), 7.45 (d, J = 8.6 Hz, 2H), 6.77 (d, J = 11.5 Hz, 2H), 6.33 (t, J = 7.0 Hz, 1H), 5.71 - 5.61 (m, 1H), 5.14 - 4.97 (m, 2H), 4.67 - 4.56 (m, 1H), 4.29 (dd, J = 11.7, 8.3 Hz, 1H), 3.83 - 3.69, (m, 4H), 3.65 (td, J= 5.4, 10.9 Hz, 2H), 3.34 - 3.32 (m, 1H), 3.23 (s, 3H), 0.91 (br d, J = 6.8 Hz, 3H).



294


embedded image


632.2
Method D, RT = 1.808 min, 98.1%

1H NMR (400 MHz, DMSO-d6) δ = 9.18 - 8.84 (m, 1H), 8.00 - 7.82 (m, 2H), 7.73 - 7.06 (m, 3H), 7.34 (t, J = 73.6 Hz, 1H), 6.79 - 6.73 (m, 2H), 6.35 - 6.11 (m, 1H), 5.37 - 4.75 (m, 1H), 4.49 - 4.03 (m, 5H), 3.88 - 3.74 (m, 4H), 3.55 - 3.48 (m, 1H), 2.25 - 2.01 (2 s, 3H). (mixture of interconvertible atropisomers)



295


embedded image


613.3
Method D, RT = 1.563 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 8.94 (d, J = 9.0 Hz, 1H), 7.97 - 7.87 (m, 2H), 7.65 - 7.56 (m, 1H), 7.52 - 7.15 (m, 4H), 6.95 - 6.80 (m, 2H), 6.28 (d, J = 7.6 Hz, 1H), 6.02 (s, 1H), 5.21 - 4.73 (m, 1H), 4.11 - 4.03 (m, 1H), 3.93 - 3.75 (m, 5H), 3.74 - 3.67 (2 s, 3H), 3.28 - 3.22 (2 s, 3H), 3.16 - 3.05 (m, 3H), 2.90 - 2.80 (2 s, 3H), 2.24 - 2.06 (2 s, 3H). (mixture of interconvertible atropisomers)



296


embedded image


518.2
Method D, RT = 1.656 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 8.90 (d, J = 8.6 Hz, 1H), 7.78 - 7.70 (m, 3H), 7.66 (dd, J= 7.3, 2.0 Hz, 1H), 7.28 (d, J = 8.1 Hz, 2H), 6.77 (d, J = 10.8 Hz, 2H), 6.42 (t, J = 8.0 Hz, 1H), 6.35 (tt, J = 56.2 Hz, 1H), 5.11 (dd, J = 8.6, 11.0 Hz, 1H), 4.55 - 4.35 (m, 2H), 4.16 - 4.05 (m, 1H), 3.98 (br d, J = 9.3 Hz, 2H), 3.76 (s, 3H), 2.35 (s, 3H).



297


embedded image


664.2
Method D, RT = 2.100 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.27 - 8.88 (m, 1H), 8.04 - 7.82 (m, 2H), 7.71 - 7.54 (m, 1H), 7.54 - 7.26 (m, 2H), 6.77 (dd, J = 10.6, 5.5 Hz, 2H), 6.44 - 6.10 (m, 1H), 5.40 - 4.80 (m, 1H), 4.43 - 3.89 (m, 5H), 3.83 - 3.69 (m, 3H), 3.61 - 3.46 (m, 1H), 3.38 - 3.33 (m, 3H), 2.26 - 2.03 (m, 3H). (mixture of interconvertible atropisomers)



298


embedded image


594.2
Method D, RT = 1.773 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.12 (d, J = 8.6 Hz, 1H), 7.98 - 7.89 (m, 2H), 7.64 (dd, J = 7.1, 2.0 Hz, 1H), 7.59 (dd, J = 7.2, 2.0 Hz, 1H), 7.49 (dd, J = 1.0, 8.8 Hz, 2H), 6.78 (d, J = 10.8 Hz, 2H), 6.41 (t, J = 7.1 Hz, 1H), 5.45 - 5.39 (m, 1H), 5.12 (dd, J = 11.1, 8.7 Hz, 1H), 4.17 -4.02 (m, 2H), 3.98 (br d, J= 8.8 Hz, 2H), 3.87 (d, J = 4.4 Hz, 2H), 3.82 - 3.69 (m, 4H), 2.48 - 2.40 (m, 1H), 1.98 (m, 1H).



299


embedded image


545.2
Method D, RT = 1.397 min, 94.9%

1H NMR (400 MHz, DMSO-d6) δ = 9.83 (s, 1H), 9.07 (d, J = 8.6 Hz, 1H), 8.14 (d, J= 2.7 Hz, 1H), 7.84 (d, J= 8.6 Hz, 2H), 7.66 (d, J = 2.7 Hz, 1H), 7.58 - 7.52 (m, 3H), 6.78 (d, J = 10.8 Hz, 2H), 5.01 (br dd, J = 8.2, 9.9 Hz, 1H), 4.16 - 3.94 (m, 3H), 3.74 (s, 3H), 3.49 (s, 3H), 2.00 (s, 3H).



300


embedded image


491.1
Method D, RT = 1.65 min, 99%

1H NMR (400 MHz, DMSO-d6) δ = 9.19 - 9.01 (m, 2H), 8.66 - 8.51 (m, 1H), 7.89 (d, J = 8.6 Hz, 2H), 7.78 (dd, J = 9.3, 4.6 Hz, 1H), 7.35 (t, J = 76 Hz, 1H), 7.30-7.29 (m, 2H), 6.80 (br d, J = 10.5 Hz, 2H), 5.06 (br t, J = 9.4 Hz, 1H), 4.58 (br t, J = 8.8 Hz, 1H), 4.30 - 4.05 (m, 2H), 3.78 (s, 3H).



301


embedded image


582.1
Method D, RT = 1.73 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 8.97 (d, J = 8.8 Hz, 1H), 8.02 - 7.91 (m, 2H), 7.67 (dd, J = 6.6, 2.0 Hz, 1H), 7.59 (dd, J = 6.6, 2.0 Hz, 1H), 7.45 (d, J = 8.1 Hz, 2H), 6.82 - 6.70 (m, 2H), 6.31 (t, J = 7.0 Hz, 1H), 5.67 (dd, J = 12.0, 8.6 Hz, 1H), 4.65 - 4.59 (m, 1H), 4.32 - 4.27 (m, 1H), 4.12 - 4.06 (m, 2H), 3.97 - 3.92 (m, 2H), 3.76 (s, 3H), 3.34 - 3.30 (m, 1H), 0.92 (d, J = 6.8 Hz, 3H).



302


embedded image


582.2
Method D, RT = 1.808 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.12 (d, J = 8.5 Hz, 1H), 7.99 - 7.90 (m, 2H), 7.67 (dd, J= 6.8, 1.8 Hz, 1H), 7.60 (dd, J = 7.0, 2.0 Hz, 1H), 7.49 (d, J = 8.0 Hz, 2H), 6.77 (d, J = 10.5 Hz, 2H), 6.33 (t, J = 7.0 Hz, 1H), 5.13 (dd, J = 10.8, 8.8 Hz, 1H), 4.17 - 4.04 (m, 3H), 4.03 - 3.93 (m, 2H), 3.77 (s, 3H), 3.60 (t, J= 5.3 Hz, 2H), 3.25 (s, 3H).



303


embedded image


618.2
Method D, RT = 1.76 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.03 (br d, J = 9.0 Hz, 1H), 7.95 - 7.83 (m, 2H), 7.62 (d, J = 9.0 Hz, 1H), 7.34 (t, J = 76 Hz, 1H), 7.28 - 7.26 (m, 2H), 6.97 (d, J = 9.0 Hz, 1H), 6.78 (d, J = 10.8 Hz, 2H), 5.21 - 5.16 (m, 1H), 4.34 - 4.12 (m, 3H), 4.11 - 4.05 (m, 1H), 3.93 - 3.83 (m, 1H), 3.79 (s, 3H), 3.77 (s, 3H), 3.58 -3.47 (m, 2H), 3.18 - 2.96 (m, 4H), 2.86 (s, 3H).



304


embedded image


562.2
Method D, RT = 1.527 min, 96%

1H NMR (400 MHz, DMSO-d6) δ = 9.01 (d, J = 8.6 Hz, 1H), 7.89 (d, J = 8.8 Hz, 2H), 7.82 (dd, J = 7.0, 1.6 Hz, 1H), 7.64 (dd, J = 7.2, 1.6 Hz, 1H), 7.34 (t, J = 76.0 Hz, 1H), 7.27 - 7.25 (m, 2H), 6.77 (d, J = 10.8 Hz, 2H), 6.45 (t, J = 7.1 Hz, 1H), 5.54 (m, 1H), 5.09 (dd, J = 10.6, 8.7 Hz, 1H), 4.89 (t, J = 7.2 Hz, 2H), 4.77 (q, J = 7.2 Hz, 2H), 4.15 - 4.03 (m, 1H), 3.99 -3.95 (m, 2H), 3.76 (s, 3H).



305


embedded image


534.1
Method D, RT = 1.55 min, 95.6%

1H NMR (400 MHz, DMSO-d6) δ = 9.10 -9.07 (m, 1H), 8.76 - 8.75 (d, J = 4.4 Hz, 1H), 7.98 -7.97 (m, 1H), 7.84 (d, J = 8.6 Hz, 2H), 7.78 - 7.74 (m, 1H), 7.57 - 7.51 (m, 2H), 6.76 - 6.74 (d, J = 10.8 Hz, 1 H), 6.63 - 6.60 (d, J = 11.2 Hz, 1H), 5.17 -5.13 (m, 1H), 4.22 - 4.19 (m, 1H), 4.1 -4.03 (m, 2H), 3.77 (s, 3H), 1.85 - 1.65 (m, 6H).



306


embedded image


667.2
Method D, RT = 1.524 min, 98.4%

1H NMR (400 MHz, DMSO-d6) δ = 9.01 (d, J = 8.8 Hz, 1H), 7.94 - 7.84 (m, 2H), 7.75 (dd, J = 6.7, 2.0 Hz, 1H), 7.60 (dd, J = 7.1, 2.0 Hz, 1H), 7.34 (t, J = 73.6 Hz, 1H), 7.28 (m, 2H), 6.77 (d, J = 10.8 Hz, 2H), 6.35 (t, J = 7.0 Hz, 1H), 5.11 (dd, J = 10.9, 8.4 Hz, 1H), 4.14 - 4.01 (m, 3H), 3.98 (br d, J = 8.6 Hz, 2H), 3.76 (s, 3H), 3.14 - 3.05 (m, 4H), 3.04 - 2.90 (m, 4H), 2.85 - 2.77 (m, 2H).



307


embedded image


562.2
Method D, RT = 1.618 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 8.97 (d, J = 8.8 Hz, 1H), 7.92 (d, J = 9.0 Hz, 2H), 7.68 (dd, J = 7.2, 1.8 Hz, 1H), 7.58 - 7.54 (m, 1H), 7.53 - 7.32 (m, 5H), 7.34 (t, J = 73.6 Hz, 1H), 7.28 - 7.22 (m, 1H), 6.34 (t, J = 7.1 Hz, 1H), 5.12 - 4.99 (m, 3H), 4.20 - 4.13 (m, 1H), 3.88 - 3.59 (m, 6H), 3.22 (s, 3H).



308


embedded image


578.2
Method D, RT = 1.575 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.02 (d, J = 8.8 Hz, 1H), 7.95 - 7.81 (m, 2H), 7.65 (dd, J = 6.8, 2.0 Hz, 1H), 7.60 (dd, J = 7.3, 2.0 Hz, 1H), 7.34 (t, J = 76 Hz, 1H), 7.27 - 7.25 (m, 2H), 6.77 (d, J= 10.8 Hz, 2H), 6.32 (t, J = 7.1 Hz, 1H), 5.15 (dd, J = 10.9, 8.7 Hz, 1H), 4.79 (br s, 1H), 4.12 - 4.03 (m, 1H), 4.02 - 3.88 (m, 4H), 3.76 (s, 3H), 1.09 (d, J = 5.1 Hz, 6H).



309


embedded image


592.2
Method D, RT = 1.86 min, 94%

1H NMR (400 MHz, DMSO-d6) δ = 9.08 (d, J = 8.5 Hz, 1H), 7.95 - 7.84 (m, 2H), 7.73 - 7.60 (m, 1H), 7.35 (t, J = 73.6 Hz, 1H), 7.32 - 7.29 (m, 2H), 6.89 - 6.73 (m, 3H), 5.12 (dd, J = 8.5, 10.5 Hz, 1H), 4.25 - 4.14 (m, 2H), 4.03-3.95 (m, 1H), 3.77 (s, 3H), 3.74 - 3.66 (m, 4H), 3.43-3.41 (m, 4H).



310


embedded image


534.2
Method D, RT = 1.575 min, 99.1 %

1H NMR (400 MHz, DMSO-d6) δ = 9.14 - 8.90 (m, 1H), 7.98 - 7.79 (m, 2H), 7.74 - 7.58 (m, 1H), 7.53 -7.16 (m, 3H), 6.85 - 6.70 (m, 2H), 6.26 - 6.16 (m, 1H), 5.38 - 4.83 (m, 1H), 4.31 - 4.06 (m, 2H), 3.81 - 3.71 (2 s, 3H), 3.53 - 3.41 (m, 4H), 2.23 - 1.97 (2 s, 3H). (mixture of interconvertible atropisomers)



311


embedded image


588.2
Method D, RT = 1.792 min, 98.8%

1H NMR (400 MHz, DMSO-d6) δ = 9.19 - 8.89 (m, 1H), 8.15 - 8.01 (m, 1H), 7.89 (dd, J = 8.7, 5.0 Hz, 2H), 7.34 - 7.16 (m, 3H), 6.80 - 6.68 (m, 2H), 6.57 (dd, J = 7.0, 5.3 Hz, 1H), 5.36 - 5.10 (m, 1H), 4.26 - 4.12 (m, 1H), 4.03 - 3.86 (m, 1H), 3.75 (s, 3H), 3.61 - 3.40 (m, 4H). (mixture of interconvertible atropisomers).



312


embedded image


574.3
Method C, RT = 1.94 min, 98.3%

1H NMR (400 MHz, DMSO-d6) δ = 9.11 - 9.89 (m, 1H), 8.02 - 7.89 (m, 2H), 7.72 - 7.66 (m, 1H), 7.57 - 7.41 (m, 3H), 6.87 - 6.74 (m, 2H), 6.22 (d, J = 6.8 Hz, 1H), 5.42 - 4.75 (m, 1H), 4.18 - 3.95 (m, 1H), 3.86 - 3.81 (m, 1H), 3.78 -3.74 (2 s, 3H) 3.76 - 3.65 (m, 1H), 3.42 - 3.35 (m, 2H), 2.20 - 2.10 (2 s, 3H), 1.27 - 1.18 (m, 1H), 0.53 - 0.44 (m, 2H), 0.42 - 0.34 (m, 2H) (mixture of interconvertible atropisomers isomers)



313


embedded image


534.2
Method D, RT = 1.85 min, 99%

1H NMR (400 MHz, DMSO-d6) δ = 9.17 (d, J = 8.6 Hz, 1H), 7.91 - 7.75 (m, 3H), 7.65 (dd, J = 8.4, 3.5 Hz, 1H), 7.61 - 7.49 (m, 2H), 6.80 (d, J = 10.8 Hz, 2H), 5.34 (br s, 1H), 5.16 (dd, J = 10.6, 8.7 Hz, 1H), 4.32 - 4.15 (m, 2H), 4.11 - 4.02 (m, 1H), 3.77 (s, 3H), 1.43 (s, 3H), 1.42 (s, 3H).



314


embedded image


646.3
Method D, RT = 1.943 min, 98.6%

1H NMR (400 MHz, DMSO-d6) δ = 9.19 - 8.87 (m, 1H), 8.04 - 7.81 (m, 2H), 7.73 - 7.57 (m, 1H), 7.36 - 7.16 (m, 3H), 6.82 - 6.63 (m, 2H), 6.36 - 6.16 (m, 1H), 5.42 - 4.81 (m, 1H), 4.46 - 3.90 (m, 5H), 3.84 - 3.72 (2 s, 3H), 3.61 - 3.50 (m, 1H), 3.37 - 3.34 (2 s, 3H), 2.24 - 2.08 (2 s, 3H). (mixtrue of interconvertible atropisomers)



315


embedded image


558.3
Method D, RT = 1.424 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 8.94 - 8.88 (m, 1H), 7.92 (d, J = 8.8 Hz, 2H), 7.71 - 7.64 (m, 1H), 7.56 (d, J = 7.3 Hz, 1H), 7.33 (t, J = 80 Hz, 1H), 7.54 - 7.13 (m, 4H), 6.90 (d, J = 8.3 Hz, 2H), 6.34 (t, J = 6.8 Hz, 1H), 5.11 - 4.97 (m, 3H), 4.16 - 4.08 (m, 2H), 3.80 - 3.62 (m, 8H), 3.23 (s, 3H).



316


embedded image


592.2
Method D, RT = 1.95 min, 98%

1H NMR (400 MHz, DMSO-d6) δ = 9.10 (br d, J = 8.6 Hz, 1H), 7.90 (d, J = 8.6 Hz, 2H), 7.86 - 7.72 (m, 1H), 7.35 (t, J = 70 Hz, 1H), 7.37 - 7.29 (m, 3H), 6.79 (d, J = 10.8 Hz, 2H), 5.14-5.11 (m, 1H), 4.32 - 4.17 (m, 2H), 4.16 - 4.03 (m, 1H), 3.99 - 3.88 (m, 2H), 3.78 (s, 3H), 3.45 - 3.42 (m, 2H), 3.02 - 2.91 (m, 1H), 1.86 - 1.61 (m, 4H).



317


embedded image


603.2
Method D, RT = 1.696 min, 96.6%

1H NMR (400 MHz, DMSO-d6) δ = 9.02 - 8.90 (m, 1H), 7.97 - 7.86 (m, 2H), 7.70 (dd, J = 7.0, 1.8 Hz, 1H), 7.61 (dd, J = 7.2, 1.8 Hz, 1H), 7.50 - 7.37 (m, 4H), 7.34 (t, J = 73.6 Hz, 1H), 7.27 (d, J = 8.2 Hz, 2H), 6.41 (t, J = 7.1 Hz, 1H), 6.07 (dd, J = 8.4, 5.0 Hz, 1H), 5.07 - 4.95 (m, 1H), 4.13 - 4.08 (m, 1H), 3.91 - 3.77 (m, 4H), 3.26 (s, 3H), 3.10 (s, 3H), 2.84 (s, 3H).



318


embedded image


609.3
Method D, RT = 1.95 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.21 (d, J = 8.3 Hz, 1H), 8.08 (d, J = 8.2 Hz, 1H), 7.84 (d, J = 8.8 Hz, 2H), 7.52 (d, J = 8.4 Hz, 2H), 7.06 (d, J = 9.0 Hz, 1H), 6.82 (d, J = 10.8 Hz, 2H), 5.05 (dd, J = 10.9, 8.4 Hz, 1H), 4.67 - 4.52 (m, 2H), 4.49 - 4.40 (m, 1H), 4.27 - 4.16 (m, 1H), 4.05 - 3.96 (m, 1H), 3.78 (s, 3H), 3.40 -3.28 (m, 2H), 3.16 - 3.02 (m, 2H), 2.85 (s, 3H), 1.37 (d, J = 6.8 Hz, 6H).



319


embedded image


493.2
Method D, RT = 1.458 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.27 (d, J = 8.8 Hz, 1H), 7.98 (d, J = 1.2 Hz, 4H), 7.77 (dd, J = 6.6, 2.0 Hz, 1H), 7.58 (dd, J= 7.1, 2.0 Hz, 1H), 6.78 (d, J= 10.8 Hz, 2H), 6.35 (t, J = 7.0 Hz, 1H), 5.14 (dd, J = 11.0, 8.6 Hz, 1H), 4.17 - 4.04 (m, 1H), 4.04 - 3.86 (m, 4H), 3.76 (s, 3H), 1.25 (t, J= 7.2 Hz, 3H).



320


embedded image


576.2
Method D, RT = 1.591 min, 98%

1H NMR (400 MHz, DMSO-d6) δ = 7.93 - 7.84 (m, 2H), 7.64 (dd, J = 1.8, 7.0 Hz, 1H), 7.59 (dd, J = 2.0, 7.1 Hz, 1H), 7.34 (t, J = 76 Hz, 1H), 7.27 - 7.28 (m, 3H), 6.77 (d, J = 11.0 Hz, 2H), 6.41 (t, J = 7.1 Hz, 1H), 5.44 - 5.40 (m, 1H), 5.13 - 5.09 (m, 1H), 4.16 - 3.91 (m, 4H), 3.87 (d, J = 4.4 Hz, 2H), 3.80 - 3.72 (m, 4H), 2.47 -2.40 (m, 1H), 2.06 - 1.93 (m, 1H).



321


embedded image


529.2
Method D, RT = 1.542 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.27 (d, J = 8.6 Hz, 1H), 8.05 - 7.90 (m, 4H), 7.74 (dd, J = 6.8, 2.0 Hz, 1H), 7.67 (dd, J = 7.3, 2.0 Hz, 1H), 6.78 (d, J = 10.8 Hz, 2H), 6.35 (t, J = 56.2 Hz, 1H), 6.43 - 6.4 (m, 1H), 5.13 (dd, J = 11.0, 8.6 Hz, 1H), 4.56 - 4.34 (m, 2H), 4.16 - 4.05 (m, 1H), 4.05 - 3.90 (m, 2H), 3.77 (s, 3H).



322


embedded image


600.2
Method D, RT = 1.824 min, 97.6%

1H NMR (400 MHz, DMSO-d6) δ = 9.12 (d, J = 8.8 Hz, 1H), 7.99 - 7.88 (m, 3H), 7.81 (dd, J= 8.4, 3.3 Hz, 1H), 7.54 - 7.40 (m, 2H), 6.78 (d, J = 10.8 Hz, 2H), 5.14 (dd, J= 8.6, 10.8 Hz, 1H), 4.20 - 4.03 (m, 4H), 4.02 - 3.91 (m, 1H), 3.77 (s, 3H), 3.61 (t, J = 5.4 Hz, 2H), 3.26 (s, 3H).



323


embedded image


577.2
Method D, RT = 1.382 min, 99.03%

1H NMR (400 MHz, DMSO-d6) δ =9.83 (s, 1H), 9.01 (d, J= 8.1 Hz, 1H), 8.14 (d, J= 2.7 Hz, 1H), 7.89 (d, J= 8.8 Hz, 2H), 7.66 (d, J = 2.7 Hz, 1H), 7.34 (t, J = 73.6 Hz, 1H), 7.28 (m, 2H), 6.77 (d, J = 10.8 Hz, 2H), 5.07 - 4.94 (m, 1H), 4.19 - 3.91 (m, 3H), 3.77 (s, 3H), 3.49 (s, 3H), 2.01 (s, 3H).



324


embedded image


534.2
Method D, RT = 1.589 min, 99.7%

1H NMR (400 MHz, DMSO-d6) δ = 9.00 (d, J = 9.0 Hz, 1H), 7.92 - 7.83 (m, 2H), 7.55 - 7.14 (m, 3H), 7.34 (t, J = 73.6 Hz, 1H), 6.77 (d, J= 11.0 Hz, 2H), 6.28 - 6.20 (m, 1H), 5.11 (dd, J = 10.8, 8.6 Hz, 1H), 4.12 - 4.03 (m, 1H), 3.97 - 3.92 (m, 2H), 3.76 (s, 3H), 3.49 (s, 3H), 2.40 (s, 3H).



325


embedded image


626.3
Method D, RT = 1.762 min, 98.6%

1H NMR (400 MHz, DMSO-d6) δ = 9.27 - 8.91 (m, 1H), 8.02 - 7.84 (m, 2H), 7.70 - 7.54 (m, 1H), 7.54 - 7.34 (m, 2H), 6.79 - 3.72 (m, 2H), 6.31 - 6.13 (m, 1H), 5.38 - 4.83 (m, 3H), 4.27 - 4.05 (m, 2H), 3.81 - 3.55 (m, 7H), 3.55 - 3.45 (m, 1H), 3.24 - 3.16 (2 s, 3H), 2.23 - 1.94 (2 s, 3H). (mixture of interconvertible atropisomers)



326


embedded image


625.2
Method D, RT = 1.85 min, 98%

1H NMR (400 MHz, DMSO-d6) δ = 9.22 (d, J = 8.3 Hz, 1H), 8.29 (dd, J = 9.0, 2.9 Hz, 1H), 8.03 - 7.88 (m, 3H), 7.55 - 7.41 (m, 2H), 6.80 (d, J = 10.8 Hz, 2H), 5.86 (d, J = 6.1 Hz, 1H), 5.12 (dd, J = 10.5, 8.3 Hz, 1H), 4.44 - 4.38 (m, 1H), 4.29 -4.16 (m, 2H), 4.13 - 3.93 (m, 2H), 3.77 (s, 3H), 3.73-3.69 (m, 1H), 2.44 - 2.33 (m, 1H), 1.88 - 1.75 (m, 1H).



327


embedded image


597.2
Method C, RT = 1.73 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.10 (d, J = 8.8 Hz, 1H), 8.26 - 8.21 (m, 1H), 7.89 -7.80 (m, 2H), 7.63 - 7.55 (m, 2H), 6.98 - 6.89 (m, 1H), 6.79 (d, J = 10.8 Hz, 2H), 6.51 - 6.45 (m, 1H), 5.19 - 5.11 (m, 1H), 4.86 - 4.81(m, 2H), 4.77 - 4.69 (m, 1H), 4.65 - 4.60 (m, 2H), 4.35 - 4.26 (m, 1H), 4.22 - 4.15 (m, 1H), 3.76 (s, 3H), 3.75 - 3.63 (m, 1H).



328


embedded image


630.3
Method C, RT = 1.47 min, 97%

1H NMR (400 MHz, DMSO-d6) δ = 9.05 (d, J = 8.8 Hz, 1H), 7.96 - 7.82 (m, 2H), 7.50 - 7.48 (m, 1H), 7.35 (t, J = 73.6 Hz, 1H), 7.29 - 7.27 (m, 2H), 6.84 - 6.69 (m, 2H), 6.52 (d, J = 9.0 Hz, 1H), 5.22-5.198 (m, 1H), 4.48 - 4.42 (m, 1H), 4.18 - 4.08 (m, 1H), 4.04 - 3.96 (m, 1H), 3.91 - 3.82 (m, 1H), 3.76 (s, 3H), 3.74 (s, 3H), 3.47 - 3.40 (br s, 2H), 3.25 - 3.230 (m, 1H), 2.89 - 2.74 (m, 1H), 2.47 - 2.43 (m, 1H), 2.30 (s, 3H), 1.88 - 1.81 (m, 1H), 1.71-1.68 (m, 1H).



329


embedded image


509.2
Method D, RT = 1.268 min, 97.5%

1H NMR (400 MHz, DMSO-d6) δ = 9.28 (br d, J = 8.8 Hz, 1H), 8.07 - 7.87 (m, 4H), 7.65 (dd, J = 6.8, 2.0 Hz, 1H), 7.59 (dd, J = 7.3, 2.0 Hz, 1H), 6.77 (d, J = 10.8 Hz, 2H), 6.31 (t, J = 7.0 Hz, 1H), 5.16 - 5.11 (m, 2H), 4.14 - 3.93 (m, 5H), 3.76 (s, 3H), 3.64 (t, J = 5.5 Hz, 2H).



330


embedded image


545.2
Method D, RT = 1.621 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.02 (d, J = 8.3 Hz, 1H), 8.65 (d, J = 2.2 Hz, 1H), 7.98 - 7.79 (m, 3H), 7.34 (t, J = 73.6 Hz, 1H), 7.28 (m, 2H), 6.77 (d, J = 10.8 Hz, 2H), 5.10 (dd, J = 8.6, 11.0 Hz, 1H), 4.17 - 4.07 (m, 1H), 4.01 (br t, J = 8.8 Hz, 2H), 3.76 (s, 3H), 3.53 (s, 3H).



331


embedded image


636.1
Method D, RT = 1.555 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.12 (d, J = 8.1 Hz, 1H), 8.01 - 7.93 (m, 2H), 7.89 (d, J = 8.8 Hz, 2H), 7.34 (t, J = 72.6 Hz,1H), 7.28 (d, J = 8.6 Hz, 2H), 6.83 -6.75 (m, 2H), 5.14 - 5.06 (m, 2H), 4.35 -4.19 (m, 4H), 4.13 - 3.91 (m, 3H), 3.77 (s, 3H), 3.68 - 3.47 (m, 3H).



332


embedded image


641.3
Method D, RT = 1.94 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.13 (d, J = 9.0 Hz, 1H), 8.07 (d, J = 8.6 Hz, 1H), 7.90 - 7.87 (d, J = 8.8 Hz, 2H), 7.35 (t, J= 73.6 Hz, 1H), 7.30 - 7.28 (m, 2H), 7.06 - 7.04 (m, 1H), 6.81 (d, J= 10.8 Hz, 2H), 5.04 (dd, J = 10.8, 8.3 Hz, 1H), 4.66 - 4.54 (m, 2H), 4.49 - 4.43 (m, 1H), 4.24 - 4.21 (m, 1H), 4.03 - 4.01 (m, 1H), 3.78 (s, 3H), 3.13 - 3.02 (m, 2H), 2.91 - 2.79 (m, 2H), 2.48 (s, 3H) 1.39 - 1.30 (m, 6H).



333


embedded image


606.2
Method C, RT = 1.88 min, 90.3%

1H NMR (400 MHz, DMSO-d6) δ = 9.09 (br d, J = 8.1 Hz, 1H), 8.50 - 8.37 (m, 1H), 7.91 - 7.72 (m, 2H), 7.56 (d, J = 8.6 Hz, 2H), 7.47 (t, J = 64.2 Hz, 1H), 7.19 (br d, J = 5.6 Hz, 1H), 6.78 (br d, J = 10.8 Hz, 2H), 5.17 - 5.04 (m, 1H), 4.42 - 4.10 (m, 2H), 3.88 - 3.78 (m, 1H), 3.77 (s, 3H), 3.47 - 3.36 (m, 2H), 3.21 - 3.09 (m, 2H), 2.47 - 2.34 (m, 4H), 2.22 (s, 3H).



334


embedded image


636.2
Method D, RT = 1.72 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.12 (d, J = 8.8 Hz, 1H), 8.18 - 8.07 (m, 1H), 7.85 (br d, J = 7.6 Hz, 2H), 7.57 (d, J = 8.6 Hz, 2H), 7.02 - 6.84 (m, 1H), 6.79 (d, J = 10.8 Hz, 2H), 5.15 - 5.04 (m, 1H), 4.46 (br s, 1H), 4.39 - 4.26 (m, 1H), 4.21 - 4.06 (m, 1H), 3.88 - 3.75 (m, 1H), 3.71 (s, 3H), 3.62 - 3.53 (m, 1H), 3.26 - 3.21 (m, 2H), 3.49 - 3.41 (m, 1H), 2.81 - 2.73 (m, 1H), 2.25 (s, 3H), 1.98 - 1.87 (m, 1H), 1.83 - 1.66 (m, 1H).



335


embedded image


485.2
Method D, RT = 2.003 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.01 (d, J = 8.8 Hz, 1H), 8.00 - 7.89 (m, 2H), 7.48 (d, J = 8.3 Hz, 2H), 6.76 (d, J = 10.8 Hz, 2H), 4.92 (dd, J = 10.4, 8.7 Hz, 1H), 3.93 - 3.89(m, 1H), 3.76 (s,3H), 3.75 -3.68 (m, 1H), 3.66 - 3.54 (m, 1H), 3.29 -3.24 (m, 1H), 3.06 (dd, J = 13.9, 7.1 Hz, 1H), 1.01 - 0.89 (m, 1H), 0.50 (d, J = 8.1 Hz, 2H), 0.29 - 0.11 (m, 2H).



336


embedded image


578.2
Method D, RT = 1.709 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.01 (d, J= 8.6 Hz, 1H), 7.94 - 7.81 (m, 2H), 7.34 (t, J = 76 Hz, 1H), 7.48 - 7.25 (m, 3H), 6.77 (d, J= 10.5 Hz, 2H), 6.26 - 6.17 (m, 1H), 5.12 (dd, J = 11.1, 8.7 Hz, 1H), 4.17 (t, J = 5.5 Hz, 2H), 4.13 - 4.01 (m, 1H), 3.94 (br d, J = 9.8 Hz, 2H), 3.76 (s, 3H), 3.59 (t, J = 5.6 Hz, 2H), 3.24 (s, 3H), 2.44 (s, 3H).



337


embedded image


556.2
Method D, RT = 1.832 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.22 - 8.90 (m, 1H), 8.13 - 7.98 (m, 1H), 7.91 - 7.72 (m, 2H), 7.61 - 7.45 (m, 2H), 6.77 (dd, J = 2.1, 10.6 Hz, 2H), 6.62 - 6.48 (m, 1H), 5.33 - 5.12 (m, 1H), 4.27 - 4.07 (m, 1H), 4.03 - 3.89 (m, 2H), 3.75 (s, 3H), 3.59 - 3.54 (2 s, 3H). (mixture of interconvertible atropisomers)



338


embedded image


459.1
Method D, RT = 1.65 min, 96%

1H NMR (400 MHz, DMSO-d6) δ = 9.19 (d, J = 8.1 Hz, 1H), 9.08 (dd, J= 4.6, 1.5 Hz, 1H), 8.59 (dd, J = 9.0, 1.5 Hz, 1H), 7.91 - 7.74 (m, 3H), 7.64 - 7.51 (m, 2H), 6.81 (d, J = 10.8 Hz, 2H), 5.07 (dd, J = 10.8, 8.2 Hz, 1H), 4.59 (t, J = 9.0 Hz, 1H), 4.27 - 4.05 (m, 2H), 3.78 (s, 3H).



339


embedded image


564.2
Method D, RT = 1.961 min, 98.7%

1H NMR (400 MHz, DMSO-d6) δ = 9.21 - 8.98 (m, 1H), 8.05 - 7.89 (m, 2H), 7.56 (dd, J = 7.0, 4.3 Hz, 1H), 7.54 - 7.42 (m, 5H), 7.42 - 7.32 (m, 1H), 6.23 - 6.19 (m, 1H), 5.31 - 5.28 (m, 1H), 4.17 - 3.85 (m, 5H), 3.73 - 3.52 (m, 2H), 3.24 (s, 3H), 2.22 - 2.09 (2 s, 3H).



340


embedded image


546.2
Method D, RT = 1.776 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.03 - 8.88 (m, 1H), 7.95 - 7.90 (m, 2H), 7.60 - 7.48 (m, 2H), 7.45 - 7.16 (m, 5H), 6.24 - 6.14 (m, 1H), 5.27 - 4.67 (m, 1H), 4.06 (br s, 3H), 3.96 - 3.89 (m, 2H), 3.72 - 3.70 (m, 2H), 3.24 (s, 3H), 2.22 - 2.09 (2 s, 3H). (mixture of interconvertible atropisomers)



341


embedded image


500.1
Method D, RT = 1.91 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.27 - 9.17 (m, 1H), 7.93 - 7.78 (m, 4H), 7.73 - 7.63 (m, 1H), 7.62 - 7.53 (m, 2H), 6.81 (d, J= 10.8 Hz, 2H), 5.26 - 5.06 (m, 1H), 4.34 - 4.24 (m, 1H), 4.13 - 4.04 (m, 1H), 4.00 - 3.90 (m, 1H), 3.78 (s, 3H).



342


embedded image


528.2
Method D, RT = 1.468 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 8.82 (d, J = 8.8 Hz, 1H), 7.88 - 7.75 (m, 2H), 7.66 (dd, J = 6.8, 2.0 Hz, 1H), 7.59 (dd, J = 7.3, 2.0 Hz, 1H), 7.08 - 6.93 (m, 2H), 6.77 (d, J = 10.8 Hz, 2H), 6.32 (t, J = 7.0 Hz, 1H), 5.11 (dd, J = 11.0, 8.8 Hz, 1H), 4.22 - 4.01 (m, 3H), 4.01 - 3.88 (m, 2H), 3.81 (s, 3H), 3.76 (s, 3H), 3.60 (t, J = 5.3 Hz, 2H), 3.25 (s, 3H).



343


embedded image


617.2
Method D, RT = 1.65 min, 96%

1H NMR (400 MHz, DMSO-d6) δ = 9.05 (d, J = 8.6 Hz, 1H), 7.89 (d, J = 8.8 Hz, 2H), 7.45-7.43 (m, 1H), 7.44 (d, J = 8.2 Hz, 1H), 7.35 (t, J = 73.6 Hz, 1H), 7.28 -7.16 (m, 2H), 6.78 (d, J = 10.8 Hz, 2H), 5.19 (dd, J = 11.4, 8.9 Hz, 1H), 4.28 -4.15 (m, 1H), 4.13 - 4.03 (m, 1H), 4.01 -3.90 (m, 3H), 3.76 (s, 3H), 3.43 - 3.39 (m, 2H), 2.85 - 2.84 (m, 1H), 2.75 (s, 6H), 1.80 - 1.63 (m, 4H).



344


embedded image


527.1
Method C, RT = 1.67 min, 94.1%

1H NMR (400 MHz, DMSO-d6) δ = 9.36 (d, J = 8.6 Hz, 1H), 8.90 (dd, J = 4.8, 1.3 Hz, 1H), 8.84 - 8.78 (m, 1H), 8.40 (dd, J = 7.9, 1.3 Hz, 1H), 8.22 (dd, J = 8.3, 2.4 Hz, 1H), 7.80 - 7.61 (m, 2H), 6.90 - 6.71 (m, 2H), 5.15 (dd, J = 11.0, 8.6 Hz, 1H), 4.29- 4.21 (m, 1H), 4.17 - 4.14 (m, 1H), 4.01 - 3.99 (m, 1H), 3.78 (s, 3H).



345


embedded image


498.2
Method D, RT = 1.502 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 8.96 (d, J = 8.6 Hz, 1H), 7.76 (dd, J = 6.8, 1.5 Hz, 1H), 7.58 (dd, J = 7.3, 1.5 Hz, 1H), 7.48 - 7.30 (m, 3H), 7.19 - 7.03 (m, 1H), 6.77 (d, J = 10.8 Hz, 2H), 6.35 (t, J = 7.0 Hz, 1H), 5.12 (dd, J = 10.8, 9.0 Hz, 1H), 4.19 - 4.04 (m, 1H), 4.04 - 3.89 (m, 4H), 3.79 (s, 3H), 3.77 (s, 3H), 1.25 (t, J = 7.1 Hz, 3H).



346


embedded image


507.1
Method D, RT = 1.41 min, 95%

1H NMR (400 MHz, DMSO-d6) δ = 13.11 - 12.82 (m, 1H), 9.08 - 8.96 (m, 1H), 8.30 - 8.01 (m, 2H), 7.97 - 7.81 (m, 2H), 7.35 (t, J = 70 Hz, 1H), 7.31- 7.26 (m, 2H), 6.78 (d, J = 11.0 Hz, 2H), 5.15-5.11 (m, 1H), 4.15 - 3.89 (m, 3H), 3.77 (s, 3H).



347


embedded image


556.3
Method D, RT = 1.639 min, 98%

1H NMR (400 MHz, DMSO-d6) δ = 8.79 (d, J = 8.6 Hz, 1H), 7.84 - 7.72 (m, 2H), 7.65 (dd, J = 6.8, 2.0 Hz, 1H), 7.58 (dd, J = 7.3, 2.0 Hz, 1H), 7.04 - 6.90 (m, 2H), 6.76 (d, J = 10.5 Hz, 2H), 6.32 (t, J = 7.0 Hz, 1H), 5.10 (dd, J = 11.0, 8.6 Hz, 1H), 4.70 (m, 1H), 4.21 - 4.03 (m, 3H), 4.02 -3.89 (m, 2H), 3.76 (s, 3H), 3.60 (t, J= 5.3 Hz, 2H), 3.25 (s, 3H), 1.27 (d, J = 5.9 Hz, 6H).



348


embedded image


656.3
Method C, RT = 1.66 min, 95.3%

1H NMR (400 MHz, DMSO-d6) δ = 9.04 (d, J = 8.4 Hz, 1H), 7.89 - 7.87 (m, 2H), 7.42 (d, J = 8.4 Hz, 1H), 7.35 (t, J= 73.6 Hz, 1H), 7.28 (d, J = 8.2 Hz, 2H), 6.95 -6.92 (m, 1H), 6.80 (d, J = 10.8 Hz, 2H), 5.11 (dd, J = 10.8, 8.6 Hz, 1H), 4.46 -4.35 (m, 3H), 4.26 - 4.05 (m, 2H), 4.01 -3.92 (m, 1H), 3.77 (s, 3H), 3.08 - 2.71 (m, 6H), 1.97 - 1.87 (m, 1H), 1.36 (d, J = 6.8 Hz, 6 H), 0.96 - 0.76 (m, 2H), 0.62 - 0.43 (m, 2H).



349


embedded image


576.3
Method D, RT = 1.95 min, 100%
1H NMR (400 MHz, DMSO-d6) δ = 8.89 - 8.82 (m, 1H), 8.50 (t, J = 7.9 Hz, 1H), 8.38 (d, J = 8.1 Hz, 1H), 7.73 - 7.70 (m, 1H), 6.94 - 6.84 (m, 1H), 6.84 - 6.80 (m, 2H), 6.67 - 6.59 (m, 2H), 4.98 - 4.81 (m, 1H), 4.18 - 4.02 (m, 2H), 4.01 - 3.89 (m, 1H), 3.78 (s, 3H), 3.69 (s, 3H), 2.78 -2.56 (m, 4H), 2.51 - 2.54 (m, 1H), 1.93 -1.77 (m, 1H), 1.66 - 1.48 (m, 1H).


350


embedded image


608.3
Method F, RT = 1.84 min, 98%

1H NMR (400 MHz, DMSO-d6) δ = 9.23 - 9.01 (m, 1H), 8.01 - 7.85 (m, 2H), 7.60 - 7.51 (m, 1H), 7.51 - 7.38 (m, 2H), 6.79-6.75 (m, 2H), 6.36 - 6.21 (m, 1H), 5.43 -4.87 (m, 2H), 4.31 - 4.00 (m, 3H), 3.90 -3.81 (m, 2H), 3.81 - 3.69 (m, 4H), 3.54 -3.48 (m, 1H), 2.47 - 2.39 (m, 1H), 2.22 -2.04 (2 s, 3H), 2.00 - 1.86 (m, 1H). (mixture of interconvertible atropisomers)



351


embedded image


560.2
Method D, RT = 1.7 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.17 - 8.82 (m, 1H), 8.01 - 7.81 (m, 2H), 7.59 - 7.09 (m, 4H), 6.86 - 6.77 (m, 2H), 6.26 - 6.07 (m, 1H), 5.38 - 4.82 (m, 2H), 4.32 - 4.05 (m, 2H), 3.79 - 3.74 (2 s, 3H), 3.51 - 3.46 (m, 1H), 2.22 - 2.00 (2 s, 3H), 1.07 - 0.92 (m, 2H), 0.92 - 0.72 (m, 2H). (mixture of interconvertible atropisomers)



352


embedded image


578.2
Method D, RT = 1.87 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.26 - 8.88 (m, 1H), 8.03 - 7.83 (m, 2H), 7.58 - 7.35 (m, 3H), 6.81 - 6.73 (m, 2H), 6.25 - 6.08 (m, 1H), 5.35 - 4.85 (m, 2H), 4.27 - 4.05 (m, 2H), 3.78 - 3.74 (2 s, 3H), 3.54 - 3.47 (m, 1H), 2.22 - 1.99 (2 s, 3H), 1.06 - 0.92 (m, 2H), 0.92 - 0.70 (m, 2H). (mixture of interconvertible atropisomers)



353


embedded image


572.2
Method D, RT = 1.732 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.03 (d, J = 8.3 Hz, 1H), 7.92 (d, J = 8.6 Hz, 2H), 7.47 (d, J = 8.6 Hz, 2H), 6.75 (d, J = 10.8 Hz, 2H), 4.96 (dd, J = 10.8, 8.8 Hz, 1H), 4.84 (t, J = 9.3 Hz, 1H), 3.97 -3.89 (m, 1H), 3.75 (s, 3H), 3.67 - 3.61 (m, 1H), 3.46 - 3.39 (m, 7H), 3.22 (s, 3H), 2.28 - 2.19 (m, 1H), 2.13 - 2.04 (m, 1H).



354


embedded image


600.2
Method D, RT = 1.813 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.03 (d, J = 8.6 Hz, 1H), 8.03 - 7.90 (m, 2H), 7.66 (m, 2H), 7.47 (d, J = 8.3 Hz, 2H), 7.35 (d, J = 8.6 Hz, 2H), 6.91 (d, J = 8.6 Hz, 2H), 6.37 (t, J = 7.0 Hz, 1H), 5.05 -4.94 (m, 1H), 4.44 (dd, J = 13.2, 2.7 Hz, 1H), 4.38 - 4.29 (m, 1H), 4.14 - 4.04 (m, 1H), 3.92 - 3.74 (m, 3H), 3.72 (s, 3H), 3.34 -3.30 (m, 1H).



355


embedded image


604.2
Method D, RT = 2.015 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.07 (br d, J = 8.6 Hz, 1H), 8.04 - 7.90 (m, 2H), 7.73 - 7.57 (m, 2H), 7.51 - 4.45 (m, 4H), 7.44 - 7.32 (m, 2H), 6.81 - 6.73 (brs, 1H), 6.41 - 6.31 (m, 1H), 5.08 - 5.01 (m, 1H), 4.48 - 4.42 (m, 1H), 4.37 - 4.30 (m, 1H), 4.14 - 4.04 (m, 1H), 3.90 - 3.79 (m, 3H).



356


embedded image


569.2
Method D, RT = 1.69 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.14 (br d, J = 8.1 Hz, 1H), 8.00 (d, J= 4.6 Hz, 1H), 7.94 (d, J = 9.0 Hz, 2H), 7.69 (d, J = 4.6 Hz, 1H), 7.49 (d, J = 8.3 Hz, 2H), 6.78 (d, J= 10.8 Hz, 2H), 5.07 - 5.05 (m, 1H), 4.84 (t, J = 5.9 Hz, 1H), 4.36 - 4.27 (m, 1H), 4.22 - 4.01 (m, 4H), 3.77 (s, 3H), 3.73 (ABq, J = 5.9 Hz, 2H).



357


embedded image


553.2
Method D, RT = 1.95 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.13 (d, J = 8.1 Hz, 1H), 8.01 (d, J = 4.6 Hz, 1H), 7.99 - 7.82 (m, 2H), 7.70 (d, J = 4.4 Hz, 1H), 7.49 (d, J = 8.1 Hz, 2H), 6.78 (d, J= 10.8 Hz, 2H), 5.01 - 5.05 (m, 1H), 4.42 - 4.27 (m, 1H), 4.25 - 4.05 (m, 4H), 3.77 (s, 3H), 1.28 (t, J = 7.2 Hz, 3H).



358


embedded image


535.3
Method D, RT = 1.77 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.02 (d, J = 8.3 Hz, 1H), 8.01 (d, J = 4.4 Hz, 1H), 7.88 (d, J = 8.8 Hz, 2H), 7.70 (d, J = 4.4 Hz, 1H), 7.34 (t, J = 73.6 Hz, 1H), 7.28 - 7.26 (m, 2H), 6.78 (d, J = 10.8 Hz, 2H), 5.05 (dd, J = 10.8, 8.6 Hz, 1H), 4.37 - 4.26 (m, 1H), 4.23 - 4.05 (m, 4H), 3.77 (s, 3H), 1.28 (t, J = 7.1 Hz, 3H).



359


embedded image


596.2
Method D, RT = 1.75 min, 98 %

1H NMR (400 MHz, DMSO-d6) δ = 9.28 - 8.97 (m, 1H), 8.07 - 7.82 (m, 2H), 7.61 - 7.34 (m, 3H), 6.79 - 6.75 (m, 2H), 6.28 - 6.09 (m, 1H), 5.41 - 4.80 (m, 2H), 4.31 - 3.97 (m, 3H), 3.95 - 3.85 (m, 1H), 3.82 - 3.73 (2 s, 3H), 3.63 - 3.45 (m, 2H), 2.23 - 2.01 (2 s, 3H), 1.09 (d, J = 6.4 Hz, 3H). (mixture of interconvertible atropisomers)



360


embedded image


578.3
Method C, RT = 1.57 min, 99 %

1H NMR (400 MHz, DMSO-d6) δ = 9.15 - 8.81 (m, 1H), 7.99 - 7.77 (m, 2H), 7.63 - 7.09 (m, 4H), 6.79 - 6.72 (m, 2H), 6.30 - 6.09 (m, 1H), 5.40 - 4.82 (m, 2H), 4.35 - 3.98 (m, 3H), 3.94 - 3.84 (m, 1H), 3.81 - 3.72 (2 s, 3H), 3.63 - 3.45 (m, 2H), 2.23 - 2.02 (2 s, 3H), 1.09 (d, J = 6.1 Hz, 3H). (mixture of interconvertible atropisomers)



361


embedded image


596.2
Method C, RT = 1.80 min, 93 %

1H NMR (400 MHz, DMSO-d6) δ = 9.18 - 9.05 (m, 1H), 7.97 - 7.91 (m, 2H), 7.57 - 7.46 (m, 3H), 6.77 - 6.73 (m, 2H), 6.30 - 6.17 (m, 1H), 5.40 - 4.88 (m, 2H), 4.35 - 3.98 (m, 3H), 3.94 - 3.84 (m, 1H), 3.81 - 3.72 (2 s, 3H), 3.63 - 3.45 (m, 2H), 2.19 - 2.02 (2 s, 3H), 1.11 - 1.06 (m, 3H). (mixture of interconvertible atropisomers)



362


embedded image


546.2
Method D, RT = 1.61 min, 97 %

1H NMR (400 MHz, DMSO-d6) δ = 9.20 - 8.90 (m, 1H), 7.91 - 7.74 (m, 2H), 7.64 - 7.36 (m, 3H), 6.82 - 6.64 (m, 2H), 6.27 - 6.07 (m, 1H), 5.36 - 4.81 (m, 2H), 4.28 - 3.82 (m, 4H), 3.80 - 3.73 (2 s, 3H), 3.69 - 3.46 (m, 2H), 2.23 - 2.04 (2 s, 3H), 1.09 - 1.06 (m, 3H). (mixture of interconvertible atropisomers)



363


embedded image


707.3
Method D, RT = 1.78 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.11 (d, J = 8.8 Hz, 1H), 7.94 (d, J = 8.3 Hz, 2H), 7.78 - 3.73 (m, 1H), 7.67 - 7.57 (m, 1H), 7.52 -7.41 (m, 2H), 6.76 (d, J= 10.8 Hz, 2H), 6.41 (t, J = 7.2 Hz, 1H), 6.05 -5.64 (m, 1H), 5.16 - 5.00 (m, 1H), 4.74 -4.54 (m, 2H), 4.15 - 3.78 (m, 6H), 3.76 (s, 3H), 3.68 - 3.51 (m, 3H), 3.27 (s, 3H), 1.90 - 1.69 (m, 2H).



364


embedded image


632.2
Method D, RT = 2.06 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.07 (d, J = 8.8 Hz, 1H), 7.97 (d, J = 8.8 Hz, 2H), 7.74 - 7.63 (m, 2H), 7.54 - 7.41 (m, 3H), 6.87 - 6.73 (m, 2H), 6.39 (t, J = 7.0 Hz, 1H), 5.13 (dd, J = 11.1, 9.2 Hz, 1H), 4.41 (dd, J = 13.0, 3.4 Hz, 1H), 4.35 -4.26 (m, 1H), 4.16 - 4.08 (m, 1H), 4.06 -3.95 (m, 1H), 3.78 - 3.72 (m, 4H) 3.77 -3.69 (m, 1H), 3.36 (s, 3H).



365


embedded image


510.2
Method D, RT = 1.588 min, 89%

1H NMR (400 MHz, DMSO-d6) δ = 9.02 - 8.97 (m, 1H), 7.92 - 8.86 (m, 2H), 7.60 - 7.49 (m, 3H), 7.43 - 7.24 (m, 2H), 6.97 - 6.80 (m, 2H), 6.22 - 6.18 (m, 1H), 5.27 - 4.64 (m, 1H), 4.18 - 3.96 (m, 3H), 3.93 - 3.80 (m, 2H), 3.75 - 3.70 (2 s, 3H), 3.66 - 3.53 (m, 2H), 3.24 (s, 3H), 2.21 - 2.04 (2 s, 3H). (mixture of interconvertible atropisomers)



366


embedded image


516.2
Method D, RT = 1.67 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.03 - 8.98 (m, 1H), 7.91 - 7.76 (m, 2H), 7.65 - 7.61 (m, 1H), 7.57 - 7.51 (m, 2H), 7.44 - 7.25 (m, 2H), 6.94 - 6.98 (m, 2H), 6.48 - 6.12 (m, 2H), 5.31 - 4.61 (m, 1H), 4.51 - 4.31 (m, 2H), 4.10 - 3.78 (m, 2H), 3.74 - 3.70 (2 s, 3H), 3.71 - 3.64 (m, 1H), 2.23 - 2.09 (2 s, 3H). (mixture of interconvertible atropisomers)



367


embedded image


546.2
Method D, RT = 1.51 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 8.99 - 8.94 (m, 1H), 7.99 - 7.84 (m, 2H), 7.61 - 7.52 (m, 2H), 7.37 - 7.33 (m, 1H), 7.31 - 7.22 (m, 2H), 6.90 - 6.70 (m, 2H), 6.22 - 6.17 (m, 1H), 5.41 - 4.73 (m, 1H), 4.15 - 3.87 (m, 5H), 3.74 - 3.71(2 s, 3H), 3.64 - 3.54 (m, 3H), 2.25 - 2.02 (2 s, 3H). (mixture of interconvertible atropisomers)



368


embedded image


586.1
Method D, RT = 1.852 min, 98.6%

1H NMR (400 MHz, DMSO-d6) δ = 8.95 (d, J = 8.8 Hz, 1H), 7.96 - 7.85 (m, 2H), 7.69 (dd, J = 6.8, 2.0 Hz, 1H), 7.65 (dd, J = 7.3, 2.0 Hz, 1H), 7.49 - 7.39 (m, 4H), 7.34 (t, J = 73.6 Hz, 1H), 7.28 - 7.24 (m, 2H), 6.79 - 6.70 (m, 1H), 6.37 (t, J = 7.0 Hz, 1H), 5.03 (dd, J = 11.0, 8.8 Hz, 1H), 4.45 (dd, J = 13.1, 2.8 Hz, 1H), 4.37 -4.29 (m, 1H), 4.20 (t, J = 8.8 Hz, 1H), 3.89 - 3.79 (m, 2H), 3.75 - 3.67 (m, 1H).



369


embedded image


535.2
Method D, RT = 1.60 min, 98.7%

1H NMR (400 MHz, DMSO-d6) δ = 9.01 (d, J = 8.6 Hz, 1H), 8.54 (s, 1H), 8.13 (s, 1H), 7.97 - 7.84 (m, 2H), 7.34 (t, J = 73.0 Hz, 1H), 7.28 - 7.25 (m, 2H), 6.77 (d, J= 10.8 Hz, 2H), 5.12 (dd, J = 11.1, 8.7 Hz, 1H), 4.19 - 4.05 (m, 1H), 4.05 - 3.90 (m, 4H), 3.76 (s, 3H), 1.28 (t, J= 7.1 Hz, 3H).



370


embedded image


565.2
Method D, RT = 1.61 min, 98.7%

1H NMR (400 MHz, DMSO-d6) δ = 9.01 (d, J = 8.8 Hz, 1H), 8.40 (s, 1H), 8.14 (s, 1H), 7.88 (d, J = 8.6 Hz, 2H), 7.34 (t, J = 73.0 Hz, 1H), 7.28 - 7.25 (m, 2H), 6.77 (d, J = 10.8 Hz, 2H), 5.12 (dd, J = 10.9, 8.9 Hz, 1H), 4.23 - 4.03 (m, 3H), 4.03 -3.88 (m, 2H), 3.76 (s, 3H), 3.60 (t, J= 5.1 Hz, 2H), 3.26 (s, 3H).



371


embedded image


582.2
Method D, RT = 1.644 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 8.93 (d, J = 8.6 Hz, 1H), 7.94 - 7.92 (m, 2H), 7.68 (dd, J= 6.7, 1.8 Hz, 1H), 7.63 (dd, J = 7.2, 1.8 Hz, 1H), 7.33 (t, J = 72.0 Hz, 1H), 7.35 - 7.10 (m, 4H), 6.97 - 6.87 (m, 2H), 6.84 - 6.61 (m, 1H), 6.37 (t, J 7.0 Hz, 1H), 4.99 (dd, J = 10.9, 8.9 Hz, 1H), 4.44 (dd, J = 13.2, 2.9 Hz, 1H), 4.38 -4.29 (m, 1H), 4.12 - 4.05 (m, 1H), 3.85 (dd, J= 13.1, 9.2 Hz, 1H), 3.82 - 3.73 (m, 2H), 3.72 (s, 3H).



372


embedded image


542.2
Method D, RT = 1.77 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.03 (d, J = 8.8 Hz, 1H), 8.00 - 7.86 (m, 2H), 7.47 (d, J = 8.1 Hz, 2H), 6.75 (d, J 10.8 Hz, 2H), 4.97 (dd, J = 10.8, 8.6 Hz, 1H), 4.84 (t, J = 9.4 Hz, 1H), 4.01 - 3.85 (m, 1H), 3.75 (s, 3H), 3.64 (br t, J = 8.7 Hz, 1H), 3.36 (m, 3H), 3.23 (dt, J 13.7, 6.6 Hz, 2H), 2.28 - 2.18 (m, 1H), 2.15 - 2.03 (m, 1H), 1.03 (t, J 7.2 Hz, 3H).



373


embedded image


552.2
Method D, RT = 1.717 min, 94.7%

1H NMR (400 MHz, DMSO-d6) δ = 9.09 - 9.01 (m, 1H), 8.01 - 7.85 (m, 3H), 7.53 - 7.23 (m, 3H), 6.84 - 6.72 (m, 2H), 6.50 - 6.46 (m, 1H), 5.07 - 4.99 (m, 1H), 4.27 - 4.10 (m, 1H), 4.06 - 3.92 (m, 4H), 3.79 - 3.75 (2 s, 3H), 1.31 - 1.19 (m, 3H). (mixture of interconvertible atropisomers)



374


embedded image


498.2
Method D, RT = 1.68 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.05 - 9.0 (m, 1H), 7.92 - 7.79 (m, 2H), 7.68 -7.61 (m, 1H), 7.59 - 7.35 (m, 3H), 6.89 -6.72 (m, 2H), 6.25 - 6.20 (m, 1H), 5.41 -4.74 (m, 1H), 4.18 - 3.85 (m, 4H), 3.76 -3.72 (2 s, 3H), 3.62 -3.36 (m, 1H), 2.22 -2.04 (2 s, 3H), 1.22 (m, 3H). (Mixture of interconvertible atropisomers)



375


embedded image


564.2
Method D, RT = 1.61 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.09 - 9.06 (m, 1H), 8.03 - 7.87 (m, 2H), 7.62 - 7.37 (m, 4H), 6.89 - 6.68 (m, 2H), 6.22 - 6.18 (m, 1H), 5.41 - 4.78 (m, 2H), 4.16 - 3.89 (m, 4H), 3.78 - 3.74 (2 s, 3H), 3.64 - 3.60 (m, 3H), 2.21 - 2.03 (2 s, 3H). (Mixture of interconvertible atropisomers)



376


embedded image


566.2
Method D, RT = 1.74 min, 94.2%

1H NMR (400 MHz, DMSO-d6) δ = 9.02 - 8.93 (m, 1H), 7.99 - 7.83 (m, 2H), 7.69 - 7.61 (m, 1H), 7.56 - 7.45 (m, 1H), 7.51 - 7.21 (m, 3H), 6.88 - 6.69 (m, 2H), 6.36 - 6.13 (m, 2H), 5.41 - 4.74 (m, 1H), 4.50 - 4.32 (m, 2H), 4.18 - 3.89 (m, 2H), 3.74 (2 s, 3H), 3.62 - 3.36 (m, 1H), 2.22 - 2.10 (2 s, 3H). (mixture of interconvertible atropisomers)



377


embedded image


534.2
Method D, RT = 1.76 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.12 - 8.96 (m, 1H), 7.99 - 7.83 (m, 2H), 7.66 - 7.61 (m, 1H), 7.59 - 7.35 (m, 3H), 6.89 - 6.71 (m, 2H), 6. 51 - 6.26 (m, 2H), 5.41 - 4.74 (m, 1H), 4.50 - 4.32 (m, 2H), 4.18 - 3.89 (m, 2H), 3.74 (2 s, 3H), 3.62 - 3.36 (m, 1H), 2.23 - 2.03 (2 s, 3H). (mixture of interconvertible atropisomers)



378


embedded image


503.2
Method D, RT = 1.62 min, 97.9%

1H NMR (400 MHz, DMSO-d6) δ = 9.07 (d, J = 8.6 Hz, 1H), 8.54 (s, 1H), 8.13 (s, 1H), 7.88 - 7.77 (m, 2H), 7.60 - 7.50 (m, 2H), 6.77 (d, J = 10.8 Hz, 2H), 5.12 (dd, J = 11.0, 8.6 Hz, 1H), 4.16 - 4.05 (m, 1H), 4.03 - 3.90 (m, 4H), 3.76 (s, 3H), 1.28 (t, J = 7.1 Hz, 3H).



379


embedded image


615.2
Method F, RT = 1.63 min, 96.0%

1H NMR (400 MHz, DMSO-d6) δ = 9.20 - 8.89 (m, 1H), 7.91 - 7.71 (m, 2H), 7.66 - 7.34 (m, 3H), 6.84 - 6.64 (m, 2H), 6.31 - 6.12 (m, 1H), 5.33 - 4.73 (m, 3H), 4.30 - 4.01 (m, 2H), 3.76 (s, 3H), 3.70 - 3.62 (m, 2H), 3.61 - 3.36 (m, 7H), 2.25 - 1.99 (2 s, 3H). (mixture of interconvertible atropisomers)



380


embedded image


582.2
Method D, RT = 1.92 min, 95.7%

1H NMR (400 MHz, DMSO-d6) δ = 9.03 (d, J = 8.6 Hz, 1H), 7.93 - 7.78 (m, 2H), 7.72 - 7.65 (m, 2H), 7.61 - 7.43 (m, 3H), 6.89 - 6.75 (m, 2H), 6.39 (t, J = 7.1 Hz, 1H), 5.14 (dd, J = 11.2, 8.8 Hz, 1H), 4.42 (dd, J = 13.6, 3.5 Hz, 1H), 4.36 - 4.25 (m, 1H), 4.18 - 4.09 (m, 1H), 4.08 - 3.95 (m, 2H), 3.78 (s, 3H), 3.77 - 3.71 (m, 1H), 3.25 (s, 3H).



381


embedded image


570.2
Method D, RT = 1.812 min, 96%

1H NMR (400 MHz, DMSO-d6) δ = 9.12 - 8.94 (m, 1H), 8.05 - 7.68 (m, 4H), 7.51 - 7.24 (m, 3H), 6.87 - 6.69 (m, 2H), 6.52 - 6.39 (m, 1H), 5.33 - 4.74 (m, 1H), 4.35 - 4.00 (m, 2H), 3.79 - 3.74 (2 s, 3H), 3.62 - 3.51 (m, 1H), 2.28 - 2.00 (2 s, 3H). (mixture of interconvertible atropisomers)



382


embedded image


480.2
Method D, RT = 1.685 min, 96%

1H NMR (400 MHz, DMSO-d6) δ = 9.02 - 8.97 (m, 1H), 7.90 - 7.86 (m, 2H), 7.68 - 7.63 (m, 1H), 7.60 - 7.47 (m, 2H), 7.41 - 7.18 (m, 2H), 6.93 - 6.89 (m, 2H), 6.24 - 6.17 (m, 1H), 5.29 - 4.64 (m, 1H), 4.13 - 3.80 (m, 4H), 3.74 - 3.71 (2 s, 3H), 3.47 - 3.42 (m, 1H), 2.24 - 2.02 (2 s, 3H), 1.32 - 1.13 (m, 3H). (mixture of interconvertible atropisomers)



383


embedded image


552.2
Method D, RT = 1.884 min, 97%

1H NMR (400 MHz, DMSO-d6) δ = 9.14 - 8.94 (m, 1H), 8.05 - 7.67 (m, 4H), 7.57 - 7.42 (m, 2H), 7.42 - 7.25 (m, 2H), 7.04 - 6.79 (m, 2H), 6.47 - 6.41 (m, 1H), 5.32 - 4.54 (m, 1H), 4.08 - 3.79 (m, 2H), 3.79 - 3.51 (m, 4H), 2.28 - 2.10 (2 s, 3H). (mixture of interconvertible atropisomers)



384


embedded image


534.2
Method D, RT = 1.726 min, 93%

1H NMR (400 MHz, DMSO-d6) δ = 9.06 - 8.82 (m, 1H), 8.08 - 7.68 (m, 4H), 7.57 - 7.06 (m, 5H), 6.97 - 6.76 (m, 2H), 6.47 - 6.42 (m, 1H), 5.31 - 4.56 (m, 1H), 4.07 - 3.78 (m, 2H), 3.76 - 3.49 (m, 4H), 2.30 - 2.10 (2 s, 3H). (mixture of interconvertible atropisomers)



385


embedded image


506.2
Method D, RT = 1.758 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.02 - 8.98 (m, 1H), 7.94 - 7.79 (m, 2H), 7.70 - 7.66 (m, 1H), 7.60 - 7.47 (m, 2H), 7.42 - 7.23 (m, 2H), 7.00 - 6.80 (m, 2H), 6.24 - 6.20 (m, 1H), 5.28 - 4.62 (m, 1H), 4.15 - 3.78 (m, 3H), 3.75 - 3.70 (m, 4H), 3.51 - 3.40 (m, 1H), 2.23 - 2.02 (2 s, 3H), 1.28 - 1.08 (m, 1H), 0.55 - 0.44 (m, 2H), 0.42 - 0.30 (m, 2H). (mixture of interconvertible atropisomers)



386


embedded image


548.2
Method D, RT = 1.794 min, 97%

1H NMR (400 MHz, DMSO-d6) δ = 9.03 - 8.98 (m, 1H), 7.90 - 7.86 (m, 2H), 7.70 - 7.66 (m, 1H), 7.63 - 7.50 (m, 2H), 7.46 - 7.21 (m, 2H), 6.94 - 6.88 (m, 2H), 6.28 - 6.23 (m, 1H), 5.32 - 4.58 (m, 1H), 4.27 - 3.77 (m, 4H), 3.74 - 3.70 (2 s, 3H) 3.48 - 3.46 (m, 1H), 2.85 - 2.66 (m, 2H), 2.24 - 2.02 (2 s, 3H). (mixture of interconvertible atropisomers)



387


embedded image


580.2
Method D, RT = 1.766 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 8.96 - 8.92 (m, 1H), 7.95 - 7.91 (m, 2H), 7.70 - 7.65 (m, 1H), 7.55 - 7.07 (m, 5H), 6.93 - 6.87 (m, 2H), 6.28 - 6.23 (m, 1H), 5.30 - 4.64 (m, 1H), 4.29 - 3.78 (m, 4H), 3.74 - 3.70 (2 s, 3H) 3.48 - 3.46 (m, 1H), 2.86 - 2.64 (m, 2H), 2.23 - 2.06 (2 s, 3H). (mixture of interconvertible atropisomers)



388


embedded image


512.3
Method D, RT = 1.572 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 8.96 - 8.92 (m, 1H), 8.00 - 7.88 (m, 2H), 7.67 - 7.62 (m, 1H), 7.55 - 7.05 (m, 5H), 6.93 - 6.88 (m, 2H), 6.24 - 6.18 (m, 1H), 5.32 - 4.63 (m, 1H), 4.14 - 3.77 (m, 4H), 3.74 - 3.70 (2 s, 3H), 3.47 - 3.42 (m, 1H), 2.25 - 2.04 (2 s, 3H), 1.25- 1.19 (m, 3H). (mixture of interconvertible atropisomers)



389


embedded image


572.3
Method D, RT = 1.517 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.00 - 8.88 (m, 1H), 7.96 - 7.90 (m, 2H), 7.62 - 7.56 (m, 1H), 7.53 - 7.12 (m, 5H), 6.93 - 6.95 (m, 2H), 6.26 - 6.18 (m, 1H), 5.27 - 5.16 (m, 1H), 5.10 - 4.94 (m, 2H), 4.75 - 4.65 (m, 1H), 4.14 - 4.05 (m, 1H), 3.95 - 3.82 (m, 2H), 3.77 - 3.57 (m, 6H), 3.24 - 3.20 (2 s, 3H), 2.20 - 2.08 (2 s, 3H). (mixture of atrop and diastereomers)



390


embedded image


524.2
Method D, RT = 1.603 min, 98%

1H NMR (400 MHz, DMSO-d6) δ = 8.92 (d, J = 8.6 Hz, 1H), 7.91 - 7.75 (m, 2H), 7.33 (t, J = 73.6 Hz, 1H), 7.27 - 7.24 (m, 2H), 6.74 (d, J = 10.8 Hz, 2H), 4.96 (dd, J = 10.9, 8.9 Hz, 1H), 4.84 (t, J = 9.4 Hz, 1H), 3.97 - 3.86 (m, 1H), 3.75 (s, 3H), 3.64 (br t, J = 8.7 Hz, 1H), 3.37 - 3.31 (m, 3H), 3.26 - 3.20 (m, 2H), 2.26 - 2.17 (m, 1H), 2.13 - 2.03 (m, 1H), 1.03 (t, J= 7.2 Hz, 3H).



391


embedded image


496.1
Method D, RT = 1.467 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 8.98 (d, J = 8.6 Hz, 1H), 7.92 - 7.81 (m, 2H), 7.64 - 7.49 (m, 4H), 7.38 - 7.27 (m, 2H), 6.90 (d, J = 8.6 Hz, 2H), 6.30 (t, J = 7.0 Hz, 1H), 5.05 - 4.96 (m, 1H), 4.96 - 4.88 (m, 1H), 4.12 - 4.04 (m, 2H), 3.96 - 3.90 (m, 1H), 3.79 - 3.70 (m, 2H), 3.72 (s, 3H), 3.70 - 3.61 (m, 1H), 1.08 (d, J= 6.1 Hz, 3H).



392


embedded image


532.2
Method D, RT = 1.606 min, 97.2%

1H NMR (400 MHz, DMSO-d6) δ = 9.02 - 8.95 (m, 1H), 7.98 - 7.90 (m, 2H), 7.58 - 7.49 (m, 2H), 7.46 - 7.15 (m, 6H), 6.23 - 6.18 (m, 1H), 5.33 - 4.97 (m, 1H), 5.05 - 4.97 (m, 1H), 4.94 - 4.90 (m, 1H), 4.06 - 3.86 (m, 4H), 3.67 - 3.58 (m, 2H), 2.22 - 2.10 (2 s, 3H). (mixture of interconvertible atropisomers)



393


embedded image


564.2
Method D, RT = 1.848 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 8.98 (d, J= 9.3 Hz, 1H), 7.89 - 7.81 (m, 2H), 7.73 - 7.63 (m, 2H), 7.59 - 7.51 (m, 2H), 7.34 (d, J = 8.6 Hz, 2H), 6.90 (d, J = 8.6 Hz, 2H), 6.38 (t, J = 7.0 Hz, 1H), 5.05 -4.98 (m, 1H), 4.44 - 4.37 (m, 1H), 4.32 -4.26 (m, 1H), 4.13 - 4.02 (m, 3H), 3.80 -3.74 (m, 1H), 3.72 (s, 3H), 3.36 (s, 3H).



394


embedded image


514.2
Method D, RT = 1.52 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.05 - 8.98 (m, 1H), 7.88 - 7.75 (m, 2H), 7.59 - 7.43 (m, 4H), 6.86 - 6.74 (m, 2H), 6.21 - 6.18 (m, 1H), 5.42 - 4.74 (m, 2H), 4.15 - 3.92 (m, 4H), 3.76 - 3.72 (2 s, 3H), 3.66 - 3.56 (m, 3H), 2.22 - 2.05 (2 s, 3H). (mixture of interconvertible atropisomers)



395


embedded image


578.2
Method D, RT = 1.85 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.05 (d, J = 8.3 Hz, 1H), 7.96 (d, J = 8.8 Hz, 2H), 7.63 - 7.56 (m, 2H), 7.53 - 7.43 (m, 3H), 6.85 - 6.76 (m, 2H), 6.32 (t, J = 7.0 Hz, 1H), 5.15 - 5.10 (m, 1H), 4.13 - 3.93 (m, 3H), 3.91 (br d, J = 7.1 Hz, 2H), 3.76 (s, 3H), 3.74 - 3.64 (m, 1H), 3.25 (s, 3H), 1.08 (d, J = 6.1 Hz, 3H).



396


embedded image


568.2
Method D, RT = 1.84 min, 94.9%

1H NMR (400 MHz, DMSO-d6) δ = 9.14 (d, J = 8.6 Hz, 1H), 8.13 (dd, J = 4.9, 2.0 Hz, 1H), 7.98 - 7.90 (m, 2H), 7.79 (dd, J = 7.6, 1.7 Hz, 1H), 7.49 (d, J = 8.6 Hz, 2H), 7.09 (dd, J = 7.6, 4.9 Hz, 1H), 6.78 (d, J = 10.8 Hz, 2H), 5.08 (dd, J = 10.9, 8.4 Hz, 1H), 4.74 (t, J = 5.5 Hz, 1H), 4.38 (td, J= 5.5, 2.6 Hz, 2H), 4.15 (q, J = 9.8 Hz, 1H), 4.05 - 4.96 (m, 2H), 3.76 (s, 3H), 3.75 - 3.69 (m, 2H).



397


embedded image


526.2
Method D, RT = 1.471 min, 91%

1H NMR (400 MHz, DMSO-d6) δ = 9.01 - 8.94 (m, 1H), 7.91 - 7.83 (m, 2H), 7.68 (dd, J = 6.8, 2.0 Hz, 1H), 7.58 - 7.49 (m, 3H), 7.34 (d, J = 8.6 Hz, 2H), 6.90 (d, J = 8.6 Hz, 2H), 6.33 (t, J = 7.1 Hz, 1H), 5.11 - 4.97 (m, 3H), 4.13 - 4.10 (m, 1H), 3.78 - 3.65 (m, 8H), 3.65 - 3.60 (m, 1H), 3.23 (s, 3H).



398


embedded image


565.2
Method D, RT = 1.73 min, 97 %

1H NMR (400 MHz, DMSO-d6) δ = 9.02 (d, J = 8.3 Hz, 1H), 8.01 (d, J = 4.6 Hz, 1H), 7.90 - 7.80 (m, 2H), 7.69 (d, J = 4.6 Hz, 1H), 7.34 (t, J = 73.6 Hz, 1H), 7.28 -7.26 (m, 2H), 6.78 (d, J = 10.8 Hz, 2H), 5.05 (dd, J = 10.9, 8.4 Hz, 1H), 4.37 -4.22 (m, 3H), 4.21 - 4.05 (m, 2H), 3.77 (s, 3H), 3.70 (t, J = 5.5 Hz, 2H), 3.24 (s, 3H).



399


embedded image


538.1
Method D, RT = 1.88 min, 94 %

1H NMR (400 MHz, DMSO-d6) δ = 9.15 -9.04 (m, 1H), 8.07 - 7.68 (m, 4H), 7.64 - 7.45 (m, 2H), 6.87 - 6.65 (m, 2H), 6.51 - 6.36 (m, 1H), 5.36 - 4.78 (m, 1H), 4.35 - 3.99 (m, 2H), 3.83 - 3.73 (2 s, 3H), 3.66 - 3.52 (m, 1H), 2.29 - 2.05 (2 s, 3H). (mixture of interconvertible atropisomers)



400


embedded image


596.3
Method D, RT = 1.721 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.24 - 8.92 (m, 1H), 7.99 - 7.86 (m, 1H), 7.96 -7.91 (m, 1H), 7.60 - 7.42 (m, 3H), 6.83 - 6.69 (m, 2H), 6.26 - 6.16 (m, 1H), 5.00 - 4.84 (m, 2H), 4.30 - 3.96 (m, 4H), 3.80 - 3.74 (2 s, 3H), 3.62 - 3.47 (m, 2H), 2.24 - 2.02 (2 s, 3H), 1.14 - 1.03 (m, 3H). (mixture of interconvertible atropisomers)



401


embedded image


566.2
Method D, RT = 1.87 min, 94.4%

1H NMR (400 MHz, DMSO-d6) δ = 9.05 - 9.00 (m, 1H), 7.99 - 7.81 (m, 2H), 7.70 - 7.65 (m, 1H), 7.62 - 7.50 (m, 2H), 7.45 - 7.40 (m, 1H), 6.90 - 6.72 (m, 2H), 6.28 - 6.24 (m, 1H), 5.42 - 4.74 (m, 1H), 4.30 - 3.94 (m, 3H), 3.76 - 3.70 (2 s, 3H), 3.49 - 3.34 (m, 2H), 2.81 - 2.68 (m, 2H), 2.22 - 2.06 (2 s, 3H). (mixture of interconvertible atropisomers)



402


embedded image


598.2
Method D, RT = 1.83 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 8.99 - 8.95 (m, 1H), 7.99 - 7.84 (m, 2H), 7.61 - 7.52 (m, 1H), 7.58 - 7.12 (m, 4H), 6.90 - 6.70 (m, 2H), 6.21 - 6.17 (m, 1H), 5.42 - 4.74 (m, 1H), 4.30 - 3.94 (m, 3H), 3.76 - 3.70 (2 s, 3H), 3.49 - 3.34 (m, 2H), 2.81 - 2.68 (m, 2H), 2.22 - 2.06 (2 s, 3H). (mixture of interconvertible atropisomers)



403


embedded image


566.2
Method D, RT = 1.87 min, 94.4%

1H NMR (400 MHz, DMSO-d6) δ = 9.06 - 9.01 (m, 1H), 7.99 - 7.82 (m, 2H), 7.71 - 7.67 (m, 1H), 7.63 - 7.52 (m, 2H), 7.49 - 7.37 (m, 1H), 6.90 - 6.73 (m, 2H), 6.25 - 6.21 (m, 1H), 5.42 - 4.74 (m, 1H), 4.22 - 3.95 (m, 2H), 3.95 - 3.82 (m, 1H), 3.79 -3.75 (2 s, 3H), 3.74 - 3.54 (m, 2H), 2.23 - 2.03 (2 s, 3H), 1.32 - 1.09 (m, 1H), 0.58 - 0.45 (m, 2H), 0.42 - 0.26 (m, 2H) (mixture of interconvertible atropisomers)



404


embedded image


598.2
Method D, RT = 1.83 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.06 - 9.01 (m, 1H), 7.99 - 7.82 (m, 2H), 7.71 - 7.67 (m, 1H), 7.63 - 7.52 (m, 2H), 7.49 - 7.37 (m, 1H), 6.90 - 6.73 (m, 2H), 6.25 - 6.21 (m, 1H)), 5.42 - 4.69 (m, 1H), 4.19 - 3.90 (m, 4H), 3.78 - 3.72 (2 s, 3H), 3.63 - 3.35 (m, 3H), 3.24 (s, 3H), 2.23 - 2.02 (2 s, 3H). (mixture of interconvertible atropisomers)



405


embedded image


560.3
Method D, RT = 1.885 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.05 - 8.99 (m, 1H), 7.99 (d, J = 8.8 Hz, 2H), 7.60 (d, J = 7.1 Hz, 2H), 7.49 (d, J = 8.8 Hz, 2H), 7.35 (d, J = 8.8 Hz, 2H), 6.91 (d, J = 8.8 Hz, 2H), 6.32 (d, J = 7.1 Hz, 1H), 5.05 - 4.97 (m, 1H), 4.12 - 4.08 (m, 1H), 4.08 - 4.02 (m, 1H), 3.93 - 3.86 (m, 1H), 3.78 - 3.73 (m, 2H), 3.72 (s, 3H), 3.68 - 3.62 (m, 1H), 3.2 (s, 3H), 1.09 (d, J = 6.4 Hz, 3H).



406


embedded image


530.2
Method D, RT = 1.681 min, 97.2%

1H NMR (400 MHz, DMSO-d6) δ = 9.07 - 8.96 (m, 1H), 7.90 - 7.84 (m, 2H), 7.68 (dd, J= 7.0, 1.8 Hz, 1H), 7.59 - 7.52 (m, 3H), 7.50 - 7.44 (m, 2H), 7.43 - 7.38 (m, 2H), 6.37 - 6.31 (m, 1H), 5.13 - 4.98 (m, 2H), 4.20 - 4.12 (m, 1H), 3.88 - 3.58 (m, 7H), 3.23 (s, 3H).



407


embedded image


564.2
Method D, RT = 1.59 min, 100 %

1H NMR (400 MHz, DMSO-d6) δ = 8.98 (d, J = 8.6 Hz, 1H), 7.94 - 7.81 (m, 2H), 7.67 (dd, J = 6.6, 2.2 Hz, 1H), 7.47 -7.45 (m, 1H), 7.35 (t, J = 73.6 Hz, 1H), 7.28 - 7.26 (m, 2H), 6.85 - 6.67 (m, 2H), 6.33 (t, J = 7.0 Hz, 1H), 5.11 (dd, J = 11.4, 8.7 Hz, 1H), 4.55 - 4.47 (m, 1H), 4.03 - 3.97 (m, 3H), 3.77 (s, 3H), 3.67 -3.61 (m, 3H), 0.99 (d, J = 5.9 Hz, 3H).



408


embedded image


582.2
Method D, RT = 2.052 min, 95.7%

1H NMR (400 MHz, DMSO-d6) δ = 9.14 (d, J = 8.3 Hz, 1H), 8.13 (dd, J = 4.9, 2.0 Hz, 1H), 8.01 - 7.88 (m, 2H), 7.79 (dd, J = 7.6, 1.7 Hz, 1H), 7.49 (d, J = 8.3 Hz, 2H), 7.11 (dd, J = 7.6, 4.9 Hz, 1H), 6.78 (d, J = 10.5 Hz, 2H), 5.11 (dd, J = 11.0, 8.6 Hz, 1H), 4.47 - 4.40 (m, 2H), 4.19 -4.09 (m, 1H), 4.03 (t, J = 9.7 Hz, 1H), 3.97 - 3.91 (m, 1H), 3.77 (s, 3H), 3.72 -3.67 (m, 2H), 3.30 (s, 3H).



409


embedded image


532.2
Method D, RT = 1.618 min, 98.4%

1H NMR (400 MHz, DMSO-d6) δ = 8.96 (br d, J = 8.6 Hz, 1H), 7.96 - 7.83 (m, 2H), 7.62 - 7.57 (m, 2H), 7.50 - 7.37 (m, 4H), 7.34 (t, J= 73.6 Hz, 1H), 7.29 - 7.25 (m, 2H), 6.31 (t, J = 7.0 Hz, 1H), 5.08 -4.98 (m, 2H), 4.98 - 4.86 (m, 1H), 4.17 (t, J= 8.3 Hz, 1H), 4.08 (dd, J = 12.7, 3.7 Hz, 1H), 3.96 - 3.88 (m, 1H), 3.81 (dd, J = 10.5, 8.3 Hz, 1H), 3.76 - 3.69 (m, 1H), 1.09 (d, J = 6.4 Hz, 3H).



410


embedded image


599.2
Method D, RT = 1.94 min, 95.8%

1H NMR (400 MHz, DMSO-d6) δ = 8.85 (d, J = 7.6 Hz, 1H), 8.25 - 8.13 (m, 1H), 7.61 (d, J = 8.6 Hz, 2H), 7.45 (d, J = 8.6 Hz, 2H), 6.85 (d, J = 6.1 Hz, 1H), 6.69 -6.56 (m, 2H), 6.40 - 6.30 (m, 1H), 4.99 (dd, J = 9.2, 7.7 Hz, 1H), 4.59 - 4.53 (m, 1H), 4.32 - 4.23 (m, 1H), 3.99 (br t, J= 8.9 Hz, 1H), 3.70 (s, 3H), 3.53 - 3.44 (m, 4H), 3.28 (s, 3H).



411


embedded image


526.2
Method D, RT = 1.465 min, 93%

1H NMR (400 MHz, DMSO-d6) δ = 8.98 (d, J = 8.6 Hz, 1H), 7.93 - 7.81 (m, 2H), 7.67 (dd, J= 6.8, 1.7 Hz, 1H), 7.59 - 7.48 (m, 3H), 7.34 (d, J= 8.8 Hz, 2H), 6.90 (d, J = 8.6 Hz, 2H), 6.33 (t, J = 7.0 Hz, 1H), 5.12 - 4.93 (m, 3H), 4.13 - 4.05 (m, 1H), 3.80 - 3.73 (m, 4H), 3.72 (s, 3H), 3.69 -3.58 (m, 2H), 3.23 (s, 3H).



412


embedded image


564.2
Method D, RT = 1.78 min, 99.3%

1H NMR (400 MHz, DMSO-d6) δ = 9.03 (d, J = 8.6 Hz, 1H), 8.13 (dd, J = 4.9, 1.7 Hz, 1H), 7.94 - 7.83 (m, 2H), 7.79 (dd, J = 7.6, 1.7 Hz, 1H), 7.34 (t, J = 73.0 Hz, 1H), 7.28 - 7.26 (m, 2H), 7.14 - 7.14 (m, 1H), 6.78 (d, J = 10.8 Hz, 2H), 5.09 (dd, J = 10.9, 8.7 Hz, 1H), 4.44 (dd, J = 5.4, 3.9 Hz, 2H), 4.20 - 4.09 (m, 1H), 4.03 (t, J = 9.5 Hz, 1H), 3.97 - 3.90 (m, 1H), 3.77 (s, 3H), 3.73 - 3.65 (m, 2H), 3.30 (s, 3H).



413


embedded image


532.2
Method D, RT = 1.87 min, 98.2%

1H NMR (400 MHz, DMSO-d6) δ = 9.10 (d, J = 8.8 Hz, 1H), 8.13 (dd, J = 5.0, 1.8 Hz, 1H), 7.89 - 7.81 (m, 2H), 7.79 (dd, J = 7.6, 2.0 Hz, 1H), 7.61 - 7.50 (m, 2H), 7.11 (dd, J= 7.6, 5.1 Hz, 1H), 6.78 (d, J = 10.8 Hz, 2H), 5.10 (dd, J = 11.0, 8.8 Hz, 1H), 4.51 - 4.40 (m, 2H), 4.19 - 4.08 (m, 1H), 4.02 (t, J = 9.7 Hz, 1H), 3.97 -3.91 (m, 1H), 3.77 (s, 3H), 3.73 - 3.67 (m, 2H), 3.30 (s, 3H).



414


embedded image


530.2
Method D, RT = 1.670 min, 97.1%

1H NMR (400 MHz, DMSO-d6) δ = 9.02 (d, J = 8.3 Hz, 1H), 7.87 (d, J = 8.8 Hz, 2H), 7.68 (dd, J = 1.6, 7.0 Hz, 1H), 7.61 - 7.52 (m, 3H), 7.51 - 7.44 (m, 2H), 7.44 - 7.30 (m, 2H), 6.34 (t, J = 7.1 Hz, 1H), 5.11 - 4.97 (m, 3H), 4.14 (t, J = 7.3 Hz, 1H), 3.86 - 3.61 (m, 6H), 3.23 (s, 3H).



415


embedded image


552.2
Method D, RT = 1.838 min, 97.2%

1H NMR (400 MHz, DMSO-d6) δ = 9.09 - 8.88 (m, 1H), 8.01 - 7.87 (m, 2H), 7.71 - 7.57 (m, 1H), 7.55 - 7.10 (m, 7H), 6.48 - 6.12 (m, 2H), 5.32 - 4.71 (m, 1H), 4.45 - 4.31 (m, 2H), 4.15 - 3.69 (m, 3H),2.23 - 2.11 (2 s, 3H). (mixture of interconvertible atropisomers)



416


embedded image


596.2
Method D, RT = 1.824 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 8.92 (d, J = 8.3 Hz, 1H), 7.92 (d, J = 8.8 Hz, 2H), 7.69 (dd, J = 6.7, 1.8 Hz, 1H), 7.66 (dd, J = 7.3, 1.8 Hz, 1H), 7.37 - 7.22 (m, 4H), 7.33 (t, J = 76.0 Hz, 1H), 6.90 (d, J = 8.8 Hz, 2H), 6.38 (t, J = 7.0 Hz, 1H), 5.07 - 4.94 (m, 1H), 4.41 (dd, J = 13.3, 3.5 Hz, 1H), 4.36 - 4.26 (m, 1H), 4.16 -3.95 (m, 2H), 3.82 - 3.73 (m, 2H), 3.72 (s, 3H), 3.36 (s, 3H).



417


embedded image


600.2
Method D, RT = 1.95 min, 100 %

1H NMR (400 MHz, DMSO-d6) δ = 9.07 (d, J = 8.8 Hz, 1H), 7.89 - 7.77 (m, 2H), 7.71 (dd, J= 6.8, 2.0 Hz, 1H), 7.68 (dd, J = 2.0, 7.1 Hz, 1H), 7.60 - 7.48 (m, 2H), 6.77 (d, J = 10.8 Hz, 2H), 6.39 (t, J = 7.0 Hz, 1H), 5.12 (dd, J = 10.8, 8.8 Hz, 1H), 4.42 (dd, J = 13.3, 3.3 Hz, 1H), 4.33 -4.24 (m, 1H), 4.15 - 3.92 (m, 4H), 3.76 (s, 3H), 3.36 (s, 3H).



418


embedded image


560.3
Method D, RT = 1.67 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 8.95 (d, J = 8.8 Hz, 1H), 7.97 - 7.83 (m, 2H), 7.66 - 7.56 (m, 2H), 7.54 - 7.48 (m, 1H), 7.35 (t, J = 76.0 Hz, 1H), 7.31 - 7.24 (m, 2H), 6.87 - 6.73 (m, 2H), 6.31 (t, J= 7.0 Hz, 1H), 5.13 (dd, J = 11.5, 8.8 Hz, 1H), 4.22 - 4.12 (m, 1H), 4.08 (dd, J = 13.2, 3.7 Hz, 1H), 4.04 - 3.94 (m, 1H), 3.84 (dd, J = 13.3, 7.7 Hz, 1H), 3.74 (s, 3H), 3.70 - 3.60 (m, 2H), 3.18 (s, 3H), 1.09 (d, J= 6.4 Hz, 3H).



419


embedded image


585.2
Method D, RT = 1.79 min, 92.4%

1H NMR (400 MHz, DMSO-d6) δ = 9.15 - 8.96 (m, 1H), 8.34 (d, J = 5.1 Hz, 1H), 7.83 (d, J = 8.6 Hz, 2H), 7.61 - 7.50 (m, 2H), 6.87 - 6.73 (m, 2H), 6.71 (d, J= 5.1 Hz, 1H), 6.43 (br t, J = 6.1 Hz, 1H), 5.08 - 4.91 (m, 1H), 4.81 - 4.71 (m, 1H), 4.27 - 4.00 (m, 2H), 3.81 -3.77 (m, 1H), 3.76 (s, 3H), 3.61 - 3.47 (m, 4H).



420


embedded image


611.2
Method D, RT = 1.94 min, 97.4%

1H NMR (400 MHz, DMSO-d6) δ = 9.10 (br d, J = 8.1 Hz, 1H), 8.55 - 8.41 (m, 1H), 7.82 (br d, J = 8.1 Hz, 2H), 7.66 -7.39 (m, 2H), 7.22 (d, J = 5.6 Hz, 1H), 6.87 - 6.59 (m, 2H), 5.19 - 5.01 (m, 1H), 4.42 - 4.11 (m, 2H), 3.80 (s, 3H), 3.79 -3.56 (m, 5H), 3.28 - 3.19 (m, 2H), 3.17 -3.05 (m, 2H).



421


embedded image


552.2
Method D, RT = 1.77 min, 100 %

1H NMR (400 MHz, DMSO-d6) δ = 9.22 - 8.91 (m, 1H), 7.91 - 7.76 (m, 2H), 7.72 - 7.44 (m, 3H), 6.87 - 6.68 (m, 2H), 6.51 - 6.03 (m, 2H), 5.38 - 4.75 (m, 1H), 4.51 - 4.32 (m, 2H), 4.30 - 4.02 (m, 2H), 3.79 - 3.73 (2 s, 3H), 3.60 - 3.44 (m, 1H), 2.25 - 2.02 (2 s, 3H). (mixture of interconvertible atropisomers)



422


embedded image


546.3
Method D, RT = 1.69 min, 100 %

1H NMR (400 MHz, DMSO-d6) δ = 9.23 - 8.89 (m, 1H), 7.98 - 7.74 (m, 2H), 7.68 - 7.41 (m, 3H), 6.79 - 6.74 (m, 2H), 6.28 - 6.09 (m, 1H), 5.44 - 4.77 (m, 1H), 4.29 - 3.96 (m, 4H), 3.77 - 3.74 (2 s, 3H), 3.63 - 3.42 (m, 3H), 3.27 - 3.23 (2 s, 3H), 2.23 - 1.99 (2 s, 3H). (mixture of interconvertible atropisomers)



423


embedded image


599.2
Method D, RT = 1.94 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.11 - 9.07 (m, 1H), 8.25 - 8.13 (m, 1H), 7.88 - 7.82 (m, 2H), 7.56 (d, J = 8.6 Hz, 2H), 6.91 - 6.85 (m, 1H), 6.69 - 6.56 (d, J = 10.8 Hz, 2H), 6.46 - 6.33 (m, 1H), 5.16 -5.11 (m, 1H), 4.35 - 4.13 (m, 2H), 3.79 (s, 3H), 3.78 - 3.71 (m,1H), 3.53 - 3.44 (m, 4H), 3.28 (s, 3H). (mixture of interconvertible atropisomers)



424


embedded image


500.2
Method D, RT = 1.635 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.03 (d, J = 8.8 Hz, 1H), 7.90 - 7.82 (m, 2H), 7.65 - 7.52 (m, 4H), 7.50 - 7.44 (m, 2H), 7.43 - 7.36 (m, 2H), 6.31 (t, J = 7.0 Hz, 1H), 5.07 - 5.00 (m, 1H), 4.98 - 4.88 (m, 1H), 4.17 - 4.10 (m, 1H), 4.06 (dd, J = 12.7, 3.7 Hz, 1H), 3.96 - 3.88 (m, 1H), 3.84 - 3.74 (m, 2H), 3.68 - 3.64 (m, 1H), 1.08 (d, J = 6.4 Hz, 3H).



425


embedded image


510.2
Method D, RT = 1.937 min, 97.2%

1H NMR (400 MHz, DMSO-d6) δ = 9.08 - 9.02 (m, 1H), 7.90 - 7.86 (m, 2H), 7.71 - 7.67 (m, 1H), 7.60 - 7.47 (m, 3H), 7.46 - 7.31 (m, 3H), 6.24 - 6.20 (m, 1H), 5.36 - 4.62 (m, 1H), 4.15 - 3.82 (m, 3H), 3.81 - 3.47 (m, 2H), 2.22 - 2.07 (2 s, 3H), 1.31 - 1.16 (m, 1H), 0.54 - 0.41 (m, 2H), 0.41 - 0.28 (m, 2H). (mixture of interconvertible atropisomers)



426


embedded image


608.3
Method D, RT = 1.539 min, 97.8%

1H NMR (400 MHz, DMSO-d6) δ = 9.17 - 8.79 (m, 1H), 8.01 - 7.80 (m, 2H), 7.68 - 7.56 (m, 1H), 7.56 - 7.05 (m, 3H), 6.79 - 6.74 (m, 2H), 6.30 - 6.10 (m, 1H), 5.39 - 4.78 (m, 3H), 4.32 - 4.00 (m, 2H), 3.78 - 3.75 (2 s, 3H), 3.74 - 3.58 (m, 3H), 3.51 - 3.48 (m, 1H), 3.53 - 3.44 (m, 1H), 3.25 - 3.18 (2 s, 3H), 2.26 - 1.91 (2 s, 3H). (mixture of interconvertible atropisomers)



427


embedded image


626.2
Method D, RT = 1.759 min, 98.3%

1H NMR (400 MHz, DMSO-d6) δ = 9.23 - 8.88 (m, 1H), 8.04 - 7.87 (m, 2H), 7.71 - 7.55 (m, 1H), 7.55 - 7.35 (m, 2H), 6.85 - 6.62 (m, 2H), 6.29 - 6.12 (m, 1H), 5.39 - 4.82 (m, 3H), 4.32 - 4.02 (m, 2H), 3.77 - 3.74 (2 s, 3H), 3.74 - 3.57 (m, 4H), 3.53 - 3.50 (m, 1H), 3.23 - 3.19 (2 s, 3H), 2.23 - 2.00 (2 s, 3H). (mixture of interconvertible atropisomers)



428


embedded image


617.7
Method D, RT = 1.58 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 8.95 (d, J= 8.8 Hz, 1H), 7.97 - 7.83 (m, 2H), 7.66 - 7.56 (m, 2H), 7.54 - 7.48 (m, 1H), 7.35 (t, J = 76.0 Hz, 1H), 7.31 - 7.24 (m, 2H), 6.87 - 6.73 (m, 2H), 6.31 (t, J= 7.0 Hz, 1H), 5.16 - 5.04 (m, 1H), 4.15 - 3.98 (m, 2H), 3.93 - 3.80 (m, 2H), 3.78 (s, 3H), 3.68 - 3.51 (m, 2H), 3.27 (s, 3H), 3.01 (s, 3H), 2.99 (s, 3H).



429


embedded image


626.3
Method D, RT = 1.775 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.27 - 9.01 (m, 1H), 8.05 - 7.81 (m, 2H), 7.69 - 7.53 (m, 1H), 7.53 - 7.32 (m, 2H), 6.79 - 6.75 (m, 2H), 6.32 - 6.13 (m, 1H), 5.40 - 4.81 (m, 3H), 4.32 - 4.01 (m, 2H), 3.76 - 3.74 (2 s, 3H), 3.74 - 3.57 (m, 3H), 3.51 - 3.49 (m, 1H), 3.55 - 3.46 (m, 1H), 3.22 (s, 3H), 2.24 - 1.96 (2 s, 3H). (mixture of interconvertible atropisomers)



430


embedded image


584.2
Method D, RT = 1.89 min, 99 %

1H NMR (400 MHz, DMSO-d6) δ = 9.21 - 8.84 (m, 1H), 7.92 - 7.78 (m, 2H), 7.76 - 7.64 (m, 1H), 7.61 - 7.43 (m, 2H), 6.79 - 6.75 (m, 2H), 6.34 - 6.17 (m, 1H), 5.37 - 4.78 (m, 1H), 4.31 - 4.00 (m, 4H), 3.78 - 3.75 (2 s, 3H), 3.55 - 3.40 (m, 1H), 2.83 - 2.66 (m, 2H), 2.24 - 1.98 (2 s, 3H). (mixture of interconvertible atropisomers)



431


embedded image


516.2
Method D, RT = 1.69 min, 94 %

1H NMR (400 MHz, DMSO-d6) δ = 9.21 - 8.89 (m, 1H), 7.91 - 7.76 (m, 2H), 7.73 - 7.61 (m, 1H), 7.61 - 7.39 (m, 2H), 6.79 - 6.75 (m, 2H), 6.29 - 6.13 (m, 1H), 5.38 - 4.77 (m, 1H), 4.30 - 3.82 (m, 4H), 3.77 - 3.75 (2 s, 3H), 3.55 - 3.44 (m, 1H), 2.21 - 2.01 (2 s, 3H), 1.30 - 1.13 (m, 3H). (mixture of interconvertible atropisomers)



432


embedded image


502.2
Method D, RT = 2.02 min, 100 %

1H NMR (400 MHz, DMSO-d6) δ = 8.90 (d, J = 8.6 Hz, 1H), 8.26 (d, J = 5.9 Hz, 1H), 7.97 (d, J= 2.2 Hz, 1H), 7.93 - 7.80 (m, 2H), 7.58 - 7.08 (m, 2H), 6.93 - 6.71 (m, 3H), 5.72-5.67 (m, 1H), 5.02 - 4.88 (m, 1H), 4.32 - 4.27 (m, 1H), 3.84 (s, 3H), 3.78 (s, 3H), 1.17 (d, J = 6.6 Hz, 3H).



433


embedded image


614.2
Method D, RT = 1.97 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.02 (d, J = 8.3 Hz, 1H), 8.05 - 7.86 (m, 2H), 7.72 - 7.59 (m, 2H), 7.47 (d, J = 8.3 Hz, 2H), 7.35 (d, J = 8.6 Hz, 2H), 6.91 (d, J = 8.6 Hz, 2H), 6.39 (t, J = 7.1 Hz, 1H), 5.08 - 4.97 (m, 1H), 4.46 - 4.38 (m, 1H), 4.33 - 4.24 (m, 1H), 4.16 (t, J = 7.8 Hz, 1H), 4.02 (dd, J= 13.3, 8.7 Hz, 1H), 3.81 - 3.72 (m, 2H), 3.72 (s, 3H), 3.36 (s, 3H).



434


embedded image


528.3
Method D, RT = 1.412 min, 98%

1H NMR (400 MHz, DMSO-d6) δ = 8.96 - 8.89 (m, 1H), 7.96 - 7.89 (m, 2H), 7.64 - 7.55 (m, 2H), 7.35 - 7.33 (m, 2H), 7.33 (t, J= 76.0 Hz, 1H), 7.25 - 7.20 (m, 2H), 6.95 - 6.88 (m, 2H), 6.34 - 6.26 (m, 1H), 5.05 - 4.91 (m, 2H), 4.12 - 4.01 (m, 2H), 3.95 - 3.88 (m, 1H), 3.80 - 3.62 (m, 6H), 1.09 (d, J = 6.4 Hz, 3H).



435


embedded image


564.2
Method D, RT = 1.66 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.06 (d, J= 8.8 Hz, 1H), 8.03 - 7.86 (m, 2H), 7.62 - 7.57 (m, 2H), 7.55 - 7.38 (m, 3H), 6.88 - 6.71 (m, 2H), 6.31 (t, J = 7.1 Hz, 1H), 5.12 (dd, J= 11.2, 8.8 Hz, 1H), 4.95 - 4.91 (m, 1H), 4.16 - 3.87 (m, 4H), 3.78 (s, 3H), 3.77 - 3.61 (m, 2H), 1.08 (d, J = 6.4 Hz, 3H).



436


embedded image


546.2
Method D, RT = 1.48 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.02 - 8.87 (m, 1H), 7.91 (d, J = 7.8 Hz, 2H), 7.66 - 7.55 (m, 2H), 7.53 - 7.46 (m, 1H), 7.35 (t, J = 72.0 Hz, 1H), 7.28 - 7.24 (m, 2H), 6.89 - 6.70 (m, 2H), 6.31 (t, J= 7.1 Hz, 1H), 5.17 - 5.02 (m, 1H), 4.95 - 4.91 (m, 1H), 4.14 - 3.86 (m, 4H), 3.77(s, 3H), 3.76 - 3.63 (m, 2H), 1.09 (d, J= 6.1 Hz, 3H).



437


embedded image


594.3
Method D, RT = 1.68 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.06 (br d, J = 8.8 Hz, 1H), 7.97 (d, J= 8.8 Hz, 2H), 7.69 (br d, J = 7.1 Hz, 1H), 7.57 (br d, J = 7.3 Hz, 1H), 7.54 - 7.38 (m, 3H), 6.90 - 6.73 (m, 2H), 6.41 - 6.26 (m, 1H), 5.19 - 4.98 (m, 3H), 4.18 - 4.10 (m, 1H), 4.04 - 3.94 (m, 1H), 3.79 (s, 3H) 3.77 -3.59 (m, 5H), 3.23 (s, 3H).



438


embedded image


576.2
Method D, RT = 1.50 min, 98.8%

1H NMR (400 MHz, DMSO-d6) δ = 8.94 (d, J = 8.6 Hz, 1H), 7.96 - 7.86 (m, 2H), 7.68 (dd, J= 7.0, 1.8 Hz, 1H), 7.56 (dd, J = 7.2, 1.8 Hz, 1H), 7.53 - 7.48 (m, 1H), 7.33 (t, J = 74.0 Hz, 1H), 7.28 - 7.24 (m, 2H), 6.86 - 6.70 (m, 2H), 6.34 (t, J= 7.1 Hz, 1H), 5.19 - 4.98 (m, 3H), 4.18 - 4.10 (m, 1H), 4.04 - 3.94 (m, 1H), 3.79 (s, 3H) 3.78 - 3.59 (m, 5H), 3.23 (s, 3H).



439


embedded image


550.2
Method D, RT = 1.788 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.13 - 8.99 (m, 1H), 7.98 (d, J = 8.6 Hz, 2H), 7.68 - 7.55 (m, 2H), 7.51 - 7.45 (m, 4H), 7.44 - 7.34 (m, 2H), 6.31 (t, J = 7.1 Hz, 1H), 5.10 - 4.99 (m, 1H), 4.99 - 4.84 (m, 1H), 4.18 - 4.01 (m, 2H), 3.96 - 3.86 (m, 1H), 3.84 - 3.75 (m, 2H), 3.71 - 3.61 (m, 1H), 1.08 (d, J = 6.4 Hz, 3H).



440


embedded image


546.2
Method D, RT = 1.596 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.02 (d, J = 8.8 Hz, 1H), 8.05 - 7.85 (m, 2H), 7.67 - 7.55 (m, 2H), 7.47 (d, J = 7.8 Hz, 2H), 7.40 - 7.25 (m, 2H), 6.90 (d, J= 8.8 Hz, 2H), 6.30 (t, J = 7.0 Hz, 1H), 5.01 (dd, J= 11.0, 8.8 Hz, 1H), 4.97 - 4.86 (m, 1H), 4.20 - 4.03 (m, 2H), 3.98 - 3.86 (m, 1H), 3.72 (s, 3H), 3.82 - 3.56 (m, 3H), 1.09 (d, J = 6.4 Hz, 3H).



441


embedded image


641.3
Method D, RT = 1.505 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 8.97 - 8.84 (m, 1H), 7.93 (d, J = 8.1 Hz, 2H), 7.72 - 7.59 (m, 2H), 7.36 - 7.34 (m, 2H), 7.33 (t, J = 74.0 Hz, 1H), 7.27 - 7.25 (m, 2H), 6.90 (d, J= 8.8 Hz, 2H), 6.47 - 6.33 (m, 1H), 6.07 - 6.04 (m, 1H), 5.05 - 4.93 (m, 1H), 4.12 - 4.04 (m, 1H), 3.93 - 3.74 (m, 3H), 3.72 (s, 3H), 3.64 - 3.44 (m, 6H), 3.28 (s, 3H), 3.38 - 3.19 (m, 3H).



442


embedded image


542.2
Method D, RT = 1.901 min, 97.7%

1H NMR (400 MHz, DMSO-d6) δ = 9.02 - 8.97 (m, 1H), 7.99 - 7.85 (m, 2H), 7.71 - 7.67 (m, 1H), 7.56 - 7.47 (m, 1H), 7.45 - 7.12 (m, 6H), 6.25 - 6.21 (m, 1H), 5.33 - 4.62 (m, 1H), 4.17 - 3.94 (m, 1H), 4.17 - 3.82 (m, 2H), 3.81 - 3.47 (m, 2H), 2.21 - 2.07 (2 s, 3H), 1.28 - 1.16 (m, 1H), 0.52 - 0.45 (m, 2H), 0.42 - 0.34 (m, 2H). (mixture of interconvertible atropisomers)



443


embedded image


570.2
Method D, RT = 2.006 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.15 - 9.03 (m, 1H), 8.03 - 7.94 (m, 2H), 7.67 - 7.63 (m, 1H), 7.55 - 7.37 (m, 6H), 6.50 - 6.15 (m, 1H), 6.33 - 6.29 (m, 1H) 5.36 - 4.67 (m, 1H), 4.51 - 4.35 (m, 2H), 4.16 - 3.50 (m, 3H), 2.26 - 2.12 (2 s, 3H). (mixture of interconvertible atropisomers)



444


embedded image


625.3
Method D, RT = 1.594 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 8.91 (d, J= 9.0 Hz, 1H), 7.95 - 7.88 (m, 2H), 7.76 - 7.72 (m, 1H), 7.64 - 7.59 (m, 1H), 7.35 - 7.33 (m, 2H), 7.33 (t, J = 72.0 Hz, 1H), 7.28 - 7.24 (m, 2H), 6.94 - 6.83 (m, 2H), 6.43 - 6.35 (m, 1H), 5.95 - 5.87 (m, 1H), 5.03 - 4.94 (m, 1H), 4.05 (br d, J = 1.2 Hz, 1H), 3.92 - 3.84 (m, 1H), 3.80 -3.75 (m, 2H), 3.72 (s, 3H), 3.66 - 3.59 (m, 2H), 3.57 - 3.49 (m, 2H), 3.35 - 3.29 (m, 1H), 3.27 (s, 3H), 1.96 - 1.84 (m, 2H), 1.82 - 1.70 (m, 2H).



445


embedded image


564.2
Method D, RT = 1.49 min, 100 %

1H NMR (400 MHz, DMSO-d6) δ = 8.86 (d, J = 8.6 Hz, 1H), 7.95 - 7.82 (m, 2H), 7.66 (dd, J = 6.6 Hz, 2.0, 1H), 7.58 (dd, J = 6.6, 2.0, Hz, 1H), 7.35 (t, J = 73.6 Hz, 1H), 7.28 - 7.26 (m, 2H), 6.85 - 6.65 (m, 2H), 6.31 (t, J = 7.0 Hz, 1H), 5.66 (dd, J = 11.9, 8.7 Hz, 1H), 4.94 (t, J = 5.3 Hz, 1H), 4.69 - 4.56 (m, 1H), 4.30 (dd, J = 12.0, 8.1 Hz, 1H), 4.16 - 4.03 (m, 1H), 3.99 - 3.89 (m, 1H), 3.76 (s, 3H), 3.71 -3.57 (m, 2H), 0.91 (d, J = 6.6 Hz, 3H).



446


embedded image


604.3
Method D, RT = 1.792 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.01 - 8.96 (m, 1H), 7.91 - 7.85 (m, 2H), 7.34 (t, J = 73.2 Hz, 1H), 7.34 (s, 1H), 7.29 -7.21 (m, 2H), 6.80 - 6.72 (m, 2H), 5.14 -5.06 (m, 1H), 5.00 - 4.92 (m, 1H), 4.14 -4.01 (m, 3H), 3.98 - 3.90 (m, 2H), 3.76 (s, 3H), 3.66 - 3.58 (m, 2H), 2.86 - 2.79 (m, 2H), 2.56 - 2.47 (m, 2H), 1.81 - 1.71 (m, 2H), 1.70 - 1.60 (m, 2H).



447


embedded image


625.2
Method D, RT = 2.1 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.14 - 8.95 (m, 1H), 8.33 - 8.14 (m, 1H), 7.89 - 7.76 (m, 2H), 7.56 (d, J = 8.6 Hz, 2H), 6.96 - 6.86 (m, 1H), 6.78 (d, J= 11.0 Hz, 2H), 6.44 - 6.29 (m, 1H), 5.17 - 5.05 (m, 1H), 4.33 - 4.02 (m, 3H), 3.80 (s, 3H), 3.79 - 3.68 (m, 1H), 3.68 - 3.57 (m, 1H), 3.46 - 3.36 (m, 2H), 1.98 - 1.76 (m, 2H), 1.68 - 1.54 (m, 1H), 1.21 - 1.04 (m, 2H).



448


embedded image


677.2
Method D, RT = 1.71 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.02 - 8.98 (m, 1H), 7.88 (d, J = 8.1 Hz, 2H), 7.83 - 7.73 (m, 1H), 7.63 - 7.59 (m, 1H), 7.33 (t, J = 74.0 Hz, 1H), 7.28 - 7.24 (m, 2H), 6.84 - 6.67 (m, 2H), 6.40 (dt, J= 7.2, 1.6 Hz, 1H), 5.89 - 5.81 (m, 1H), 5.14 -4.91 (m, 2H), 4.39 - 4.20 (m, 1H), 4.15 -4.05 (m, 1H), 4.02 - 3.81 (m, 4H), 3.78 (s, 3H), 3.76 - 3.68 (m, 1H), 3.51 - 3.38 (m, 3H), 3.27 (2 s, 3H), 2.02 - 1.66 (m, 2H).



449


embedded image


590.3
Method D, RT = 1.72 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.08 - 7.02 (m, 1H), 8.07 - 7.90 (m, 2H), 7.67 - 7.54 (m, 1H), 7.54 - 7.41 (m, 2H), 7.38 (d, J = 8.5 Hz, 1H), 7.32 (d, J = 8.5 Hz, 1H), 6.98 - 6.78 (m, 2H), 6.21 (d, J= 7.5 Hz, 1H), 5.23 - 4.64 (m, 3H), 4.14 - 3.81 (m, 2H), 3.78 - 3.70 (m, 4H), 3.64 - 3.42 (m, 4H), 3.23 - 3.20 (2 s, 3H), 2.20 - 2.08 (2 s, 3H). (mixture of interconvertible atropisomers)



450


embedded image


542.2
Method D, RT = 1.87 min, 97%

1H NMR (400 MHz, DMSO-d6) δ = 9.23 - 8.96 (m, 1H), 7.91 - 7.78 (m, 2H), 7.73 - 7.65 (m, 1H), 7.59 - 7.52 (m, 2H), 6.79-6.75 (m, 2H), 6.27 - 6.19 (m, 1H), 5.36 -4.89 (m, 1H), 4.28 - 4.03 (m, 3H), 3.86 -3.80 (m, 1H), 3.77 - 3.74 (2 s, 3H), 3.58 -3.45 (m, 1H), 2.26 - 1.96 (2 s, 3H), 1.28 -1.15 (m, 1H), 0.50 - 0.46 (m, 2H), 0.40 -0.37 (m, 2H). (mixture of interconvertible atropisomers)



451


embedded image


647.2
Method C, RT = 1.88 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.09 (d, J = 8.8 Hz, 1H), 8.33 - 8.22 (m, 1H), 7.90 - 7.75 (m, 2H), 7.58 - 7.54 (m, 2H), 6.94 - 6.85 (m, 1H), 6.85 - 6.68 (m, 3H), 5.17 - 5.06 (m, 1H), 4.32 - 4.18 (m, 2H), 3.82 - 3.67 (m, 6H), 3.45 (t, J = 6.7 Hz, 2H), 3.07 (s, 3H).



452


embedded image


613.2
Method D, RT = 2.002 min, 96%

1H NMR (400 MHz, DMSO-d6) δ = 9.16 (br s, 1H), 8.05 (d, J = 4.6 Hz, 1H), 7.94 (d, J = 8.8 Hz, 2H), 7.66 (d, J = 4.4 Hz, 1H), 7.49 (d, J = 8.8 Hz, 2H), 6.78 (d, J = 10.8 Hz, 2H), 5.34 - 5.22 (m, 1H), 5.08 (br d, J= 10.8 Hz, 1H), 4.98 - 4.81 (br s, 1H), 4.37 - 4.28 (m, 1H), 4.21 - 4.04 (m, 2H), 3.77 (s, 3H), 3.72 - 3.56 (m, 4H), 3.21 (s, 3H).



453


embedded image


490.2
Method D, RT = 1.84 min, 96%

1H NMR (400 MHz, DMSO-d6) δ = 9.05 (d, J = 8.3 Hz, 1H), 8.41 (d, J = 4.6 Hz, 1H), 7.94-7.84 (m, 3H), 7.57 - 7.48 (m, 3H), 6.89 - 6.73 (m, 2H), 5.53 (dd, J = 10.8, 8.6 Hz, 1H), 4.84 - 4.70 (m, 1H), 4.37 (dd, J = 10.8, 8.6 Hz, 1H), 3.78 (s, 3H), 1.03 (d, J = 6.6 Hz, 3H).



454


embedded image


600.2
Method D, RT = 1.846 min, 96%

1H NMR (400 MHz, DMSO-d6) δ = 9.13 - 8.94 (m, 1H), 7.97 - 7.78 (m, 2H), 7.72 - 7.61 (m, 1H), 7.54 - 7.11 (m, 3H), 6.85 - 6.66 (m, 2H), 6.42 - 6.30 (m, 1H), 6.02 - 5.89 (m, 1H), 5.36 - 4.84 (m, 1H), 4.32 - 3.99 (m, 4H), 3.76 (2 s, 3H), 3.59 - 3.52 (m, 1H), 2.26 - 2.08 (2 s, 3H). (mixture of interconvertible atropisomers)



455


embedded image


577.2
Method D, RT = 2.02 min, 98%

1H NMR (400 MHz, DMSO-d6) δ = 9.26 - 9.01 (m, 1H), 8.04 - 7.86 (m, 2H), 7.81 - 7.65 (m, 1H), 7.57 - 7.40 (m, 2H), 6.90 - 6.66 (m, 2H), 6.44 - 6.27 (m, 1H), 5.39 - 4.81 (m, 3H), 4.30 - 4.05 (m, 2H), 3.77 (s, 3H), 3.62 - 3.47 (m, 1H), 2.25 - 2.02 (2 s, 3H). (mixture of interconvertible atropisomers)



456


embedded image


636.3
Method D, RT = 1.904 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.30 - 8.92 (m, 1H), 8.10 - 7.83 (m, 2H), 7.73 - 7.53 (m, 1H), 7.53 - 7.23 (m, 2H), 6.84 - 6.60 (m, 2H), 6.30 - 6.13 (m, 1H), 5.43 - 4.78 (m, 1H), 4.34 - 4.02 (m, 2H), 3.95 - 3.69 (m, 4H), 3.70 (s, 3H), 3.56 - 3.43 (m, 1H), 3.27 - 3.13 (m, 2H), 2.22 - 2.04 (2 s, 3H), 2.04 - 1.83 (m, 1H), 1.44 - 1.38 (m, 2H), 1.35 - 1.11 (m, 2H). (mixture of interconvertible atropisomers)



457


embedded image


618.3
Method D, RT = 1.732 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.20 - 8.79 (m, 1H), 8.01 - 7.76 (m, 2H), 7.71 - 7.55 (m, 1H), 7.55 - 7.00 (m, 3H), 6.78 - 6.73 (m, 2H), 6.30 - 6.06 (m, 1H), 5.42 - 4.82 (m, 1H), 4.33 - 4.01 (m, 2H), 3.93 - 3.78 (m, 4H), 3.78 - 3.76 (2 s, 3H), 3.55 - 3.43 (m, 1H), 3.27 - 3.15 (m, 2H), 2.23 - 2.03 (2 s, 3H), 2.03 - 1.88 (m, 1H), 1.43 (m, 2H), 1.36 - 1.13 (m, 2H). (mixture of interconvertible atropisomers)



458


embedded image


592.2
Method D, RT = 2.021 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.28 - 8.95 (m, 1H), 8.05 - 7.90 (m, 2H), 7.84 - 7.64 (m, 1H), 7.57 - 7.38 (m, 2H), 6.78 - 6.73 (m, 2H), 6.35 - 6.15 (m, 1H), 5.37 - 4.79 (m, 2H), 4.33 - 3.91 (m, 2H), 3.78 - 3.77 (2 s, 3H), 3.74 - 3.63 (m, 1H), 3.59 - 3.37 (m, 1H), 2.40 - 2.20 (m, 3H), 2.20 - 1.97 (2 s, 3H), 1.83 - 1.13 (m, 1H), 0.59 - 0.27 (m, 1H). (mixture of interconvertible atropisomers)



459


embedded image


538.3
Method D, RT = 1.714 min, 94%

1H NMR (400 MHz, DMSO-d6) δ = 9.03 - 8.82 (m, 1H), 7.99 - 7.89 (m, 2H), 7.70 - 7.66 (m, 1H), 7.55 - 7.06 (m, 5H), 6.92 - 6.89 (m, 2H), 6.24 - 6.21 (m, 1H), 5.29 - 4.62 (m, 1H), 4.13 - 3.81 (m, 2H), 3.79 - 3.59 (m, 5H), 3.48 - 3.44 (m, 1H), 2.25 - 2.04 (2 s, 3H), 1.25 - 1.20 (m, 1H), 0.56 - 0.27 (m, 4H). (mixture of interconvertible atropisomers)



460


embedded image


588.3
Method D, RT = 2.136 min, 100%
1H NMR (400 MHz, DMSO-d6) δ = 8.99 (d, J= 8.8 Hz, 1H), 7.93 - 7.81 (m, 2H), 7.34 (t, J = 73.6 Hz, 1H), 7.34 (s, 1H), 7.27 - 7.25 (m, 2H), 6.76 (d, J= 10.8 Hz, 2H), 5.11 (dd, J= 11.1, 8.7 Hz, 1H), 4.16 - 3.99 (m, 3H), 3.94 (br d, J = 9.3 Hz, 2H), 3.76 (s, 3H), 2.75 (br t, J = 6.0 Hz, 2H), 2.52 - 2.47 (m, 2H), 1.85 - 1.72 (m, 2H), 1.70 - 1.54 (m, 2H), 1.18 (t, J = 7.0 Hz, 3H).


461


embedded image


586.2
Method D, RT = 2.146 min, 95%

1H NMR (400 MHz, DMSO-d6) δ = 9.06 (d, J= 8.6 Hz, 1H), 7.91 - 7.73 (m, 2H), 7.62 - 7.44 (m, 2H), 7.34 (s, 1H), 6.76 (d, J = 10.8 Hz, 2H), 5.12 (dd, J = 11.1, 8.7 Hz, 1H), 4.22 - 4.03 (m, 3H), 3.98 - 3.90 (m, 2H), 3.76 (s, 3H), 3.55 (t, J= 5.6 Hz, 2H), 3.23 (s, 3H), 2.86 - 2.70 (m, 2H), 2.52 - 2.47 (m, 2H), 1.87 - 1.69 (m, 2H), 1.69 - 1.49 (m, 2H).



462


embedded image


639.2
Method D, RT = 1.707 min, 98.7%

1H NMR (400 MHz, DMSO-d6) δ = 9.08 (d, J = 8.6 Hz, 1H), 8.50 (s, 1H), 8.18 (s, 1H), 7.89 - 7.76 (m, 2H), 7.61 - 7.48 (m, 2H), 6.77 (d, J= 10.8 Hz, 2H), 6.40 (tt, J = 52.0, 4.2 Hz, 1H), 5.12 (dd, J = 11.1, 8.7 Hz, 1H), 4.62 - 4.36 (m, 2H), 4.18 -4.04 (m, 1H), 4.04 - 3.86 (m, 2H), 3.76 (s, 3H).



463


embedded image


594.2
Method D, RT = 1.777 min, 95%

1H NMR (400 MHz, DMSO-d6) δ = 9.24 - 9.01 (m, 1H), 8.02 - 7.85 (m, 2H), 7.78 - 7.74 (m, 1H), 7.54 - 7.39 (m, 2H), 6.86 - 6.65 (m, 2H), 6.41 - 6.26 (m, 1H), 5.58 - 5.41 (m, 1H), 5.37 - 4.65 (m, 5H), 4.30 - 4.00 (m, 2H), 3.77 - 3.74 (2 s, 3H), 3.53 - 3.50 (m, 1H), 2.25 - 2.02 (2 s, 3H). (mixture of interconvertible atropisomers)



464


embedded image


556.2
Method D, RT = 2.145 min, 94%

1H NMR (400 MHz, DMSO-d6) δ = 9.06 (d, J = 8.6 Hz, 1H), 7.83 (d, J = 8.6 Hz, 2H), 7.56 (d, J = 8.6 Hz, 2H), 7.32 (s, 1H), 6.76 (d, J = 10.8 Hz, 2H), 5.12 (dd, J = 11.1, 8.7 Hz, 1H), 4.15 - 3.98 (m, 3H), 3.94 (br d, J = 9.0 Hz, 2H), 3.76 (s, 3H), 2.81 - 2.66 (m, 2H), 2.52 - 2.47 (m, 2H), 1.87 - 1.70 (m, 2H), 1.70 - 1.56 (m, 2H), 1.18 (t, J = 7.0 Hz, 3H).



465


embedded image


600.2
Method D, RT = 1.85 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 8.96 (d, J = 8.3 Hz, 1H), 7.97 - 7.85 (m, 2H), 7.69 (dd, J= 6.8, 2.0 Hz, 1H), 7.65 (dd, J = 7.3, 2.0 Hz, 1H), 7.52 (d, J = 9.8 Hz, 1H), 7.35 (t, J= 73.6 Hz, 1H), 7.29 - 7.2 (m, 2H), 6.88 - 6.76 (m, 2H), 6.38 (t, J = 7.0 Hz, 1H), 5.12 (dd, J = 11.2, 8.8 Hz, 1H), 4.45 (dd, J = 13.0, 2.7 Hz, 1H), 4.39 - 4.30 (m, 1H), 4.13 - 4.06 (m, 1H), 4.05 - 3.97 (m, 1H), 3.90 - 3.82 (m, 1H), 3.77 - 3.72 (m, 4H).



466


embedded image


637.2
Method D, RT = 2.07 min, 97%

1H NMR (400 MHz, DMSO-d6) δ = 9.16 (d, J = 8.6 Hz, 1H), 8.05 (d, J = 4.6 Hz, 1H), 7.99 - 7.85 (m, 2H), 7.74 (d, J = 4.6 Hz, 1H), 7.49 (d, J = 8.6 Hz, 2H), 6.79 (d, J = 10.8 Hz, 2H), 5.06 (br dd, J= 4.6, 1.7 Hz, 1H), 5.10 - 4.98 (m, 1H), 4.55 -4.45 (m, 1H), 4.42 - 4.23 (m, 3H), 4.23 -4.02 (m, 2H), 3.77 (s, 3H).



467


embedded image


565.2
Method D, RT = 1.619 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.02 (d, J = 8.6 Hz, 1H), 8.34 (s, 1H), 8.12 (s, 1H), 7.96 - 7.80 (m, 2H), 7.34 (t, J= 72.6 Hz, 1H), 7.30 - 7.24 (m, 2H), 6.77 (d, J = 10.8 Hz, 2H), 5.13 - 5.02 (m, 2H), 4.17 -4.04 (m, 2H), 4.04 - 3.83 (m, 3H), 3.76 (s, 3H), 3.66 (dd, J = 13.1, 8.7 Hz, 1H), 1.11 (d, J = 6.4 Hz, 3H).



468


embedded image


603.1
Method D, RT = 1.97 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.04 (d, J = 8.3 Hz, 1H), 8.04 (d, J = 4.6 Hz, 1H), 7.92 - 7.83 (m, 2H), 7.74 (d, J = 4.6 Hz, 1H), 7.35 (t, J = 73.6 Hz, 1H), 7.29 -7.27 (m, 2H), 6.78 (d, J = 10.8 Hz, 2H), 5.05 (dd, J = 11.0, 8.3 Hz, 1H), 4.40 -4.28 (m, 3H), 4.25 - 4.15 (m, 1H), 4.15 -4.04 (m, 1H), 3.77 (s, 3H), 2.86 - 2.74 (m, 2H).



469


embedded image


644.2
Method D, RT = 2.00 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.26 - 8.90 (m, 1H), 8.06 - 7.85 (m, 2H), 7.76 - 7.61 (m, 1H), 7.55 - 7.35 (m, 2H), 6.86 - 6.63 (m, 2H), 6.36 - 6.19 (m, 1H), 5.39 - 4.81 (m, 1H), 4.38 - 4.06 (m, 4H), 3.82 - 3.69 (2 s, 3H), 3.61 - 3.46 (m, 3H), 3.10 - 2.97 (2 s, 3H), 2.25 - 1.96 (2 s, 3H). (mixture of interconvertible atropisomers)



470


embedded image


626.2
Method D, RT = 1.84 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.19 - 8.87 (m, 1H), 7.99 - 7.80 (m, 2H), 7.73 - 7.63 (m, 1H), 7.56 - 7.05 (m, 3H), 6.87 - 6.56 (m, 2H), 6.34 - 6.17 (m, 1H), 5.39 - 4.84 (m, 1H), 4.44 - 4.05 (m, 4H), 3.84 - 3.73 (2 s, 3H), 3.64 - 3.42 (m, 3H), 3.10 - 2.98 (2 s, 3H), 2.24 - 1.98 (2 s, 3H). (mixture of interconvertible atropisomers)



471


embedded image


597.2
Method D, RT = 2.12 min, 98%

1H NMR (400 MHz, DMSO-d6) δ = 9.25 - 9.00 (m, 1H), 8.08 - 7.76 (m, 3H), 7.59 - 7.35 (m, 2H), 6.90 - 6.64 (m, 2H), 5.38 - 4.75 (m, 1H), 4.42 - 4.10 (m, 4H), 3.81 - 3.74 (2 s, 3H), 3.74 - 3.50 (m, 3H), 3.23 (s, 3H), 2.28 - 2.03 (2 s, 3H). (mixture of interconvertible atropisomers)



472


embedded image


579.2
Method D, RT = 1.89 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.16 - 8.93 (m, 1H), 8.05 - 7.93 (m, 1H), 7.93 - 7.77 (m, 2H), 7.56 - 7.09 (m, 3H), 6.88 - 6.66 (m, 2H), 5.36 - 4.74 (m, 1H), 4.45 - 4.12 (m, 4H), 3.82 - 3.72 (2 s, 3H), 3.72 - 3.51 (m, 3H), 3.23 (s, 3H), 2.26 - 2.02 (2 s, 3H). (mixture of interconvertible atropisomers)



473


embedded image


589.2
Method D, RT = 2.17 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.16 (d, J = 8.3 Hz, 1H), 8.07 (d, J = 4.6 Hz, 1H), 7.94 (d, J = 8.8 Hz, 2H), 7.77 (d, J = 4.6 Hz, 1H), 7.50 (d, J = 8.6 Hz, 2H), 6.79 (d, J = 10.8 Hz, 2H), 6.40 (tt, J = 56.0, 4.0 Hz, 1H), 5.07 (dd, J = 11.0, 8.3 Hz, 1H), 4.56 (td, J = 14.4, 4.0 Hz, 2H), 4.42 - 4.30 (m, 1H), 4.27 - 4.16 (m, 1H), 4.16 - 4.03 (m, 1H), 3.77 (s, 3H).



474


embedded image


571.3
Method D, RT = 2.00 min, 97%

1H NMR (400 MHz, DMSO-d6) δ = 9.05 (d, J = 8.1 Hz, 1H), 8.06 (d, J = 4.6 Hz, 1H), 7.87 (d, J = 8.8 Hz, 2H), 7.76 (d, J = 4.6 Hz, 1H), 7.34 (t, J = 73.6 Hz, 1H), 7.29 - 7.26 (m, 2H), 6.78 (d, J= 10.8 Hz, 2H), 6.40 (tt, J= 56.0, 4.0 Hz, 1H), 5.05 (dd, J = 11.0, 8.3 Hz, 1H), 4.55 (td, J = 14.3, 4.2 Hz, 2H), 4.39 - 4.29 (m, 1H), 4.26 - 4.15 (m, 1H), 4.15 - 4.02 (m, 1H), 3.76 (s, 3H).



475


embedded image


619.2
Method D, RT = 1.95 min, 95%

1H NMR (400 MHz, DMSO-d6) δ = 9.05 (d, J = 8.1 Hz, 1H), 8.04 (d, J = 4.4 Hz, 1H), 7.87 (d, J = 8.6 Hz, 2H), 7.74 (d, J = 4.6 Hz, 1H), 7.34 (t, J = 73.6 Hz, 1H), 7.29 - 7.26 (m, 2H), 6.78 (d, J= 11.0 Hz, 2H), 6.70 - 6.50 (brs, 1H), 5.04 (dd, J = 11.2, 7.8 Hz, 1H), 4.56 - 4.46 (m, 1H), 4.39 - 4.06 (m, 5H), 3.77 (s, 3H).



476


embedded image


595.2
Method D, RT = 1.74 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.04 (d, J = 8.3 Hz, 1H), 8.05 (d, J = 4.4 Hz, 1H), 7.93 - 7.83 (m, 2H), 7.65 (d, J= 4.6 Hz, 1H), 7.35 (t, J = 73.6 Hz, 1H), 7.29 -7.26 (m, 2H), 6.78 (d, J = 10.8 Hz, 2H), 5.32 - 5.22 (m, 1H), 5.05 (dd, J = 11.2, 8.6 Hz, 1H), 4.91 (t, J = 5.9 Hz, 1H), 4.33 - 4.25 (m, 1H), 4.19 - 4.12 (m, 1H), 4.15 - 4.06 (m, 1H), 3.77 (s, 3H), 3.71 - 3.57 (m, 4H), 3.20 (s, 3H).



477


embedded image


563.2
Method C, RT = 1.76 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.09 (d, J = 8.6 Hz, 1H), 8.04 (d, J = 4.6 Hz, 1H), 7.86 - 7.75 (m, 2H), 7.65 (d, J = 4.4 Hz, 1H), 7.57 (d, J = 8.6 Hz, 2H), 6.78 (d, J= 10.8 Hz, 2H), 5.35 - 5.24 (m, 1H), 5.07 (dd, J = 10.9, 8.4 Hz, 1H), 4.89 (t, J = 5.7 Hz, 1H), 4.37 - 4.27 (m, 1H), 4.22 - 4.04 (m, 2H), 3.77 (s, 3H), 3.72 - 3.57 (m, 4H), 3.21 (s, 3H).



478


embedded image


622.3
Method D, RT = 1.86 min, 98%

1H NMR (400 MHz, DMSO-d6) δ = 9.22 - 8.93 (m, 1H), 8.05 - 7.84 (m, 2H), 7.80 - 7.65 (m, 1H), 7.56 - 7.35 (m, 2H), 6.87 - 6.63 (m, 2H), 6.37 - 6.16 (m, 1H), 5.38 - 4.80 (m, 2H), 4.31 - 4.07 (m, 2H), 4.04 - 3.93 (m, 2H), 3.77 - 3.69 (2 s, 3H), 3.55 - 3.39 (m, 3H), 2.25 - 2.05 (2 s, 3H), 1.99 - 1.84 (m, 2H), 1.77 - 1.60 (m, 2H). (mixture of interconvertible atropisomers)



479


embedded image


590.2
Method D, RT = 1.66 min, 98%

1H NMR (400 MHz, DMSO-d6) δ = 9.11 - 8.87 (m, 1H), 7.94 - 7.79 (m, 2H), 7.61 - 7.47 (m, 1H), 7.46 - 7.05 (m, 3H), 6.78 - 6.75 (m, 2H), 6.35 - 6.20 (m, 1H), 5.41 - 5.24 (m, 1H), 4.88 - 4.86 (m, 1H), 4.28 - 4.00 (m, 3H), 3.89 - 3.82 (m, 3H), 3.79 - 3.76 (2 s, 3H) 3.50 - 3.47 (m, 1H), 2.47 - 2.37 (m, 1H), 2.24 - 2.04 (2 s, 3H), 2.02 - 1.88 (m, 1H). (mixture of interconvertible atropisomers)



480


embedded image


625.3
Method D, RT = 2.03 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.07 (br d, J = 8.6 Hz, 1H), 8.13 (d, J = 6.1 Hz, 1H), 7.81 (br d, J = 8.6 Hz, 2H), 7.56 (d, J = 8.6 Hz, 2H), 6.89 - 6.67 (m, 3H), 5.20 - 5.11 (m, 1H), 4.88 (br s, 1H), 4.51 - 4.41 (m, 1H), 4.24 - 4.16 (m, 1H), 3.77 (s, 3H), 3.76 - 3.66 (m, 2H), 3.48 - 3.43 (m, 1H), 3.39 - 3.09 (m, 2H), 1.94 - 1.83 (m, 2H), 1.36 (s, 3H).



481


embedded image


650.3
Method D, RT = 2.15 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.16 - 9.00 (m, 1H), 8.40 (d, J = 5.6 Hz, 1H), 7.82 (br d, J = 6.8 Hz, 2H), 7.56 (d, J = 8.3 Hz, 2H), 7.20 (d, J = 5.6 Hz, 1H), 6.78 (d, J = 11.0 Hz, 2H), 5.18 - 5.02 (m, 1H), 4.42 - 4.31 (m, 1H), 4.28 - 4.14 (m, 1H), 3.83 - 3.70 (m, 4H), 3.67 - 3.41 (m, 2H), 3.13 - 2.96 (m, 3H), 2.89 - 2.70 (m, 1H), 2.18 - 1.94 (m, 3H), 1.83 - 1.62 (m, 3H), 1.40 - 1.25 (m, 1H).



482


embedded image


707.2
Method D, RT = 1.83 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.18 (d, J = 8.0 Hz, 1H), 8.11 (dd, J = 4.8, 1.8 Hz, 1H), 8.01 - 7.94 (m, 2H), 7.84 (dd, J = 7.8, 1.8 Hz, 1H), 7.53 - 7.44 (m, 2H), 7.16 (dd, J = 7.5, 5.0 Hz, 1H), 6.80 (d, J = 10.5 Hz, 2H), 5.41 (dd, J = 6.0, 3.5 Hz, 1H), 5.12 - 5.05 (m, 1H), 4.70 - 4.59 (m, 4H), 4.29 - 4.14 (m, 2H), 4.10 - 3.98 (m, 4H), 3.80 - 3.74 (m, 5H), 3.51 - 3.69 (m, 1H), 3.30 (s, 3H).



483


embedded image


600.2
Method D, RT = 1.84 min, 97%

1H NMR (400 MHz, DMSO-d6) δ = 9.23 - 8.89 (m, 1H), 7.94 - 7.75 (m, 2H), 7.67 - 7.42 (m, 3H), 6.87 - 6.60 (m, 3H), 6.38 - 6.16 (m, 1H), 5.39 - 4.80 (m, 1H), 4.48 - 4.03 (m, 4H), 3.86 - 3.78 (m, 1H), 3.77-3.74 (2 s, 3H), 3.58 - 3.45 (m, 1H), 2.26 -1.96 (2 s, 3H). (mixture of interconvertible atropisomers)



484


embedded image


586.2
Method D, RT = 2.007 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.05 - 8.97 (m, 1H), 7.92 (d, J = 8.8 Hz, 2H), 7.47 (d, J = 8.6 Hz, 2H), 6.78 - 6.70 (m, 2H), 5.02 - 4.94 (m, 1H), 4.66 - 4.57 (m, 1H), 3.96 - 3.85 (m, 1H), 3.75 (s, 3H), 3.59 - 3.52 (m, 1H), 3.46 - 3.41 (m, 4H), 3.41 - 3.35 (m, 3H), 3.23 (s, 3H), 2.04 -1.82 (m, 4H).



485


embedded image


661.3
Method D, RT = 1.93 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.01 (d, J = 8.3 Hz, 1H), 7.88 (d, J = 8.8 Hz, 2H), 7.77 (dd, J = 6.8, 1.7 Hz, 1H), 7.60 (dd, J = 7.2, 1.7 Hz, 1H), 7.35 (t, J = 73.6 Hz, 1H), 7.30 - 7.23 (m, 2H), 6.80 - 6.74 (m, 2H), 6.40 (t, J = 7.0 Hz, 1H), 5.92 (dd, J = 8.6, 5.1 Hz, 1H), 5.09 (dd, J = 10.9, 8.4 Hz, 1H), 4.13 - 4.05 (m, 1H), 4.03 - 3.95 (m, 1H), 3.95 - 3.83 (m, 3H), 3.76 (s, 3H), 3.65 - 3.53 (m, 2H), 3.34 -3.28 (m, 2H), 3.27 (s, 3H), 1.96 - 1.85 (m, 2H), 1.82 - 1.68 (m, 2H).



486


embedded image


587.2
Method D, RT = 1.862 min, 98.9%

1H NMR (400 MHz, DMSO-d6) δ = 9.06 (br s, 1H), 8.45 (s, 1H), 8.19 (s, 1H), 7.83 (d, J = 8.6 Hz, 2H), 7.56 (d, J = 8.6 Hz, 2H), 6.78 (d, J = 10.5 Hz, 2H), 5.10 (d, J = 11.2 Hz, 1H), 4.43 - 4.29 (m, 2H), 4.12 (br dd, J = 10.3, 9.5 Hz, 1H), 4.05 - 3.87 (m, 3H), 3.76 (s, 3H), 3.35 - 3.32 (m, 1H).



487


embedded image


603.2
Method D, RT = 1.791 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.03 (d, J = 8.6 Hz, 1H), 8.56 (s, 1H), 8.17 (s, 1H), 7.96 - 7.79 (m, 2H), 7.34 (t, J = 74.0 Hz, 1H), 7.29 - 7.24 (m, 2H), 6.77 (d, J = 10.8 Hz, 2H), 5.12 (dd, J = 11.2, 8.6 Hz, 1H), 4.23 (t, J = 7.2 Hz, 2H), 4.17 - 4.05 (m, 1H), 4.05 - 3.87 (m, 2H), 3.76 (s, 3H), 2.92 - 2.72 (m, 2H).



488


embedded image


551.2
Method D, RT = 1.441 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.01 (d, J = 8.6 Hz, 1H), 8.37 (s, 1H), 8.13 (s, 1H), 7.95 - 7.83 (m, 2H), 7.34 (t, J = 73.0 Hz, 1H), 7.28 - 7.25 (m, 2H), 6.76 (d, J = 10.8 Hz, 2H), 5.11 (dd, J = 11.0, 8.6 Hz, 1H), 4.17 - 4.06 (m, 1H), 4.02 (t, J = 5.1 Hz, 2H), 3.99 - 3.91 (m, 3H), 3.76 (s, 3H), 3.68 - 3.60 (m, 2H).



489


embedded image


632.3
Method D, RT = 1.77 min, 98%

1H NMR (400 MHz, DMSO-d6) δ = 9.12 - 8.89 (m, 1H), 7.99 - 7.79 (m, 2H), 7.61-7.52 (m, 1H), 7.55 - 7.09 (m, 3H), 6.86 -6.55 (m, 3H), 6.235 - 6.25 (m, 1H), 5.34 - 4.77 (m, 1H), 4.47 - 4.23 (m, 3H), 4.19 -4.10 (m,1H), 3.82 - 3.79(m, 1H), 3.77 -3.73 (2 s, 3H), 3.57 - 3.47 (m, 1H), 2.24 -2.00 (2 s, 3H). (mixture of interconvertible atropisomers)



490


embedded image


618.2
Method F, RT = 1.999 min, 93%

1H NMR (400 MHz, DMSO-d6) δ = 9.23 - 9.03 (m, 1H), 8.01 - 7.87 (m, 2H), 7.71 - 7.62 (m, 1H), 7.54 - 7.41 (m, 2H), 6.85 - 6.68 (m, 2H), 6.42 - 6.28 (m, 1H), 6.01 - 5.86 (m, 1H), 5.33 - 4.77 (m, 1H), 4.32 - 4.17 (m, 3H), 4.14 - 4.02 (m, 1H), 3.78 - 3.76 (2 s, 3H), 3.61 - 3.54 (m, 1H), 2.26 - 2.08 (2 s, 3H). (mixture of interconvertible atropisomers)



491


embedded image


675.2
Method-D, RT = 1.742 min, 97.5%

1H NMR (400 MHz, DMSO-d6) δ = 8.89 (d, J = 8.5 Hz, 1H), 7.89 (d, J = 8.8 Hz, 2H), 7.82 (d, J = 2.0 Hz, 1H), 7.34 (t, J = 76.0 Hz, 1H), 7.27 (d, J = 8.5 Hz, 2H), 6.80 (d, J = 11.5 Hz, 2H), 6.75 (d, J = 2.0 Hz, 1H), 5.66 (dd, J = 12.6, 8.4 Hz, 1H), 4.97 (quin, J = 7.1 Hz, 1H), 4.31 (dd, J = 12.6, 7.9 Hz, 1H), 3.82 (s, 3H), 3.79 (s, 3H), 3.53 - 3.40 (m, 2H), 3.25 (s, 3H), 3.09 - 2.87 (m, 2H), 2.65 - 2.54 (m, 2H), 2.47 - 2.38 (m, 1H), 2.16 - 1.95 (m, 2H), 1.88 - 1.67 (m, 4H), 1.20 (br d, J = 6.3 Hz, 3H).



492


embedded image


649.2
Method-D, RT = 1.963 min, 94.7%

1H NMR (400 MHz, DMSO-d6) δ = 9.11 (d, J = 8.3 Hz, 1H), 7.92 - 7.86 (m, 2H), 7.84 (d, J = 2.0 Hz, 1H), 7.34 (t, J = 76.0 Hz, 1H), 7.29 (d, J = 8.3 Hz, 2H), 6.81 (d, J = 10.8 Hz, 2H), 6.75 (d, J = 2.0 Hz, 1H), 5.06 (dd, J = 10.5, 8.3 Hz, 1H), 4.86 (dt, J = 47.2, 4.5 Hz, 2H), 4.44 - 4.43 (m, 1H), 4.47 (br t, J = 9.9 Hz, 1H), 4.15 (q, J = 9.9 Hz, 1H), 3.97 (br t, J = 10.5 Hz, 1H), 3.85 (s, 3H), 3.79 (s, 3H), 3.67 -3.51 (m, 4H), 3.20 - 3.04 (m, 1H), 2.96 -2.83 (m, 1H), 2.15 - 1.96 (m, 4H).



493


embedded image


511.2
Method C, RT = 1.465 min, 98.3 %.

1H NMR (400 MHz, DMSO-d6) δ = 9.14 (d, J = 8.5 Hz, 1H), 8.43 (d, J = 6.8 Hz, 1H), 7.86 (d, J = 8.5 Hz, 2H), 7.77 (s, 1H), 7.58 (d, J = 8.5 Hz, 2H), 7.42 (d, J = 7.5 Hz, 1H), 6.90 (t, J = 7.1 Hz, 1H), 6.80 (d, J = 10.8 Hz, 2H), 5.20 (dd, J = 11.0, 8.5 Hz, 1H), 4.55 - 4.46 (m, 1H), 4.33 (br t, J = 9.9 Hz, 1H), 4.25 - 4.13 (m, 1H), 3.78 (s, 3H), 2.36 (s, 3H).



494


embedded image


527.12
Method C, RT = 1.387 min, 95.6%.

1H NMR (400 MHz, DMSO-d6) δ = 9.13 (d, J = 8.5 Hz, 1 H), 8.49 (d, J = 6.5 Hz, 1H), 7.92 - 7.82 (m, 3H), 7.58 (d, J = 8.5 Hz, 2H), 7.47 (d, J = 7.25 Hz, 1H), 6.93 (t, J = 7.1 Hz, 1H), 6.85 - 6.75 (m, 2H), 5.26 - 5.17 (m, 2H), 4.62 (d, J = 4.7 Hz, 2H), 4.59 - 4.48 (m, 1H), 4.37 - 4.17 (m, 2H), 3.78 (s, 3 H).



495


embedded image


537.14
Method C, RT = 1.635 min, 100 %.

1H NMR (400 MHz, DMSO-d6) δ = 9.12 (d, J = 8.8 Hz, 1H), 8.38 (dd, J = 6.8, 1.0 Hz, 1H), 7.90 - 7.81 (m, 2H), 7.77 (s, 1H), 7.62 - 7.49 (m, 2H),7.39 (dd, J = 7.3, 1.0 Hz, 1H), 6.92 - 6.86 (m, 1H), 6.80 (d, J = 10.8 Hz, 2H), 5.17 (dd, J = 11.0, 8.8 Hz, 1H), 4.51 - 4.42 (m, 1H), 4.35 (t, J = 11.0 Hz, 1H), 4.25 - 4.13 (m, 1H), 3.78 (s, 3H), 2.08 - 1.96 (m, 1H), 0.96 - 0.89 (m, 2H), 0.84 - 0.76 (m, 2H).



496


embedded image


539
Method C, RT = 1.685 min, 100 %.

1H NMR (400 MHz, DMSO-d6) δ = 9.13 (d, J = 8.8 Hz, 1H), 8.42 (dd, J = 6.6, 1.1 Hz, 1H), 7.92 - 7.80 (m, 2H), 7.76 (s, 1H), 7.62 - 7.51 (m, 2H), 7.42 (dd, J = 7.5, 1.1 Hz, 1H), 6.90 (t, J = 7.0 Hz, 1H), 6.80 (d, J = 10.8 Hz, 2H), 5.20 (dd, J = 11.1, 8.6 Hz, 1H), 4.60 - 4.48 (m, 1H), 4.37 (t, J = 10.3 Hz, 1H), 4.21 (q, J = 10.3 Hz, 1H), 3.77 (s, 3H), 3.04 - 2.97 (m, 1H), 1.29 (d, J = 6.8 Hz, 6H).



497


embedded image


565
Method C, RT = 2.034 min, 94.3 %.

1H NMR (400 MHz, DMSO-d6) δ = 9.14 (d, J = 8.5 Hz, 1H), 8.65 (d, J = 1.0 Hz, 1H), 8.57 (dd, J = 6.8, 1.0 Hz, 1H), 7.93 - 7.80 (m, 2H), 7.70 (dd, J = 7.5, 1.0 Hz, 1H), 7.62 - 7.51 (m, 2H), 7.21 - 7.09 (m, 1H), 6.80 (d, J = 10.8 Hz, 2H), 5.19 (dd, J = 10.8, 8.6 Hz, 1H), 4.54 - 4.45 (m, 1H), 4.37 - 4.29 (m, 1H), 4.29 - 4.19 (m, 1H), 3.77 (s, 3H).



498


embedded image


617.2
Method D, RT = 1.564 min, 98.7%

1H NMR (400 MHz, DMSO-d6) δ = 9.09 (d, J = 8.3 Hz, 1H), 7.95 - 7.84 (m, 2H), 7.80 (d, J = 2.2 Hz, 1H), 7.36 (t, J = 74.1 Hz, 1H), 7.29 (d, J = 8.3 Hz, 2H), 6.80 (d, J = 11.0 Hz, 2H), 6.70 (d, J = 2.2 Hz, 1H), 5.07 (dd, J = 11.0, 8.3 Hz, 1H), 4.47 (t, J = 9.8 Hz, 1H), 4.16 - 4.05 (m, 1H), 4.00 - 3.90 (m, 1H), 3.83 (s, 3H), 3.78 (s, 3H), 2.84 - 2.80 (m, 2H), 2.16 (s, 3H), 1.98 - 1.86 (m, 3H), 1.83 - 1.71 (m, 4H).



499


embedded image


559.15
Method C, RT = 2.043 min, 100 %.

1H NMR (400 MHz, DMSO-d6) δ = 9.17 (d, J = 8.0 Hz, 1H), 8.65 (d, J = 0.8 Hz, 1H), 7.88 - 7.74 (m, 2H), 7.66 (d, J = 0.8 Hz, 1H), 7.62 - 7.52 (m, 2H), 6.78 (d, J = 10.8 Hz, 2H), 5.05 (dd, J = 11.1, 8.1 Hz, 1H), 4.45 (t, J = 9.8 Hz, 1H), 4.38 - 4.24 (m, 2H), 4.21 - 4.07 (m, 2H), 4.00 - 3.89 (m,1H), 3.82 - 3.72 (m, 4H), 3.70 - 3.59 (m, 1H), 2.04 - 1.93 (m, 1H), 1.92 - 1.75 (m, 2H), 1.71 - 1.59 (m, 1H).



500


embedded image


571.2
Method D, RT = 1.489 min, 98%.

1H NMR (400 MHz, DMSO-d6) δ = 9.09 (d, J = 8.3 Hz, 1H), 8.19 (d, J = 8.3 Hz, 1H), 7.89 (d, J = 8.8 Hz, 2H), 7.84 (t, J = 8.0 Hz, 1H), 7.35 (t, J = 72.5 Hz, 1H), 7.36 - 7.23 (m, 3H), 6.88 - 6.72 (m, 3H), 5.08 (dd, J = 10.8, 8.3 Hz, 1H), 4.49 (t, J = 9.9 Hz, 1H), 4.13 (q, J = 9.9 Hz, 1H), 4.02 - 3.96 (m, 1H), 3.78 (s, 3H), 3.77 -3.72 (m, 2H), 3.54 - 3.49 (brs, 1H), 2.92 - 1.89 (m, 2H), 2.28 - 2.24 (m, 2H).



501


embedded image


617.3
Method D, RT = 1.473 min, 100%.

1H NMR (400 MHz, DMSO-d6) δ = 9.09 (d, J = 8.5 Hz, 1H), 8.17 (d, J = 8.5 Hz, 1H), 7.89 (d, J = 9.0 Hz, 2H), 7.80 (t, J = 7.8 Hz, 1H), 7.35 (t, J = 73.6 Hz, 1H), 7.29 (d, J = 8.5 Hz, 2H), 7.12 (d, J = 7.5 Hz, 1H), 6.80 (m, 2H), 5.08 (dd, J = 10.8, 8.3 Hz, 1H), 4.49 (t, J = 9.8 Hz, 1H), 4.34 - 4.30 (m, 1H), 4.12 (q, J = 9.8 Hz, 1H), 4.00 - 3.89 (m, 1H), 3.79 (s, 3H), 3.51 -3.47 (m, 2H), 3.04 - 3.00 (m, 1H), 2.88 -2.84 (m, 2H), 2.43 - 2.39 (m, 2H), 2.17 -2.12 (m, 1H), 2.02 - 1.92 (m, 1H), 1.90 -1.86 (m, 1H), 1.74 - 1.45 (m, 3H).



502


embedded image


617.2
Method D, RT = 1.494 min, 95%.

1H NMR (400 MHz, DMSO-d6) δ = 9.09 (d, J = 8.5 Hz, 1H), 8.18 (d, J = 8.0 Hz, 1H), 7.90 (d, J = 8.5 Hz, 2H), 7.80 (t, J = 8.0 Hz, 1H), 7.29 (d, J = 8.5 Hz, 2H), 7.35 (t, J = 73.6 Hz, 1H), 7.13 (d, J = 7.5 Hz, 1H), 6.80 (d, J = 11.0 Hz, 2H), 5.08 (dd, J = 10.8, 8.3 Hz, 1H), 4.48 (t, J = 9.5 Hz, 2H), 4.13 (q, J = 10.0 Hz, 1H), 4.03 - 3.92 (m, 1H), 3.79 (s, 3H), 3.52 (s, 2H), 3.06 - 3.02 (m, 1H), 2.96 - 2.82 (m, 2H), 2.65 - 2.55 (m, 1H), 2.48 - 2.41 (m, 1H), 2.31 - 2.00 (m, 2H), 1.92 - 1.83 (m, 1H), 1.78 - 1.50 (m, 3H).



503


embedded image


553.2
Method D, RT = 2.977 min, 99%.

1H NMR (400 MHz, DMSO-d6) δ = 9.09 - 9.07 (d, J = 8.4 Hz, 1H), 8.48 (s, 1H), 8.05 (s, 1H), 7.79 (d, J = 8.5 Hz, 2H), 7.54 (d, J = 8.5 Hz, 2H), 6.76 (d, J = 11.0 Hz, 2H), 6.36 (t, J = 48.0 Hz, 1H), 5.10 (d, J = 11.5 Hz, 1H), 4.57 - 4.31 (m, 3H), 3.74 (s, 3H), 3.64 (t, J = 10.5 Hz, 1H), 1.03 (d, J = 6.0 Hz, 3H).



504


embedded image


661.35
Method-D, RT = 1.605 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 8.92 - 8.86 (m, 1H), 7.93 - 7.86 (m, 2H), 7.84 - 7.79 (m, 1H), 7.34 (t, J = 76.0 Hz, 1H), 7.31 - 7.22 (m, 2H), 6.84 - 6.76 (m, 2H), 6.69 (d, J = 2.0 Hz, 1H), 5.67 (dd, J = 12.8, 8.3 Hz, 1H), 5.02 - 4.92 (m, 1H), 4.39 - 4.26 (m, 2H), 3.82 (s, 3H), 3.79 (s, 3H), 3.55 - 3.47 (m, 2H), 2.99 - 2.92 (m, 2H), 2.63 - 2.55 (m, 2H), 2.42 - 2.36 (m, 2H), 2.09 - 1.97 (m, 1H), 1.82 - 1.66 (m, 4H), 1.19 (d, J = 6.6 Hz, 3H).



505


embedded image


580.2
Method D, RT = 1.636 min, 98%.

1H NMR (400 MHz, DMSO-d6) δ = 8.94 (d, J = 8.5 Hz, 1H), 8.49 (dd, J = 8.5, 1.3 Hz, 1H), 8.05 (m, 1H), 7.95 - 7.82 (m, 2H), 7.77 - 7.65 (m, 1H), 7.33 (t, J = 74.6 Hz, 1H), 7.26 (d, J = 8.8 Hz, 2H), 6.86 -6.69 (m, 2H), 5.66 (dd, J = 12.5, 8.3 Hz, 1H), 5.04 - 4.91 (m, 1H), 4.35 (dd, J = 12.5, 7.8 Hz, 1H), 3.78 (s, 3H), 1.68 (d, J = 13.6 Hz, 3H), 1.57 (d, J = 13.6 Hz, 3H), 1.22 (d, J = 6.8 Hz, 3H).



506


embedded image


571.2
Method C, RT = 1.427 min, 92%.

1H NMR (400 MHz, DMSO-d6) δ = 9.22 - 8.93 (m, 1H), 7.91 - 7.77 (m, 2H), 7.70 - 7.60 (m, 1H), 7.60 - 7.43 (m, 2H), 6.85 - 6.67 (m, 2H), 6.35 - 6.14 (m, 1H), 5.36 - 4.85 (m, 1H), 4.81 - 4.65 (m, 1H), 4.29 - 4.05 (m, 2H), 3.81 - 3.72 (2 s, 3H), 3.52 - 3.48 (m, 2H), 3.15 - 3.06 (m, 2H), 2.66 - 2.56 (m, 2H), 2.48 - 2.44 (m, 1H), 2.24 - 2.01 (2 s, 3H), 1.77 - 1.65 (m, 3H). (Mixture of interconvertible atropisomers)



507


embedded image


603.2
Method D, RT = 1.531 min, 100%.

1H NMR (400 MHz, DMSO-d6) δ = 9.11 - 8.90 (m, 1H), 7.95 - 7.83 (m, 2H), 7.38 - 7.22 (m, 4H), 6.83 - 6.73 (m, 2H), 6.44 - 6.32 (m, 1H), 5.30 - 4.96 (m, 2H), 4.35 - 4.03 (m, 2H), 3.98 - 3.80 (m, 2H), 3.77 (s, 3H), 3.63 - 3.49 (m, 2H), 3.15 - 3.06 (m, 1H), 2.93 - 2.88 (2 s, 3H), 2.24 - 2.09 (2 s, 3H), 1.26 - 1.15 (m, 2H). (Mixture of interconvertible atropisomers)



508


embedded image


603.2
Method D, RT = 1.503 min, 96%.

1H NMR (400 MHz, DMSO-d6) δ = 9.10 - 8.93 (m, 1H), 7.91 - 7.86 (m, 2H), 7.76 - 7.63 (m, 1H), 7.37 - 7.24 (m, 3H), 6.78 (m, 2H), 6.43 - 6.30 (m, 1H), 5.33 - 4.93 (m, 2H), 4.34 - 4.11 (m, 2H), 3.94 - 3.80 (m, 2H), 3.77 (s, 3H), 3.63 - 3.49 (m, 2H), 3.19 - 3.05 (m, 1H), 2.93 - 2.88 (2 s, 3H), 2.25 - 2.07 (2 s, 3H), 1.27 - 1.14 (m, 2H). (Mixture of interconvertible atropisomers)



509


embedded image


559.15
Method C, RT = 2.012 min, 100 %.

1H NMR (400 MHz, DMSO-d6) δ = 9.18 (br d, J = 7.8 Hz, 1H), 8.65 (s, 1H), 7.83 (d, J = 8.5 Hz, 2H), 7.66 (s, 1H), 7.57 (d, J = 8.5 Hz, 2H), 6.78 (d, J = 10.8 Hz, 2H), 5.08 - 4.97 (m, 1H), 4.45 (t, J = 9.8 Hz, 1H), 4.39 - 4.31 (m, 1H), 4.29 - 4.22 (m, 1H), 4.14 (q, J = 9.8 Hz, 1H), 3.99 -3.91 (m, 1H), 3.81 - 3.71 (m, 5H), 3.64 (q, J = 7.8 Hz, 1H), 3.53 (dd, J = 8.6, 5.6 Hz, 1H), 2.72 - 2.64 (m, 1H), 2.07 - 1.95 (m, 1H), 1.71 - 1.59 (m, 1H).



510


embedded image


572.2
Method D, RT = 1.564 min, 94%.

1H NMR (400 MHz, DMSO-d6) δ = 9.20 - 8.94 (m, 1H), 7.91 - 7.78 (m, 2H), 7.76 - 7.64 (m, 1H), 7.62 - 7.50 (m, 2H), 6.85 - 6.66 (m, 2H), 6.46 - 6.29 (m, 1H), 5.28 - 4.87 (m, 2H), 4.31 - 4.06 (m, 2H), 3.94 - 3.75 (m, 2H), 3.77 (s, 3H), 3.61 - 3.43 (m, 2H), 3.17 - 3.13 (m, 1H), 2.89 (s, 3H), 2.55 - 2.49 (m, 2H), 2.28 - 1.99 (2 s, 3H). (Mixture of interconvertible atropisomers)



511


embedded image


534.1
Method D, RT = 1.671 min, 100%.

1H NMR (400 MHz, DMSO-d6) δ = 9.17 (d, J = 8.0 Hz, 1H), 8.47 (dd, J = 8.5, 1.3 Hz, 1H), 8.05 (m, 1H), 7.91 - 7.80 (m, 2H), 7.73 (dd, J = 6.9, 5.9 Hz, 1H), 7.62 - 7.49 (m, 2H), 6.80 (d, J = 10.5 Hz, 2H), 5.09 (dd, J = 10.9, 8.1 Hz, 1H), 4.54 (t, J = 9.5 Hz, 1H), 4.15 (q, J = 9.9 Hz, 1H), 4.03 - 3.89 (m, 1H), 3.78 (s, 3H), 1.68 (d, J = 13.6 Hz, 3H), 1.57 (d, J = 13.6 Hz, 3H).



512


embedded image


601.2
Method D, RT = 1.661 min, 94%.

1H NMR (400 MHz, DMSO-d6) δ = 8.91 (d, J = 8.5 Hz, 1H), 8.18 (d, J = 8.3 Hz, 1H), 7.94 - 7.85 (m, 2H), 7.80 (t, J = 7.9 Hz, 1H), 7.34 (t, J = 75.4 Hz, 1H), 7.78 -7.15 (m, 2H), 7.12 (d, J = 7.5 Hz, 1H), 6.80 (d, J = 11.5 Hz, 2H), 5.65 (dd, J = 12.6, 8.4 Hz, 1H), 5.01 - 4.91 (m, 1H), 4.32 (dd, J = 12.5, 8.3 Hz, 1H), 3.78 (s, 3H), 3.09 - 2.79 (m, 3H), 2.36 - 2.28 (m, 4H), 2.11 - 2.01 (m, 1H), 1.91 - 1.87 (m, 1H), 1.78 - 1.71 (m, 1H), 1.68 - 1.44 (m, 2H), 1.21 (d, J = 6.5 Hz, 3H).



513


embedded image


601.3
Method D, RT = 1.657 min, 100%.

1H NMR (400 MHz, DMSO-d6) δ = 8.91 (d, J = 8.3 Hz, 1H), 8.19 (d, J = 8.3 Hz, 1H), 7.94 - 7.85 (m, 2H), 7.81 (t, J = 8.0 Hz, 1H), 7.28 - 7.21 (m, 2H), 7.42 (t, J = 73.8 Hz, 1H), 7.17 - 7.07 (m, 1H), 6.89 -6.71 (m, 2H), 5.64 (dd, J = 12.4, 8.1 Hz, 1H), 5.02 - 4.88 (m, 1H), 4.32 (dd, J = 12.6, 7.9 Hz, 1H), 3.78 (s, 3H), 3.08 -2.86 (m, 3H), 2.41 - 2.27 (m, 4H), 2.23 -2.08 (m, 1H), 1.97 - 1.85 (m, 1H), 1.81 -1.42 (m, 3H), 1.22 (d, J = 6.5 Hz, 3H).



514


embedded image


558.1
Method D, RT = 1.464 min, 100%.

1H NMR (400 MHz, DMSO-d6) δ = 9.07 (d, J = 8.8 Hz, 1H), 8.63 (s, 1H), 8.12 (s, 1H), 7.88 - 7.75 (m, 2H), 7.63 - 7.48 (m, 2H), 6.77 (d, J = 10.8 Hz, 2H), 5.25 - 5.17 (m, 1H), 5.11 (dd, J = 11.1, 8.4 Hz, 1H), 4.16 - 4.05 (m, 1H), 3.96 (d, J = 9.5 Hz, 2H), 3.76 (s, 3H), 3.13 - 3.03 (m, 1H), 3.00 - 2.88 (m, 1H), 2.63 - 2.50 (m, 2H), 2.47 - 2.38 (m, 1H), 2.33 (s, 3H), 1.93 -1.89 (m, 1H).



515


embedded image


631.3
Method C, RT = 1.553 min, 94%.

1H NMR (400 MHz, DMSO-d6) δ = 8.91 (d, J = 7.8 Hz, 1H), 8.18 (d, J = 8.5 Hz, 1H), 7.90 (d, J = 8.8 Hz, 2H), 7.79 (t, J = 7.9 Hz, 1H), 7.34 (t, J = 73.5 Hz, 1H), 7.27 (d, J = 8.8 Hz, 2H), 7.12 (d, J = 7.8 Hz, 1H), 6.86 - 6.74 (m, 2H), 5.66 (dd, J = 12.5, 8.3 Hz, 1H), 5.00 - 4.90 (m, 1H), 4.42 - 4.39 (m, 1H), 4.32 (dd, J = 12.6, 8.4 Hz, 1H), 3.79 (s, 3H), 3.52 - 3.49 (m, 2H), 3.07 (d, J = 10.8 Hz, 1H), 2.94 - 2.83 (m, 2H), 2.47 - 2.44 (m, 2H), 2.21 - 2.13 (m, 1H), 2.06 - 1.98 (m, 1H), 1.92 - 1.85 (m, 1H), 1.72 - 1.68 (m, 1H), 1.64 - 1.46 (m, 2H), 1.22 (d, J = 6.8 Hz, 3H).



516


embedded image


631.2
Method D, RT = 1.642 min, 98%.

1H NMR (400 MHz, DMSO-d6) δ = 9.34 (s, 1H), 8.93 (s, 1H), 8.32 - 8.23 (m, 1H), 7.89 (d, J = 9.0 Hz, 3H), 7.34 (t, J = 72.5 Hz, 1H), 7.27 (d, J = 8.8 Hz, 2H), 6.82 (d, J = 11.5 Hz, 2H), 5.65 - 5.60 (m, 1H), 5.33 - 5.29 (m, 1H), 5.01 - 4.95 (m, 1H), 4.37 - 4.33 (m, 1H), 3.79 (s, 3H), 3.76 -3.71 (m, 2H), 3.52 - 3.49 (m, 1H), 3.24 -3.19 (m, 4H), 2.97 - 2.91 (m, 2H), 2.04 -1.84 (m, 4H), 1.22 (d, J = 6.8 Hz, 3H).



517


embedded image


587.1
Method D, RT = 1.683 min, 100%.

1H NMR (400 MHz, DMSO-d6) δ = 9.09 (d, J = 8.6 Hz, 1H), 8.45 (s, 1H), 8.18 (s, 1H), 7.89 - 7.76 (m, 2H), 7.63 - 7.46 (m, 2H), 7.15 - 6.85 (br s, 1H), 6.78 (d, J = 10.8 Hz, 2H), 5.11 (dd, J = 10.6, 8.7 Hz, 1H), 4.45 - 4.27 (m, 2H), 4.18 - 4.07 (m, 1H), 4.07 - 3.89 (m, 3H), 3.77 (s, 3H).



518


embedded image


587.1
Method D, RT = 1.684 min, 100%.

1H NMR (400 MHz, DMSO-d6) δ = 9.09 (d, J = 8.3 Hz, 1H), 8.46 (s, 1H), 8.20 (s, 1H), 7.84 (d, J = 8.6 Hz, 2H), 7.63 - 7.48 (m, 2H), 7.15 - 6.85 (br s, 1H), 6.78 (d, J = 10.8 Hz, 2H), 5.11 (dd, J = 10.8, 8.8 Hz, 1H), 4.45 - 4.25 (m, 2H), 4.19 - 4.08 (m, 1H), 4.08 - 3.87 (m, 3H), 3.77 (s, 3H).



519


embedded image


497.11
Method C, RT = 1.449 min, 98 %.

1H NMR (400 MHz, DMSO-d6) δ = 9.14 (d, J = 8.5 Hz, 1H), 8.53 (dd, J = 6.8, 1.0 Hz, 1H), 8.04 (d, J = 1.3 Hz, 1H), 7.90 -7.79 (m, 2H), 7.61 (d, J = 1.0 Hz, 1H), 7.60 - 7.52 (m, 2H), 7.48 (dd, J = 7.4, 1.0 Hz, 1H), 6.97 (t, J = 7.0 Hz, 1H), 6.79 (d, J = 10.8 Hz, 2H), 5.20 (dd, J = 11.3, 8.5 Hz, 1H), 4.54 - 4.46 (m, 1H), 4.41 (t, J = 9.9 Hz, 1H), 4.21 (q, J = 10.1 Hz, 1H), 3.77 (s, 3H).



520


embedded image


517.1
Method D, RT = 1.681 min, 100%.

1H NMR (400 MHz, DMSO-d6) δ = 9.20 - 8.97 (m, 1H), 8.52 - 8.39 (m, 1H), 7.88 - 7.77 (m, 2H), 7.60 - 7.50 (m, 2H), 6.81 - 6.71 (m, 2H), 5.30 - 4.85 (m, 1H), 4.29 - 4.02 (m, 2H), 3.99 - 3.87 (m, 2H), 3.80 - 3.74 (2 s, 3H), 3.64 - 3.55 (m, 1H), 2.54 - 2.48 (m, 1H), 2.29 - 2.14 (2 s, 3H), 1.30 - 1.21 (m, 3H). (Mixture of interconvertible atrop isomers)



521


embedded image


547.1
Method D, RT = 1.686 min, 100%.

1H NMR (400 MHz, DMSO-d6) δ = 9.22 - 8.92 (m, 1H), 8.48 - 8.21 (m, 1H), 7.89 - 7.78 (m, 2H), 7.65 - 7.52 (m, 2H), 6.85 - 6.69 (m, 2H), 5.36 - 4.77 (m, 1H), 4.35 - 4.19 (m, 1H), 4.17 - 4.04 (m, 3H), 3.85 - 3.71 (2 s, 3H), 3.65 - 3.53 (m, 2H), 2.47 - 2.38 (m, 1H), 2.36 - 2.24 (2 s, 3H), 2.22 - 2.03 (m, 3H). (Mixture of interconvertible atrop isomers)



522


embedded image


573.2
Method D, RT = 1.547 min, 94%.

1H NMR (400 MHz, DMSO-d6) δ = 9.21 - 9.01 (m, 1H), 8.36 - 8.27 (m, 1H), 7.89 - 7.80 (m, 2H), 7.61 - 7.52 (m, 2H), 6.85 - 6.73 (m, 2H), 5.36 - 4.81 (m, 1H), 4.68 (br s, 2H), 4.33 - 3.98 (m, 1H), 3.97 - 3.86 (m, 2H), 3.81 - 3.73 (2 s, 3H), 3.65 - 3.53 (m, 1H), 3.28 - 3.15 (m, 3H), 2.30 - 2.16 (2 s, 3H), 0.79 - 0.70 (2 s, 3H). (Mixture of interconvertible atropisomers)



523


embedded image


601.2
Method D, RT = 1.942 min, 99%.

1H NMR (400 MHz, DMSO-d6) δ = 8.91 (d, J = 8.5 Hz, 1H), 8.17 (d, J = 8.5 Hz, 1H), 7.92 - 7.87 (m, 2H), 7.78 (dd, J = 8.5, 7.5 Hz, 1H), 7.34 (t, J = 76.0 Hz, 1H), 7.28 - 7.26 (m, 2H), 7.09 (d, J = 7.0 Hz, 1H), 6.84 - 6.77 (m, 2H), 5.67 (dd, J = 12.5, 8.5 Hz, 1H), 5.03 - 4.92 (m, 1H), 4.32 (dd, J = 12.8, 7.8 Hz, 1H), 3.79 (s, 3H), 2.87 - 2.83 (m, 2H), 2.65 - 2.55 (m, 1H), 2.18 (s, 3H), 1.96 (td, J = 11.4, 2.3 Hz, 2H), 1.85 - 1.68 (m, 4H), 1.21 (d, J = 6.5 Hz, 3H).



524


embedded image


631.2
Method D, RT = 1.87 min, 99%.

1H NMR (400 MHz, DMSO-d6) δ = 8.90 (d, J = 8.3 Hz, 1H), 8.17 (d, J = 8.0 Hz, 1H), 7.90 (d, J = 8.8 Hz, 2H), 7.78 (t, J = 7.9 Hz, 1H), 7.34 (t, J = 72.0 Hz, 1H), 7.26 (d, J = 8.8 Hz, 2H), 7.08 (d, J = 7.4 Hz, 1H), 6.81 (d, J = 10.8 Hz, 2H), 5.67 (dd, J = 12.5, 8.4 Hz, 1H), 5.03 - 4.95 (m, 1H), 4.39 - 4.28 (m, 2H), 3.79 (s, 3H), 3.60 - 3.43 (m, 2H), 3.43 - 3.37 (m, 1H), 3.03- 2.95 (m, 2H), 2.42 - 2.38 (m, 2H), 2.32 - 2.01 (m, 2H), 1.84 - 1.68 (m, 4H), 1.21 (d, J = 6.4 Hz, 3H).



525


embedded image


587.2
Method D, RT = 1.896 min, 99%.

1H NMR (400 MHz, DMSO-d6) δ = 9.09 (d, J = 8.3 Hz, 1H), 8.16 (d, J = 8.1 Hz, 1H), 7.89 (d, J = 8.9 Hz, 2H), 7.79 (t, J = 7.9 Hz, 1H), 7.35 (t, J = 72.0 Hz, 1H), 7.29 (d, J = 8.9 Hz, 2H), 7.10 (d, J = 7.5 Hz, 1H), 6.80 (d, J = 10.8 Hz, 2H), 5.08 (dd, J = 10.8, 8.3 Hz, 1H), 4.48 (t, J = 9.7 Hz, 1H), 4.12 (q, J = 9.8 Hz, 1H), 4.03 -3.92 (m, 1H), 3.78 (s, 3H), 2.84 (m, 2H), 2.65 - 2.55 (m, 2H), 2.17 (s, 3H), 2.02 -1.87 (m, 2H), 1.87 - 1.69 (m, 3H).



526


embedded image


614.2
Method D, RT = 1.645 min, 94%.

1H NMR (400 MHz, DMSO-d6) δ = 8.88 (d, J = 8.8 Hz, 1H), 7.90 (d, J = 8.8 Hz, 2H), 7.59 - 7.47 (m, 2H), 7.34 (t, J = 72.0 Hz, 1H), 7.28 (d, J = 8.6 Hz, 2H), 6.80 (d, J = 11.5 Hz, 2H), 6.31 - 6.22 (m, 1H), 5.67 (dd, J = 12.6, 8.4 Hz, 1H), 4.98 -4.86 (m, 2H), 4.26 (dd, J = 12.7, 8.1 Hz, 2H), 3.80 - 3.74 (2 s, 3H), 3.52 - 3.41 (m, 2H), 3.12 - 3.15 (m, 2H), 2.89 - 2.75 (2 s, 3H), 2.40 - 2.35 (m, 1H), 2.21 - 2.15 (m, 1H), 1.20 (d, J = 6.4 Hz, 3H). (Mixture of interconvertible atropisomers)



527


embedded image


617.2
Method D, RT = 1.497 min, 98%.

1H NMR (400 MHz, DMSO-d6) δ = 9.10 (d, J = 7.8 Hz, 1H), 8.16 (d, J = 8.3 Hz, 1H), 7.95 - 7.86 (m, 2H), 7.80 (t, J = 7.9 Hz, 1H), 7.32 - 7.24 (m, 2H), 7.36 (t, J = 73.6 Hz, 1H), 7.10 (d, J = 7.6 Hz, 1H), 6.80 (d, J = 10.8 Hz, 2H), 5.08 (dd, J = 11.0, 8.6 Hz, 1H), 4.52 - 4.44 (m, 1H), 4.38 - 4.33 (m, 1H), 4.17 - 4.06 (m, 1H), 4.02 - 3.94 (m, 1H), 3.79 (s, 3H), 3.50 (t, J = 6.5 Hz, 2H), 2.99 - 2.95 (m, 2H), 2.65 - 2.56 (m, 1H), 2.41 (t, J = 6.5 Hz, 2H), 2.12 - 2.02 (m, 2H), 1.84 - 1.68 (m, 4H).



528


embedded image


587.2
Method D, RT = 1.943 min, 99%.

1H NMR (400 MHz, DMSO-d6) δ = 8.90 (d, J = 8.3 Hz, 1H), 8.15 (d, J = 8.3 Hz, 1H), 7.89 (d, J = 8.8 Hz, 2H), 7.78 (t, J = 7.9 Hz, 1H), 7.33 (t, J = 72.0 Hz, 1H), 7.26 (d, J = 8.6 Hz, 2H), 7.06 (d, J = 7.5 Hz, 1H), 6.80 (d, J = 11.5 Hz, 2H), 5.67 (dd, J = 11.2, 8.3 Hz, 1H), 5.05 - 4.97 (m, 1H), 4.32 (dd, J = 12.5, 8.3 Hz, 1H), 3.79 (s, 3H), 3.05 - 2.97 (m, 2H), 2.77 - 2.70 (m, 1H), 2.62 - 2.54 (m, 3H), 1.80 - 1.71 (m, 2H), 1.66 - 1.52 (m, 2H), 1.20 (d, J = 6.4 Hz, 3H).



529


embedded image


617.3
Method-D, RT = 1.555 min, 97.7%

1H NMR (400 MHz, DMSO-d6) δ = 8.92 (d, J = 8.3 Hz, 1H), 7.94 - 7.84 (m, 3H), 7.34 (t, J= 76.0 Hz, 1H), 7.27 (d, J = 8.8 Hz, 2H), 7.02 (br s, 1H), 6.84 - 6.79 (m, 2H), 6.70 (d, J= 2.0 Hz, 1H), 5.65 (dd, J = 12.6, 8.2 Hz, 1H), 5.02 - 4.93 (m, 1H), 4.34 (dd, J = 12.7, 7.8 Hz, 1H), 3.84 (s, 3H), 3.79 (s, 3H), 3.08 - 2.89 (m, 4H), 2.53 - 2.52 (m, 1H), 2.06 - 1.83 (m, 4H), 1.22 - 1.18 (m, 3H).



530


embedded image


557.2
Method D, RT = 1.679 min, 99%.

1H NMR (400 MHz, DMSO-d6) δ = 9.23 - 8.93 (m, 1H), 7.92 - 7.81 (m, 2H), 7.78 - 7.67 (m, 1H), 7.62 - 7.51 (m, 2H), 6.85 - 6.71 (m, 2H), 6.34 - 6.17 (m, 1H), 5.41 - 4.84 (m, 2H), 4.33 - 4.05 (m, 2H), 3.85 - 3.73 (2 s, 3H), 3.55 - 3.36 (m, 2H), 3.16 - 3.02 (m, 2H), 2.92 - 2.75 (m, 2H), 2.29 - 2.24 (m, 1H), 2.25 - 2.06 (2 s, 3H), 1.80 - 1.63 (m, 1H). (Mixture of interconvertible atropisomers)



531


embedded image


600.2
Method C, RT = 1.491 min, 99%.

1H NMR (400 MHz, DMSO-d6) δ = 9.06 (d, J= 8.3 Hz, 1H), 7.95 - 7.86 (m, 2H), 7.57 - 7.53 (m, 2H), 7.35 (t, J = 72.0 Hz, 1H), 7.34 - 7.16 (m, 2H), 6.80 (d, J= 10.8 Hz, 2H), 6.29 (dd, J = 5.3, 3.5 Hz, 1H), 5.08 (dd, J = 11.0, 8.3 Hz, 1H), 4.65 -4.61 (m, 1H), 4.53 - 4.43 (m, 1H), 4.13 -4.01 (m, 1H), 3.95 - 3.84 (m, 1H), 3.78 (s, 3H), 3.42 - 3.31 (m, 1H), 3.00 - 2.93 (m, 1H), 2.90 - 2.83 (m, 1H), 2.41 (s, 3H), 1.94 - 1.87 (m, 3H), 1.82 - 1.74 (m, 1H).



532


embedded image


504.1
Method D, RT = 1.771 min, 97%.

1H NMR (400 MHz, DMSO-d6) δ = 9.13 (d, J = 8.3 Hz, 1H), 8.47 (s, 1H), 7.89 -7.79 (m, 2H), 7.63 - 7.52 (m, 2H), 6.79 (d, J = 10.8 Hz, 2H), 5.00 (dd, J = 9.9, 8.9 Hz, 1H), 4.24 - 4.06 (m, 2H), 4.02 -3.89 (m, 3H), 3.78 (s, 3H), 2.12 (m, 1H), 0.88 (d, J = 6.6 Hz, 3H), 0.86 (d, J = 6.6 Hz, 3H).



533


embedded image


553.1
Method D, RT = 1.665 min, 100%.

1H NMR (400 MHz, DMSO-d6) δ = 9.22 - 8.96 (m, 1H), 8.51 - 8.30 (m, 1H), 8.00 - 7.73 (m, 2H), 7.63 - 7.41 (m, 2H), 6.85 - 6.70 (m, 2H), 6.42 (t, J = 52.2 Hz, 1H), 5.35 - 4.70 (m, 1H), 4.57 - 4.36 (m, 2H), 4.32 - 3.96 (m, 2H), 3.82 - 3.71 (2 s, 3H), 3.67 - 3.51 (m, 1H), 2.33 - 2.14 (2 s, 3H). (Mixture of interconvertible atropisomers)



534


embedded image


603.3
Method D, RT = 1.486 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.13 - 9.08 (m, 1H), 7.90 (d, J = 8.8 Hz, 2H), 7.79 (d, J= 2.0 Hz, 1H), 7.35 (t, J = 72.0 Hz, 1H), 7.27 (d, J = 8.8 Hz, 2H), 6.80 (d, J = 10.8 Hz, 2H), 6.68 (d, J= 1.7 Hz, 1H), 5.08 (dd, J= 10.9, 8.2 Hz, 1H), 4.51 - 4.43 (m, 1H), 4.16 - 4.06 (m, 1H), 3.99 - 3.92 (m, 1H), 3.83 (s, 3H), 3.78 (s, 3H), 3.07 - 2.98 (m, 2H), 2.62 - 2.56 (m, 1H), 1.80 - 1.71 (m, 5H), 1.64 (dt, J = 9.4, 1.6 Hz, 2H).



535


embedded image


608.2
Method D, RT = 1.93 min, 94%

1H NMR (400 MHz, DMSO-d6) δ = 9.10 (d, J = 8.6 Hz, 1H), 7.97 - 7.86 (m, 3H), 7.35 J= 73.2 Hz, 1H), 7.27 (d, J = 8.4 Hz, 2H), 6.85 (dd, J = 8.8, 2.7 Hz, 1H), 6.80 (d, J= 10.8 Hz, 2H), 5.17 - 5.04 (m, 1H), 4.30 - 3.94 (m, 5H), 3.82 - 3.71 (m, 5H), 3.67 - 3.63 (m, 1H), 3.55 - 3.51 (m, 1H), 2.71 - 2.64 (m, 1H), 2.06 - 1.94 (m, 1H), 1.72 - 1.60 (m, 1H).



536


embedded image


587.2
Method D, RT = 1.521 min, 94%.

1H NMR (400 MHz, DMSO-d6) δ = 8.75 (d, J = 7.8 Hz, 1H), 8.24 (d, J = 8.3 Hz, 1H), 7.79 (t, J = 7.5 Hz, 1H), 7.74 - 7.64 (m, 2H), 7.17 (d, J = 8.8 Hz, 1H), 7.31 (t, J = 73.5 Hz, 2H), 7.09 (d, J = 7.5 Hz, 1H), 6.61 (d, J = 11.0 Hz, 2H), 5.30 (t, J = 8.5 Hz, 1H), 4.47 - 4.24 (m, 3H), 3.70 (s, 3H), 2.97 - 2.87 (m, 2H), 2.65 - 2.58 (m, 1H), 2.25 (s, 3H), 2.15 - 2.00 (m, 2H), 1.90 - 1.67 (m, 4H).



537


embedded image


651.2
Method D, RT = 2.252 min, 94%.

1H NMR (400 MHz, DMSO-d6) δ = 8.91 (d, J = 8.5 Hz, 1H), 8.19 (d, J = 8.5 Hz, 1H), 7.83 (d, J= 9.2 Hz, 2H), 7.80 (t, J = 8.0 Hz, 1H), 7.35 (t, J = 75.3 Hz, 1H), 7.27 (d, J = 9.2 Hz, 2H), 7.11 (d, J = 7.5 Hz, 1H), 6.87 - 6.72 (m, 2H), 6.40 - 6.10 (m, 1H), 5.66 (dd, J= 12.5, 8.5 Hz, 1H), 5.06 - 4.91 (m, 1H), 4.33 (dd, J = 12.5, 8.0 Hz, 1H), 3.79 (s, 3H), 3.33 - 3.29 (m, 1H), 3.11 - 2.66 (m, 5H), 2.28 - 2.24 (m, 1H), 1.87 - 1.80 (m, 4H), 1.22 (d, J= 6.5 Hz, 3H).



538


embedded image


631.2
Method C, RT = 1.499 min, 95.9%

1H NMR (400 MHz, DMSO-d6) δ = 8.88 (d, J = 8.3 Hz, 1H), 7.89 (d, J = 8.8 Hz, 2H), 7.81 (d, J= 2.1 Hz, 1H), 7.34 (t, J= 76.0 Hz, 1H), 7.26 (d, J = 8.6 Hz, 2H), 6.80 (d, J= 11.5 Hz, 2H), 6.69 (d, J= 2.0 Hz, 1H), 5.67 (dd, J = 12.6, 8.4 Hz, 1H), 5.02 - 4.93 (m, 1H), 4.30 (dd, J = 12.6, 7.9 Hz, 1H), 3.82 (s, 3H), 3.78 (s, 3H), 2.84 (br d, J = 10.8 Hz, 2H), 2.18 (s, 3H), 1.99 - 1.96 (m, 1H), 1.97 - 1.92 (m, 2H), 1.82 - 1.70 (m, 4H), 1.19 (br d, J = 6.4 Hz, 3H).



539


embedded image


618.3
Method C, RT = 1.910 min, 93.3%

1H NMR (400 MHz, DMSO-d6) δ = 9.09 (d, J = 7.8 Hz, 1H), 7.93 - 7.88 (m, 2H), 7.40 - 7.37 (m, 1H), 7.34 (t, J = 76.0 Hz, 1H), 7.32 - 7.26 (m, 2H), 6.86 - 6.78 (m, 2H), 6.77 - 6.74 (m, 1H), 5.04 - 4.95 (m, 1H), 4.66 - 4.57 (m, 1H), 3.98 - 3.89 (m, 2H), 3.86 - 3.84 (m, 3H), 3.79 (s, 3H), 3.74 - 3.65 (m, 1H), 3.48 - 3.38 (m, 2H), 2.93 - 2.80 (m, 1H), 1.81 - 1.70 (m, 4H), 1.35 (d, J = 6.6 Hz, 3H).



540


embedded image


647.2
Method D, RT = 1.552 min, 98.4%

1H NMR (400 MHz, DMSO-d6) δ = 9.08 (d, J = 8.3 Hz, 1H), 7.93 - 7.87 (m, 2H), 7.79 (d, J = 2.2 Hz, 1H), 7.35 (t, J = 74.3 Hz, 1H), 7.29 (d, J = 8.8 Hz, 2H), 6.83 -6.76 (m, 2H), 6.70 (d, J = 2.2 Hz, 1H), 5.07 (dd, J = 10.9, 8.2 Hz, 1H), 4.48 (br t, J = 9.9 Hz, 1H), 4.16 - 4.06 (m, 1H), 4.00 - 3.91 (m, 1H), 3.83 (s, 3H), 3.78 (s, 3H), 3.49 (t, J = 6.4 Hz, 3H), 2.98 - 2.91 (m, 2H), 2.55 (br d, J = 5.1 Hz, 1H), 2.38 (t, J = 6.5 Hz, 2H), 2.08 - 1.98 (m, 2H), 1.81 - 1.72 (m, 4H).



541


embedded image


512.1
Method D, RT = 1.627 min, 98%.

1H NMR (400 MHz, DMSO-d6) δ = 9.14 (d, J = 8.3 Hz, 1H), 8.56 (s, 1H), 7.83 (d, J= 8.6 Hz, 2H), 7.58 (d, J = 8.6 Hz, 2H), 6.79 (d, J = 10.8 Hz, 2H), 6.42 (tt, J = 54.5, 9.1 Hz, 1H), 5.03 - 4.92 (m, 1H), 4.78 - 4.71 (m, 2H), 4.27 - 4.09 (m, 2H), 4.00 - 3.91 (m, 1H), 3.78 (s, 3H).



542


embedded image


559.1
Method D, RT = 1.574 min, 95%.

1H NMR (400 MHz, DMSO-d6) δ = 9.07 (d, J = 8.5 Hz, 1H), 8.60 (s, 1H), 8.13 (s, 1H), 7.88 - 7.74 (m, 2H), 7.60 - 7.46 (m, 2H), 6.77 (d, J = 10.8 Hz, 2H), 5.11 (dd, J = 11.0, 8.5 Hz, 1H), 4.78 (t, J = 12.2, 3.8 Hz, 1H), 4.19 - 4.05 (m, 1H), 4.03 -3.92 (m, 4H), 3.76 (s, 3H), 3.48 - 3.44 (m, 2H), 2.14 - 1.96 (m, 2H), 1.83 - 1.78 (m, 2H).



543


embedded image


559.2
Method D, RT = 1.7 min, 99%.

1H NMR (400 MHz, DMSO-d6) δ = 9.12 (d, J= 8.5 Hz, 1H), 8.74 (s, 1H), 8.63 (s, 1H), 7.90 - 7.76 (m, 2H), 7.62 - 7.44 (m, 2H), 6.80 (d, J = 10.8 Hz, 2H), 5.43 (t, J = 7.5 Hz, 1H), 5.09 (d, J = 10.9 Hz, 1H), 4.18 (q, J = 10.0 Hz, 1H), 4.03 - 3.95 (m, 2H), 3.82 (d, J = 11.3 Hz, 2H), 3.77 (s, 3H), 3.64 - 3.52 (m, 2H), 2.10 - 1.92 (m, 2H), 1.80 - 1.61 (m, 2H).



544


embedded image


476.2
Method D, RT = 2.282 min, 99%.

1H NMR (400 MHz, DMSO-d6) δ = 9.12 (d, J = 8.4 Hz, 1H), 8.47 (s, 1H), 7.87 -7.79 (m, J = 8.6 Hz, 2H), 7.62 - 7.54 (m, 2H), 6.80 (s, 1H), 6.77 (s, 1H), 4.98 (dd, J = 10.4, 8.4 Hz, 1H), 4.24 - 4.10 (m, 4H), 4.00 - 3.87 (m, 1H), 3.78 (s, 3H), 1.40 (t, J= 7.3 Hz, 3H).



545


embedded image


557.1
Method D, RT = 1.798 min, 96%.

1H NMR (400 MHz, DMSO-d6) δ = 9.13 (d, J = 8.5 Hz, 1H), 7.92 - 7.74 (m, 2H), 7.64 - 7.46 (m, 3H), 7.15 (d, J = 7.5 Hz, 1H), 6.82 (d, J= 11.3 Hz, 2H), 6.26 (d, J = 8.3 Hz, 1H), 5.00 (dd, J= 10.8, 8.5 Hz, 1H), 4.92 (d, J= 3.0 Hz, 1H), 4.62 - 4.48 (m, 1H), 4.37 (d, J= 1.3 Hz, 1H), 3.79 (s, 3H), 3.64 (t, J = 9.9 Hz, 1H), 3.50 - 3.30 (m, 4H), 2.06 - 1.96 (m, 1H), 1.91 - 1.79 (m, 1H), 1.38 (d, J = 6.0 Hz, 3H).



546


embedded image


515.1
Method D, RT = 1.597 min, 100%.

1H NMR (400 MHz, DMSO-d6) δ = 9.11 (d, J = 8.8 Hz, 1H), 7.90 - 7.73 (m, 2H), 7.66 - 7.50 (m, 3H), 7.25 - 7.12 (m, 1H), 6.77 (d, J = 10.8 Hz, 2H), 5.16 (dd, J = 10.3, 9.0 Hz, 1H), 4.21 - 4.02 (m, 2H), 3.99 - 3.88 (m, 1H), 3.76 (s, 3H), 3.52 -3.41 (m, 1H), 1.09 - 1.01 (m, 2H), 0.99 -0.89 (m, 2H).



547


embedded image


573.2
Method D, RT = 1.604 min, 96%.

1H NMR (400 MHz, DMSO-d6) δ = 9.08 (d, J = 8.8 Hz, 1H), 8.50 (s, 1H), 8.15 (s, 1H), 7.86 - 7.81 (m, 2H), 7.60 - 7.54 (m, 2H), 6.78 (d, J = 10.8 Hz, 2H), 5.13 (dd, J = 11.2, 8.6 Hz, 1H), 4.16 - 4.04 (m, 1H), 4.03 - 3.92 (m, 2H), 3.90 - 3.81 (m, 4H), 3.77 (s, 3H), 3.24 (t, J = 11.5 Hz, 2H), 2.10 - 1.95 (m, 1H), 1.47 - 1.42 (m, 2H), 1.34 - 1.21 (m, 2H).



548


embedded image


699.2
Method-D, RT = 2.434 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 8.93 - 8.87 (m, 1H), 7.90 (d, J = 8.6 Hz, 2H), 7.84 - 7.81 (m, 1H), 7.34 (t, J= 76.0 Hz, 1H), 7.28 (d, J = 8.6 Hz, 2H), 6.80 (d, J = 11.0 Hz, 2H), 6.73 - 6.70 (m, 1H), 5.67 (dd, J= 12.7, 8.3 Hz, 1H), 5.02 - 4.92 (m, 1H), 4.30 (dd, J= 12.7, 8.1 Hz, 1H), 3.86 (s, 3H), 3.79 (s, 3H), 3.18 (q, J = 10.2 Hz, 2H), 3.01 (br d, J = 11.5 Hz, 2H), 2.65 -2.54 (m, 1H), 2.46 -2.42 (m, 2H), 1.86 -1.67 (m, 4H), 1.21 (d, J = 6.6 Hz, 3H).



549


embedded image


655.2
Method D, RT = 2.089 min, 95%

1H NMR (400 MHz, DMSO-d6) δ = 9.10 (d, J = 8.6 Hz, 1H), 7.90 (d, J = 8.6 Hz, 2H), 7.80 (t, J = 9.0 Hz, 1H), 7.34 (t, J = 76.0 Hz, 1H), 7.34 (t, J = 71.7 Hz, 1H), 7.28 (d, J= 8.6 Hz, 2H), 6.79 (d, J = 11.0 Hz, 2H), 6.15 (tt, J= 54.3, 11.5 Hz, 1H), 5.13 (br t, J= 9.4 Hz, 1H), 4.31 - 4.15 (m, 2H), 4.12 - 4.01 (m, 1H), 3.78 (s, 3H), 3.00 (br d, J = 11.5 Hz, 2H), 2.80 - 2.62 (m, 3H), 2.32 - 2.19 (m, 2H), 1.86 - 1.64 (m, 4H).



550


embedded image


673.2
Method D, RT = 2.24 min, 96%

1H NMR (400 MHz, DMSO-d6) δ = 9.10 (d, J = 8.6 Hz, 1H), 7.90 (d, J = 8.6 Hz, 2H), 7.80 (dd, J = 8.6, 9.8 Hz, 1H), 7.39 - 7.33 (m, 1H), 7.35 (t, J = 73.6 Hz, 1H), 7.28 (d, J= 8.6 Hz, 2H), 6.79 (d, J= 10.8 Hz, 2H), 5.20 - 5.04 (m, 1H), 4.30 - 4.16 (m, 2H), 4.13 - 4.00 (m, 1H), 3.78 (s, 3H), 3.19 (q, J = 10.3 Hz, 2H), 3.02 (br d, J= 11.2 Hz, 2H), 2.74 - 2.66 (m, 1H), 2.48 - 2.41 (m, 2H), 1.88 - 1.66 (m, 4H).



551


embedded image


601.1
Method D, RT = 2.257 min, 98.7%

1H NMR (400 MHz, DMSO-d6) δ = 9.28 (d, J = 8.3 Hz, 1H), 8.78 (d, J = 7.8 Hz, 1H), 8.06 (d, J= 8.1 Hz, 1H), 8.01 - 7.88 (m, 2H), 7.51 (d, J= 8.3 Hz, 2H), 6.81 (d, J = 10.8 Hz, 2H), 5.11 (dd, J = 10.5, 8.3 Hz, 1H), 4.51 - 4.39 (m, 1H), 4.36 - 4.24 (m, 1H), 4.22 - 4.12 (m, 1H), 3.78 (s, 3H).



552


embedded image


649.3
Method-C, RT = 1.916 min, 82.51%

1H NMR (400 MHz, DMSO-d6) δ = 8.99 - 8.91 (m, 1H), 7.97 - 7.92 (m, 2H), 7.51 - 7.45 (m, 2H), 7.29 (d, J = 2.0 Hz, 1H), 6.83 - 6.75 (m, 2H), 5.87 (d, J = 1.5 Hz, 1H), 5.71 - 5.63 (m, 1H), 4.92 - 4.82 (m, 1H), 4.79 - 4.75 (m, 1H), 4.65 - 4.61 (m, 1H), 4.28 - 4.20 (m, 1H), 3.80 (s, 3H), 3.78 (s, 3H), 3.70 - 3.63 (m, 1H), 3.47 -3.41 (m, 1H), 3.25 - 3.15 (m, 2H), 1.90 -1.80 (m, 2H), 1.21 (br d, J = 6.4 Hz, 3H).



553


embedded image


539.2
Method D, RT = 2.426 min, 99%.

1H NMR (400 MHz, DMSO-d6) δ = 9.09 (d, J= 8.6 Hz, 1H), 8.51 (s, 1H), 8.19 (s, 1H), 7.86 - 7.81 (m, 2H), 7.60 - 7.54 (m, 2H), 6.77 (d, J= 10.8 Hz, 2H), 6.40 (tt, J = 56.0, 9.2 Hz, 1H), 5.12 (dd, J = 11.0, 8.6 Hz, 1H), 4.58 - 4.42 (m, 2H), 4.17 -4.06 (m, 1H), 4.05 - 3.92 (m, 2H), 3.77 (s, 3H).



554


embedded image


553.1
Method D, RT = 1.76 min, 98%.

1H NMR (400 MHz, DMSO-d6) δ = 9.15 (d, J = 8.8 Hz, 1H), 7.90 - 7.79 (m, 2H), 7.76 (d, J = 4.4 Hz, 1H), 7.62 - 7.50 (m, 2H), 7.38 (d, J = 4.4 Hz, 1H), 6.80 (d, J = 11.2 Hz, 2H), 6.41 (tt, J= 54.8, 4.3 Hz, 1H), 5.24 (dd, J = 11.2, 8.8 Hz, 1H), 4.56 - 4.42 (m, 3H), 3.78 (s, 3H), 3.69 (t, J = 10.4 Hz, 1H), 1.09 (d, J= 6.1 Hz, 3H).



555


embedded image


585.1
Method D, RT = 1.793 min, 100%.

1H NMR (400 MHz, DMSO-d6) δ = 8.96 - 8.87 (m, 1H), 8.52 (s, 1H), 7.90 (d, J = 9.9 Hz, 2H), 7.34 (t, J = 72.0 Hz, 1H), 7.27 (m, 3H), 6.80 (d, J = 9.9 Hz, 2H), 6.35 (tt, J= 54.8, 4.3 Hz, 1H), 5.69 - 5.57 (m, 1H), 4.84 (m, 1H), 4.48 - 4.26 (m, 3H), 3.78 (s, 3H), 1.19 (d, J = 6.8 Hz, 3H).



556


embedded image


605.2
Method D, RT = 1.43 min, 93%

1H NMR (400 MHz, DMSO-d6) δ = 9.10 (d, J = 8.6 Hz, 1H), 7.96 - 7.86 (m, 2H), 7.80 (dd, J = 9.8, 8.6 Hz, 1H), 7.34 (t, J = 74.0 Hz, 1H), 7.32 - 7.27 (m, 3H), 6.79 (d, J = 10.8 Hz, 2H), 5.18 - 5.09 (m, 1H), 4.28 - 4.17 (m, 2H), 4.10 - 4.04 (m, 1H), 3.78 (s, 3H), 2.88 - 2.80 (m, 2H), 2.70 -2.60 (m, 1H), 2.21 (s, 3H), 2.05 - 1.96 (m, 2H), 1.86 - 1.69 (m, 4H).



557


embedded image


588.1
Method-D, RT = 2.076 min, 94.45%

1H NMR (400 MHz, DMSO-d6) δ = 9.18 - 9.12 (m, 1H), 7.87 - 7.82 (m, 2H), 7.60 - 7.55 (m, 2H), 6.99 - 6.92 (m, 1H), 6.85 - 6.78 (m, 2H), 6.21 - 6.16 (m, 1H), 5.06 - 4.94 (m, 1H), 4.57 - 4.48 (m, 1H), 3.82 (s, 3H), 3.78 (s, 3H), 3.73 - 3.57 (m, 5H), 3.44 - 3.35 (m, 4H), 1.35 (d, J = 5.9 Hz, 3H).



558


embedded image


600.2
Method-D, RT = 1.712 min, 98.72%

1H NMR (400 MHz, DMSO-d6) δ = 9.18 - 9.12 (m, 1H), 7.86 (d, J = 8.6 Hz, 2H), 7.59 (d, J = 8.6 Hz, 2H), 7.36 (d, J = 2.0 Hz, 1H), 6.85 - 6.79 (m, 2H), 6.76 - 6.73 (m, 1H), 5.04 - 4.97 (m, 1H), 4.65 - 4.57 (m, 1H), 3.84 (s, 3H), 3.79 (s, 3H), 3.72 -3.63 (m, 1H), 2.90 - 2.81 (m, 2H), 2.63 -2.54 (m, 1H), 2.19 (s, 3H), 2.03 - 1.92 (m, 2H), 1.82 - 1.69 (m, 4H), 1.34 (d, J= 5.6 Hz, 3H).



559


embedded image


564.1
Method D, RT = 1.744 min, 95%.

1H NMR (400 MHz, DMSO-d6) δ = 8.90 (d, J = 8.3 Hz, 1H), 7.97 - 7.87 (m, 3H), 7.78 (t, J = 7.8 Hz, 1H), 7.34 (t, J = 72.9 Hz, 1H), 7.27 (d, J = 8.6 Hz, 2H), 6.81 (d, J = 11.5 Hz, 2H), 6.61 (d, J = 7.8 Hz, 1H), 5.68 (dd, J= 12.6, 8.2 Hz, 1H), 4.97 - 4.86 (m, 1H), 4.81 (t, J = 5.5 Hz, 1H), 4.39 - 4.18 (m, 3H), 3.79 (s, 3H), 3.71 (q, J= 5.1 Hz, 2H), 1.24 (d, J= 6.6 Hz, 3H).



560


embedded image


553.1
Method D, RT = 1.727 min, 96%.

1H NMR (400 MHz, DMSO-d6) δ = 8.96 (d, J = 8.6 Hz, 1H), 7.85 (d, J = 8.6 Hz, 2H), 7.73 (d, J= 4.4 Hz, 1H), 7.57 - 7.50 (m, 2H), 7.35 (d, J = 4.4 Hz, 1H), 6.85 -6.75 (m, 2H), 6.41 (tt, J = 55.5, 4.5 Hz, 1H), 5.60 (dd, J = 11.7, 8.6 Hz, 1H), 4.73 - 4.60 (m, 1H), 4.49 (tt, J = 14.7, 4.4 Hz, 2H), 4.37 (dd, J= 12.0, 8.3 Hz, 1H), 3.78 (s, 3H), 0.98 (d, J = 6.6 Hz, 3H).



561


embedded image


589.2
Method C, RT = 1.536 min, 94%.

1H NMR (400 MHz, DMSO-d6) δ = 8.86 (d, J= 8.1 Hz, 1H), 7.90 (d, J = 9.0 Hz, 2H), 7.57 - 7.49 (m, 2H), 7.35 (t, J= 73.0 Hz, 1H), 7.26 (d, J = 9.0 Hz, 2H), 6.80 (d, J = 9.0 Hz, 2H), 6.24 - 6.19 (m, 1H), 5.68 (m, 1H), 4.93 (t, J = 7.2 Hz, 2H), 4.38 (s, 1H), 4.28 - 4.24 (m, 1H), 3.78 (s, 3H), 3.53 - 3.34 (m, 3H), 3.30 - 3.22 (m, 1H), 2.06 - 1.97 (m, 1H), 1.92 - 1.87 (m, 1H), 1.24 (d, J = 6.1 Hz, 3H).



562


embedded image


550.1
Method C, RT = 1.687 min, 96%.

1H NMR (400 MHz, DMSO-d6) δ = 9.09 (d, J = 8.3 Hz, 1H), 7.92 - 7.88 (m, 3H), 7.78 (t, J = 8.1 Hz, 1H), 7.34 (t, J = 72.9 Hz, 1H), 7.27 (d, J = 8.6 Hz, 2H), 6.80 (d, J = 9.0 Hz, 2H), 6.61 (d, J = 8.1 Hz, 1H), 5.11 - 5.07 (m, 1H), 4.78 (t, J = 5.5 Hz, 1H), 4.48 (t, J = 9.8 Hz, 1H), 4.33 -4.22 (m, 2H), 4.12 (q, J = 10.1 Hz, 1H), 4.01 - 3.94 (m, 1H), 3.80 - 3.77 (m, 3H), 3.77 - 3.64 (m, 2H).



563


embedded image


590.1
Method D, RT = 1.729 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.07 - 9.00 (dd, J = 13.8, 8.8 Hz, 1H), 8.03 -7.97 (m, 2H), 7.60 (d, J = 7.0 Hz, 1H), 7.53 - 7.44 (m, 2H), 7.39 (d, J = 8.5 Hz, 1H), 7.35 - 7.31 (m, 1H), 6.96 - 6.87 (m, 2H), 6.22 (dd, J = 7.0, 2.5 Hz, 1H), 5.27 - 4.67 (m, 3H), 4.15 - 3.81 (m, 2H), 3.79 - 3.58 (m, 8H), 3.24 (d, J = 1.0 Hz, 3H), 2.22 - 2.09 (m, 3H). (Mixture of interconvertible atrop isomers)



564


embedded image


590.1
Method D, RT = 1.675 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.07 - 9.00 (dd, J = 13.8, 8.8 Hz, 1H), 8.06 -7.97 (m, 2H), 7.60 (dd, J = 7.0, 6.0 Hz, 1H), 7.56 - 7.44 (m, 2H), 7.42 - 7.30 (m, 2H), 6.98 - 6.88 (m, 2H), 6.22 (d, J= 7.5 Hz, 1H), 5.29 - 4.67 (m, 3H), 4.15 - 3.82 (m, 2H), 3.80 - 3.58 (m, 8H), 3.23 (d, J = 1.0 Hz, 3H), 2.23 - 2.08 (m, 3H). (Mixture of interconvertible atropisomers)



565


embedded image


649.2
Method-D, RT = 1.792 min, 96.9%

1H NMR (400 MHz, DMSO-d6) δ = 9.01 (d, J = 8.3 Hz, 1H), 7.95 (d, J= 11.5 Hz, 2H), 7.86 (d, J = 2.0 Hz, 1H), 7.48 (br d, J = 8.0 Hz, 2H), 6.82 (d, J = 11.5 Hz, 2H), 6.73 (d, J= 2.0 Hz, 1H), 5.66 (dd, J = 12.8, 8.3 Hz, 1H), 4.97 (quin, J = 7.0 Hz, 1H), 4.33 (dd, J = 12.8, 8.0 Hz, 1H), 3.84 (s, 3H), 3.79 (s, 3H), 2.95 - 2.76 (m, 3H), 2.74 - 2.62 (m, 4H), 2.33 (td, J= 3.7, 1.8 Hz, 1H), 2.05 - 1.83 (m, 4H), 1.20 (br d, J = 6.5 Hz, 3H).



566


embedded image


588.2
Method D, RT = 1.775 min, 93%.

1H NMR (400 MHz, DMSO-d6) δ = 9.06 (d, J = 8.3 Hz, 1H), 7.89 (d, J = 8.8 Hz, 2H), 7.62 - 7.57 (m, 2H), 7.35 (t, J = 73.0 Hz, 1H), 7.26 (d, J = 8.8 Hz, 2H), 6.80 (d, J = 8.8 Hz, 2H), 6.65 - 6.58 (m, 1H), 5.14 - 5.04 (m, 1H), 4.48 - 4.38 (m, 1H), 4.12 - 4.01 (m, 1H), 3.95 - 3.90 (m, 1H), 3.78 (s, 3H), 3.46 (m, 4H), 2.40 - 2.34 (m, 4H), 2.21 (s, 3H).



567


embedded image


652.1
Method D, RT = 1.866 min, 97%.

1H NMR (400 MHz, DMSO-d6) δ = 9.07 (d, J= 8.0 Hz, 1H), 7.89 (d, J = 9.0 Hz, 2H), 7.67 - 7.62 (m, 2H), 7.35 (t, J= 73.0 Hz, 1H), 7.26 (d, J = 8.8 Hz, 2H), 6.80 (d, J = 8.8 Hz, 2H), 6.71 - 6.65 (m, 1H), 5.12 - 5.05 (m, 1H), 4.48 - 4.44 (m, 1H), 4.09 (d, J = 10.0 Hz, 1H), 3.95 (d, J = 10.5 Hz, 1H), 3.78 (s, 3H), 3.65 - 360 (m, 4H), 3.20 - 3.16 (m, 4H), 2.89 (s, 3H).



568


embedded image


589.2
Method D, RT = 1.829 min, 96%.

1H NMR (400 MHz, DMSO-d6) δ = 8.86 (d, J= 8.3 Hz, 1H), 7.89 (d, J = 9.0 Hz, 2H), 7.56 - 7.50 (m, 2H), 7.35 (t, J= 73.0 Hz, 1H), 7.26 (d, J = 8.8 Hz, 2H), 6.80 (d, J = 8.8 Hz, 2H), 6.21 (m, 1H), 5.68 (m, 1H), 4.98 - 4.85 (m, 1H), 4.41 - 4.35 (m, 2H), 4.31 - 4.22 (m, 1H), 3.78 (s, 3H), 3.51 - 3.38 (m, 3H), 3.34 - 3.26 (m, 1H), 2.07 - 1.83 (m, 2H), 1.24 (d, J= 6.1 Hz, 3H).



569


embedded image


618.2
Method D, RT = 1.59 min, 95%

1H NMR (400 MHz, DMSO-d6) δ = 9.06 (d, J = 8.3 Hz, 1H), 7.93 - 7.84 (m, 2H), 7.57 - 7.41 (m, 2H), 7.35 (t, J = 73.6 Hz, 1H), 7.28 (d, J = 8.6 Hz, 2H), 6.79 (d, J = 10.8 Hz, 2H), 5.07 (dd, J = 10.9, 8.4 Hz, 1H), 4.63 - 4.60 (m, 1H), 4.44 (br t, J = 9.9 Hz, 1H), 4.12 - 3.96 (m, 1H), 3.92 - 3.83 (m, 1H), 3.78 (s, 3H), 3.62 (br dd, J= 9.7, 3.5 Hz, 1H), 3.47 - 3.42 (m, 1H), 3.42 - 3.33 (m, 1H), 2.80 (dd, J= 9.4, 1.8 Hz, 1H), 2.60 (br d, J = 10.0 Hz, 1H), 2.29 (s, 3H), 1.85 - 1.80 (m, 1H), 1.74 -1.70 (m, 1H).



570


embedded image


614.2
Method D, RT = 1.55 min, 98%

1H NMR (400 MHz, DMSO-d6) δ = 9.05 (d, J = 8.6 Hz, 1H), 7.93 - 7.83 (m, 2H), 7.40 (s, 1H), 7.35 (t, J = 73.6 Hz, 1H), 7.28 (d, J= 8.6 Hz, 2H), 6.79 (d, J = 10.8 Hz, 2H), 6.12 (s, 1H), 5.05 (dd, J = 11.1, 8.2 Hz, 1H), 4.58 - 4.54 (m, 1H), 4.47 -4.42 (m, 1H), 4.07 - 4.01 (m, 1H), 3.89 -3.80 (m, 2H), 3.78 (s, 3H), 3.45 - 3.40 (m, 1H), 3.26 - 3.19 (m, 1H), 2.79 - 2.77 (m, 1H), 2.45 - 2.41 (m, 1H), ), 2.26 (s, 3H), 2.23 (s, 3H), 1.84 - 1.80 (m, 1H), 1.73 -1.62 (m, 1H).



571


embedded image


632.2
Method D, RT = 1.77 min,98%

1H NMR (400 MHz, DMSO-d6) δ = 9.15 (d, J = 8.3 Hz, 1H), 7.99 - 7.90 (m, 2H), 7.54 - 7.44 (m, 2H), 7.40 (s, 1H), 6.84 -6.71 (m, 2H), 6.12 (s, 1H), 5.06 (dd, J = 11.0, 8.3 Hz, 1H), 4.58 - 4.54 (m, 1H), 4.50 - 4.42 (m, 1H), 4.11 - 4.02 (m, 1H), 3.91 - 3.85 (m, 1H), 3.78 (s, 3H), 3.43 -3.39 (m, 2H), 3.25 - 3.22 (m, 1H), 2.80 (dd, J = 9.4, 2.1 Hz, 1H), 2.43 (d, J= 9.5 Hz, 1H), 2.26 (s, 3H), 2.23 (s, 3H), 1.84 - 1.80 (m, 1H), 1.73 - 1.62 (m, 1H).



572


embedded image


636.2
Method D, RT = 1.77 min,95%

1H NMR (400 MHz, DMSO-d6) δ = 9.16 (d, J = 8.3 Hz, 1H), 7.98 - 7.92 (m, 2H), 7.57 - 7.41 (m, 4H), 6.86 - 6.73 (m, 2H), 5.08 (dd, J = 11.0, 8.1 Hz, 1H), 4.63 -4.60 (m, 1H), 4.45 (br t, J = 9.7 Hz, 1H), 4.12 - 4.03 (m, 1H), 3.92 - 3.86 (m, 1H), 3.78 (s, 3H), 3.65 - 3.58 (m, 1H), 3.45 -3.42 (m, 1H), 3.40 - 3.36 (m, 1H), 2.79 (dd, J = 9.5, 2.0 Hz, 1H), 2.58 (dd, J = 9.5, 2.0 Hz, 1H), 2.28 (s, 3H), 1.85 - 1.77 (m, 1H), 1.74 - 1.66 (m, 1H).



573


embedded image


502
Method D, RT = 1.695 min, 100%.

1H NMR (400 MHz, DMSO-d6) δ = 9.16 (d, J= 7.8 Hz, 1H), 7.94 - 7.81 (m, 3H), 7.78 (d, J = 7.8 Hz, 1H), 7.62 - 7.52 (m, 2H), 7.32 (d, J = 7.6 Hz, 1H), 6.82 (d, J = 11.2 Hz, 2H), 5.03 - 4.99 (m, 1H), 4.68 - 4.46 (m, 3H), 3.79 (s, 3H), 3.74 - 3.67 (m, 1H), 3.51 - 3.15 (m, 1H), 1.30 (d, J= 5.9 Hz, 3H).



574


embedded image


589.2
Method D, RT = 1.994 min, 97%.

1H NMR (400 MHz, DMSO-d6) δ = 8.88 (d, J = 8.3 Hz, 1H), 7.90 (d, J = 8.8 Hz, 2H), 7.70 - 7.60 (m, 2H), 7.35 (t, J= 76.0 Hz, 1H), 7.26 (d, J = 8.8 Hz, 2H), 6.79 (d, J = 8.8 Hz, 2H), 6.61 (d, J = 8.1 Hz, 1H), 5.68 - 5.65 (m, 1H), 4.94 - 4.85 (m, 1H), 4.29 - 4.24 (m, 1H), 3.78 (s, 3H), 3.74 - 3.71 - 3.65 (m, 4H), 3.49 - 3.39 (m, 4H), 1.21 (d, J = 6.4 Hz, 3H).



575


embedded image


592.1
Method-D, RT = 2.416 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 8.98 (d, J= 8.3 Hz, 1H), 7.98 - 7.92 (m, 2H), 7.74 (d, J = 2.0 Hz, 1H), 7.48 (br d, J = 8.9 Hz, 2H), 6.83 - 6.81 (m, 1H), 6.80 -6.77 (m, 2H), 5.66 (dd, J = 12.6, 8.4 Hz, 1H), 4.92 - 4.80 (m, 1H), 4.26 (dd, J = 12.8, 8.0 Hz, 1H), 3.82 (s, 3H), 3.78 (s, 3H), 1.77 - 1.57 (m, 1H), 1.16 (d, J = 6.6 Hz, 3H), 1.00 - 0.88 (m, 3H), 0.87 - 0.80 (m, 1H).



576


embedded image


644.2
Method F, RT = 2.488 min, 99%

1H NMR (400 MHz, DMSO-d6) δ = 9.23 - 9.04 (m, 1H), 8.00 - 7.92 (m, 2H), 7.74 - 7.64 (m, 1H), 7.53 - 7.44 (m, 2H), 6.81 - 6.76 (m, 2H), 6.32 - 6.24 (m, 1H), 5.37 - 4.86 (m, 1H), 4.36 - 4.26 (m, 2H), 4.26 - 4.14 (m, 1H), 4.26 - 4.07 (m, 2H), 3.79 - 3.74 (2 s, 3H), 3.61 - 3.53 (m, 2H), 3.07 - 3.04 (2 s, 3H), 2.22 - 2.06 (2 s, 3H). (Mixture of interconvertible atropisomers)



577


embedded image


538.2
Method D, RT = 2.596 min, 100%.

1H NMR (400 MHz, DMSO-d6) δ = 8.95 - 8.88 (m, 1H), 7.92 - 7.88 (m, 2H), 7.75 - 7.70 (m, 1H), 7.47 - 7.07 (m, 5H), 6.96 - 6.85 (m, 2H), 6.33 - 6.27 (m, 1H), 5.22 - 4.68 (m, 2H), 4.06 - 3.80 (m, 2H), 3.73 - 3.68 (2 s, 3H), 3.60 - 3.39 (m, 1H), 2.37 - 2.21 (m, 4H), 2.19 - 2.07 (2 s, 3H), 1.82 - 1.77 (m, 2H). (Mixture of interconvertible atrop isomers)



578


embedded image


558.3
Method D, RT = 2.358 min, 99%.

1H NMR (400 MHz, DMSO-d6) δ = 9.06 - 9.02 (m, 1H), 8.02 - 7.98 (m, 2H), 7.76 - 7.72 (m, 1H), 7.54 - 7.44 (m, 2H), 7.41 - 7.28 (m, 2H), 6.93 - 6.88 (m, 2H), 6.36 - 6.32 (m, 1H), 5.58 - 5.17 (m, 1H), 4.95 - 4.65 (m, 4H), 4.09 - 4.01 (m, 1H), 3.96 - 3.77 (m, 2H), 3.75 - 3.70 (m, 3H), 3.69 - 3.42 (m, 1H), 2.26 - 2.10 (2 s, 3H). (Mixture of interconvertible atropisomers)



579


embedded image


615.1
Method D, RT = 1.693 min, 94%.

1H NMR (400 MHz, DMSO-d6) δ = 9.11 - 8.92 (m, 1H), 7.93 - 7.85 (m, 2H), 7.82 - 7.73 (m, 1H), 7.54 - 7.11 (m, 3H), 6.82 - 6.72 (m, 2H), 6.36 - 6.24 (m, 2H), 5.37 - 4.83 (m, 3H), 4.32 - 4.04 (m, 2H), 3.79 - 3.74 (2 s, 3H), 3.57 - 3.48 (m, 1H), 2.25 - 2.20 (2 s, 3H), 2.21 - 2.08 (2 s, 3H). (Mixture of interconvertible atropisomers)



580


embedded image


575.1
Method D, RT = 1.977 min, 100%.

1H NMR (400 MHz, DMSO-d6) δ = 9.07 (d, J = 8.3 Hz, 1H), 7.90 (d, J = 8.6 Hz, 2H), 7.68 - 7.60 (m, 2H), 7.35 (t, J= 73.6 Hz, 1H), 7.28 (d, J = 8.6 Hz, 2H), 6.79 (d, J= 10.8 Hz, 2H), 6.65 - 6.57 (m, 1H), 5.10 (dd, J = 10.9, 8.4 Hz, 1H), 4.50 -4.39 (m, 1H), 4.15 - 4.01 (m, 1H), 3.98 -3.87 (m, 1H), 3.78 (s, 3H), 3.74 - 3.63 (m, 4H), 3.48 - 3.39 (m, 4H).



581


embedded image


546.2
Method F, RT = 2.40 min, 99%,

1H NMR (400 MHz, DMSO-d6) δ = 9.20 - 8.90 (m, 1H), 7.91 - 7.74 (m, 2H), 7.64 - 7.36 (m, 3H), 6.82 - 6.64 (m, 2H), 6.27 - 6.07 (m, 1H), 5.36 - 4.81 (m, 2H), 4.28 - 3.82 (m, 4H), 3.80 - 3.73 (2 s, 3H), 3.69 - 3.46 (m, 2H), 2.23 - 2.04 (2 s, 3H), 1.16 - 0.98 (m, 3H). (Mixture of interconvertible atropisomers)



582


embedded image


618.2
Method D, RT = 1.757 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.01 (br d, J= 8.5 Hz, 1H), 7.89 (d, J= 8.5 Hz, 2H), 7.74 - 7.61 (m, 2H), 7.35 (t, J= 76.4 Hz, 1H), 7.27 (d, J= 8.5 Hz, 2H), 6.82 -6.74 (m, 1H), 6.77 (br d, J = 11.0 Hz, 1H), 6.38 (t, J= 7.0 Hz, 1H), 5.09 (br t, J = 9.3 Hz, 1H), 4.49 - 4.42 (m, 1H), 4.37 - 4.33 (m, 1H), 4.15 - 4.01 (m, 3H), 3.99 - 3.90 (m, 1H), 3.87 - 3.84 (m, 1H), 3.77 (s, 3H).



583


embedded image


618.2
Method D, RT = 1.744 min, 97.2%

1H NMR (400 MHz, DMSO-d6) δ = 9.01 (br d, J= 8.5 Hz, 1H), 7.89 (d, J= 8.5 Hz, 2H), 7.74 - 7.61 (m, 2H), 7.35 (t, J= 76.4 Hz, 1H), 7.27 (d, J= 8.5 Hz, 2H), 6.82 -6.74 (m, 1H), 6.77 (br d, J = 11.0 Hz, 1H), 6.38 (t, J= 7.0 Hz, 1H), 5.09 (br t, J = 9.3 Hz, 1H), 4.49 - 4.42 (m, 1H), 4.37 - 4.33 (m, 1H), 4.15 - 4.01 (m, 3H), 3.99 - 3.90 (m, 1H), 3.87 - 3.84 (m, 1H), 3.77 (s, 3H).



584


embedded image


596.1
Method-D, RT = 2.103 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.18 (d, J = 8.3 Hz, 1H), 7.95 (d, J = 8.8 Hz, 2H), 7.79 (d, J= 2.0 Hz, 1H), 7.51 (d, J = 8.8 Hz, 2H), 7.04 - 7.02 (d, J= 2.0 Hz, 1H), 6.80 (d, J= 10.8 Hz, 2H), 5.33 - 5.13 (m, 1H), 5.09 (dd, J= 11.0, 8.3 Hz, 1H), 4.50 (br t, J= 9.9 Hz, 1H), 4.16 - 4.07 (m, 1H), 3.98 - 3.91 (m, 1H), 3.85 (s, 3H), 3.78 (s, 3H), 1.42 (s, 3H), 1.41 (s, 3H).



585


embedded image


578.1
Method-D, RT = 1.924 min, 93.8%

1H NMR (400 MHz, DMSO-d6) δ = 9.08 (d, J = 8.3 Hz, 1H), 7.89 (d, J= 8.8 Hz, 2H), 7.80 (d, J= 2.2 Hz, 1H), 7.34 (t, J= 76.0 Hz, 1H), 7.29 (d, J = 8.8 Hz, 2H), 7.02 (d, J = 2.2 Hz, 1H), 6.80 (d, J= 10.8 Hz, 2H), 5.33 - 5.13 (m, 1H), 5.07 (dd, J = 11.0, 8.1 Hz, 1H), 4.54 - 4.44 (m, 1H), 4.17 - 4.05 (m, 1H), 3.99 - 3.90 (m, 1H), 3.85 (s, 3H), 3.78 (s, 3H), 1.42 (s, 3H), 1.41 (s, 3H).



586


embedded image


550.1
Method-C, RT = 1.508 min, 98.1%

1H NMR (400 MHz, DMSO-d6) δ = 9.09 (d, J = 8.3 Hz, 1H), 7.89 (d, J= 8.8 Hz, 2H), 7.82 (d, J= 2.2 Hz, 1H), 7.34 (t, J = 76.0 Hz, 1H), 7.29 (d, J = 8.8 Hz, 2H), 6.88 (d, J= 2.2 Hz, 1H), 6.79 (d, J= 10.8 Hz, 2H), 5.43 - 5.39 (m, 1H), 5.08 (dd, J = 11.1, 8.2 Hz, 1H), 4.46 (d, J= 5.9 Hz, 2H), 4.43 - 4.38 (m, 1H), 4.10 (q, J= 10.1 Hz, 1H), 3.98 - 3.91 (m, 1H), 3.86 (s, 3H), 3.78 (s, 3H).



587


embedded image


568.1
Method-D, RT = 1.895 min, 98.4%

1H NMR (400 MHz, DMSO-d6) δ = 9.19 (d, J= 8.1 Hz, 1H), 7.95 (d, J= 8.8 Hz, 2H), 7.81 (d, J= 2.0 Hz, 1H), 7.51 (d, J = 8.1 Hz, 2H), 6.88 (d, J = 2.0 Hz, 1H), 6.80 (d, J= 10.8 Hz, 2H), 5.48 - 5.35 (m, 1H), 5.09 (dd, J= 10.8, 8.3 Hz, 1H), 4.46 (d, J = 5.9 Hz, 2H), 4.44 - 4.39 (m, 1H), 4.15 - 4.04 (m, 1H), 3.98 - 3.90 (m, 1H), 3.87 - 3.84 (m, 3H), 3.78 (s, 3H).



588


embedded image


534.1
Method-D, RT = 2.060 min, 96.8%

1H NMR (400 MHz, DMSO-d6) δ = 9.09 (d, J= 8.1 Hz, 1H), 7.89 (d, J= 8.8 Hz, 2H), 7.78 (d, J= 2.2 Hz, 1H), 7.34 (t, J= 76.0 Hz, 1H), 7.29 (d, J = 8.8 Hz, 2H), 6.79 (d, J= 11.0 Hz, 2H), 6.72 (d, J= 2.2 Hz, 1H), 5.07 (dd, J= 11.0, 8.3 Hz, 1H), 4.46 - 4.39 (m, 1H), 4.14 - 4.04 (m, 1H), 3.99 - 3.92 (m, 1H), 3.83 (s, 3H), 3.78 (s, 3H), 2.39 (s, 3H).



589


embedded image


560.2
Method-D, RT = 2.253 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.06 (d, J= 8.3 Hz, 1H), 7.92 - 7.84 (m, 2H), 7.72 (d, J = 2.0 Hz, 1H), 7.34 (t, J = 76.0 Hz, 1H), 7.28 (d, J = 9.0 Hz, 2H), 6.78 (d, J = 2.0 Hz, 2H), 6.72 (d, J = 2.2 Hz, 1H), 5.06 (dd, J= 11.1, 8.4 Hz, 1H), 4.40 (t, J = 9.9 Hz, 1H), 4.07 (q, J = 10.0 Hz, 1H), 3.91 - 3.84 (m, 1H), 3.83 (s, 3H), 3.78 (s, 3H), 2.07 - 1.97 (m, 1H), 0.99 -0.92 (m, 2H), 0.91 - 0.85 (m, 2H).



590


embedded image


635.2
Method D, RT = 1.43 min, 98%

1H NMR (400 MHz, DMSO-d6) δ = 9.09 (d, J= 9.0 Hz, 1H), 7.95 - 7.84 (m, 2H), 7.78 (dd, J= 9.8, 8.5 Hz, 1H), 7.34 (t, J = 74.0 Hz, 1H), 7.32 - 7.27 (m, 3H), 6.79 (d, J = 10.8 Hz, 2H), 5.12 -5.10 (m, 1H), 4.35 (t, J = 5.4 Hz, 1H), 4.28 - 4.16 (m, 2H), 4.13 - 3.99 (m, 1H), 3.77 (s, 3H), 3.50 (q, J = 6.4 Hz, 2H), 3.17 (d, J= 5.3 Hz, 1H), 2.99 - 2.89 (m, 2H), 2.71 - 2.64 (m, 1H), 2.40 (t, J = 6.4 Hz, 2H), 2.10 -2.00 (m, 2H), 1.85 - 1.64 (m, 3H).



591


embedded image


604.1
Method D, RT = 1.656 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.18 - 8.84 (m, 1H), 7.99 - 7.82 (m, 2H), 7.55 - 7.15 (2t, J= 74.3 Hz, 1H), 7.28 - 7.24 (m, 2H), 6.80 - 6.74 (m, 2H), 5.41 - 4.85 (m, 2H), 4.30 - 3.88 (m, 4H), 3.80 - 3.72 (2 s, 3H), 3.63 (quin, J= 5.1 Hz, 2H), 3.50 - 3.41 (m, 1H), 3.06 (br t, J= 7.2 Hz, 2H), 2.83 - 2.68 (m, 2H), 2.18 - 1.94 (m, 5H). (Mixture of interconvertible atropisomers)



592


embedded image


622.1
Method D, RT = 1.788 min, 98.6%

1H NMR (400 MHz, DMSO-d6) δ = 9.33 - 8.91 (m, 1H), 8.04 - 7.82 (m, 2H), 7.60 - 7.33 (m, 2H), 6.81 - 6.75 (m, 2H), 5.41 - 4.85 (m, 2H), 4.30 - 3.88 (m, 4H), 3.80 - 3.72 (2 s, 3H), 3.64 - 3.61 (m, 2H), 3.50 - 3.41 (m, 1H), 3.08 - 3.04 (m, 2H), 2.83 - 2.68 (m, 2H), 2.18 - 1.94 (m, 5H). (Mixture of interconvertible atropisomers)



593


embedded image


572.1
Method D, RT = 1.649 min, 99.9%

1H NMR (400 MHz, DMSO-d6) δ = 9.25 - 8.91 (m, 1H), 7.91 - 7.70 (m, 2H), 7.64 - 7.42 (m, 2H), 6.81 - 6.75 (m, 2H), 5.41 - 4.81 (m, 2H), 4.29 - 3.84 (m, 4H), 3.80 - 3.71 (2 s, 3H), 3.65 - 3.61 (m, 2H), 3.52 - 3.39 (m, 1H), 3.12 - 2.99 (m, 2H), 2.80 - 2.67 (m, 2H), 2.15 - 1.90 (m, 5H). (Mixture of interconvertible atropisomers)



594


embedded image


548.2
Method D, RT = 2.609 min, 99%.

1H NMR (400 MHz, DMSO-d6) δ = 9.02 - 8.95 (m, 1H), 7.83 (d, J = 8.5 Hz, 2H), 7.64 - 7.59 (m, 1H), 7.56 - 7.49 (m, 2H), 7.38 - 7.29 (m, 2H), 6.93 - 6.84 (m, 2H), 6.30 - 6.26 (m, 1H), 5.21 - 4.74 (m, 1H), 4.18 - 4.10 (m, 1H), 4.21 - 3.98 (m, 1H), 3.96 - 3.81 (m, 2H), 3.72 - 3.68 (2 s, 3H), 3.63 - 3.42 (m, 1H), 2.78 - 2.63 (m, 2H), 2.21 - 2.06 (2 s, 3H). (Mixture of interconvertible atropisomers)



595


embedded image


577.2
Method D, RT = 2.167 min, 99%.

1H NMR (400 MHz, DMSO-d6) δ = 9.35 - 8.94 (m, 1H), 8.02 - 7.91 (m, 2H), 7.78 - 7.71 (m, 1H), 7.54 - 7.44 (m, 2H), 6.85 - 6.73 (m, 2H), 6.43 - 6.32 (m, 1H), 5.39 - 4.82 (m, 3H), 4.33 - 4.22 (m, 1H), 4.20 - 4.05 (m, 1H), 3.81 - 3.74 (2 s, 3H), 3.63 - 3.52 (m, 1H), 2.27 - 2.05 (2S, 3H). (Mixture of interconvertible atropisomers)



596


embedded image


503.1
Method-D, RT = 1.319 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.05 (d, J= 8.6 Hz, 1H), 8.03 (s, 1H), 7.82 (d, J = 8.8 Hz, 2H), 7.56 (d, J= 8.6 Hz, 2H), 6.77 (d, J = 10.8 Hz, 2H), 5.00 (dd, J = 10.6, 8.7 Hz, 1H), 4.28 - 4.20 (m, 1H), 4.02 (q, J = 9.6 Hz, 1H), 3.91 - 3.84 (m, 1H), 3.79 (t, J= 7.0 Hz, 2H), 3.76 (s, 3H), 3.75 - 3.71 (m, 2H), 2.55 - 2.52 (m, 1H), 2.49 - 2.46 (m, 1H).



597


embedded image


535.2
Method-D, RT = 1.308 min, 93.5%

1H NMR (400 MHz, DMSO-d6) δ = 9.03 - 8.94 (m, 1H), 8.03 (s, 1H), 7.88 (d, J = 8.6 Hz, 2H), 7.34 (t, J = 76.0 Hz, 1H), 7.27 (d, J= 8.6 Hz, 2H), 6.77 (d, J = 10.8 Hz, 2H), 5.00 (dd, J= 10.6, 8.7 Hz, 1H), 4.28 - 4.20 (m, 1H), 4.02 (q, J = 9.6 Hz, 1H), 3.91 - 3.84 (m, 1H), 3.79 (t, J= 7.0 Hz, 2H), 3.76 (s, 3H), 3.75 - 3.71 (m, 2H), 2.55 - 2.52 (m, 1H), 2.49 - 2.46 (m, 1H).



598


embedded image


553.1
Method-D, RT = 1.412 min, 97%

1H NMR (400 MHz, DMSO-d6) δ = 9.09 (d, J= 8.6 Hz, 1H), 8.03 (s, 1H), 7.94 (d, J= 8.8 Hz, 2H), 7.49 (d, J= 8.8 Hz, 2H), 6.77 (d, J = 10.8 Hz, 2H), 5.00 (dd, J = 10.6, 8.7 Hz, 1H), 4.28 - 4.20 (m, 1H), 4.02 (q, J = 9.6 Hz, 1H), 3.91 - 3.84 (m, 1H), 3.79 (t, J= 7.0 Hz, 2H), 3.76 (s, 3H), 3.75 - 3.71 (m, 2H), 2.55 - 2.52 (m, 1H), 2.49 - 2.46 (m, 1H).



599


embedded image


544.1
Method C, RT = 1.557 min, 99.1%

1H NMR (400 MHz, DMSO-d6) δ = 9.09 (d, J= 8.5 Hz, 1H), 8.30 (dd, J= 6.9, 0.9 Hz, 1H), 7.90 (d, J = 8.8 Hz, 2H), 7.67 (dd, J= 7.3, 0.9 Hz, 1H), 7.35 (t, J= 72.8 Hz, 1H), 7.28 (d, J= 8.8 Hz, 2H), 7.06 (t, J = 7.0 Hz, 1H), 6.80 (d, J = 10.8 Hz, 2H), 5.16 (dd, J= 11.1, 8.4 Hz, 1H), 4.67 - 4.57 (m, 1H), 4.42 (t, J= 10.3 Hz, 1H), 4.24 (q, J = 10.3 Hz, 1H), 3.78 (s, 3H), 2.71 (s, 3H).



600


embedded image


683.1
Method D, RT = 1.644 min, 100%.

1H NMR (400 MHz, DMSO-d6) δ = 9.12 - 8.94 (m, 1H), 7.96 - 7.82 (m, 3H), 7.55 - 7.11 (m, 3H), 6.83 - 6.68 (m, 2H), 6.57 - 6.46 (m, 1H), 5.31 - 4.76 (m, 1H), 4.32 - 3.96 (m, 2H), 3.78 - 3.74 (2 s, 3H), 3.65 - 3.46 (m, 6H), 3.37 - 3.34 (m, 1H), 2.30 - 2.10 (2 s, 3H), 1.66 - 1.60 (m, 1H), 1.31 - 1.16 (m, 1H). (Mixture of interconvertible atrop isomers)



601


embedded image


589.2
Method D, RT = 1.422 min, 100%.

1H NMR (400 MHz, DMSO-d6) δ = 9.13 - 8.89 (m, 1H), 7.96 - 7.83 (m, 2H), 7.77 - 7.67 (m, 1H), 7.54 - 7.10 (m, 3H), 6.84 - 6.70 (m, 2H), 6.33 - 6.22 (m, 1H), 5.36 - 4.84 (m, 2H), 4.27 - 4.10 (m, 2H), 3.78 - 3.75 (2 s, 3H), 3.52 - 3.49 (m, 3H), 3.15 - 3.05 (m, 2H), 2.88 - 2.77 (m, 2H), 2.27 - 2.02 (2 s, 3H), 1.80 - 1.68 (m, 1H). (Mixture of interconvertible atropisomers)



602


embedded image


607.1
Method D, RT = 1.586 min, 95%.

1H NMR (400 MHz, DMSO-d6) δ = 9.25 - 8.96 (m, 1H), 8.05 - 7.87 (m, 2H), 7.77 - 7.65 (m, 1H), 7.57 - 7.38 (m, 2H), 6.77 (m, 2H), 6.27 (m, 1H), 5.40 - 5.14 (m, 1H), 4.93 - 4.07 (m, 3H), 3.80 - 3.72 (2 s, 3H), 3.53 - 3.49 (m, 3H), 3.13 - 2.99 (m, 2H), 2.90 - 2.74 (m, 2H), 2.27 - 2.00 (2 s, 3H), 1.81 - 1.60 (m, 1H). (Mixture of interconvertible atropisomers)



603


embedded image


512.1
Method C, RT = 1.625 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.16 (d, J= 8.5 Hz, 1H), 8.30 (dd, J = 6.8, 0.8 Hz, 1H), 7.94 - 7.80 (m, 2H), 7.68 (dd, J = 7.3, 0.8 Hz, 1H), 7.62 - 7.51 (m, 2H), 7.07 (t, J = 7.0 Hz, 1H), 6.81 (d, J= 10.8 Hz, 2H), 5.18 (dd, J= 11.1, 8.4 Hz, 1H), 4.70 - 4.55 (m, 1H), 4.42 (t, J = 10.1 Hz, 1H), 4.24 (q, J = 10.1 Hz, 1H), 3.78 (s, 3H), 2.72 (s, 3H).



604


embedded image


562.1
Method C, RT = 1.728 min, 99.7%

1H NMR (400 MHz, DMSO-d6) δ = 9.20 (d, J = 8.3 Hz, 1H), 8.31 (dd, J = 6.8, 0.8 Hz, 1H), 8.04 - 7.87 (m, 2H), 7.68 (dd, J = 7.3, 0.8 Hz, 1H), 7.57 - 7.41 (m, 2H), 7.07 (t, J = 7.0 Hz, 1H), 6.81 (d, J= 10.8 Hz, 2H), 5.19 (dd, J= 11.1, 8.4 Hz, 1H), 4.68 - 4.55 (m, 1H), 4.42 (t, J= 10.0 Hz, 1H), 4.25 (q, J = 10.1 Hz, 1H), 3.79 (s, 3H), 2.72 (s, 3H).



605


embedded image


618.2
Method D, RT = 1.791 min, 99.9%

1H NMR (400 MHz, DMSO-d6) δ = 9.14 - 8.90 (m, 1H), 7.96 - 7.77 (m, 2H), 7.54 - 7.14 (2t, J= 74.3 Hz, 1H), 7.28 - 7.24 (m, 2H), 6.82 - 6.68 (m, 2H), 5.40 - 4.82 (m, 2H), 4.30 - 4.00 (m, 4H), 3.78 - 3.72 (2 s, 3H), 3.61 (quin, J= 5.8 Hz, 2H), 3.51 - 3.41 (m, 1H), 2.85 - 2.80 (m, 2H), 2.47 - 2.40 (m, 2H), 2.14 - 1.93 (2 s, 3H), 1.81 - 1.61 (m, 4H). (Mixture of interconvertible atrop isomers)



606


embedded image


636.1
Method D, RT = 1.766 min, 94.5%

1H NMR (400 MHz, DMSO-d6) δ = 9.26 - 8.98 (m, 1H), 8.02 - 7.84 (m, 2H), 7.56 - 7.37 (m, 2H), 6.84 - 6.66 (m, 2H), 5.41 - 4.80 (m, 2H), 4.28 - 3.99 (m, 4H), 3.81 - 3.73 (2 s, 3H), 3.61 (quin, J = 5.8 Hz, 2H), 3.50 - 3.42 (m, 1H), 2.89 - 2.77 (m, 2H), 2.47 - 2.38 (m, 2H), 2.14 - 1.91 (2 s, 3H), 1.80 - 1.57 (m, 4H). (Mixture of interconvertible atropisomers)



607


embedded image


586.1
Method D, RT = 1.629 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.21 - 8.93 (m, 1H), 7.92 - 7.76 (m, 2H), 7.67 - 7.46 (m, 2H), 6.83 - 6.69 (m, 2H), 5.41 - 4.87 (m, 2H), 4.29 - 3.99 (m, 4H), 3.79 - 3.72 (2 s, 3H), 3.60 (quin, J = 5.8 Hz, 2H), 3.49 - 3.42 (m, 1H), 2.90 - 2.75 (m, 2H), 2.47 - 2.39 (m, 2H), 2.14 - 1.91 (2 s, 3H), 1.81 - 1.54 (m, 4H). (Mixture of interconvertible atropisomers)



608


embedded image


604.2
Method D, RT = 2.015 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.08 (d, J= 8.5 Hz, 1H), 8.03 - 7.96 (m, 2H), 7.72 - 7.64 (m, 2H), 7.49 (d, J = 9.0 Hz, 4H), 7.46 - 7.39 (m, 2H), 6.38 (t, J= 7.0 Hz, 1H), 5.04 (dd, J= 11.0, 8.5 Hz, 1H), 4.45 (dd, J = 13.1, 2.5 Hz, 1H), 4.40 -4.28 (m, 1H), 4.19 - 4.09 (m, 1H), 3.92 -3.79 (m, 3H), 3.51 - 3.40 (m, 1H).



609


embedded image


604.2
Method D, RT = 2.029 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.08 (d, J= 8.5 Hz, 1H), 8.03 - 7.96 (m, 2H), 7.72 - 7.64 (m, 2H), 7.49 (d, J = 9.0 Hz, 4H), 7.46 - 7.39 (m, 2H), 6.38 (t, J= 7.0 Hz, 1H), 5.04 (dd, J= 11.0, 8.5 Hz, 1H), 4.45 (dd, J = 13.1, 2.5 Hz, 1H), 4.40 -4.28 (m, 1H), 4.19 - 4.09 (m, 1H), 3.92 -3.79 (m, 3H), 3.51 - 3.40 (m, 1H).



610


embedded image


538.2
Method F, RT = 2.51 min, 99%,

1H NMR (400 MHz, DMSO-d6) δ = 9.03 (m, 1H), 7.99 - 7.89 (m, 2H), 7.72 - 7.64 (m, 1H), 7.55 - 7.06 (m, 5H), 6.93 - 6.89 (m, 2H), 6.22 (d, J = 6.8 Hz, 1H), 5.29 -4.62 (m, 1H), 4.13 - 3.81 (m, 2H), 3.79 -3.75 (2 s, 3H) 3.69 - 3.59 (m, 2H), 3.46-3.40 (m, 1H), 2.25 - 2.04 (2 s, 3H), 1.22-120 (m, 1H), 0.49 - 0.47 (m, 4H). (Mixture of interconvertible atropisomers)



611


embedded image


584.2
Method F, RT = 2.65 min, 99%,

1H NMR (400 MHz, DMSO-d6) δ = 9.21 - 9.00 (m, 1H), 7.91 - 7.79 (m, 2H), 7.69 (d, J= 7.0 Hz, 1H), 7.61, - 7.51 (m, 2H), 6.78 (br d, J = 10.5 Hz, 2H), 6.27 (d, J = 7.0 Hz, 1H), 5.40 - 4.85 (m, 1H), 4.33 -4.06 (m, 4H), 3.80 - 3.74 (2 s, 3H), 3.56 -3.47 (m, 1H), 2.83 - 2.68 (m, 2H), 2.25 -2.04 (2 s, 3H). (Mixture of interconvertible atrop isomers)



612


embedded image


589.1
Method D, RT = 1.34 min, 93%.

1H NMR (400 MHz, DMSO-d6) δ = 9.13 - 8.86 (m, 1H), 7.95 - 7.80 (m, 2H), 7.78 - 7.66 (m, 1H), 7.56 - 7.12 (m, 3H), 6.82 - 6.65 (m, 2H), 6.32 - 6.17 (m, 1H), 5.36 - 4.89 (m, 2H), 4.30 - 4.07 (m, 3H), 3.80 - 3.72 (2 s, 3H), 3.49 (t, J= 8.4 Hz, 1H), 3.14 - 3.01 (m, 2H), 2.88 - 2.75 (m, 2H), 2.26 - 2.13 (m, 4H), 1.77 - 1.62 (m, 1H). (Mixture of interconvertible atropisomers)



613


embedded image


607.2
Method D, RT = 1.527 min, 95%.

1H NMR (400 MHz, DMSO-d6) δ = 9.25 - 9.00 (m, 1H), 8.00 - 7.85 (m, 2H), 7.78 - 7.65 (m, 1H), 7.55 - 7.40 (m, 2H), 6.88 - 6.69 (m, 2H), 6.34 - 6.18 (m, 1H), 5.37 - 4.82 (m, 2H), 4.30 - 4.06 (m, 3H), 3.79 - 3.72 (2 s, 3H), 3.50 (t, J = 8.1 Hz, 1H), 3.16 - 2.99 (m, 2H), 2.88 - 2.78 (m, 2H), 2.25 - 2.00 (m, 4H), 1.78 - 1.63 (m, 1H). (Mixture of interconvertible atropisomers)



614


embedded image


558.1
Method D, RT = 1.611 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.21 - 8.94 (m, 1H), 7.90 - 7.78 (m, 2H), 7.71 - 7.48 (m, 3H), 6.83 - 6.70 (m, 2H), 6.31 - 6.15 (m, 1H), 5.35 - 4.83 (m, 2H), 4.53 - 4.45 (m, 1H), 4.39 (qd, J= 9.1, 5.7 Hz, 1H), 4.30 - 4.06 (m, 4H), 3.82 - 3.70 (2 s, 3H), 3.55 - 3.48 (m, 1H), 2.69 - 2.61 (m, 1H), 2.40 - 2.34 (m, 1H), 2.26 - 2.04 (2 s, 3H). (Mixture of interconvertible atropisomers)



615


embedded image


608.1
Method D, RT = 1.759 min, 97.1%

1H NMR (400 MHz, DMSO-d6) δ = 9.28 - 8.90 (m, 1H), 8.03 - 7.84 (m, 2H), 7.70 - 7.56 (m, 1H), 7.52 - 7.37 (m, 2H), 6.86 - 6.65 (m, 2H), 6.30 - 6.15 (m, 1H), 5.41 - 4.80 (m, 2H), 4.55 - 4.45 (m, 1H), 4.43 - 4.33 (m, 1H), 4.31 - 4.06 (m, 4H), 3.82 - 3.70 (2 s, 3H), 3.60 - 3.44 (m, 1H), 2.72 - 2.61 (m, 1H), 2.39 - 2.30 (m, 1H), 2.24 - 1.96 (2 s, 3H). (Mixture of interconvertible atropisomers)



616


embedded image


590.1
Method D, RT = 1.579 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.19 - 8.84 (m, 1H), 7.97 - 7.78 (m, 2H), 7.71 - 7.57 (m, 1H), 7.34 (t, J = 74.3 Hz, 1H), 7.28 - 7.24 (m, 2H), 6.81 - 6.75 (m, 2H), 6.31 - 6.16 (m, 1H), 5.39 - 4.78 (m, 2H), 4.55 - 4.45 (m, 1H), 4.41 - 4.36 (m, 1H), 4.30 - 4.04 (m, 4H), 3.80 - 3.68 (2 s, 3H), 3.57 - 3.46 (m, 1H), 2.70 - 2.59 (m, 1H), 2.40 - 2.32 (m, 1H), 2.23 - 2.01 (2 s, 3H). (Mixture of interconvertible atropisomers)



617


embedded image


590.1
Method D, RT = 1.597 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.16 - 8.86 (m, 1H), 7.97 - 7.81 (m, 2H), 7.69 - 7.57 (m, 1H), 7.34 (t, J = 74.3 Hz, 1H), 7.28 - 7.24 (m, 2H), 6.81 - 6.75 (m, 2H), 6.31 - 6.14 (m, 1H), 5.38 - 4.82 (m, 2H), 4.54 - 4.43 (m, 1H), 4.41 - 4.33 (m, 1H), 4.31 - 4.08 (m, 4H), 3.81 - 3.74 (2 s, 3H), 3.56 - 3.45 (m, 1H), 2.68 - 2.62 (m, 1H), 2.40 - 2.32 (m, 1H), 2.22 - 2.01 (2 s, 3H). (Mixture of interconvertible atropisomers)



618


embedded image


558.1
Method D, RT = 1.616 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.23 - 8.86 (m, 1H), 7.93 - 7.76 (m, 2H), 7.71 - 7.38 (m, 3H), 6.81 - 6.75 (m, 2H), 6.32 - 6.12 (m, 1H), 5.41 - 4.78 (m, 2H), 4.57 - 4.44 (m, 1H), 4.42 - 4.31 (m, 1H), 4.29 - 4.06 (m, 4H), 3.81 - 3.70 (2 s, 3H), 3.54 - 3.44 (m, 1H), 2.70 - 2.62 (m, 1H), 2.38 - 2.30 (m, 1H), 2.25 - 1.96 (2 s, 3H). (Mixture of interconvertible atropisomers)



619


embedded image


619.1
Method D, RT = 1.484 min, 94.4%

1H NMR (400 MHz, DMSO-d6) δ = 9.15 - 8.87 (m, 1H), 7.99 - 7.84 (m, 2H), 7.71 - 7.56 (m, 2H), 7.34 (t, J = 74.3 Hz, 1H), 7.28 - 7.24 (m, 1H), 6.81 - 6.75 (m, 2H), 6.37 - 6.19 (m, 1H), 5.38 - 4.81 (m, 2H), 4.34 - 4.09 (m, 4H), 3.80 - 3.75 (2 s, 3H), 3.64 - 3.50 (m, 3H), 3.27 - 3.19 (m, 1H), 2.25 - 2.06 (2 s, 3H). (Mixture of interconvertible atropisomers)



620


embedded image


553.1
Method D, RT = 1.75 min,96 %

1H NMR (400 MHz, DMSO-d6) δ = 8.97 (d, J = 8.6 Hz, 1H), 8.05 (d, J = 4.9 Hz, 1H), 7.94 - 7.84 (m, 2H), 7.78 (d, J = 4.6 Hz, 1H), 7.56 - 7.52 (m, 2H), 7.39 (t, J = 74.0 Hz, 1H), 7.27 - 7.25 (m, 1H) 6.85 -6.77 (m, 2H), 6.40 (tt, J = 52.6, 4.8 Hz, 1H), 5.12 - 5.09 (m, 1H), 4.56 - 4.50 (m, 2H), 4.46 (t, J = 8.3 Hz, 1H), 4.07 - 3.90 (m, 2H), 3.74 (s, 3H).



621


embedded image


574.1
Method D, RT = 1.59 min,97 %

1H NMR (400 MHz, DMSO-d6) δ = 9.21 - 8.94 (m, 1H), 7.90 - 7.75 (m, 2H), 7.63 - 7.35 (m, 3H), 6.86 - 6.69 (m, 2H), 6.35 - 6.22 (m, 1H), 5.36 - 4.84 (m, 2H), 4.37 - 4.04 (m, 5H), 3.91 - 3.83 (m, 1H), 3.86 - 3.82 (2 s, 3H), 3.61 - 3.50 (m, 3H), 2.22 - 2.05 (2 s, 3H). (Mixture of interconvertible atropisomers)



622


embedded image


624.1
Method D, RT = 1.66 min,99 %

1H NMR (400 MHz, DMSO-d6) δ = 9.24 - 8.94 (m, 1H), 8.04 - 7.85 (m, 2H), 7.59 - 7.45 (m, 3H), 6.85 - 6.63 (m, 2H), 6.37 - 6.22 (m, 1H), 5.79 - 5.60 (m, 1H), 5.05 - 4.84 (m, 2H), 4.39 - 4.05 (m, 5H), 3.88 - 3.85 (m, 1H), 3.78 - 3.74 (2 s, 3H), 3.59 - 3.50 (m, 2H), 2.24 - 2.00 (2 s, 3H). (Mixture of interconvertible atropisomers)



623


embedded image


574.1
Method D, RT = 1.53 min,10 0%

1H NMR (400 MHz, DMSO-d6) δ = 9.25 - 8.90 (m, 1H), 7.92 - 7.76 (m, 2H), 7.65 - 7.53 (m, 2H), 7.53 - 7.38 (m, 1H), 6.85 - 6.69 (m, 2H), 6.36 - 6.23 (m, 1H), 5.50 - 5.30 (m, 1H), 5.0-4.28 (m, 1H), 4.34 -4.03 (m, 4H), 3.89 - 3.80 (m, 1H), 3.78 -3.74 (2 s, 3H), 3.58 - 3.51 (m, 2H), 3.17 (s, 2H), 2.21 - 2.01 (2 s, 3H). (Mixture of interconvertible atropisomers)



624


embedded image


606.1
Method D, RT = 1.50 min,99 %

1H NMR (400 MHz, DMSO-d6) δ = 9.14 - 8.83 (m, 1H), 8.00 - 7.76 (m, 2H), 7.53 - 7.46 (m, 1H), 7.35 (t, J = 73.8 Hz, 1H), 7.28 - 7.24 (m, 2H), 6.86 - 6.67 (m, 2H), 6.36 - 6.22 (m, 1H), 5.75 - 5.59 (m, 1H), 5.38 - 4.76 (m, 2H), 4.38 - 4.00 (m, 5H), 3.93 - 3.85 (m, 1H), 3.78 - 3.74 (2 s, 3H), 3.61 - 3.47 (m, 2H), 2.24 - 2.00 (2 s, 3H). (Mixture of interconvertible atropisomers)



625


embedded image


621
Method D, RT = 1.59 min, 10 0%

1H NMR (400 MHz, DMSO-d6) δ = 9.18 - 8.86 (m, 1H), 7.92 - 7.76 (m, 2H), 7.74 - 7.66 (m, 1H), 7.59 - 7.43 (m, 2H), 6.85 - 6.65 (m, 2H), 6.32 - 6.19 (m, 1H), 5.36 - 4.82 (m, 2H), 4.28 - 4.04 (m, 2H), 3.78 - 3.75 (2 s, 3H), 3.54 - 3.42 (m, 3H), 3.22 - 3.13 (m, 2H), 2.43 - 2.29 (m, 2H), 2.19 - 2.0 (2 s, 3H), 2.15 - 2.05 (m, 2H). (Mixture of interconvertible atropisomers)



626


embedded image


652.1
Method D, RT = 1.57 min,10 0%

1H NMR (400 MHz, DMSO-d6) δ = 9.11 - 8.81 (m, 1H), 7.96 - 7.81 (m, 2H), 7.75 - 7.62 (m, 1H), 7.28 - 7.23 (m, 2H), 7.35 (t, J= 73.8 Hz, 1H), 6.81 - 6.74 (m, 2H), 6.38 - 6.20 (m, 1H), 5.37 - 4.77 (m, 2H), 4.32 - 4.04 (m, 2H), 3.78 - 3.75 (2 s, 3H), 3.56 - 3.40 (m, 3H), 3.23 - 3.11 (m, 2H), 2.43 - 2.25 (m, 2H), 2.19 - 2.0 (2 s, 3H), 2.15 - 2.05 (m, 2H). (Mixture of interconvertible atropisomers)



627


embedded image


670.1
Method D, RT = 1.74 min,98 %

1H NMR (400 MHz, DMSO-d6) δ = 9.24 - 8.96 (m, 1H), 8.04 - 7.85 (m, 2H), 7.77 - 7.64 (m, 1H), 7.56 - 7.38 (m, 2H), 6.88 - 6.65 (m, 2H), 6.34 - 6.20 (m, 1H), 5.36 - 4.79 (m, 2H), 4.33 - 4.00 (m, 2H), 3.82 - 3.68 (m, 3H), 3.57 - 3.39 (m, 3H), 3.22 - 3.09 (m, 2H), 2.45 - 2.28 (m, 2H), 2.19 - 2.0 (2 s, 3H), 2.15 - 2.05 (m, 2H). (Mixture of interconvertible atropisomers)



628


embedded image


577.1
Method D, RT = 1.56 min,98 %

1H NMR (400 MHz, DMSO-d6) δ = 9.12 (d, J = 8.1 Hz, 1H), 7.95 - 7.82 (m, 2H), 7.28 (d, J= 8.6 Hz, 2H), 7.35 (t, J = 73.8 Hz, 1H), 6.96 (d, J = 1.2 Hz, 1H), 6.81 (d, J = 10.8 Hz, 2H), 5.77 (quin, J = 7.0 Hz, 1H), 4.91 (dd, J= 10.6, 8.2 Hz, 1H), 4.87 - 4.70 (m, 4H), 4.29 (q, J= 9.7 Hz, 1H), 4.15 - 3.97 (m, 2H), 3.77 (s, 3H), 2.24 (s, 3H).



629


embedded image


491.1
Method D, RT = 1.70 min,97 %

1H NMR (400 MHz, DMSO-d6) δ = 9.06 (d, J= 8.6 Hz, 1H), 7.85 (s, 1H), 7.82 (d, J= 8.3 Hz, 2H), 7.56 (d, J= 8.3 Hz, 2H), 6.77 (d, J= 10.8 Hz, 2H), 5.06 - 4.93 (m, 1H), 4.11 - 3.92 (m, 2H), 3.85 - 3.78 (m, 4H), 3.76 (s, 3H), 3.69 (s, 3H).



630


embedded image


523.1
Method D, RT = 1.67 min,98 %

1H NMR (400 MHz, DMSO-d6) δ = 9.00 (d, J= 8.8 Hz, 1H), 7.92 - 7.81 (m, 3H), 7.34 (t, J= 72.9 Hz, 1H), 7.27 (d, J= 8.8 Hz, 2H), 6.77 (d, J= 10.8 Hz, 2H), 5.00 (dd, J= 10.3, 8.8 Hz, 1H), 4.13 - 3.92 (m, 2H), 3.87 - 3.79 (m, 4H), 3.76 (s, 3H), 3.69 (s, 3H).



631


embedded image


541.1
Method D, RT = 1.84 min,98 %

1H NMR (400 MHz, DMSO-d6) δ = 9.10 (d, J = 8.6 Hz, 1H), 7.93 (d, J = 8.8 Hz, 2H), 7.86 (s, 1H), 7.48 (d, J = 8.6 Hz, 2H), 6.77 (d, J= 10.8 Hz, 2H), 5.01 (t, J = 9.4 Hz, 1H), 4.12 - 3.94 (m, 2H), 3.87 - 3.79 (m, 4H), 3.76 (s, 3H), 3.69 (s, 3H).



632


embedded image


548.3
Method D, RT = 2.482 min, 100%.

1H NMR (400 MHz, DMSO-d6) δ = 9.01 - 8.95 (m, 1H), 7.97 - 7.90 (m, 2H), 7.67 - 7.61 (m, 1H), 7.55 - 7.13 (m, 5H), 6.96 - 6.86 (m, 2H), 6.48 - 6.16 (m, 2H), 5.28 - 4.63 (m, 1H), 4.50 - 4.34 (m, 2H), 4.11 - 3.79 (m, 2H), 3.72 - 3.67 (2 s, 3H), 3.52 - 3.44 (m, 1H), 2.25 - 2.10 (2 s, 3H). (Mixture of interconvertible atropisomers)



633


embedded image


546.3
Method D, RT = 1.68 min,10 0%

1H NMR (400 MHz, DMSO-d6) δ = 9.14 - 8.85 (m, 1H), 7.86 - 7.81 (m, 2H), 7.57 - 7.54 (m, 3H), 6.78 - 6.74 (m, 2H), 6.23 - 6.18 (m, 1H), 5.38 - 4.87 (m, 1H), 4.44 - 4.07 (m, 4H), 3.78 - 3.74 (2 s, 3H), 3.52 - 3.50 (m, 3H), 3.24 (s, 3H), 2.23 - 2.05 (2 s, 3H). (Mixture of interconvertible atropisomers)



634


embedded image


632.2
Method D, RT = 1.82 min,98 %

1H NMR (400 MHz, DMSO-d6) δ = 9.14 - 8.85 (m, 1H), 7.97 - 7.81 (m, 2H), 7.67 - 7.54 (m, 1H), 7.34 (t, J = 74.0 Hz, 1H), 7.28 - 7.24 (m, 2H), 6.83 - 6.61 (m, 3H), 6.33 - 6.18 (m, 1H), 5.38 - 4.81 (m, 1H), 4.44 - 4.07 (m, 4H), 3.86 - 3.71 (m, 4H), 3.52 - 3.50 (m, 1H), 2.23 - 2.05 (2 s, 3H). (Mixture of interconvertible atropisomers)



635


embedded image


528.2
Method F, RT = 1.991 min, 99.1%

1H NMR (400 MHz, DMSO-d6) δ = 9.08 - 9.03 (m, 1H), 7.91 - 7.83 (m, 2H), 7.61 - 7.50 (m, 3H), 7.44 (t, J= 9.0 Hz, 1H), 6.87 - 6.77 (m, 2H), 6.21 (d, J = 7.0 Hz, 1H), 5.40 - 5.31 (m, 1H), 4.82 (dd, J = 11.0, 8.5 Hz, 1H), 4.20 - 3.91 (m, 4H), 3.77 - 3.72 (2 s, 3H), 3.63 - 3.55 (m, 2H), 3.25 (s, 3H), 2.22 - 2.07 (2 s, 3H). (Mixture of interconvertible atropisomers)



636


embedded image


564.2
Method F, RT = 2.338 min, 99.7%

1H NMR (400 MHz, DMSO-d6) δ = 9.12 - 9.07 (m, 1H), 8.01 - 7.95 (m, 2H), 7.60 - 7.38 (m, 4H), 6.87 - 6.75 (m, 2H), 6.20 (d, J = 7.0 Hz, 1H), 5.38 (dd, J = 11.5, 9.5 Hz, 1H), 4.94 (br t, J= 4.5 Hz, 1H), 4.83 - 4.80 (m, 1H), 4.19 - 3.87 (m, 4H), 3.80 - 3.70 (2 s, 3H), 3.68 - 3.54 (m, 2H), 2.22 - 2.07 (2 s, 3H). (Mixture of interconvertible atrop isomers)



637


embedded image


594.2
Method F, RT = 2.526 min, 99.5%

1H NMR (400 MHz, DMSO-d6) δ = 9.23 - 9.05 (m, 1H), 8.00 - 7.91 (m, 2H), 7.76 (d, J= 7.1 Hz, 1H), 7.53 - 7.45 (m, 2H), 6.83 - 6.73 (m, 2H), 6.39 - 6.32 (m, 1H), 5.51 (t, J = 7.3 Hz, 1H), 4.93 - 4.83 (m, 3H), 4.82 - 4.70 (m, 2H), 4.32 - 4.20 (m, 1H), 4.20 - 4.01 (m, 2H), 3.79 - 3.74 (2 s, 3H), 2.25 - 2.07 (2 s, 3H). (Mixture of interconvertible atropisomers)



638


embedded image


580.2
Method-D, RT = 1.890 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.23 - 9.03 (m, 1H), 7.97 - 7.90 (m, 2H), 7.58 - 7.42 (m, 3H), 6.80 - 6.72 (m, 2H), 5.38 - 4.84 (m, 1H), 4.29 - 4.02 (m, 2H), 3.99 - 3.80 (m, 2H), 3.76 - 3.71 (2 s, 3H), 3.51 - 3.40 (m, 1H), 2.12 (s, 3H), 2.02 - 1.96 (2 s, 3H), 1.24 - 1.16 (m, 3H). (Mixture of interconvertible atropisomers)



639


embedded image


580.1
Method-D, RT = 1.891 min, 98.5%

1H NMR (400 MHz, DMSO-d6) δ = 9.25 - 9.04 (m, 1H), 7.99 - 7.90 (m, 2H), 7.60 - 7.43 (m, 3H), 6.81 - 6.73 (m, 2H), 5.40 - 4.83 (m, 1H), 4.30 - 4.05 (m, 2H), 4.00 - 3.82 (m, 2H), 3.77 - 3.74 (2 s, 3H), 3.53 - 3.42 (m, 1H), 2.13 (s, 3H), 2.03 - 1.97 (2 s, 3H), 1.25 - 1.17 (m, 3H). (Mixture of interconvertible atropisomers)



640


embedded image


560.1
Method-D, RT = 1.737 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.20 - 8.98 (m, 1H), 7.88 - 7.80 (m, 2H), 7.60 7.43 (m, 3H), 6.81 - 6.73 (m, 2H), 5.39 -4.88 (m, 1H), 4.30 - 3.96 (m, 4H), 3.77 -3.75 (2 s, 3H), 3.60 - 3.54 (m, 2H), 3.52 -3.43 (m, 1H), 3.24 (2 s, 3H), 2.15 (s, 3H), 2.03 - 1.98 (2 s, 3H). (Mixture of interconvertible atropisomers)



641


embedded image


560.1
Method-D, RT = 1.739 min, 98.5%

1H NMR (400 MHz, DMSO-d6) δ = 9.19 - 8.99 (m, 1H), 7.87 - 7.80 (m, 2H), 7.58 - 7.42 (m, 3H), 6.81 - 6.73 (m, 2H), 5.37 - 4.86 (m, 1H), 4.28 - 3.94 (m, 4H), 3.76 - 3.74 (2 s, 3H), 3.60 - 3.54 (m, 2H), 3.51 - 3.40 (m, 1H), 3.23 (2 s, 3H), 2.13 (s, 3H), 2.02 - 1.97 (2 s, 3H). (Mixture of interconvertible atropisomers)



642


embedded image


562.1
Method-D, RT = 1.725 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.14 - 8.96 (m, 1H), 7.94 - 7.86 (m, 2H), 7.60 - 7.50 (m, 1H), 7.51 - 7.13 (m, 3H), 6.81 - 6.72 (m, 2H), 5.40 - 4.86 (m, 1H), 4.31 - 4.05 (m, 2H), 4.01 - 3.82 (m, 2H), 3.78 - 3.73 (2 s, 3H), 3.53 - 3.40 (m, 1H), 2.14 - 2.04 (2 s, 3H), 2.04 - 1.98 (2 s, 3H), 1.26 - 1.17 (m, 3H). (Mixture of interconvertible atrop isomers)



643


embedded image


582.1
Method D, RT = 1.603 min, 100%.

1H NMR (400 MHz, DMSO-d6) δ = 8.92 (d, J = 9.0 Hz, 1H), 7.97 - 7.87 (m, 2H), 7.69 (dd, J = 6.8, 2.0 Hz, 1H), 7.64 (dd, J = 7.3, 2.0 Hz, 1H), 7.35 (t, J = 74.6 Hz, 1H), 7.35 - 7.33 (m, 2H), 7.26 (d, J = 8.8 Hz, 2H), 6.94 - 6.84 (m, 2H), 6.37 (t, J = 7.1 Hz, 1H), 5.01 (dd, J = 11.2, 8.8 Hz, 1H), 4.46 - 4.42 (m, 1H), 4.33 - 4.29 (m, 1H), 4.16 (t, J = 8.4 Hz, 1H), 3.88 - 3.73 (m, 3H), 3.72 (s, 3H), 3.69 - 3.64 (m, 1H).



644


embedded image


582.1
Method D, RT = 1.59 min, 100%.

1H NMR (400 MHz, DMSO-d6) δ = 8.94 (d, J = 8.8 Hz, 1H), 7.92 (d, J = 8.6 Hz, 2H), 7.68 (dd, J = 6.6, 1.7 Hz, 1H), 7.64 (dd, J = 7.6, 1.7 Hz, 1H), 7.35 (t, J = 74.6 Hz, 1H), 7.35 - 7.33 (m, 2H), 7.26 (d, J = 8.8 Hz, 2H), 6.90 (d, J = 8.6 Hz, 2H), 6.37 (t, J = 7.0 Hz, 1H), 5.04 - 4.95 (m, 1H), 4.44 (dd, J = 12.8, 2.6 Hz, 1H), 4.38 - 4.29 (m, 1H), 4.12 - 4.04 (m, 1H), 3.91 - 3.72 (m, 4H), 3.72 (s, 3H).



645


embedded image


567.1
Method D, RT = 1.81 min,95 %

1H NMR (400 MHz, DMSO-d6) δ = 8.65 - 8.53 (m, 1H), 8.07 (d, J = 4.8 Hz, 1H), 7.77 (d, J = 4.8 Hz, 1H), 7.74 - 7.62 (m, 4H), 7.32 (t, J = 76.0 Hz, 1H), 7.19 (dd, J = 8.5, 2.5 Hz, 2H), 6.82 (d, J = 8.3 Hz, 2H), 5.08 - 4.99 (m, 1H), 4.48 - 4.32 (m, 4H), 4.00 - 3.88 (m, 1H), 3.70 (s, 3H), 2.89 - 2.74 (m, 2H).



646


embedded image


604.2
Method D, RT = 1.649 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.13 - 8.87 (m, 1H), 8.01 - 7.81 (m, 2H), 7.47 - 7.43 (m, 1H), 7.34 (t, J = 74.3 Hz, 1H), 7.28 - 7.24 (m, 2H), 6.83 - 6.69 (m, 2H), 5.38 - 4.87 (m, 2H), 4.26 - 3.87 (m, 5H), 3.78 - 3.74 (2 s, 3H), 3.67 - 3.59 (m, 2H), 3.53 - 3.43 (m, 1H), 2.71 - 2.65 (m, 1H), 2.55 - 2.50 (m, 1H), 1.83 - 1.49 (m, 5H).



647


embedded image


475.1
Method C, RT = 1.824 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.10 (d, J = 8.3 Hz, 1H), 7.80 (d, J = 9.0 Hz, 2H), 7.72 (d, J = 2.4 Hz, 1H), 7.60 - 7.48 (m, 2H), 6.78 (d, J = 10.8 Hz, 2H), 6.64 (d, J = 2.2 Hz, 1H), 4.97 (dd, J = 10.1, 8.7 Hz, 1H), 4.25 - 4.16 (m, 1H), 4.15 -4.03 (m, 3H), 3.92 - 3.81 (m, 1H), 3.77 (s, 3H), 1.35 (t, J = 7.2 Hz, 3H).



648


embedded image


507.1
Method C, RT = 1.780 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.04 (d, J = 8.6 Hz, 1H), 7.90 (d, J = 9.0 Hz, 2H), 7.72 (d, J = 2.4 Hz, 1H), 7.34 (t, J = 72.6 Hz, 1H), 7.28 (d, J = 9.0 Hz, 2H), 6.78 (d, J = 10.8 Hz, 2H), 6.65 (d, J = 2.4 Hz, 1H), 4.97 (dd, J = 10.3, 8.6 Hz, 1H), 4.27 - 4.16 (m, 1H), 4.16 - 4.01 (m, 3H), 3.90 - 3.81 (m, 1H), 3.77 (s, 3H), 1.35 (t, J = 7.2 Hz, 3H).



649


embedded image


525.1
Method C, RT = 1.961 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.14 (d, J = 8.3 Hz, 1H), 7.91 (d, J = 8.8 Hz, 2H), 7.73 (d, J = 2.4 Hz, 1H), 7.49 (d, J = 8.8 Hz, 2H), 6.78 (d, J = 10.8 Hz, 2H), 6.65 (d, J = 2.4 Hz, 1H), 4.98 (dd, J = 10.3, 8.3 Hz, 1H), 4.28 - 4.16 (m, 1H), 4.16 - 3.98 (m, 3H), 3.86 (t, J = 9.7 Hz, 1H), 3.77 (s, 3H), 1.35 (t, J = 7.2 Hz, 3H).



650


embedded image


505.1
Method D, RT = 1.658 min, 97.5%

1H NMR (400 MHz, DMSO-d6) δ = 9.14 (d, J = 8.3 Hz, 1H), 7.89 - 7.75 (m, 2H), 7.64 - 7.47 (m, 2H), 7.19 (d, J = 1.2 Hz, 1H), 6.88 (d, J = 1.2 Hz, 1H), 6.80 (d, J = 10.8 Hz, 2H), 4.87 (dd, J = 10.8, 8.1 Hz, 1H), 4.32 - 4.21 (m, 1H), 4.17 - 4.00 (m, 2H), 3.95 (br d, J = 10.0 Hz, 2H), 3.77 (s, 3H), 3.67 - 3.58 (m, 2H), 3.27 (s, 3H).



651


embedded image


537.2
Method D, RT = 1.622 min, 95.9%

1H NMR (400 MHz, DMSO-d6) δ = 9.08 (d, J = 8.1 Hz, 1H), 7.94 - 7.81 (m, 2H), 7.34 (t, J = 73.4 Hz, 1H), 7.28 (d, J = 8.8 Hz, 2H), 7.19 (d, J = 1.5 Hz, 1H), 6.88 (d, J = 1.5 Hz, 1H), 6.80 (d, J = 10.8 Hz, 2H), 4.86 (dd, J = 10.8, 8.1 Hz, 1H), 4.32 - 4.20 (m, 1H), 4.17 - 4.00 (m, 2H), 3.98 - 3.89 (m, 2H), 3.77 (s, 3H), 3.67 - 3.56 (m, 2H), 3.27 (s, 3H).



652


embedded image


555.1
Method D, RT = 1.809 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.18 (d, J = 8.1 Hz, 1H), 7.99 - 7.77 (m, 2H), 7.55 - 7.39 (m, 2H), 7.19 (d, J = 1.2 Hz, 1H), 6.88 (d, J = 1.2 Hz, 1H), 6.80 (d, J = 10.8 Hz, 2H), 4.88 (dd, J = 10.8, 8.1 Hz, 1H), 4.33 - 4.21 (m, 1H), 4.18 - 3.90 (m, 4H), 3.77 (s, 3H), 3.69 - 3.54 (m, 2H), 3.27 (s, 3H).



653


embedded image


552.2
Method D, RT = 1.77 min,10 0%

1H NMR (400 MHz, DMSO-d6) δ = 9.15 - 9.02 (m, 1H), 7.89 - 7.79 (m, 2H), 7.68 - 7.51 (m, 3H), 6.83 - 6.70 (m, 2H), 6.32 - 6.31(m, 1H), 6.29 (tt, J = 54.8, 5.1 Hz, 1H), 5.32 - 4.85 (m, 1H), 4.40 - 4.05 (m, 4H), 3.78 - 3.74 (2 s, 3H), 3.51 - 3.50 (m, 1H), 2.49 - 2.07 (2 s, 3H). (Mixture of interconvertible atropisomers)



654


embedded image


558.2
Method D, RT = 1.69 min,10 0%

1H NMR (400 MHz, DMSO-d6) δ = 9.04 - 8.98 (m, 1H), 7.87 - 7.82 (m, 2H), 7.59 - 7.52 (m, 3H), 6.81 - 6.57 (m, 2H), 6.32 - 6.27 (m, 1H), 5.41 - 5.32 (m, 1H), 4.90 (dd, J = 10.5, 8.5 Hz, 1H), 4.21 - 4.02 (m, 3H), 3.90 - 3.72 (m, 6H), 3.53 - 3.48 (m, 1H), 2.54 - 2.52 (m, 1H), 2.24 - 2.20 (2 s, 3H), 2.01 - 1.94 (m, 1H). (Mixture of interconvertible atropisomers)



655


embedded image


608.2
Method D, RT = 1.846 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.25 - 9.05 (m, 1H), 8.02 - 7.91 (m, 2H), 7.60 - 7.45 (m, 3H), 6.84 - 6.73 (m, 2H), 6.35 - 6.26 (m, 1H), 5.43 - 4.86 (m, 2H), 4.32 - 4.01 (m, 3H), 3.91 - 3.71 (m, 6H), 3.53 - 3.48 (m, 1H), 2.46 - 2.38 (m, 1H), 2.23 - 2.04 (2 s, 3H), 2.01 - 1.90 (m, 1H). (Mixture of interconvertible atrop isomers)



656


embedded image


600.2
Method D, RT = 1.813 min, 98.2%

1H NMR (400 MHz, DMSO-d6) δ = 9.05 (d, J = 9.0 Hz, 1H), 7.99 (d, J = 9.0 Hz, 2H), 7.69 - 7.65 (m, 2H), 7.49 (d, J = 8.5 Hz, 2H), 7.36 (d, J = 8.5 Hz, 2H), 6.91 (d, J = 9.0 Hz, 2H), 6.38 (t, J = 7.0 Hz, 1H), 5.06 - 4.98 (m, 1H), 4.45 (dd, J = 12.8, 2.8 Hz, 1H), 4.40 - 4.28 (m, 1H), 4.16 - 4.03 (m, 1H), 3.91 - 3.70 (m, 4H), 3.73 (s, 3H).



657


embedded image


600.2
Method D, RT = 1.828 min, 98.4%

1H NMR (400 MHz, DMSO-d6) δ = 9.03 (d, J = 8.5 Hz, 1H), 7.99 (d, J = 8.5 Hz, 2H), 7.69 - 7.65 (m, 2H), 7.49 (d, J = 8.5 Hz, 2H), 7.36 (d, J = 9.0 Hz, 2H), 6.91 (d, J = 9.0 Hz, 2H), 6.38 (t, J = 7.0 Hz, 1H), 5.02 (dd, J = 11.3, 8.8 Hz, 1H), 4.46 (dd, J = 13.1, 2.5 Hz, 1H), 4.39 - 4.28 (m, 1H), 4.17 (t, J = 8.3 Hz, 1H), 3.91 - 3.70 (m, 4H), 3.73 (s, 3H).



658


embedded image


579.2
Method D, RT = 1.89 min, 10 0%

1H NMR (400 MHz, DMSO-d6) δ = 9.16 - 8.93 (m, 1H), 8.05 - 7.93 (m, 1H), 7.93 - 7.77 (m, 2H), 7.34 (t, J = 74.0 Hz, 1H), 7.27 (d, J = 8.8 Hz, 2H), 6.88 - 6.66 (m, 2H), 5.36 - 4.74 (m, 1H), 4.45 - 4.12 (m, 4H), 3.82 - 3.72 (2 s, 3H), 3.72 - 3.51 (2 s, 3H), 3.23 - 3.18 (2 s, 3H), 2.26 - 2.02 (2 s, 3H). (Mixture of interconvertible atrop isomers)



659


embedded image


618.2
Method D, RT = 2.709 min, 99%.

1H NMR (400 MHz, DMSO-d6) δ = 9.23 - 9.04 (m, 1H), 8.00 - 7.91 (m, 2H), 7.72 - 7.61 (m, 1H), 7.53 - 7.44 (m, 2H), 6.83 - 6.73 (m, 2H), 6.39 - 6.32 (m, 1H), 5.98 - 5.91 (m, 1H), 5.37 - 4.82 (m, 1H), 4.34 - 4.00 (m, 4H), 3.80 - 3.75 (2 s, 3H), 3.63 - 3.52 (m, 1H), 2.28 - 2.07 (2 s, 3H). (Mixture of interconvertible atropisomers)



660


embedded image


511.1
Method C, RT = 1.895 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.13 (d, J = 8.3 Hz, 1H), 7.83 (d, J = 8.8 Hz, 2H), 7.80 (d, J = 2.4 Hz, 1H), 7.56 (d, J = 8.8 Hz, 2H), 6.79 (d, J = 10.8 Hz, 2H), 6.75 (d, J = 2.4 Hz, 1H), 6.34 (tt, J = 55.0, 8.6 Hz, 1H), 4.96 (dd, J = 10.1, 8.4 Hz, 1H), 4.62 - 4.56 (m, 2H), 4.26 - 4.03 (m, 2H), 3.86 (t, J = 9.3 Hz, 1H), 3.77 (s, 3H).



661


embedded image


543.1
Method C, RT = 1.852 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.06 (d, J = 8.3 Hz, 1H), 7.88 (d, J = 8.8 Hz, 2H), 7.80 (d, J = 2.4 Hz, 1H), 7.35 (t, J = 74.6 Hz, 1H), 7.26 (d, J = 8.8 Hz, 2H), 6.79 (d, J = 10.8 Hz, 2H), 6.75 (d, J = 2.2 Hz, 1H), 6.34 (tt, J = 55.0, 8.6 Hz, 1H), 4.95 (dd, J = 10.0, 8.6 Hz, 1H), 4.62 -4.56 (m, 2H), 4.27 - 4.07 (m, 2H), 3.86 (t, J = 9.3 Hz, 1H), 3.77 (s, 3H).



662


embedded image


561.1
Method C, RT = 2.041 min, 97.1%

1H NMR (400 MHz, DMSO-d6) δ =9.16 (d, J = 8.3 Hz, 1H), 7.93 (d, J = 8.8 Hz, 2H), 7.80 (d, J = 2.4 Hz, 1H), 7.50 (d, J = 8.8 Hz, 2H), 6.79 (d, J = 10.8 Hz, 2H), 6.75 (d, J = 2.4 Hz, 1H), 6.34 (tt, J = 58.2, 11.0 Hz, 1H), 4.97 (dd, J = 10.0, 8.6 Hz, 1H), 4.62 - 4.56 (m, 2H), 4.28 - 4.06 (m, 2H), 3.86 (t, J = 9.5 Hz, 1H), 3.77 (s, 3H).



663


embedded image


588.1
Method D, RT = 1.849 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.15 - 8.91 (m, 1H), 7.94 - 7.85 (m, 2H), 7.61 - 7.54 (m, 1H), 7.34 (t, J = 73.4 Hz, 1H), 7.30 - 7.22 (m, 2H), 6.78 - 6.74 (m, 2H), 5.40 - 4.92 (m, 1H), 4.25 - 3.84 (m, 4H), 3.78 - 3.74 (m, 3H), 3.53 - 3.43 (m, 1H), 2.71 - 2.52 (m, 3H), 1.82 - 1.53 (m, 5H), 1.22 (2t, J = 6.8 Hz, 3H). (Mixture of interconvertible atropisomers)



664


embedded image


588.1
Method D, RT = 1.849 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.15 - 8.91 (m, 1H), 7.94 - 7.85 (m, 2H), 7.61 - 7.54 (m, 1H), 7.34 (t, J = 73.4 Hz, 1H), 7.30 - 7.22 (m, 2H), 6.78 - 6.74 (m, 2H), 5.40 - 4.92 (m, 1H), 4.25 - 3.84 (m, 4H), 3.78 - 3.74 (m, 3H), 3.53 - 3.43 (m, 1H), 2.71 - 2.52 (m, 3H), 1.82 - 1.53 (m, 5H), 1.22 (2t, J = 6.8 Hz, 3H). (Mixture of interconvertible atropisomers)



665


embedded image


619.1
Method D, RT = 1.485 min, 95.7%

1H NMR (400 MHz, DMSO-d6) δ = 9.14 - 8.87 (m, 1H), 8.01 - 7.81 (m, 2H), 7.73 - 7.58 (m, 1H), 7.55 - 7.11 (m, 4H), 6.87 - 6.66 (m, 2H), 6.35 - 6.20 (m, 1H), 5.37 - 4.79 (m, 2H), 4.33 - 4.05 (m, 3H), 3.81 - 3.78 (2 s, 3H), 3.63 - 3.51 (m, 2H), 3.26 - 3.22 (m, 2H), 2.23 - 2.06 (2 s, 3H). (Mixture of interconvertible atropisomers)



666


embedded image


467.1
Method D, RT = 1.62 min,97 %

1H NMR (400 MHz, DMSO-d6) δ = 9.07 - 8.63 (m, 1H), 8.09 - 7.96 (m, 1H), 7.91 - 7.61 (m, 3H), 7.60 - 7.44 (m, 2H), 7.39 - 7.16 (m, 2H), 6.96 - 6.75 (m, 2H), 5.12 - 4.97 (m, 1H), 4.53 - 4.27 (m, 1H), 4.24 - 4.08 (m, 2H), 3.98 - 3.87 (m, 1H), 3.77 (s, 3H), 3.80 - 3.74 (m, 1H), 1.30 (t, J = 7.2 Hz, 3H).



667


embedded image


594
Method D, RT = 1.751 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.12 (d, J = 8.3 Hz, 1H), 7.94 (d, J = 9.0 Hz, 2H), 7.83 (d, J = 7.8 Hz, 1H), 7.49 (d, J = 9.0 Hz, 2H), 7.25 (d, J = 7.8 Hz, 1H), 6.78 (d, J = 10.8 Hz, 2H), 5.11 - 5.00 (m, 1H), 4.68 (t, J = 5.3 Hz, 2H), 4.28 - 4.19 (m, 2H), 4.14 - 4.10 (m, 3H), 3.77 (s, 3H).



668


embedded image


576.1
Method D, RT = 1.568 min, 97.9%

1H NMR (400 MHz, DMSO-d6) δ = 9.04 (d, J = 8.5 Hz, 1H), 7.99 - 7.85 (m, 2H), 7.83 (d, J = 7.6 Hz, 1H), 7.35 (t, J = 74.8 Hz, 1H), 7.27 (t, J = 7.9 Hz, 3H), 6.79 (d, J = 10.8 Hz, 2H), 5.12 - 4.98 (m, 1H), 4.68 (t, J = 5.2 Hz, 2H), 4.32 - 4.19 (m, 2H), 4.17 - 4.04 (m, 3H), 3.77 (s, 3H).



669


embedded image


598.2
Method D, RT = 1.57 min,98 %

1H NMR (400 MHz, DMSO-d6) δ = 9.11 (d, J = 8.5 Hz, 1H), 7.95 (d, J = 8.8 Hz, 2H), 7.62 - 7.58 (m, 2H), 7.49 (d, J = 8.8 Hz, 2H), 6.77 (d, J = 10.8 Hz, 2H), 6.32 (t, J = 6.9 Hz, 1H), 5.13 (dd, J =10.8, 8.5 Hz, 1H), 4.30 (dd, J =12.9, 3.4 Hz, 1H), 4.16 - 3.91 (m, 4H), 3.77 (s, 3H), 3.63 -3.59 (m, 2H), 3.41 - 3.33 (m, 3H).



670


embedded image


467.1
Method D, RT = 1.62 min,97 %

1H NMR (400 MHz, DMSO-d6) δ = 9.07 - 8.63 (m, 1H), 8.09 - 7.96 (m, 1H), 7.91 - 7.61 (m, 3H), 7.60 - 7.44 (m, 2H), 7.39 - 7.16 (m, 2H), 6.96 - 6.75 (m, 2H), 5.12 - 4.97 (m, 1H), 4.53 - 4.27 (m, 2H), 4.24 - 4.08 (m, 2H), 3.96 - 3.89 (m, 1H), 3.77 (s, 3H), 1.36 - 1.20 (t, J = 7.2 Hz, 3H).



671


embedded image


535.1
Method D, RT = 1.84 min,92 %

1H NMR (400 MHz, DMSO-d6) δ = 9.07 - 8.61 (m, 1H), 8.04 (dd, J = 13.4, 4.9 Hz, 1H), 7.86 (d, J = 8.8 Hz, 2H), 7.78 (d, J = 8.8 Hz, 1H), 7.56 (d, J = 8.6 Hz, 2H), 7.36 (d, J = 8.6 Hz, 2H), 6.91 (d, J = 8.6 Hz, 2H), 5.08 - 4.99 (m, 1H), 4.48 - 4.32 (m, 3H), 4.00 - 3.88 (m, 1H), 3.77 (s, 3H), 3.80 - 3.72 (m, 1H), 2.89 - 2.74 (m, 2H).



672


embedded image


567.1
Method D, RT = 1.81 min,95 %

1H NMR (400 MHz, DMSO-d6) δ = 8.95 (d, J = 8.5 Hz, 1H), 8.04 (d, J = 4.6 Hz, 1H), 7.97 - 7.86 (m, 2H), 7.77 (d, J = 4.6 Hz, 1H), 7.59 - 7.14 (m, 5H), 7.01 - 6.79 (m, 2H), 5.04 (dd, J = 11.7, 8.4 Hz, 1H), 4.54 - 4.42 (m, 1H), 4.37 (t, J = 6.8 Hz, 2H), 3.97 (t, J = 10.4 Hz, 1H), 3.84 - 3.75 (m, 1H), 3.73 (s, 3H), 2.88 - 2.72 (m, 2H).



673


embedded image


553.2
Method D, RT = 1.95 min,10 0%

1H NMR (400 MHz, DMSO-d6) δ = 9.13 (d, J = 8.1 Hz, 1H), 8.01 (d, J = 4.6 Hz, 1H), 7.99 - 7.82 (m, 2H), 7.70 (d, J = 4.4 Hz, 1H), 7.49 (d, J = 8.1 Hz, 2H), 6.78 (d, J = 10.8 Hz, 2H), 5.07 (dd, J = 10.8, 8.4 Hz, 1H), 4.42 - 4.27 (m, 1H), 4.25 -4.05 (m, 4H), 3.77 (s, 3H), 1.28 (t, J = 7.2 Hz, 3H).



674


embedded image


499.2
Method D, RT = 1.66 min,96 %

1H NMR (400 MHz, DMSO-d6) δ = 8.94 (br d, J = 8.6 Hz, 1H), 8.00 (d, J = 4.6 Hz, 1H), 7.95 - 7.85 (m, 2H), 7.72 (d, J = 4.6 Hz, 1H), 7.37 (t, J = 74.5 Hz, 1H), 7.36 -734 (m, 2H), 7.26 - 7.16 (m, 2H), 6.91 (d, J = 8.6 Hz, 2H), 5.03 (dd, J = 11.5, 8.3 Hz, 1H), 4.46 (dd, J = 9.8, 8.3 Hz, 1H), 4.14 (q, J = 7.1 Hz, 2H), 3.96 (t, J = 10.4 Hz, 1H), 3.81 - 3.68 (m, 1H), 3.77 (s, 3H), 1.28 (t, J = 7.1 Hz, 3H).



675


embedded image


517.2
Method D, RT = 1.84 min,96 %

1H NMR (400 MHz, DMSO-d6) δ = 9.03 (d, J = 8.3 Hz, 1H), 8.06 - 7.89 (m, 3H), 7.72 (d, J = 4.6 Hz, 1H), 7.48 (d, J = 8.1 Hz, 2H), 7.36 (d, J = 8.8 Hz, 2H), 6.91 (d, J = 8.8 Hz, 2H), 5.04 (dd, J = 11.9, 8.4 Hz, 1H), 4.51 - 4.38 (m, 1H), 4.14 (q, J = 7.3 Hz, 2H), 3.97 (t, J = 10.3 Hz, 1H), 3.79 - 3.75 (m, 1H), 3.73 (s, 3H), 1.28 (t, J = 7.3 Hz, 3H).



676


embedded image


614.2
Method-D, RT = 2.004 min, 93.7%

1H NMR (400 MHz, DMSO-d6) δ = 9.15 - 9.10 (m, 1H), 8.51 - 8.47 (m, 1H), 7.86 - 7.78 (m, 2H), 7.58 - 7.52 (m, 2H), 7.28 - 7.23 (m, 1H), 6.83 - 6.74 (m, 2H), 5.14 - 4.96 (m, 1H), 4.65 (s, 1H), 4.43 - 4.18 (m, 1H), 4.14 (s, 2H), 3.99 - 3.82 (m, 1H), 3.77 (s, 3H), 3.75 - 3.71 (m, 1H), 1.22 (s, 3H), 1.17 (s, 3H).



677


embedded image


548.2
Method D, RT = 1.42 min, 10 0%

1H NMR (400 MHz, DMSO-d6) δ = 9.07 (d, J = 8.8 Hz, 1H), 7.84 (d, J = 8.5 Hz, 2H), 7.63 - 7.53 (m, 4H), 6.77 (d, J = 10.5 Hz, 2H), 6.32 (t, J = 6.9 Hz, 1H), 5.12 (dd, J = 10.5, 8.6 Hz, 1H), 5.00 (br s, 1H), 4.65 (br s, 1H), 4.30 - 4.27 (m, 1H), 4.15 - 3.92 (m, 4H), 3.77 (s, 3H), 3.67-3.61 (m, 1H), 3.38 - 3.35 (m, 2H).



678


embedded image


580.2
Method D, RT = 1.40 min,98 %

1H NMR (400 MHz, DMSO-d6) δ = 9.00 (d, J = 8.3 Hz, 1H), 7.89 (d, J = 8.8 Hz, 2H), 7.61 (dd, J = 13.0, 7.0 Hz, 2H), 7.34 (t, J = 74.0 Hz, 1H), 7.27 (d, J = 8.8 Hz, 2H), 6.77 (d, J = 10.8 Hz, 2H), 6.32 (t, J = 7.0 Hz, 1H), 5.11 (t, J = 9.6 Hz, 1H), 5.04 - 4.94 (m, 1H), 4.83 - 4.68 (m, 1H), 4.30 - 4.31(m, 1H), 4.15 - 3.87 (m, 4H), 3.77 (s, 3H), 3.65 - 3.63 (m, 1H), 3.38 -3.35 (m, 2H).



679


embedded image


598.2
Method D, RT = 1.57 min,98 %

1H NMR (400 MHz, DMSO-d6) δ = 9.11 (d, J = 8.5 Hz, 1H), 8.02 - 7.89 (m, 2H), 7.63 (dd, J = 6.5, 1.9 Hz, 1H), 7.60 (dd, J = 7.1, 1.9 Hz, 1H), 7.49 (d, J = 8.5 Hz, 2H), 6.77 (d, J = 10.8 Hz, 2H), 6.32 (t, J = 7.1 Hz, 1H), 5.13 - 5.09 (dd, J = 10.8, 8.9 Hz, 1H), 5.00 (d, J = 5.8 Hz, 1H), 4.74 (t, J = 5.8 Hz, 1H), 4.30 (dd, J = 12.9, 2.9 Hz, 1H), 4.15 - 3.92 (m, 4H), 3.76 (s, 3H), 3.64 - 3.60 (m, 1H), 3.41 -3.36 (m, 2H).



680


embedded image


548.2
Method D, RT = 1.42 min,98 %

1H NMR (400 MHz, DMSO-d6) δ = 9.06 (d, J = 8.5 Hz, 1H), 7.92 - 7.78 (m, 2H), 7.63 (dd, J = 6.6, 2.0 Hz, 1H), 7.59 (dd, J = 7.3, 2.0 Hz, 1H), 7.58 - 7.43 (m, 2H), 6.77 (d, J = 10.5 Hz, 2H), 6.32 (t, J = 7.3 Hz, 1H), 5.12 - 5.07 (m, 1H), 5.04 - 4.94 (m, 1H), 4.80 - 4.69 (m, 1H), 4.30 - 4.27 (m, 1H), 4.14 - 3.90 (m, 4H), 3.77 (s, 3H), 3.64 - 3.60 (m, 1H), 3.41 - 3.36 (m, 2H).



681


embedded image


580.3
Method D, RT = 1.40 min,98 %

1H NMR (400 MHz, DMSO-d6) δ = 9.00 (d, J = 8.5 Hz, 1H), 7.90 (d, J = 8.8 Hz, 2H), 7.63 (dd, J = 6.8, 2.0 Hz, 2H), 7.34 (t, J = 74.0 Hz, 1H), 7.27 (d, J = 8.8 Hz, 2H), 6.78 - 6.75 (m, 2H), 6.32 (t, J = 7.0 Hz, 1H), 5.13 - 5.08 (m, 1H), 4.32 - 4.28 (m, 1H), 4.15 - 3.92 (m, 4H), 3.77 (s, 3H), 3.63 - 3.60 (m, 2H), 3.38 - 3.33 (m, 3H).



682


embedded image


604.3
Method D, RT = 1.69 min,98 %

1H NMR (400 MHz, DMSO-d6) δ = 9.14 - 8.87 (m, 1H), 7.96 - 7.84 (m, 2H), 7.62 - 7.50 (m, 1H), 7.28 (t, J = 75.1 Hz, 1H), 7.37 - 7.13 (m, 2H), 6.81 - 6.68 (m, 2H), 6.26 - 6.12 (m, 1H), 5.36 - 4.84 (m, 2H), 4.30 - 4.04 (m, 3H), 3.81 - 3.72 (2 s, 3H), 3.66 - 3.62 (m, 1H), 3.51 - 3.45 (m, 1H), 3.12 - 3.10 (m, 1H), 2.22 - 2.05 (2 s, 3H), 0.92 - 0.68 (m, 1H), 0.48 - 0.32 (m, 2H), 0.32 - 0.04 (m, 2H). (Mixture of interconvertible atropisomers)



683


embedded image


622.3
Method D, RT = 1.85 min,98 %

1H NMR (400 MHz, DMSO-d6) δ = 9.31 - 8.93 (m, 1H), 8.06 - 7.83 (m, 2H), 7.67 - 7.52 (m, 1H), 7.52 - 7.41 (m, 2H), 6.86 - 6.68 (m, 2H), 6.27 - 6.12 (m, 1H), 5.38 - 4.84 (m, 2H), 4.32 - 4.07 (m, 3H), 3.80 - 3.71 (2 s, 3H), 3.66 - 3.60 (m, 1H), 3.51 - 3.45 (m, 1H), 3.18 - 3.10 (m, 2H), 2.21 - 1.96 (2 s, 3H), 0.93 - 0.75 (m, 1H), 0.48 - 0.33 (m, 2H), 0.30 - 0.04 (m, 2H). (Mixture of interconvertible atropisomers)



684


embedded image


573.2
Method D, RT = 1.67 min,98 %

1H NMR (400 MHz, DMSO-d6) δ = 9.21 - 8.85 (m, 1H), 7.92 - 7.79 (m, 2H), 7.69 - 7.45 (m, 3H), 6.81 - 6.68 (m, 2H), 6.28 - 6.08 (m, 1H), 5.38 - 4.82 (m, 2H), 4.32 - 4.04 (m, 3H), 3.80 - 3.75 (2 s, 3H), 3.72 - 3.60 (m, 1H), 3.51 - 3.45 (m, 1H), 3.21 - 3.02 (m, 1H), 2.20 - 1.99 (2 s, 3H), 0.91 - 0.74 (m, 1H), 0.47 - 0.33 (m, 2H), 0.29 - 0.20 (m, 1H), 0.20 - 0.07 (m, 1H). (Mixture of interconvertible atropisomers)



685


embedded image


604.3
Method D, RT = 1.72 min,10 0%

1H NMR (400 MHz, DMSO-d6) δ = 9.17 - 8.82 (m, 1H), 8.01 - 7.81 (m, 2H), 7.33 (t, J = 75.1 Hz, 1H), 7.58 - 7.16 (m, 3H), 6.77 (dd, J = 10.6, 4.9 Hz, 2H), 6.19 (dd, J = 12.3, Hz, 1H), 5.39 - 4.78 (m, 2H), 4.31 - 4.03 (m, 3H), 3.81 - 3.72 (2 s, 3H), 3.67 - 3.60 (m, 1H), 3.51 - 3.45 (m, 1H), 3.20 - 3.06 (m, 1H), 2.23 - 1.99 (2 s, 3H), 0.91 - 0.71 (m, 1H), 0.48 - 0.33 (m, 2H), 0.31 - 0.21 (m, 1H), 0.19 - 0.07 (m, 1H). (Mixture of interconvertible atrop isomers)



686


embedded image


622.3
Method D, RT = 1.87 min, 98%

1H NMR (400 MHz, DMSO-d6) δ = 9.22 - 8.95 (m, 1H), 8.03 - 7.86 (m, 2H), 7.58 - 7.54 (m, 1H), 7.53 - 7.37 (m, 2H), 6.79 - 6.75 (m, 2H), 6.22 - 6.17 (m, 1H), 5.37 - 4.95 (m, 1H), 4.94 - 4.84 (m, 1H), 4.29 - 4.04 (m, 3H), 3.77 - 3.76 (2 s, 3H), 3.72 - 3.61 (m, 1H), 3.55 - 3.46 (m, 1H), 3.18 - 3.10 (m, 1H), 2.22 - 2.04 (2 s, 3H), 0.88 - 0.78 (m, 1H), 0.46 - 0.33 (m, 2H), 0.30 - 0.22 (m, 1H), 0.19 - 0.09 (m, 1H). (Mixture of interconvertible atropisomers)



687


embedded image


556.2
Method D, RT = 1.881 min, 100%.

1H NMR (400 MHz, DMSO-d6) δ = 9.14 - 8.91 (m, 1H), 8.08 - 7.92 (m, 2H), 7.79 - 7.62 (m, 1H), 7.50 - 7.46 (m, 2H), 7.42 - 7.23 (m, 2H), 6.93 - 6.89 (m, 2H), 6.34 - 6.14 (m, 1H), 5.28 - 4.65 (m, 2H), 4.12 - 3.82 (m, 3H), 3.78 - 3.48 (m, 4H), 2.36 - 2.24 (m, 3H), 2.21 - 2.08 (2 s, 3H), 1.84 - 1.65 (m, 1H), 0.58 - 0.21 (m, 1H). (Mixture of interconvertible atropisomers)



688


embedded image


574.2
Method D, RT = 2.072 min, 99%.

1H NMR (400 MHz, DMSO-d6) δ = 9.16 - 8.97 (m, 1H), 8.07 - 7.92 (m, 2H), 7.82 - 7.67 (m, 1H), 7.65 - 7.38 (m, 3H), 6.90 - 6.70 (m, 2H), 6.32 - 6.15 (m, 1H), 5.82 - 5.32 (m, 1H), 5.11 - 4.81 (m, 2H), 4.32 - 3.73 (m, 4H), 3.70 - 3.55 (m, 2H), 2.44 - 2.24 (m, 3H), 2.22 - 2.05 (2 s, 3H), 1.99 - 1.72 (m, 1H), 0.54 - 0.22 (m, 1H). (Mixture of interconvertible atropisomers)



689


embedded image


556.3
Method D, RT = 1.819 min, 96%.

1H NMR (400 MHz, DMSO-d6) δ = 9.05 - 8.85 (m, 1H), 8.00 - 7.87 (m, 2H), 7.81 - 7.65 (m, 1H), 7.59 - 7.39 (m, 1H), 7.38 - 6.92 (m, 3H), 6.87 - 6.66 (m, 2H), 6.33 - 6.19 (m, 1H), 5.42 - 4.81 (m, 2H), 4.20 3.89 (m, 3H), 3.78 - 3.74 (2 s, 3H), 3.63 - 3.54 (m, 1H), 2.39 - 2.23 (m, 3H), 2.22 - 2.08 (2 s, 3H), 1.84 - 1.70 (m, 1H), 0.56 - 0.30 (m, 1H). (Mixture of interconvertible atropisomers)



690


embedded image


503.1
Method D, RT = 1.71 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 8.99 (d, J = 8.6 Hz, 1H), 8.04 (d, J = 4.6 Hz, 1H), 7.91 - 7.83 (m, 2H), 7.78 (d, J = 4.6 Hz, 1H), 7.59 - 7.50 (m, 2H), 7.40 - 7.31 (m, 2H), 6.95 - 6.86 (m, 2H), 6.39 (tt, J = 54.8, 4.4 Hz, 1H), 5.04 (dd, J = 11.6, 8.4 Hz, 1H), 4.55 (dt, J = 14.5, 4.0 Hz, 2H), 4.46 (dd, J = 9.9, 8.2 Hz, 1H), 3.98 (t, J = 10.4 Hz, 1H), 3.82 - 3.74 (m, 1H), 3.73 (s, 3H).



691


embedded image


535.1
Method D, RT = 1.86 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 8.93 (d, J = 8.6 Hz, 1H), 8.04 (d, J = 4.9 Hz, 1H), 7.94 - 7.86 (m, 2H), 7.79 (d, J = 4.6 Hz, 1H), 7.40 - 7.34 (m, 2H), 7.33 (t, J = 75.1 Hz, 1H), 7.26 (d, J = 8.8 Hz, 2H), 6.95 - 6.86 (m, 2H), 6.39 (tt, J = 55.8, 4.4 Hz, 1H), 5.03 (dd, J = 11.6, 8.4 Hz, 1H), 4.56 (dt, J = 14.4, 4.2 Hz, 2H), 4.46 (dd, J = 9.9, 8.2 Hz, 1H), 3.98 (t, J = 10.4 Hz, 1H), 3.82 - 3.74 (m, 1H), 3.73 (s, 3H).



692


embedded image


553.1
Method D, RT = 1.86 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.04 (d, J = 8.3 Hz, 1H), 8.05 (d, J = 4.6 Hz, 1H), 8.01 - 7.92 (m, 2H), 7.79 (d, J = 4.6 Hz, 1H), 7.48 (d, J = 8.1 Hz, 2H), 7.41 -7.29 (m, 2H), 6.96 - 6.85 (m, 2H), 6.40 (tt, J = 55.8, 4.3, Hz, 1H), 5.05 (dd, J = 11.6, 8.4 Hz, 1H), 4.56 (dt, J = 14.5, 4.3 Hz, 2H), 4.46 (dd, J = 9.9, 8.4 Hz, 1H), 3.98 (t, J = 10.4 Hz, 1H), 3.81 - 3.73 (m, 1H), 3.72 (s, 3H).



693


embedded image


604.3
Method D, RT = 1.629 min, 99%.

1H NMR (400 MHz, DMSO-d6) δ = 9.14 - 8.81 (m, 1H), 7.96 - 7.82 (m, 2H), 7.74 - 7.58 (m, 1H), 7.58 - 7.08 (m, 3H), 6.76 (m, 2H), 6.32 - 6.18 (m, 1H), 5.39 - 4.77 (m, 1H), 4.32 - 4.02 (m, 2H), 4.00 - 3.85 (m, 2H), 3.83 - 3.71 (m, 4H), 3.68 - 3.57 (m, 2H), 3.54 - 3.43 (m, 2H), 2.71 - 2.61 (m, 1H), 2.22 - 2.02 (2 s, 3H), 1.93 - 1.78 (m, 1H), 1.68 - 1.51 (m, 1H). (Mixture of interconvertible atrop isomers)



694


embedded image


521
Method D, RT = 1.78 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.02 (d, J = 8.6 Hz, 1H), 8.05 (d, J = 4.6 Hz, 1H), 7.91 - 7.80 (m, 2H), 7.78 (d, J = 4.6 Hz, 1H), 7.61 - 7.43 (m, 3H), 6.90 - 6.75 (m, 2H), 6.39 (tt, J = 56.2, 5.1 Hz, 1H), 5.13 (dd, J = 11.1, 8.4 Hz, 1H), 4.55 (dt, J = 14.4, 4.3, Hz, 2H), 4.46 (t, J = 7.9 Hz, 1H), 4.09 - 3.88 (m, 2H), 3.75 (s, 3H).



695


embedded image


604.3
Method D, RT = 1.619 min, 100%.

1H NMR (400 MHz, DMSO-d6) δ = 9.14 - 8.81 (m, 1H), 7.98 - 7.81 (m, 2H), 7.73 - 7.58 (m, 1H), 7.56 - 7.04 (m, 3H), 6.78 - 6.74 (m, 2H), 6.31 - 6.11 (m, 1H), 5.41 - 4.81 (m, 1H), 4.32 - 3.97 (m, 3H), 3.94 - 3.72 (m, 5H), 3.69 - 3.57 (m, 2H), 3.55 - 3.42 (m, 2H), 2.70 - 2.61 (m, 1H), 2.21 - 1.97 (2 s, 3H), 1.93 - 1.80 (m, 1H), 1.71 - 1.54 (m, 1H). (Mixture of interconvertible atropisomers)



696


embedded image


571.1
Method D, RT = 1.92 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.06 (d, J = 8.6 Hz, 1H), 8.05 (d, J = 4.9 Hz, 1H), 8.00 - 7.89 (m, 2H), 7.78 (d, J = 4.9 Hz, 1H), 7.54 (t, J = 8.8 Hz, 1H), 7.48 (d, J = 8.3 Hz, 2H), 6.86 - 6.75 (m, 2H), 6.39 (tt, J = 54.8, 5.1 Hz, 1H), 5.13 (dd, J = 11.0, 8.6 Hz, 1H), 4.55 (dt, J = 14.4, 4.2 Hz, 2H), 4.47 (t, J = 7.9 Hz, 1H), 4.08 - 3.92 (m, 2H), 3.75 (s, 3H).



697


embedded image


622.2
Method D, RT = 1.788 min, 97%.

1H NMR (400 MHz, DMSO-d6) δ = 9.23 - 8.92 (m, 1H), 8.05 - 7.87 (m, 2H), 7.78 - 7.61 (m, 1H), 7.55 - 7.37 (m, 2H), 6.78 - 6.73 (m, 2H), 6.30 - 6.13 (m, 1H), 5.38 - 4.81 (m, 1H), 4.31 - 3.95 (m, 3H), 3.93 - 3.83 (m, 2H), 3.75 - 3.70 (s, 3H), 3.67 -3.58 (m, 2H), 3.53 - 3.43 (m, 2H), 2.72 -2.64 (m, 1H), 2.24 - 2.02 (2 s, 3H), 1.93 -1.82 (m, 1H), 1.68 - 1.54 (m, 1H). (Mixture of interconvertible atropisomers)



698


embedded image


600.2
Method D, RT = 1.642 min, 96%.

1H NMR (400 MHz, DMSO-d6) δ = 8.97 - 8.92 (m, 1H), 7.98 - 7.83 (m, 2H), 7.60 - 7.58 (m, 1H), 7.56 - 7.13 (m, 2H), 7.10 (m, 2H), 6.87 - 6.70 (m, 2H), 6.22 - 6.19 (m, 1H), 5.43 - 4.74 (m, 1H), 4.19 - 3.87 (m, 3H), 3.87 - 3.70 (m, 5H), 3.62 - 3.37 (m, 1H), 3.26 - 3.15 (m, 3H), 2.23 - 2.06 (2 s, 3H), 2.04 - 1.93 (m, 1H), 1.49 - 1.38 (m, 2H), 1.34 - 1.19 (m, 2H). (Mixture of interconvertible atrop isomers)



699


embedded image


582.3
Method D, RT = 1.565 min, 94%.

1H NMR (400 MHz, DMSO-d6) δ = 8.95 - 8.93 (m, 1H), 7.95 - 7.92 (m, 2H), 7.61 - 7.59 (m, 1H), 7.39 - 7.22 (m, 5H), 6.92 - 6.90 (m, 2H), 6.21 (d, J = 6.8 Hz, 1H), 5.32 - 4.58 (m, 1H), 3.94 - 3.69 (m, 9H), 3.67 - 3.38 (m, 1H), 3.30 - 3.18 (m, 2H), 2.23 - 2.06 (2 s, 3H), 2.03 - 1.90 (m, 1H), 1.51 - 1.36 (m, 2H), 1.34 - 1.16 (m, 2H). (Mixture of interconvertible atropisomers)



700


embedded image


600.3
Method D, RT = 1.75 min, 94%.

1H NMR (400 MHz, DMSO-d6) δ = 9.05 - 9.03 (m, 1H), 8.02 - 7.97 (m, 2H), 7.61 -7.59 (m, 1H),7.49 - 7.47 (m, 2H), 7.40 -7.30 (m, 2H), 6.93 - 6.90 (m, 2H), 6.21 (d, J = 6.8 Hz, 1H), 5.31 - 4.63 (m, 1H), 3.93 - 3.69 (m, 10H), 3.23 (m, 2H), 2.18 - 2.06 (2 s, 3H), 2.03 - 1.89 (m, 1H), 1.51 - 1.36 (m, 2H), 1.32 - 1.21 (m, 2H). (Mixture of interconvertible atropisomers)



701


embedded image


638.3
Method D, RT = 1.61 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.10 - 8.90 (m, 1H), 7.94 - 7.84 (m, 2H), 7.79 - 7.68 (m, 1H), 7.33 (t, J = 73.6 Hz, 1H), 7.26 - 7.24 (m, 2H), 6.81 - 6.68 (m, 2H), 6.40 - 6.29 (m, 1H), 5.49 - 4.75 (m, 2H), 4.31 - 4.04 (m, 3H), 3.78 - 3.74 (2 s, 3H), 3.62 - 3.47 (m, 4H), 3.29 - 3.23 (m, 1H), 2.48 - 2.39 (m, 1H), 2.24 - 2.02 (2 s, 3H). (Mixture of interconvertible atropisomers)



702


embedded image


656.2
Method D, RT = 1.78 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.19 - 9.00 (m, 1H), 8.00 - 7.88 (m, 2H), 7.77 - 7.67 (m, 1H), 7.52 - 7.41 (m, 2H), 6.82 - 6.70 (m, 2H), 6.40 - 6.28 (m, 1H), 5.46 - 4.81 (m, 2H), 4.29 - 4.05 (m, 3H), 3.78 - 3.74 (2 s, 3H), 3.62 - 3.45 (m, 4H), 3.27 - 3.21 (m, 1H), 2.47 - 2.38 (m, 1H), 2.24 - 2.04 (2 s, 3H). (Mixture of interconvertible atrop isomers)



703


embedded image


612.2
Method D, RT = 1.412 min, 95.6%

1H NMR (400 MHz, DMSO-d6) δ = 9.12 (dd, J = 14.9, 8.4 Hz, 1H), 7.95 (d, J = 8.8 Hz, 2H), 7.84 - 7.67 (m, 1H), 7.49 (t, J = 7.3 Hz, 2H), 7.26 (d, J = 7.5 Hz, 1H), 6.78 (t, J = 10.1 Hz, 2H), 5.20 - 4.98 (m, 1H), 4.68 (t, J = 5.1 Hz, 1H), 4.26 - 4.21 (m, 1H), 4.17 - 4.03 (m, 2H), 4.01 - 3.90 (m, 1H), 3.77 (s, 3H), 3.75 - 3.70 (m, 1H), 3.34 - 3.30 (m, 1H).



704


embedded image


572.2
Method D, RT = 3.00 min, 99%.

1H NMR (400 MHz, DMSO-d6) δ = 9.06 - 9.01 (m, 1H), 8.05 - 7.94 (m, 2H), 7.63 - 7.44 (m, 3H), 7.42 - 7.28 (m, 2H), 6.98 - 6.84 (m, 2H), 6.31 - 6.27 (m, 1H), 5.38 - 5.34 (m, 1H), 5.25 - 4.67 (m, 1H), 4.14 - 3.99 (m, 2H), 3.95 - 3.81 (m, 3H), 3.79 - 3.74 (m, 1H), 3.75 - 3.70 (2 s, 3H), 3.67 - 3.45 (m, 1H), 2.48 - 2.39 (m, 1H), 2.26 - 2.08 (2 s, 3H), 2.04 - 1.90 (m, 1H). (Mixture of interconvertible atropisomers)



705


embedded image


594.2
Method F, RT = 2.526 min, 99.9%

1H NMR (400 MHz, DMSO-d6) δ = 9.06 (d, J = 8.8 Hz, 1H), 7.98 (d, J = 8.8 Hz, 2H), 7.69 (dd, J = 7.0, 1.6 Hz, 1H), 7.57 (dd, J = 7.3, 1.6 Hz, 1H), 7.54 - 7.46 (m, 3H), 6.85 - 6.78 (m, 2H), 6.35 (t, J = 7.0 Hz, 1H), 5.20 - 5.01 (m, 3H), 4.19 - 4.12 (m, 1H), 4.06 - 3.96 (m, 1H), 3.80 - 3.64 (m, 5H), 3.75 (s, 3H), 3.24 (s, 3H).



706


embedded image


632.2
Method D, RT = 1.765 min, 98.8%

1H NMR (400 MHz, DMSO-d6) 6 = 9.15 - 8.83 (m, 1H), 7.97 - 7.79 (m, 2H), 7.69 - 7.56 (m, 1H), 7.35 (t, J = 74.8 Hz, 1H), 7.31 - 7.27 (m, 2H), 6.84 - 6.66 (m, 3H), 6.34 - 6.19 (m, 1H), 5.36 - 4.80 (m, 1H), 4.46 - 4.08 (m, 4H), 3.91 - 3.69 (m, 4H), 3.52 - 3.49 (m, 1H), 2.26 - 1.97 (2 s, 3H). (Mixture of interconvertible atropisomers)



707


embedded image


632.3
Method C, RT = 1.720 min, 100%

1H NMR (400 MHz, DMSO-d6) δ = 9.14 - 8.86 (m, 1H), 7.97 - 7.77 (m, 2H), 7.69 - 7.56 (m, 1H), 7.35 (t, J = 74.8 Hz, 1H), 7.31 - 7.27 (m, 2H), 6.85 - 6.53 (m, 3H), 6.34 - 6.15 (m, 1H), 5.38 - 4.78 (m, 1H), 4.47 - 4.01 (m, 4H), 3.91 - 3.69 (m, 4H), 3.56 - 3.47 (m, 1H), 2.25 - 2.04 (2 s, 3H). (Mixture of interconvertible atropisomers)



708


embedded image


612.2
Method-D, RT = 1.918 min, 98.4%

1H NMR (400 MHz, DMSO-d6) δ = 9.13 - 9.07 (m, 1H), 8.66 - 8.59 (m, 1H), 7.86 - 7.79 (m, 2H), 7.56 (d, J = 8.6 Hz, 2H), 7.39 - 7.32 (m, 1H), 6.78 (d, J = 11.5 Hz, 2H), 5.39 - 5.34 (m, 1H), 5.14 - 5.04 (m, 1H), 4.48 - 4.13 (m, 2H), 4.01 - 3.73 (m, 7H), 3.33 - 3.30 (m, 1H), 2.35 - 2.27 (m, 1H), 2.12 - 1.91 (m, 1H). (Mixture of interconvertible atropisomers)



709


embedded image


612.2
Method-D, RT = 1.918 min, 97.4%

1H NMR (400 MHz, DMSO-d6) δ = 9.14 - 9.07 (m, 1H), 8.67 - 8.58 (m, 1H), 7.87 - 7.76 (m, 2H), 7.56 (d, J = 8.6 Hz, 2H), 7.36 (br d, J = 5.6 Hz, 1H), 6.78 (d, J = 10.8 Hz, 2H), 5.39 - 5.31 (m, 1H), 5.13 -5.02 (m, 1H), 4.47 - 4.13 (m, 2H), 4.01 -3.73 (m, 7H), 3.33 - 3.30 (m, 1H), 2.37 -2.22 (m, 1H), 2.09 - 1.94 (m, 1H). (Mixture of interconvertible atropisomers)



710


embedded image


544.2
Method D, RT = 1.207 min, 100%.

1H NMR (400 MHz, DMSO-d6) δ = 9.07 (d, J = 8.8 Hz, 1H), 8.53 (s, 1H), 8.12 (s, 1H), 7.89 - 7.74 (m, 2H), 7.62 - 7.50 (m, 2H), 6.77 (d, J = 10.8 Hz, 2H), 5.17 - 5.04 (m, 2H), 4.17 - 4.06 (m, 1H), 4.00 - 3.92 (m, 2H), 3.76 (s, 3H), 3.19 - 3.06 (m, 3H), 2.97 (dd, J = 11.8, 3.8 Hz, 1H), 2.89 - 2.79 (m, 1H), 2.30 - 2.18 (m, 1H), 1.92 - 1.88 (m, 1H).



711


embedded image


663.3
Method-C, RT = 1.606 min, 97.14%

1H NMR (400 MHz, DMSO-d6) δ = 8.88 (d, J = 8.3 Hz, 1H), 7.93 - 7.86 (m, 2H), 7.85 - 7.80 (m, 1H), 7.35 (t, J = 72 Hz, 1H), 7.30 - 7.23 (m, 2H), 6.84 - 6.76 (m, 2H), 6.72 - 6.68 (m, 1H), 5.67 (dd, J = 12.5, 8.3 Hz, 1H), 5.03 - 4.90 (m, 1H), 4.49 (dt, J = 47.2, 4.5 Hz, 2H), 4.35 - 4.26 (m, 1H), 3.82 (s, 3H), 3.78 (s, 3H), 2.98 (br d, J = 10.8 Hz, 2H), 2.69 - 2.63 (m, 1H), 2.62 - 2.55 (m, 2H), 2.15 - 2.05 (m, 2H), 1.84 - 1.68 (m, 4H), 1.21 (d, J = 6.2 Hz, 3H).



712


embedded image


522.1
Method C, RT = 1.594 min, 96.0%.

1H NMR (400 MHz, DMSO-d6) δ = 9.33 (d, J = 1.0 Hz, 1H), 9.15 (d, J = 8.3 Hz, 1H), 8.14 (s, 1H), 7.85 (d, J = 8.2 Hz, 2H), 7.77 (d, J = 6.5 Hz, 2H), 7.58 (d, J = 8.5 Hz, 2H), 6.80 (d, J = 10.8 Hz, 2H), 5.17 (dd, J = 11.1, 8.6 Hz, 1H), 4.64 -4.54 (m, 1H), 4.41 (t, J = 10.1 Hz, 1H), 4.23 (q, J = 10.0 Hz, 1H), 3.78 (s, 3H).



713


embedded image


558.2
Method D, RT = 1.623 min, 99.7%.

1H NMR (400 MHz, DMSO-d6) δ = 9.08 (d, J = 8.5 Hz, 1H), 8.64 (s, 1H), 8.13 (s, 1H), 7.88 - 7.79 (m, 2H), 7.60 - 7.53 (m, 2H), 6.78 (d, J = 11.0 Hz, 2H), 5.26 - 5.17 (m, 1H), 5.12 (dd, J = 11.3, 8.8 Hz, 1H), 4.17 - 4.05 (m, 1H), 3.96 (d, J = 9.5 Hz, 2H), 3.77 (s, 3H), 3.06 (td, J = 8.8, 3.5 Hz, 1H), 2.92 (d, J = 9.0 Hz, 1H), 2.59 -2.53 (m, 1H), 2.47 - 2.38 (m, 1H), 2.32 (s, 3H), 2.24 (m, 1H), 1.98 - 1.83 (m, 1H).



714


embedded image


544.1
Method D, RT = 1.204 min, 98%.

1H NMR (400 MHz, DMSO-d6) δ = 9.07 (d, J = 8.5 Hz, 1H), 8.53 (s, 1H), 8.13 (s, 1H), 7.89 - 7.76 (m, 2H), 7.64 - 7.46 (m, 2H), 6.77 (d, J = 10.8 Hz, 2H), 5.18 - 5.02 (m, 2H), 4.15 - 4.04 (m, 1H), 3.99 - 3.91 (m, 2H), 3.76 (s, 3H), 3.17 - 3.09 (m, 3H), 3.01 (dd, J = 12.0, 3.8 Hz, 1H), 2.91 - 2.82 (m, 1H), 2.30 - 2.20 (m, 1H), 1.94 - 1.86 (m, 1H).



715


embedded image


631.2
Method D, RT = 1.51 min, 96%.

1H NMR (400 MHz, DMSO-d6) δ = 9.11 (d, J = 8.3 Hz, 1H), 8.05 (s, 1H), 7.90 (d, J = 8.8 Hz, 2H), 7.36 (t, J = 72.0 Hz, 1H), 7.27 (d, J = 8.8 Hz, 2H), 6.97 (s, 1H), 6.81 (d, J = 10.8 Hz, 2H), 5.34 (d, J = 3.5 Hz, 1H), 5.02 (dd, J = 8.0, 10.8 Hz, 1H), 4.46 (t, J = 10.0 Hz, 1H), 4.16 (q, J = 9.8 Hz, 1H), 4.03 - 3.93 (m, 1H), 3.78 (s, 3H), 3.78 - 3.66 (m, 2H), 3.59 (d, J = 12.0 Hz, 2H), 3.22 - 3.14 (m, 2H), 3.12 - 3.01 (m, 2H), 2.93 - 2.84 (m, 1H), 2.36 (s, 3H), 2.13 - 1.95 (m, 4H).



716


embedded image


587.2
Method D, RT = 1.485 min, 99%.

1H NMR (400 MHz, DMSO-d6) δ = 9.11 (d, J = 8.1 Hz, 1H), 8.05 (s, 1H), 7.89 (d, J = 8.8 Hz, 2H), 7.36 (t, J = 72.0 Hz, 1H), 7.29 (d, J = 8.6 Hz, 2H), 6.96 (s, 1H), 6.81 (d, J = 10.8 Hz, 2H), 5.01 (dd, J = 10.8, 8.3 Hz, 1H), 4.45 (t, J = 9.7 Hz, 1H), 4.16 (q, J = 9.8 Hz, 1H), 4.04 - 3.87 (m, 1H), 3.79 (s, 3H), 3.39 - 3.31 (m, 3H), 3.09 - 2.89 (m, 3H), 2.36 (s, 3H), 2.05 - 1.80 (m, 4H).



717


embedded image


511.12
Method C, RT = 1.484 min, 100%.

1H NMR (400 MHz, DMSO-d6) δ = 9.14 (d, J = 8.5 Hz, 1H), 8.34 (s, 1H), 7.94 (d, J = 1.3 Hz, 1H), 7.91 - 7.79 (m, 2H), 7.63 - 7.48 (m, 3H), 7.37 (d, J = 1.0 Hz, 1H), 6.80 (d, J = 10.8 Hz, 2H), 5.17 (dd, J = 11.0, 8.5 Hz, 1H), 4.56 - 4.45 (m, 1H), 4.40 (t, J = 9.9 Hz, 1H), 4.22 (q, J = 10.0 Hz, 1H), 3.78 (s, 3H), 2.31 (s, 3H).



718


embedded image


573.2
Method D, RT = 1.429 min, 96%.

1H NMR (400 MHz, DMSO-d6) 6 = 9.08 (d, J = 8.0 Hz, 1H), 8.15 (d, J = 8.3 Hz, 1H), 7.89 (d, J = 8.8 Hz, 2H), 7.78 (t, J = 8.0 Hz, 1H), 7.35 (t, J = 73.5 Hz, 1H), 7.28 (d, J = 8.8 Hz, 2H), 7.08 (d, J = 7.3 Hz, 1H), 6.79 (d, J = 10.5 Hz, 2H), 5.12 - 5.03 (m, 1H), 4.52 - 4.41 (m, 1H), 4.16 - 4.08 (m, 1H), 3.98 (d, J = 10.0 Hz, 1H), 3.78 (s, 3H), 3.09 - 3.06 (m, 1H), 2.92 -2.87 (m, 1H), 2.64 - 2.59 (m, 1H), 2.29 -2.24 (m, 1H), 1.97 - 1.92 (m, 1H), 1.70 -1.60 (m, 2H), 1.55 - 1.42 (m, 3H).



719


embedded image


573.2
Method D, RT = 1.439 min, 94%.

1H NMR (400 MHz, DMSO-d6) δ = 9.09 (d, J = 8.3 Hz, 1H), 8.14 (d, J = 8.3 Hz, 1H), 7.92 - 7.84 (m, 2H), 7.78 (t, J= 7.9 Hz, 1H), 7.35 (t, J = 73.3 Hz, 1H), 7.28 (d, J = 8.8 Hz, 2H), 7.07 (d, J = 7.5 Hz, 1H), 6.79 (d, J = 10.5 Hz, 2H), 5.07 (dd, J = 11.0, 8.3 Hz, 1H), 4.51 - 4.41 (m, 1H), 4.16 - 4.07 (m, 1H), 3.97 (t, J= 10.8 Hz, 1H), 3.78 (s, 3H), 3.10 - 3.07 (m, 1H), 2.92 - 2.87 (m, 1H), 2.65 - 2.58 (m, 1H), 1.97 - 1.90 (m, 1H), 1.76 (m, 1H), 1.69 - 1.58 (m, 2H), 1.55 - 1.34 (m, 3H).



720


embedded image


675.2
Method-D, RT = 1.799 min, 93.08%

1H NMR (400 MHz, DMSO-d6) δ = 9.08 (d, J = 8.5 Hz, 1H), 7.95 - 7.86 (m, 2H), 7.82 - 7.78 (m, 1H), 7.35 (t, J = 72 Hz, 1H), 7.32 - 7.24 (m, 2H), 6.83 - 6.75 (m, 2H), 6.71 - 6.67 (m, 1H), 5.07 (dd, J = 11.0, 8.5 Hz, 1H), 4.54 - 4.43 (m, 1H), 4.11 (q, J = 10.0 Hz, 1H), 3.99 - 3.92 (m, 1H), 3.83 (s, 3H), 3.78 (s, 3H), 3.07 -2.99 (m, 2H), 2.57 - 2.53 (m, 1H), 2.25 -2.13 (m, 4H), 1.80 - 1.72 (m, 4H), 1.07 (s, 6H).



721


embedded image


558.2
Method D, RT = 1.608 min, 97%.

1H NMR (400 MHz, DMSO-d6) δ = 9.08 (d, J = 8.5 Hz, 1H), 8.64 (s, 1H), 8.13 (s, 1H), 7.83 (d, J = 8.5 Hz, 2H), 7.57 (d, J = 8.5 Hz, 2H), 6.78 (d, J = 10.5 Hz, 2H), 5.25 - 5.16 (m, 1H), 5.12 (dd, J = 11.0, 8.5 Hz, 1H), 4.17 - 4.05 (m, 1H), 4.01 -3.92 (m, 2H), 3.77 (s, 3H), 3.06 (td, J = 8.6, 3.3 Hz, 1H), 2.94 (d, J = 11.5 Hz, 1H), 2.58 - 2.53 (m, 1H), 2.47 - 2.38 (m, 1H), 2.32 (s, 3H), 2.28 - 2.19 (m, 1H), 1.94 - 1.79 (m, 1H).







It will be evident to one skilled in the art that the present disclosure is not limited to the foregoing illustrative examples, and that it can be embodied in other specific forms without departing from the essential attributes thereof. It is therefore desired that the examples be considered in all respects as illustrative and not restrictive, reference being made to the appended claims, rather than to the foregoing examples, and all changes which come within the meaning and range of equivalency of the claims are therefore intended to be embraced therein.

Claims
  • 1. A compound of Formula (I): or a pharmaceutically acceptable salt thereof, wherein:* is an asymmetric carbon atom;Ar1 is aryl or pyridyl, each substituted with 1-3 R1;Ar2 is C3-6 cycloalkyl, aryl, or 5- to 12-membered heterocyclyl comprising 1-4 heteroatoms selected from O, S(O)p, N, and NR2a, and each substituted with 0-3 R2;Ar3 is phenyl or pyridyl, each substituted with 1 R5a, 1 R5b, and 1 R5c;R1 is halo, C1-4 haloalkyl, C1-4 alkoxy, or C1-4 haloalkoxy;R2 is oxo, cyano, halo, C1-6 alkyl substituted with 0-5 Re, -ORb, -NR3R4, -NR4C(O)Rb, -NR4(CRdRd)0-1C(O)NR3R4, (C1-4 alkyl)2(O)P-, C3-6 cycloalkyl, aryl, or 5 to 6-membered heterocyclyl comprising 1-4 heteroatoms selected from O, S(O)p, N, and NRa;R2a is hydrogen, C1-4 alkyl substituted with 0-5 Re, -(CRdRd)1-4-NR3R4, -(CRdRd)1-4-ORb, -(CRdRd)1-4-C(O)NR3R4, -(CRdRd)r-C3-6 cycloalkyl substituted with 0-5 Re, -(CRdRd)r-aryl substituted with 0-5 Re, or -(CRdRd)1-heterocyclyl comprising 1-4 heteroatoms selected from O, S(O)p, N, and NRa and substituted with 0-5 Re;R3 is hydrogen, C1-4 alkyl substituted with 0-5 Re, C3-6 cycloalkyl substituted with 0-5 Re, or heterocyclyl comprising 1-4 heteroatoms selected from O, S(O)p, N, and NR8 and substituted with 0-5 Re;R4 is hydrogen or C1-4 alkyl;alternatively, R3 and R4 together with the nitrogen to which they are both attached form a 4 to 9-membered heterocyclyl comprising 1-4 heteroatoms selected from O, S(O)p, N, and NR8 and substituted with 1-3 R6;R5a is hydrogen or halo;R5b is hydrogen or halo;R5c is halo, C1-4 alkyl, C1-4 haloalkyl, C1-4 alkoxy, or deuteroalkoxy;R6 is hydrogen, halo, oxo, hydroxy, or C1-4 alkyl substituted with 0-5 Re;R7 is hydrogen or C1-4 alkyl;R8 is hydrogen, C1-4 alkyl, or -S(O)pRc;Ra is hydrogen or C1-6 alkyl substituted with 0-5 Re, C3-6 cycloalkyl substituted with 0-5 Re, aryl substituted with 0-5 Re, or heterocyclyl comprising 1-4 heteroatoms selected from O, S(O)p, NRd and substituted with 0-5 Re;Rb is hydrogen, C1-6 alkyl substituted with 0-5 Re, C3-6 cycloalkyl substituted with 0-5 Re, aryl substituted with 0-5 Re, or heterocyclyl comprising 1-4 heteroatoms selected from O, S(O)p, NRd and substituted with 0-5 Re;Rc is C1-4 alkyl substituted with 0-5 Re;Rd is hydrogen or C1-4 alkyl substituted with 0-5 Re;Re is halo, cyano, oxo, -ORg, -NRgRg, -C(O)NRgRg, -S(O)pC1-4 alkyl, C1-6 alkyl substituted with 0-5 Rf, -(CH2)r-C3-6 cycloalkyl substituted with 0-5 Rf, -(CH2)r-aryl substituted with 0-5 Rf, or (CH2)r-heterocyclyl comprising 1-4 heteroatoms selected from O, S(O)p, N, and NRg and substituted with 0-5 Rf;Rf is halo, cyano, hydroxy, oxo, C1-5 alkyl, C3-6 cycloalkyl, or phenyl;Rg is hydrogen, C1-5 alkyl, C3-6 cycloalkyl, aryl, or heterocyclyl; or Rg and Rg together with the nitrogen atom to which they are both attached form a heterocyclyl;n is zero or 1;p is zero, 1, or 2; andr is zero, 1, 2, 3, or 4.
  • 2. The compound of claim 1, having Formula (II): or a pharmaceutically acceptable salt thereof, wherein:Ar2 is C3-6 cycloalkyl, phenyl, 5- to 6-membered heterocyclyl comprising 1-2 N or NR2a, each substituted with 0-2 R2;Ar3 is phenyl substituted with 1 R5a, 1 R5b, and 1 R5c;R1 is halo, C1-4 haloalkyl, or C1-4 haloalkoxy;R2 is oxo, cyano, halo, C1-5 alkyl substituted with 0-5 Re, -ORb, -NR3R4, -NR4C(O)Rb, (C1-3 alkyl)2(O)P-, C3-6 cycloalkyl, aryl, or 5- to 6-membered heterocyclyl comprising 1-4 heteroatoms selected from O, S, N, and NRa;R2a is hydrogen, C1-4 alkyl substituted with 0-4 Re, -(CHRd)1-3-C(O)NR3R4, -(CHRd)r-C3-6 cycloalkyl substituted with 0-4 Re, -(CHRd)r-aryl substituted with 0-4 Re, or -(CHRd)r-heterocyclyl comprising 1-4 heteroatoms selected from O, S, N, and NRa and substituted with 0-4 Re;R3 is hydrogen, C1-4 alkyl substituted with 0-4 Re, C3-6 cycloalkyl, or heterocyclyl comprising 1-4 heteroatoms selected from O, S, N, and NR8 and substituted with 0-4 Re;R4 is hydrogen or C1-3 alkyl;alternatively, R3 and R4 together with the nitrogen to which they are both attached form a 4-to 8-membered heterocyclyl comprising 1-4 heteroatoms selected from O, S, N, and NR8 and substituted with 1-3 R6;R5a is hydrogen or halo;R5b is hydrogen or halo;R5c is halo, C1-4 alkyl, C1-4 haloalkyl, or C1-4 alkoxy;R6 is hydrogen, halo, oxo, hydroxy, or C1-4 alkyl substituted with 0-4 Re;R7 is hydrogen or C1-3 alkyl;R8 is hydrogen, C1-3 alkyl, or -S(O)pRc;Ra is hydrogen or C1-6 alkyl substituted with 0-5 Re;Rb is hydrogen, C1-6 alkyl substituted with 0-5 Re, or heterocyclyl comprising 1-4 heteroatoms selected from O, S, N, NRd and substituted with 0-5 Re;Rc is C1-3 alkyl substituted with 0-5 Re;Rd is hydrogen or C1-4 alkyl substituted with 0-1 -OC1-4 alkyl;Re is halo, cyano, oxo, -ORg, -NRgRg, -C(O)NRgRg, -S(O)pC1-4 alkyl, C1-4 alkyl substituted with 0-5 Rf, -(CH2)r-C3-6 cycloalkyl substituted with 0-5 Rf, -(CH2)r-aryl substituted with 0-5 Rf, or (CH2)r-heterocyclyl comprising 1-4 heteroatoms selected from O, S, N, and NRg and substituted with 0-5 Rf;Rf is halo, cyano, hydroxy, C1-5 alkyl, or C3-6 cycloalkyl;Rg is hydrogen, C1-5 alkyl, or heterocyclyl;n is zero; andr is zero, 1, 2, or 3.
  • 3. The compound of claim 2, having Formula (III): or a pharmaceutically acceptable salt thereof, wherein:Ar2 is R1 is halo, C1-3 haloalkyl, or C1-3 haloalkoxy;R2 is cyano, halo, C1-4 alkyl substituted with 0-5 Re, -ORb, -NR3R4, -NR4C(O)Rb, (C1-4 alkyl)2(O)P-, C3-6 cycloalkyl, aryl, or 5- to 6-membered heterocyclyl comprising 1-4 heteroatoms selected from O, S, N, and NRa;R2a is hydrogen, C1-4 alkyl substituted with 0-3 Re, -(CHRd)1-2-C(O)NR3R4, -(CH2)r-C3-6 cycloalkyl substituted with 0-3 Re, -(CH2)r-aryl substituted with 0-3 Re, or -(CH2)r-heterocyclyl comprising 1-4 heteroatoms selected from O, S, N, and NRa and substituted with 0-3 Re;R3 is hydrogen, C1-4 alkyl substituted with 0-3 Re, C3-6 cycloalkyl, or heterocyclyl comprising 1-4 heteroatoms selected from O, S, N, and NR8 and substituted with 0-3 Re;R4 is hydrogen or C1-2 alkyl;alternatively, R3 and R4 together with the nitrogen to which they are both attached form a 4-to 8-membered heterocyclyl comprising 1-3 heteroatoms selected from O, S, N, and NR8 and substituted with 1-3 R6;R5a is hydrogen or halo;R5b is hydrogen or halo;R5c is halo or C1-2 alkoxy;R6 is hydrogen, halo, oxo, hydroxy, or C1-4 alkyl substituted with 0-3 Re;R7 is hydrogen or CH3;R8 is hydrogen, C1-2 alkyl, or -S(O)2C1-4 alkyl;Ra is hydrogen, C1-5 alkyl substituted with 0-4 Re;Rb is hydrogen, C1-5 alkyl substituted with 0-4 Re, heterocyclyl comprising 1-4 heteroatoms selected from O, S, N, NRd and substituted with 0-4 Re;Rd is hydrogen or C1-3 alkyl substituted with 0-1 -OC1-4 alkyl;Re is halo, cyano, oxo, -ORg, -NRgRg, C(O)NRgRg, -S(O)pC1-4 alkyl, C1-4 alkyl substituted with 0-4 Rf, -(CH2)r-C3-6 cycloalkyl substituted with 0-4 Rf, -(CH2)r-aryl substituted with 0-4 Rf, or (CH2)r-heterocyclyl comprising 1-4 heteroatoms selected from O, S, N, and NRg and substituted with 0-4 Rf;Rf is halo, cyano, hydroxy, or C1-5 alkyl;Rg is hydrogen or C1-4 alkyl; andr is zero, 1, or 2.
  • 4. The compound of claim 3, having Formula (IVa): or a pharmaceutically acceptable salt thereof, wherein:Ar2 is R1 is Cl, —CF3, —OCHF2, or —OCF3;R2 is cyano, halo, C1-4 alkyl substituted with 0-4 Re, -ORb, -NR3R4, -NR4C(O)Rb, (C1-2 alkyl)2(O)P-, C3-6 cycloalkyl, or heterocyclyl comprising 1-4 heteroatoms selected from O, S, N, and NRª;R2a is hydrogen, C1-4 alkyl substituted with 0-2 Re, -(CHRd)1-2-C(O)NR3R4, -(CH2)r-C3-6 cycloalkyl substituted with 0-2 Re, -(CH2)r-aryl substituted with 0-2 Re, or -(CH2)r-heterocyclyl comprising 1-4 heteroatoms selected from O, S, N, and NRa and substituted with 0-2 Re;R3 is hydrogen, C1-4 alkyl substituted with 0-3 Re, or heterocyclyl comprising 1-4 heteroatoms selected from O, S, N, and NR8 and substituted with 0-3 Re;R4 is hydrogen or C1-2 alkyl;alternatively, R3 and R4 together with the nitrogen to which they are both attached form a 4-to 8-membered heterocyclyl comprising 1-3 heteroatoms selected from O, S, N, and NR8 and substituted with 1-3 R6;R5a is hydrogen, F, or Cl;R5b is hydrogen, F, or Cl;R5c is Cl or —OCH3;R6 is hydrogen, halo, oxo, hydroxy, or C1-3 alkyl substituted with 0-3 Re;R8 is hydrogen, C1-2 alkyl, or S(O)2C1-3 alkyl;Ra is hydrogen, C1-4 alkyl substituted with 0-3 Re;Rb is hydrogen, C1-4 alkyl substituted with 0-3 Re, heterocyclyl comprising 1-4 heteroatoms selected from O, S, N, and NRd and substituted with 0-3 Re;Rd is hydrogen or C1-2 alkyl substituted with 0-1 -OC1-4 alkyl;Re is halo, cyano, oxo, -ORg, -NRgRg, -C(O)NRgRg, -S(O)2C1-4 alkyl, C1-6 alkyl substituted with 0-3 Rf, -(CH2)r-C3-6 cycloalkyl substituted with 0-3 Rf, or -(CH2)r-heterocyclyl comprising 1-4 heteroatoms selected from O, S, N, and NRg and substituted with 0-3 Rf;Rf is halo, cyano, hydroxy, or C1-4 alkyl;Rg is hydrogen or C1-3 alkyl; andr is zero or 1.
  • 5. The compound of claim 4, or a pharmaceutically acceptable salt thereof, wherein: Ar2 is R2 is F, Cl, CH2OH, CH3, CF3, or CHF2; andR2a is —CH3, —CH2CH3, —CH2CHF2, —CH2CF3, —CH2CH2OCH3, —CH2CH(OH)CF3, —CH2CH(OH)CH3, —CH2CH2OH, —CH2CH(CH3)OH, —CH2CH(CF3)OH, —CH2CH2CF3, —CH(CH2OH)CH2OCH3, —CH(CH2NH2)OCH3, —CH2CH(CH3)OCH3, or —CH2CH(CF3)OCH3.
  • 6. The compound of claim 4, having Formula (IVb): or a pharmaceutically acceptable salt thereof, wherein:R1 is Cl, —CF3, —OCHF2, or —OCF3;R2 is cyano, F, Cl, —CH3, —CF3, -CHF2, —CF3, or —NHC(O)CH3;R2a is —CH3, CHF2, —CH2CH3, —CH2CN, —CH2CHF2, —CH2CH2OCH3, —CH2CH(OH)CF3, —CH2CH(OH)CH3, —CH2CH2OH, —CF2CH2OH, —CH2CH(CH3)OH, —CH2CH2CF3, —CH(CH2OH)CH2OCH3, —CH(CH2NH2)OCH3, —CH2CH(CH3)OCH3, —CH2CH(CF3)OCH3, —CH(CH2NH2)CH2OCH3, —CH(C(O)N(CH3)2)CH2OCH3, —CH2C(CH3)(CH2OH)2, —CH2CH2N(CH3)2, CH2CH2S(O)2C1-4 alkyl, -CHRdC(O)NR3R4, -(CH2)0-1-C3-6 cycloalkyl, -(CH2)0-3-heterocyclyl selected from R3 and R4 together with the nitrogen to which they are both attached form a heterocyclyl selected from R5a is hydrogen or F;R5b is hydrogen or F;R5c is Cl or -OCH3;R6 is hydrogen, oxo, halo, —CH3, —CHF2, —CF3, or —CH2OH;R8 is hydrogen, C1-2 alkyl, or -S(O)2C1-3 alkyl; andRd is -CH2OCH3.
  • 7. The compound of claim 4, having Formula (IVc): or a pharmaceutically acceptable salt thereof, wherein:R1 is Cl, —CF3, —OCHF2, or —OCF3;R2 is cyano, F, Cl, —CH2OH, —CH3, —CHF2, —CF3, —OCH3, —OCH(CH3)2, —NR3R4, (CH3)2(O)P—, R3 is hydrogen or C1-4 alkyl substituted with 0-1 S(O)2C1-3 alkyl, R4 is hydrogen;alternatively, R3 and R4 together with the nitrogen to which they are both attached form a heterocyclyl selected from R5a is hydrogen or F;R5b is hydrogen or F;R5c is Cl or —OCH3R6 is hydrogen, halo, oxo, —CH3, —CH2CH3, or —CH2OH; andR8 is hydrogen, C1-4 alkyl, or -S(O)2C1-3 alkyl.
  • 8. The compound of claim 4, having Formula (IVd): or a pharmaceutically acceptable salt thereof, wherein:R1 is Cl, —CF3, —OCHF2, or —OCF3;R2 is —ORb or (C1-2 alkyl)2(O)P-;R5a is hydrogen or F;R5b is hydrogen or F;R5c is Cl or —OCH3;Rb is hydrogen, C1-4 alkyl substituted with 0-3 Re, or Re is F, Cl, or —ORg; andRg is hydrogen or C1-3 alkyl.
  • 9. The compound of claim 4, having Formula (IVe): or a pharmaceutically acceptable salt thereof, wherein:R1 is Cl, —CF3, —OCHF2, or —OCF3;R2 is cyano, F, Cl, —CH2OH, —CH3, —CHF2, —CF3, —OCH3, —OCH(CH3)2, or —NR3R4;R3 is hydrogen or C1-4 alkyl;R4 is hydrogen or C1-2 alkyl;alternatively, R3 and R4 together with the nitrogen to which they are both attached form a heterocyclyl selected from R5a is hydrogen or F;R5b is hydrogen or F; andR5c is Cl or -OCH3.
  • 10. The compound of claim 1, having Formula (IVf): or a pharmaceutically acceptable salt thereof, wherein:R1 is Cl, —CF3, —OCH3, —OCHF2, or —OCF3;R2 is cyano, F, Cl, —CH2OH, —CH3, —CHF2, or —CF3;R2a is —CH3, —CH2CH3, -CH2CHF2, —CH2CH2OCH3, —CH2CH(OH)CF3, —CH2CH(OH)CH3, —CH2CH2OH, —CH2CH(CH3)OH, or —CH2CH2CF3;R5a is hydrogen, F, or Cl;R5b is hydrogen, F, or Cl; andR5c is Cl or -OCH3.
  • 11. The compound of claim 4, having Formula (V): or a pharmaceutically acceptable salt thereof, wherein:Ar2 is C3-5 cycloalkyl;R1 is Cl, —CF3, —OCHF2, or —OCF3;R5a is F or Cl;R5b is F or Cl; andR5c is -OCH3.
  • 12. The compound of claim 3, having Formula (VI): or a pharmaceutically acceptable salt thereof, wherein:R1 is —CF3, —OCHF2, or —OCF3;R2 is cyano, F, Cl, —CH2OH, —CHF2, —CF3, —OCH3, —OCH(CH3)2, or (CH3)2(O)P—;R5a is F or Cl;R5b is F or Cl; andR5c is —OCH3.
  • 13. The compound of claim 3, having Formula (VII): or a pharmaceutically acceptable salt thereof, wherein:R1 is —CF3, —OCHF2, or —OCF3;R2 is F, Cl, or (CH3)2(O)P—;R5a is F;R5b is F; andR5c is —OCH3.
  • 14. A pharmaceutical composition comprising one or more compounds according to claim 1 and a pharmaceutically acceptable carrier or diluent.
  • 15. A method for the treatment or prophylaxis of inflammatory diseases, heart diseases, chronic airway diseases, cancers, septicemia, allergic symptoms, HIV retrovirus infection, circulatory disorders, neuroinflammation, nervous disorders, pains, prion diseases, amyloidosis, and immune disorders, comprising administrating a therapeutically effective amount of the pharmaceutical composition of claim 14 to a patient in need thereof.
  • 16. The method of claim 15, wherein the heart disease is selected from the group consisting of angina pectoris, unstable angina, myocardial infarction, heart failure, acute coronary disease, acute heart failure, chronic heart failure, and cardiac iatrogenic damage.
  • 17. The method of claim 16, wherein the heart failure results from hypertension, an ischemic heart disease, a non-ischemic heart disease, exposure to a cardiotoxic compound, myocarditis, Kawasaki’s disease, Type I and Type II diabetes, thyroid disease, viral infection, gingivitis, drug abuse, alcohol abuse, pericarditis, atherosclerosis, vascular disease, hypertrophic cardiomyopathy, dilated cardiomyopathy, myocardial infarction, atrial fibrosis, left ventricular systolic dysfunction, left ventricular diastolic dysfunction, coronary bypass surgery, pacemaker implantation surgery, starvation, an eating disorder, muscular dystrophies, and a genetic defect.
CROSS REFERENCE TO RELATED APPLICATIONS

This application is entitled to priority pursuant to 35 U.S.C. §119(e) to U.S. provisional patent application No. 63/049,838, filed Jul. 9, 2020, which is incorporated herein in its entirety.

PCT Information
Filing Document Filing Date Country Kind
PCT/US2021/040798 7/8/2021 WO
Provisional Applications (1)
Number Date Country
63049838 Jul 2020 US